"Sample","QueryID","SubjectID","Identity","Evalue","Bitscore","AlignmentLength","Coverage","Species","Cancer_Association","Mechanism","Evidence_Level","Relevance_Level","Confidence"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1736","NZ_JAUEHL010000030",100,2.33e-73,278,150,150,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLWD01000035",100,2.33e-73,278,150,150,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLXP01000026",100,2.33e-73,278,150,150,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLTT01000022",100,2.33e-73,278,150,150,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRF01000022",100,2.33e-73,278,150,150,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_FKXL01000017",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_FKWV01000005",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_FKXF01000023",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15446","NZ_FKXL01000017",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15446","NZ_FKWV01000005",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15446","NZ_FKXF01000023",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26974","NZ_FKXL01000017",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26974","NZ_FKWV01000005",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26974","NZ_FKXF01000023",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2200","NZ_JAUEHL010000030",100,2.33e-73,278,150,150,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4745","NZ_JAUEHL010000030",100,2.33e-73,278,150,150,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16628","NZ_FKXL01000017",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16628","NZ_FKWV01000005",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16628","NZ_FKXF01000023",100,2.33e-73,278,150,150,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_85152","NZ_JAUEHL010000030",100,8.32e-73,276,149,149,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_FKXL01000017",100,8.32e-73,276,149,149,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_FKWV01000005",100,8.32e-73,276,149,149,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_FKXF01000023",100,8.32e-73,276,149,149,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_FKXL01000017",100,8.32e-73,276,149,149,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_FKWV01000005",100,8.32e-73,276,149,149,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_FKXF01000023",100,8.32e-73,276,149,149,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLWD01000035",100,8.32e-73,276,149,149,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLXP01000026",100,8.32e-73,276,149,149,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLUB01000021",100,8.32e-73,276,149,149,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLTT01000022",100,8.32e-73,276,149,149,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRM01000021",100,8.32e-73,276,149,149,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRF01000022",100,8.32e-73,276,149,149,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_MLWD01000035",100,8.32e-73,276,149,149,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLWD01000035",99.333,1.09e-71,272,150,148.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLXP01000026",99.333,1.09e-71,272,150,148.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLTT01000022",99.333,1.09e-71,272,150,148.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRF01000022",99.333,1.09e-71,272,150,148.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLUB01000021",99.333,1.09e-71,272,150,148.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRM01000021",99.333,1.09e-71,272,150,148.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9864","NZ_FKXL01000017",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9864","NZ_FKWV01000005",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9864","NZ_FKXF01000023",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15447","NZ_FKXL01000017",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15447","NZ_FKWV01000005",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15447","NZ_FKXF01000023",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_FNOE01000002",99.333,1.09e-71,272,150,148.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10727","NZ_FKXL01000017",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10727","NZ_FKWV01000005",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10727","NZ_FKXF01000023",99.333,1.09e-71,272,150,148.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_FKXL01000017",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_FKWV01000005",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_FKXF01000023",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_FKXL01000017",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_FKWV01000005",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_FKXF01000023",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLWD01000035",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLXP01000026",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLUB01000021",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLTT01000022",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRM01000021",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRF01000022",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLWD01000035",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLXP01000026",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLUB01000021",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLTT01000022",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRM01000021",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRF01000022",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLWD01000035",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLXP01000026",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLUB01000021",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLTT01000022",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRM01000021",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRF01000022",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLWD01000035",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLXP01000026",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLUB01000021",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLTT01000022",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRM01000021",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRF01000022",99.329,3.87e-71,270,149,148.00021,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27036","NZ_FKXL01000017",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27036","NZ_FKWV01000005",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27036","NZ_FKXF01000023",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_MLWD01000035",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_MLWD01000035",99.333,3.87e-71,270,150,148.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_MLWD01000035",99.329,3.87e-71,270,149,148.00021,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4059","NZ_FKXL01000017",100,3.84e-71,270,146,146,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4059","NZ_FKWV01000005",100,3.84e-71,270,146,146,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4059","NZ_FKXF01000023",100,3.84e-71,270,146,146,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4020","NZ_FKXL01000017",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4020","NZ_FKWV01000005",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4020","NZ_FKXF01000023",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4021","NZ_FKXL01000017",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4021","NZ_FKWV01000005",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4021","NZ_FKXF01000023",99.329,3.87e-71,270,149,148.00021,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLWD01000035",100,1.4e-70,268,145,145,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLXP01000026",100,1.4e-70,268,145,145,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLUB01000021",100,1.4e-70,268,145,145,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLTT01000022",100,1.4e-70,268,145,145,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRM01000021",100,1.4e-70,268,145,145,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRF01000022",100,1.4e-70,268,145,145,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14086","NZ_FKXL01000017",99.324,1.39e-70,268,148,146.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14086","NZ_FKWV01000005",99.324,1.39e-70,268,148,146.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14086","NZ_FKXF01000023",99.324,1.39e-70,268,148,146.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12676","NZ_FKXL01000017",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12676","NZ_FKWV01000005",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12676","NZ_FKXF01000023",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLUB01000021",98.667,5.05e-70,267,150,148.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRM01000021",98.667,5.05e-70,267,150,148.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26973","NZ_FKXL01000017",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26973","NZ_FKWV01000005",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26973","NZ_FKXF01000023",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36013","NZ_FKXL01000017",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36013","NZ_FKWV01000005",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36013","NZ_FKXF01000023",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_FNPJ01000004",98.667,5.05e-70,267,150,148.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_FNPJ01000004",98.667,5.05e-70,267,150,148.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_FNPJ01000004",98.667,5.05e-70,267,150,148.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10728","NZ_FKXL01000017",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10728","NZ_FKWV01000005",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10728","NZ_FKXF01000023",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27605","NZ_FKXL01000017",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27605","NZ_FKWV01000005",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27605","NZ_FKXF01000023",98.667,5.05e-70,267,150,148.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4060","NZ_FKXL01000017",99.32,4.97e-70,267,147,146.0004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4060","NZ_FKWV01000005",99.32,4.97e-70,267,147,146.0004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4060","NZ_FKXF01000023",99.32,4.97e-70,267,147,146.0004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12675","NZ_FKXL01000017",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12675","NZ_FKWV01000005",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12675","NZ_FKXF01000023",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_FNPJ01000004",98.658,1.8e-69,265,149,147.00042,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLWD01000035",98.658,1.8e-69,265,149,147.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLXP01000026",98.658,1.8e-69,265,149,147.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLUB01000021",98.658,1.8e-69,265,149,147.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLTT01000022",98.658,1.8e-69,265,149,147.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRM01000021",98.658,1.8e-69,265,149,147.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRF01000022",98.658,1.8e-69,265,149,147.00042,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36012","NZ_FKXL01000017",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36012","NZ_FKWV01000005",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36012","NZ_FKXF01000023",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27035","NZ_FKXL01000017",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27035","NZ_FKWV01000005",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27035","NZ_FKXF01000023",98.658,1.8e-69,265,149,147.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_FKXL01000017",98.649,6.48e-69,263,148,146.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_FKWV01000005",98.649,6.48e-69,263,148,146.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_FKXF01000023",98.649,6.48e-69,263,148,146.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLWD01000035",98.649,6.48e-69,263,148,146.00052,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLXP01000026",98.649,6.48e-69,263,148,146.00052,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLUB01000021",98.649,6.48e-69,263,148,146.00052,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLTT01000022",98.649,6.48e-69,263,148,146.00052,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRM01000021",98.649,6.48e-69,263,148,146.00052,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRF01000022",98.649,6.48e-69,263,148,146.00052,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97133","NZ_FKXL01000017",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97133","NZ_FKWV01000005",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97133","NZ_FKXF01000023",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLWD01000035",98,2.35e-68,261,150,147,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLXP01000026",98,2.35e-68,261,150,147,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLTT01000022",98,2.35e-68,261,150,147,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRF01000022",98,2.35e-68,261,150,147,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLWD01000035",98,2.35e-68,261,150,147,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLXP01000026",98,2.35e-68,261,150,147,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLUB01000021",98,2.35e-68,261,150,147,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLTT01000022",98,2.35e-68,261,150,147,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRM01000021",98,2.35e-68,261,150,147,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRF01000022",98,2.35e-68,261,150,147,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36014","NZ_FKXL01000017",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36014","NZ_FKWV01000005",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36014","NZ_FKXF01000023",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_FNPJ01000004",98,2.35e-68,261,150,147,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_FNOE01000002",98,2.35e-68,261,150,147,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8964","NZ_FKXL01000017",98.639,2.35e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8964","NZ_FKWV01000005",98.639,2.35e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8964","NZ_FKXF01000023",98.639,2.35e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_FKXL01000017",98.639,2.35e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_FKWV01000005",98.639,2.35e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_FKXF01000023",98.639,2.35e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27606","NZ_FKXL01000017",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27606","NZ_FKWV01000005",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27606","NZ_FKXF01000023",98,2.35e-68,261,150,147,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_FKXL01000017",98.639,2.31e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_FKWV01000005",98.639,2.31e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_FKXF01000023",98.639,2.31e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_FKXL01000017",98.639,2.33e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_FKWV01000005",98.639,2.33e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_FKXF01000023",98.639,2.33e-68,261,147,144.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLWD01000035",98,2.35e-68,261,150,147,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLXP01000026",98,2.35e-68,261,150,147,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLUB01000021",98,2.35e-68,261,150,147,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLTT01000022",98,2.35e-68,261,150,147,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRM01000021",98,2.35e-68,261,150,147,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRF01000022",98,2.35e-68,261,150,147,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_MLWD01000035",98.639,2.31e-68,261,147,144.99933,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_FNPJ01000004",97.987,8.38e-68,259,149,146.00063,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_FKXL01000017",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_FKWV01000005",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_FKXF01000023",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_FNPJ01000004",97.987,8.38e-68,259,149,146.00063,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLWD01000035",97.987,8.38e-68,259,149,146.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLXP01000026",97.987,8.38e-68,259,149,146.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLUB01000021",97.987,8.38e-68,259,149,146.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLTT01000022",97.987,8.38e-68,259,149,146.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRM01000021",97.987,8.38e-68,259,149,146.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRF01000022",97.987,8.38e-68,259,149,146.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_FNPJ01000004",97.987,8.38e-68,259,149,146.00063,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_FKXL01000017",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_FKWV01000005",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_FKXF01000023",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLWD01000035",97.987,8.38e-68,259,149,146.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLXP01000026",97.987,8.38e-68,259,149,146.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLUB01000021",97.987,8.38e-68,259,149,146.00063,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLTT01000022",97.987,8.38e-68,259,149,146.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRM01000021",97.987,8.38e-68,259,149,146.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRF01000022",97.987,8.38e-68,259,149,146.00063,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36011","NZ_FKXL01000017",98.63,8.25e-68,259,146,143.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36011","NZ_FKWV01000005",98.63,8.25e-68,259,146,143.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_36011","NZ_FKXF01000023",98.63,8.25e-68,259,146,143.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FKXL01000017",98.63,8.38e-68,259,146,143.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FKWV01000005",98.63,8.38e-68,259,146,143.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FKXF01000023",98.63,8.38e-68,259,146,143.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24111","NZ_FKXL01000017",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24111","NZ_FKWV01000005",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24111","NZ_FKXF01000023",97.987,8.38e-68,259,149,146.00063,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18737","NZ_FKXL01000017",97.973,3.04e-67,257,148,145.00004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18737","NZ_FKWV01000005",97.973,3.04e-67,257,148,145.00004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18737","NZ_FKXF01000023",97.973,3.04e-67,257,148,145.00004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_FKXL01000017",97.973,3.01e-67,257,148,145.00004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_FKWV01000005",97.973,3.01e-67,257,148,145.00004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_FKXF01000023",97.973,3.01e-67,257,148,145.00004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_FNPJ01000004",97.333,1.09e-66,255,150,145.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_FNOE01000002",97.333,1.09e-66,255,150,145.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97131","NZ_FKXL01000017",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97131","NZ_FKWV01000005",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97131","NZ_FKXF01000023",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97134","NZ_FKXL01000017",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97134","NZ_FKWV01000005",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97134","NZ_FKXF01000023",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLUB01000021",97.333,1.09e-66,255,150,145.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRM01000021",97.333,1.09e-66,255,150,145.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71562","NZ_FKXL01000017",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71562","NZ_FKWV01000005",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71562","NZ_FKXF01000023",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLWD01000035",97.333,1.09e-66,255,150,145.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLXP01000026",97.333,1.09e-66,255,150,145.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLUB01000021",97.333,1.09e-66,255,150,145.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLTT01000022",97.333,1.09e-66,255,150,145.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRM01000021",97.333,1.09e-66,255,150,145.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRF01000022",97.333,1.09e-66,255,150,145.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32955","NZ_FKXL01000017",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32955","NZ_FKWV01000005",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32955","NZ_FKXF01000023",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15448","NZ_FKXL01000017",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15448","NZ_FKWV01000005",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15448","NZ_FKXF01000023",97.333,1.09e-66,255,150,145.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLWD01000035",97.333,1.09e-66,255,150,145.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLXP01000026",97.333,1.09e-66,255,150,145.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLUB01000021",97.333,1.09e-66,255,150,145.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLTT01000022",97.333,1.09e-66,255,150,145.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRM01000021",97.333,1.09e-66,255,150,145.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRF01000022",97.333,1.09e-66,255,150,145.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_FNOE01000002",97.333,1.09e-66,255,150,145.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_FNPJ01000004",97.333,1.09e-66,255,150,145.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_FNOE01000002",97.333,1.09e-66,255,150,145.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8965","NZ_FKXL01000017",97.959,1.09e-66,255,147,143.99973,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8965","NZ_FKWV01000005",97.959,1.09e-66,255,147,143.99973,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8965","NZ_FKXF01000023",97.959,1.09e-66,255,147,143.99973,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8988","NZ_FKXL01000017",98.611,1.09e-66,255,144,141.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8988","NZ_FKWV01000005",98.611,1.09e-66,255,144,141.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8988","NZ_FKXF01000023",98.611,1.09e-66,255,144,141.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_FNPJ01000004",97.333,1.09e-66,255,150,145.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_29639","NZ_FNPJ01000004",97.333,1.09e-66,255,150,145.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_FKXL01000017",97.959,1.08e-66,255,147,143.99973,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_FKWV01000005",97.959,1.08e-66,255,147,143.99973,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_FKXF01000023",97.959,1.08e-66,255,147,143.99973,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_FNOE01000002",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4761","NZ_FNPJ01000004",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FKXL01000017",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FKWV01000005",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FKXF01000023",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_FNOE01000002",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38486","NZ_FKXL01000017",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38486","NZ_FKWV01000005",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38486","NZ_FKXF01000023",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLWD01000035",97.315,3.9e-66,254,149,144.99935,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLXP01000026",97.315,3.9e-66,254,149,144.99935,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLUB01000021",97.315,3.9e-66,254,149,144.99935,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLTT01000022",97.315,3.9e-66,254,149,144.99935,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRM01000021",97.315,3.9e-66,254,149,144.99935,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRF01000022",97.315,3.9e-66,254,149,144.99935,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_FNPJ01000004",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_FNPJ01000004",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_FNOE01000002",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_FKXL01000017",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_FKWV01000005",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_FKXF01000023",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_FNPJ01000004",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20073","NZ_FKXL01000017",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20073","NZ_FKWV01000005",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20073","NZ_FKXF01000023",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6514","NZ_FNPJ01000004",97.945,3.84e-66,254,146,142.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FKXL01000017",97.945,3.9e-66,254,146,142.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FKWV01000005",97.945,3.9e-66,254,146,142.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FKXF01000023",97.945,3.9e-66,254,146,142.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_FNPJ01000004",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_FNOE01000002",97.315,3.9e-66,254,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24110","NZ_FKXL01000017",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24110","NZ_FKWV01000005",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24110","NZ_FKXF01000023",97.315,3.9e-66,254,149,144.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_64584","NZ_FKXL01000017",97.297,1.4e-65,252,148,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_64584","NZ_FKWV01000005",97.297,1.4e-65,252,148,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_64584","NZ_FKXF01000023",97.297,1.4e-65,252,148,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17673","NZ_FKXL01000017",97.297,1.4e-65,252,148,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17673","NZ_FKWV01000005",97.297,1.4e-65,252,148,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17673","NZ_FKXF01000023",97.297,1.4e-65,252,148,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6799","NZ_FNPJ01000004",97.315,1.4e-65,252,149,144.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_FNOE01000002",97.297,1.4e-65,252,148,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_FNPJ01000004",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_FNOE01000002",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FNPJ01000004",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FNOE01000002",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_FNPJ01000004",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_FNOE01000002",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97132","NZ_FKXL01000017",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97132","NZ_FKWV01000005",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_97132","NZ_FKXF01000023",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71558","NZ_FKXL01000017",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71558","NZ_FKWV01000005",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71558","NZ_FKXF01000023",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71563","NZ_FKXL01000017",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71563","NZ_FKWV01000005",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71563","NZ_FKXF01000023",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41815","NZ_FNPJ01000004",97.917,4.88e-65,250,144,141.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32954","NZ_FKXL01000017",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32954","NZ_FKWV01000005",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32954","NZ_FKXF01000023",96.667,5.09e-65,250,150,145.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_FNOE01000002",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_FNPJ01000004",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_FNPJ01000004",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12828","NZ_FKXL01000017",97.279,5.09e-65,250,147,143.00013,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12828","NZ_FKWV01000005",97.279,5.09e-65,250,147,143.00013,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12828","NZ_FKXF01000023",97.279,5.09e-65,250,147,143.00013,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_FNPJ01000004",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_29638","NZ_FNPJ01000004",96.667,5.09e-65,250,150,145.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLWD01000035",96.667,5.09e-65,250,150,145.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLXP01000026",96.667,5.09e-65,250,150,145.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLUB01000021",96.667,5.09e-65,250,150,145.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLTT01000022",96.667,5.09e-65,250,150,145.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRM01000021",96.667,5.09e-65,250,150,145.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRF01000022",96.667,5.09e-65,250,150,145.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4761","NZ_FNOE01000002",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_36060","NZ_FNPJ01000004",97.902,1.81e-64,248,143,139.99986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FKXL01000017",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FKWV01000005",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FKXF01000023",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_FNOE01000002",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_FNOE01000002",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38483","NZ_FKXL01000017",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38483","NZ_FKWV01000005",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38483","NZ_FKXF01000023",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38485","NZ_FKXL01000017",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38485","NZ_FKWV01000005",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38485","NZ_FKXF01000023",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38487","NZ_FKXL01000017",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38487","NZ_FKWV01000005",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38487","NZ_FKXF01000023",96.644,1.81e-64,248,149,143.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_FNOE01000002",96.644,1.83e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_FNOE01000002",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_FNOE01000002",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_FNOE01000002",96.644,1.83e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_FNOE01000002",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_FNPJ01000004",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_FNPJ01000004",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_FNPJ01000004",96.644,1.81e-64,248,149,143.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_64585","NZ_FKXL01000017",96.622,6.53e-64,246,148,143.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_64585","NZ_FKWV01000005",96.622,6.53e-64,246,148,143.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_64585","NZ_FKXF01000023",96.622,6.53e-64,246,148,143.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_FKXL01000017",96.622,6.53e-64,246,148,143.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_FKWV01000005",96.622,6.53e-64,246,148,143.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_FKXF01000023",96.622,6.53e-64,246,148,143.00056,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_FNOE01000002",96.622,6.53e-64,246,148,143.00056,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLWD01000035",96.622,6.53e-64,246,148,143.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLXP01000026",96.622,6.53e-64,246,148,143.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLUB01000021",96.622,6.53e-64,246,148,143.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLTT01000022",96.622,6.53e-64,246,148,143.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRM01000021",96.622,6.53e-64,246,148,143.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRF01000022",96.622,6.53e-64,246,148,143.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104356","NZ_FNPJ01000004",96.599,2.37e-63,244,147,142.00053,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_FNPJ01000004",96,2.37e-63,244,150,144,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLWD01000035",96.599,2.35e-63,244,147,142.00053,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLXP01000026",96.599,2.35e-63,244,147,142.00053,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLUB01000021",96.599,2.35e-63,244,147,142.00053,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLTT01000022",96.599,2.35e-63,244,147,142.00053,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRM01000021",96.599,2.35e-63,244,147,142.00053,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRF01000022",96.599,2.35e-63,244,147,142.00053,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLWD01000035",96.599,2.35e-63,244,147,142.00053,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLXP01000026",96.599,2.35e-63,244,147,142.00053,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLUB01000021",96.599,2.35e-63,244,147,142.00053,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLTT01000022",96.599,2.35e-63,244,147,142.00053,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRM01000021",96.599,2.35e-63,244,147,142.00053,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRF01000022",96.599,2.35e-63,244,147,142.00053,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41815","NZ_FNOE01000002",97.222,2.27e-63,244,144,139.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_MLWD01000035",96,2.37e-63,244,150,144,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_FNOE01000002",96,2.37e-63,244,150,144,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_FNOE01000002",96,2.37e-63,244,150,144,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_FNOE01000002",96,2.37e-63,244,150,144,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_36059","NZ_FNPJ01000004",97.203,8.44e-63,243,143,139.00029,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_36060","NZ_FNOE01000002",97.203,8.44e-63,243,143,139.00029,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24862","NZ_FNOE01000002",96.575,8.44e-63,243,146,140.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1079","NZ_FKXL01000017",96.575,8.44e-63,243,146,140.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1079","NZ_FKWV01000005",96.575,8.44e-63,243,146,140.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1079","NZ_FKXF01000023",96.575,8.44e-63,243,146,140.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_FNPJ01000004",96.575,8.44e-63,243,146,140.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_FNOE01000002",95.973,8.44e-63,243,149,142.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_FNPJ01000004",96.575,8.51e-63,243,146,140.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_FNPJ01000004",95.973,8.44e-63,243,149,142.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_FNOE01000002",95.973,8.44e-63,243,149,142.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6514","NZ_FNOE01000002",96.575,8.3e-63,243,146,140.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_FNPJ01000004",95.973,8.51e-63,243,149,142.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_FNPJ01000004",95.973,8.44e-63,243,149,142.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_FNOE01000002",95.973,8.44e-63,243,149,142.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_FNOE01000002",95.973,8.44e-63,243,149,142.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_MLWD01000035",95.946,3.06e-62,241,148,142.00008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_FNOE01000002",95.946,3.04e-62,241,148,142.00008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_FNOE01000002",95.395,3.06e-62,241,152,145.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_FKXL01000017",98.529,2.74e-62,241,136,133.99944,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_FKWV01000005",98.529,2.74e-62,241,136,133.99944,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_FKXF01000023",98.529,2.74e-62,241,136,133.99944,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104355","NZ_FNPJ01000004",95.918,1.1e-61,239,147,140.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104356","NZ_FNOE01000002",95.918,1.1e-61,239,147,140.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_FNOE01000002",95.333,1.1e-61,239,150,142.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_MLWD01000035",95.333,1.1e-61,239,150,142.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_FNPJ01000004",95.333,1.1e-61,239,150,142.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_FNOE01000002",95.333,1.1e-61,239,150,142.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_29639","NZ_FNOE01000002",95.333,1.1e-61,239,150,142.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_FNOE01000002",95.364,1.09e-61,239,151,143.99964,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_FNOE01000002",95.333,1.1e-61,239,150,142.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_36059","NZ_FNOE01000002",96.503,3.93e-61,237,143,137.99929,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLWD01000035",96.503,3.96e-61,237,143,137.99929,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLXP01000026",96.503,3.96e-61,237,143,137.99929,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLUB01000021",96.503,3.96e-61,237,143,137.99929,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLTT01000022",96.503,3.96e-61,237,143,137.99929,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRM01000021",96.503,3.96e-61,237,143,137.99929,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRF01000022",96.503,3.96e-61,237,143,137.99929,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24863","NZ_FNPJ01000004",95.302,3.93e-61,237,149,141.99998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24863","NZ_FNOE01000002",95.89,3.93e-61,237,146,139.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLWD01000035",95.302,3.93e-61,237,149,141.99998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLXP01000026",95.302,3.93e-61,237,149,141.99998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLUB01000021",95.302,3.93e-61,237,149,141.99998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLTT01000022",95.302,3.93e-61,237,149,141.99998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRM01000021",95.302,3.93e-61,237,149,141.99998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRF01000022",95.302,3.93e-61,237,149,141.99998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_FNOE01000002",96.503,3.8e-61,237,143,137.99929,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24594","NZ_FNPJ01000004",95.302,3.93e-61,237,149,141.99998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3847","NZ_FNOE01000002",95.302,3.93e-61,237,149,141.99998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3482","NZ_FNOE01000002",98.507,3.96e-61,237,134,131.99938,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3483","NZ_FNOE01000002",98.507,3.96e-61,237,134,131.99938,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_FNOE01000002",95.302,3.93e-61,237,149,141.99998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_58777","NZ_FNOE01000002",97.794,1.41e-60,235,136,132.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLWD01000035",96.479,1.41e-60,235,142,137.00018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLXP01000026",96.479,1.41e-60,235,142,137.00018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLUB01000021",96.479,1.41e-60,235,142,137.00018,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLTT01000022",96.479,1.41e-60,235,142,137.00018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRM01000021",96.479,1.41e-60,235,142,137.00018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRF01000022",96.479,1.41e-60,235,142,137.00018,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6799","NZ_FNOE01000002",95.302,1.41e-60,235,149,141.99998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLWD01000035",95.27,1.41e-60,235,148,140.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLXP01000026",95.27,1.41e-60,235,148,140.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLUB01000021",95.27,1.41e-60,235,148,140.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLTT01000022",95.27,1.41e-60,235,148,140.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRM01000021",95.27,1.41e-60,235,148,140.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRF01000022",95.27,1.41e-60,235,148,140.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_FNPJ01000004",95.27,1.41e-60,235,148,140.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLWD01000035",95.27,1.42e-60,235,148,140.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLXP01000026",95.27,1.42e-60,235,148,140.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLUB01000021",95.27,1.42e-60,235,148,140.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLTT01000022",95.27,1.42e-60,235,148,140.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRM01000021",95.27,1.42e-60,235,148,140.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRF01000022",95.27,1.42e-60,235,148,140.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104355","NZ_FNOE01000002",95.238,5.12e-60,233,147,139.99986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_FNPJ01000004",95.238,5.12e-60,233,147,139.99986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_FNPJ01000004",95.833,5.08e-60,233,144,137.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_FNOE01000002",95.833,5.08e-60,233,144,137.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6591","NZ_FNOE01000002",96.479,5.04e-60,233,142,137.00018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6671","NZ_FNPJ01000004",95.833,5.04e-60,233,144,137.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLWD01000035",95.238,5.08e-60,233,147,139.99986,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLXP01000026",95.238,5.08e-60,233,147,139.99986,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLUB01000021",95.238,5.08e-60,233,147,139.99986,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLTT01000022",95.238,5.08e-60,233,147,139.99986,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRM01000021",95.238,5.08e-60,233,147,139.99986,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRF01000022",95.238,5.08e-60,233,147,139.99986,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_FNOE01000002",95.238,1.84e-59,231,147,139.99986,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24861","NZ_FNOE01000002",95.205,1.83e-59,231,146,138.9993,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24864","NZ_FNOE01000002",95.205,1.83e-59,231,146,138.9993,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24865","NZ_FNOE01000002",95.205,1.83e-59,231,146,138.9993,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_58778","NZ_FNOE01000002",97.761,1.83e-59,231,134,130.99974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_FNPJ01000004",95.804,1.77e-59,231,143,136.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24535","NZ_FNOE01000002",95.833,1.84e-59,231,144,137.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6591","NZ_FNPJ01000004",95.804,1.81e-59,231,143,136.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_FNPJ01000004",95.205,1.83e-59,231,146,138.9993,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_58776","NZ_FNOE01000002",97.059,6.57e-59,230,136,132.00024,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3482","NZ_FNPJ01000004",97.761,6.63e-59,230,134,130.99974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3483","NZ_FNPJ01000004",97.761,6.63e-59,230,134,130.99974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_FNOE01000002",95.205,6.57e-59,230,146,138.9993,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_29618","NZ_FKXL01000017",95.139,2.38e-58,228,144,137.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_29618","NZ_FKWV01000005",95.139,2.38e-58,228,144,137.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_29618","NZ_FKXF01000023",95.139,2.38e-58,228,144,137.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FNPJ01000004",95.745,2.38e-58,228,141,135.00045,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_65881","NZ_FKXL01000017",96.377,2.38e-58,228,138,133.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_65881","NZ_FKWV01000005",96.377,2.38e-58,228,138,133.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_65881","NZ_FKXF01000023",96.377,2.38e-58,228,138,133.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6672","NZ_FNPJ01000004",95.139,2.34e-58,228,144,137.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26717","NZ_FNPJ01000004",95.714,8.5e-58,226,140,133.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_58777","NZ_FNPJ01000004",96.992,3.06e-57,224,133,128.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_58778","NZ_FNPJ01000004",96.992,3.06e-57,224,133,128.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_FKXL01000017",95.07,2.93e-57,224,142,134.9994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_FKWV01000005",95.07,2.93e-57,224,142,134.9994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_FKXF01000023",95.07,2.93e-57,224,142,134.9994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24535","NZ_FNPJ01000004",95.07,1.11e-56,222,142,134.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26715","NZ_FNPJ01000004",95.035,1.11e-56,222,141,133.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26716","NZ_FNPJ01000004",95.035,1.11e-56,222,141,133.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26717","NZ_FNOE01000002",96.97,1.1e-56,222,132,128.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FNOE01000002",95.035,1.11e-56,222,141,133.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT09RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4205","NZ_FNPJ01000004",96.296,1.1e-56,222,135,129.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_103889","NZ_FNOE01000002",96.97,3.96e-56,220,132,128.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_103890","NZ_FNOE01000002",96.97,3.96e-56,220,132,128.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_103891","NZ_FNOE01000002",96.97,3.96e-56,220,132,128.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_103892","NZ_FNOE01000002",96.97,3.96e-56,220,132,128.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4081","NZ_FNOE01000002",95.652,3.99e-56,220,138,131.99976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10220","NZ_FNOE01000002",95.652,3.92e-56,220,138,131.99976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_103889","NZ_FNPJ01000004",96.241,1.42e-55,219,133,128.00053,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_58776","NZ_FNPJ01000004",96.241,1.42e-55,219,133,128.00053,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11078","NZ_FNOE01000002",95.522,1.84e-54,215,134,127.99948,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_FNPJ01000004",96.85,5.64e-54,213,127,122.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_FNOE01000002",96.154,5.64e-54,213,130,125.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11078","NZ_FNPJ01000004",95.489,6.62e-54,213,133,127.00037,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15122","NZ_FNPJ01000004",95.489,2.38e-53,211,133,127.00037,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6880","NZ_FNPJ01000004",97.561,8.49e-53,209,123,120.00003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18111","NZ_FNOE01000002",97.541,8.63e-53,209,122,119.00002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_61185","NZ_FNPJ01000004",97.541,3.08e-52,207,122,119.00002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_FNPJ01000004",96.063,2.63e-52,207,127,122.00001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_FNOE01000002",95.385,2.63e-52,207,130,124.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLWD01000035",96.032,1.12e-51,206,126,121.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLXP01000026",96.032,1.12e-51,206,126,121.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLUB01000021",96.032,1.12e-51,206,126,121.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLTT01000022",96.032,1.12e-51,206,126,121.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLRM01000021",96.032,1.12e-51,206,126,121.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLRF01000022",96.032,1.12e-51,206,126,121.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLWD01000035",96,3.98e-51,204,125,120,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLXP01000026",96,3.98e-51,204,125,120,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLUB01000021",96,3.98e-51,204,125,120,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLTT01000022",96,3.98e-51,204,125,120,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLRM01000021",96,3.98e-51,204,125,120,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLRF01000022",96,3.98e-51,204,125,120,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13660","NZ_FNOE01000002",99.115,2.87e-51,204,113,111.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15195","NZ_FNOE01000002",97.458,1.41e-50,202,118,115.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLWD01000035",95.902,1.58e-49,198,122,117.00044,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLXP01000026",95.902,1.58e-49,198,122,117.00044,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLUB01000021",95.902,1.58e-49,198,122,117.00044,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLTT01000022",95.902,1.58e-49,198,122,117.00044,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRM01000021",95.902,1.58e-49,198,122,117.00044,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRF01000022",95.902,1.58e-49,198,122,117.00044,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12755","NZ_FNOE01000002",98.23,1.34e-49,198,113,110.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24941","NZ_FKXL01000017",98.23,1.43e-49,198,113,110.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24941","NZ_FKWV01000005",98.23,1.43e-49,198,113,110.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24941","NZ_FKXF01000023",98.23,1.43e-49,198,113,110.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13659","NZ_FNOE01000002",98.23,1.34e-49,198,113,110.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13660","NZ_FNPJ01000004",98.23,1.34e-49,198,113,110.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_33258","NZ_FNOE01000002",95.868,6.45e-49,196,121,116.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_33259","NZ_FNOE01000002",95.868,6.45e-49,196,121,116.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15194","NZ_FNOE01000002",96.61,6.56e-49,196,118,113.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12755","NZ_FNPJ01000004",97.345,6.22e-48,193,113,109.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13659","NZ_FNPJ01000004",97.345,6.22e-48,193,113,109.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLWD01000035",95.652,1.44e-45,185,115,109.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLXP01000026",95.652,1.44e-45,185,115,109.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLUB01000021",95.652,1.44e-45,185,115,109.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLTT01000022",95.652,1.44e-45,185,115,109.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRM01000021",95.652,1.44e-45,185,115,109.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRF01000022",95.652,1.44e-45,185,115,109.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLWD01000035",95.652,1.44e-45,185,115,109.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLXP01000026",95.652,1.44e-45,185,115,109.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLUB01000021",95.652,1.44e-45,185,115,109.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLTT01000022",95.652,1.44e-45,185,115,109.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRM01000021",95.652,1.44e-45,185,115,109.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRF01000022",95.652,1.44e-45,185,115,109.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FNOE01000002",95.652,5.23e-45,183,115,109.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_FNOE01000002",95.652,5.23e-45,183,115,109.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10312","NZ_FNOE01000002",96.364,1.87e-44,182,110,106.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10313","NZ_FNOE01000002",96.364,1.88e-44,182,110,106.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_MLWD01000035",98.058,6.77e-44,180,103,100.99974,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3739","NZ_FNOE01000002",95.575,6.71e-44,180,113,107.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26107","NZ_FNOE01000002",96.296,2.04e-43,178,108,103.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10311","NZ_FNOE01000002",95.455,8.76e-43,176,110,105.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10312","NZ_FNPJ01000004",95.455,8.68e-43,176,110,105.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10313","NZ_FNPJ01000004",95.455,8.76e-43,176,110,105.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLWD01000035",95.413,3.12e-42,174,109,104.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLXP01000026",95.413,3.12e-42,174,109,104.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLUB01000021",95.413,3.12e-42,174,109,104.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLTT01000022",95.413,3.12e-42,174,109,104.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRM01000021",95.413,3.12e-42,174,109,104.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRF01000022",95.413,3.12e-42,174,109,104.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3739","NZ_FNPJ01000004",95.413,3.12e-42,174,109,104.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26107","NZ_FNPJ01000004",95.37,9.48e-42,172,108,102.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26109","NZ_FNOE01000002",95.37,9.48e-42,172,108,102.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_FNPJ01000004",97.959,3.44e-41,171,98,95.99982,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4082","NZ_FNOE01000002",96.04,1.57e-39,165,101,97.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20651","NZ_FNOE01000002",96.04,1.57e-39,165,101,97.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5965","NZ_FNOE01000002",96.04,1.57e-39,165,101,97.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24088","NZ_FNOE01000002",96.04,1.57e-39,165,101,97.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_FNPJ01000004",97.872,5.76e-39,163,94,91.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_FNOE01000002",97.872,5.76e-39,163,94,91.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLWD01000035",96.842,7.46e-38,159,95,91.9999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLXP01000026",96.842,7.46e-38,159,95,91.9999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_FKXL01000017",95.918,7.46e-38,159,98,93.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_FKWV01000005",95.918,7.46e-38,159,98,93.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_FKXF01000023",95.918,7.46e-38,159,98,93.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLUB01000021",96.842,7.46e-38,159,95,91.9999,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLTT01000022",96.842,7.46e-38,159,95,91.9999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRM01000021",96.842,7.46e-38,159,95,91.9999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRF01000022",96.842,7.46e-38,159,95,91.9999,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4082","NZ_FNPJ01000004",95.05,7.31e-38,159,101,96.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20651","NZ_FNPJ01000004",95.05,7.31e-38,159,101,96.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5965","NZ_FNPJ01000004",95.05,7.31e-38,159,101,96.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24088","NZ_FNPJ01000004",95.05,7.31e-38,159,101,96.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_FNPJ01000004",98.864,3.17e-37,158,88,87.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7605","NZ_FNOE01000002",98.864,1.6e-37,158,88,87.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104391","NZ_FKXL01000017",96.774,1.13e-36,156,93,89.99982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104391","NZ_FKWV01000005",96.774,1.13e-36,156,93,89.99982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104391","NZ_FKXF01000023",96.774,1.13e-36,156,93,89.99982,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_FNPJ01000004",95.789,4.07e-36,154,95,90.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_FNPJ01000004",98.837,4.07e-36,154,86,84.99982,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLWD01000035",98.824,7.08e-36,152,85,84.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLXP01000026",98.824,7.08e-36,152,85,84.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLUB01000021",98.824,7.08e-36,152,85,84.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLTT01000022",98.824,7.08e-36,152,85,84.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRM01000021",98.824,7.08e-36,152,85,84.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRF01000022",98.824,7.08e-36,152,85,84.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_FNPJ01000004",98.824,7.08e-36,152,85,84.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_FNOE01000002",98.824,7.08e-36,152,85,84.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7605","NZ_FNPJ01000004",97.727,7.44e-36,152,88,85.99976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104392","NZ_FKXL01000017",95.699,5.26e-35,150,93,89.00007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104392","NZ_FKWV01000005",95.699,5.26e-35,150,93,89.00007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104392","NZ_FKXF01000023",95.699,5.26e-35,150,93,89.00007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104393","NZ_FKXL01000017",95.699,5.26e-35,150,93,89.00007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104393","NZ_FKWV01000005",95.699,5.26e-35,150,93,89.00007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_104393","NZ_FKXF01000023",95.699,5.26e-35,150,93,89.00007,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_MLWD01000035",97.674,1.44e-34,148,86,83.99964,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLWD01000035",97.647,3.29e-34,147,85,82.99995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLXP01000026",97.647,3.29e-34,147,85,82.99995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLUB01000021",97.647,3.29e-34,147,85,82.99995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLTT01000022",97.647,3.29e-34,147,85,82.99995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRM01000021",97.647,3.29e-34,147,85,82.99995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRF01000022",97.647,3.29e-34,147,85,82.99995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_FNPJ01000004",97.647,3.29e-34,147,85,82.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_FNOE01000002",97.647,3.29e-34,147,85,82.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_MLWD01000035",96.512,6.71e-33,143,86,83.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_FNOE01000002",95.455,3.19e-32,141,88,84.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_FNOE01000002",95.349,4.1e-31,137,86,82.00014,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLWD01000035",97.5,1.88e-31,137,80,78,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLXP01000026",97.5,1.88e-31,137,80,78,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLUB01000021",97.5,1.88e-31,137,80,78,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLTT01000022",97.5,1.88e-31,137,80,78,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRM01000021",97.5,1.88e-31,137,80,78,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRF01000022",97.5,1.88e-31,137,80,78,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_FKXL01000017",95.294,7.13e-31,135,85,80.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_FKWV01000005",95.294,7.13e-31,135,85,80.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_FKXF01000023",95.294,7.13e-31,135,85,80.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_FKXL01000017",95.294,7.13e-31,135,85,80.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_FKWV01000005",95.294,7.13e-31,135,85,80.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_FKXF01000023",95.294,7.13e-31,135,85,80.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21115","NZ_FKXL01000017",98.684,6.16e-31,135,76,74.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21115","NZ_FKWV01000005",98.684,6.16e-31,135,76,74.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21115","NZ_FKXF01000023",98.684,6.16e-31,135,76,74.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_FNOE01000002",96.25,9.06e-30,132,80,77,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_34731","NZ_FNPJ01000004",97.368,6.86e-29,130,76,73.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_FNOE01000002",97.333,1.54e-28,128,75,72.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_FNOE01000002",97.333,1.54e-28,128,75,72.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_FNOE01000002",97.333,1.54e-28,128,75,72.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLWD01000035",96.154,1.05e-28,128,78,75.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLXP01000026",96.154,1.05e-28,128,78,75.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLUB01000021",96.154,1.05e-28,128,78,75.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLTT01000022",96.154,1.05e-28,128,78,75.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRM01000021",96.154,1.05e-28,128,78,75.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRF01000022",96.154,1.05e-28,128,78,75.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9923","NZ_FNOE01000002",96.154,1.05e-28,128,78,75.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_FNOE01000002",96.053,1.36e-27,124,76,73.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLWD01000035",96.875,1.24e-22,108,64,62,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLXP01000026",96.875,1.24e-22,108,64,62,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLUB01000021",96.875,1.24e-22,108,64,62,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLTT01000022",96.875,1.24e-22,108,64,62,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRM01000021",96.875,1.24e-22,108,64,62,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRF01000022",96.875,1.24e-22,108,64,62,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20346","NZ_FNOE01000002",95.455,3.98e-22,106,66,63.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12649","NZ_FNOE01000002",95.455,3.98e-22,106,66,63.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15478","NZ_FNPJ01000004",97.619,4.9e-12,73.1,42,40.99998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLXP01000026",100,4.22e-11,71.3,38,38,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLUB01000021",100,4.22e-11,71.3,38,38,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLTT01000022",100,4.22e-11,71.3,38,38,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLRM01000021",100,4.22e-11,71.3,38,38,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLRF01000022",100,4.22e-11,71.3,38,38,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLXP01000026",100,4.22e-11,71.3,38,38,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLUB01000021",100,4.22e-11,71.3,38,38,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLTT01000022",100,4.22e-11,71.3,38,38,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLRM01000021",100,4.22e-11,71.3,38,38,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLRF01000022",100,4.22e-11,71.3,38,38,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLXP01000026",95.349,1.53e-10,69.4,43,41.00007,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLUB01000021",95.349,1.53e-10,69.4,43,41.00007,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLTT01000022",95.349,1.53e-10,69.4,43,41.00007,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLRM01000021",95.349,1.53e-10,69.4,43,41.00007,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLRF01000022",95.349,1.53e-10,69.4,43,41.00007,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLXP01000026",95.238,5.5e-10,67.6,42,39.99996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLUB01000021",95.238,5.5e-10,67.6,42,39.99996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLTT01000022",95.238,5.5e-10,67.6,42,39.99996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLRM01000021",95.238,5.5e-10,67.6,42,39.99996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLRF01000022",95.238,5.5e-10,67.6,42,39.99996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLXP01000026",95.122,1.96e-09,65.8,41,39.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLUB01000021",95.122,1.96e-09,65.8,41,39.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLTT01000022",95.122,1.96e-09,65.8,41,39.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLRM01000021",95.122,1.96e-09,65.8,41,39.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLRF01000022",95.122,1.96e-09,65.8,41,39.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_FNOE01000002",94.771,1.42e-60,235,153,144.99963,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLWD01000035",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLXP01000026",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLUB01000021",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLTT01000022",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRM01000021",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRF01000022",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLWD01000035",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLXP01000026",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLUB01000021",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLTT01000022",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRM01000021",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRF01000022",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_FNPJ01000004",94.667,5.12e-60,233,150,142.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_FNPJ01000004",94.667,5.12e-60,233,150,142.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_37178","NZ_FNOE01000002",94.702,5.12e-60,233,151,143.00002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLWD01000035",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLXP01000026",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLUB01000021",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLTT01000022",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRM01000021",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRF01000022",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLWD01000035",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLXP01000026",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLUB01000021",94.667,5.12e-60,233,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLTT01000022",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRM01000021",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRF01000022",94.667,5.12e-60,233,150,142.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7702","NZ_FNPJ01000004",94.667,5.12e-60,233,150,142.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_29638","NZ_FNOE01000002",94.667,5.12e-60,233,150,142.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_FNPJ01000004",94.667,5.12e-60,233,150,142.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24861","NZ_FNPJ01000004",94.631,1.83e-59,231,149,141.00019,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24862","NZ_FNPJ01000004",94.631,1.83e-59,231,149,141.00019,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24864","NZ_FNPJ01000004",94.631,1.83e-59,231,149,141.00019,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24865","NZ_FNPJ01000004",94.631,1.83e-59,231,149,141.00019,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLWD01000035",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLXP01000026",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLUB01000021",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLTT01000022",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRM01000021",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRF01000022",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3848","NZ_FNOE01000002",94.631,1.83e-59,231,149,141.00019,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLWD01000035",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLXP01000026",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLUB01000021",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLTT01000022",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRM01000021",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRF01000022",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLWD01000035",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLXP01000026",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLUB01000021",94.631,1.83e-59,231,149,141.00019,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLTT01000022",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRM01000021",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRF01000022",94.631,1.83e-59,231,149,141.00019,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_FNPJ01000004",94.595,6.63e-59,230,148,140.0006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_MLWD01000035",94.667,6.57e-59,230,150,142.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_41991","NZ_FNPJ01000004",94.667,6.57e-59,230,150,142.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31602","NZ_FKXL01000017",94.595,6.63e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31602","NZ_FKWV01000005",94.595,6.63e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31602","NZ_FKXF01000023",94.595,6.63e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47151","NZ_FKXL01000017",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47151","NZ_FKWV01000005",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47151","NZ_FKXF01000023",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLWD01000035",94.595,6.63e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLXP01000026",94.595,6.63e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLUB01000021",94.595,6.63e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLTT01000022",94.595,6.63e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRM01000021",94.595,6.63e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRF01000022",94.595,6.63e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLWD01000035",94.595,6.63e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLXP01000026",94.595,6.63e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLUB01000021",94.595,6.63e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLTT01000022",94.595,6.63e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRM01000021",94.595,6.63e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRF01000022",94.595,6.63e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25037","NZ_FKXL01000017",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25037","NZ_FKWV01000005",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25037","NZ_FKXF01000023",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25038","NZ_FKXL01000017",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25038","NZ_FKWV01000005",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25038","NZ_FKXF01000023",94.595,6.57e-59,230,148,140.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLWD01000035",94.595,6.57e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLXP01000026",94.595,6.57e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLUB01000021",94.595,6.57e-59,230,148,140.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLTT01000022",94.595,6.57e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRM01000021",94.595,6.57e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRF01000022",94.595,6.57e-59,230,148,140.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_FNPJ01000004",94.595,6.57e-59,230,148,140.0006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43125","NZ_FNPJ01000004",94,2.38e-58,228,150,141,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_FNOE01000002",94,2.38e-58,228,150,141,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20006","NZ_FKXL01000017",94,2.38e-58,228,150,141,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20006","NZ_FKWV01000005",94,2.38e-58,228,150,141,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20006","NZ_FKXF01000023",94,2.38e-58,228,150,141,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_37178","NZ_FNPJ01000004",94.04,2.38e-58,228,151,142.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_MLWD01000035",94,2.38e-58,228,150,141,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6671","NZ_FNOE01000002",94.558,2.34e-58,228,147,139.00026,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7702","NZ_FNOE01000002",94,2.38e-58,228,150,141,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLWD01000035",94,2.38e-58,228,150,141,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLXP01000026",94,2.38e-58,228,150,141,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLUB01000021",94,2.38e-58,228,150,141,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLTT01000022",94,2.38e-58,228,150,141,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRM01000021",94,2.38e-58,228,150,141,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRF01000022",94,2.38e-58,228,150,141,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_FKXL01000017",94.079,2.38e-58,228,152,143.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_FKWV01000005",94.079,2.38e-58,228,152,143.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_FKXF01000023",94.079,2.38e-58,228,152,143.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_MLWD01000035",94,2.38e-58,228,150,141,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_FNOE01000002",93.96,8.57e-58,226,149,140.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLWD01000035",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLXP01000026",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLUB01000021",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLTT01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRM01000021",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRF01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_61185","NZ_FNOE01000002",94,8.5e-58,226,150,141,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15460","NZ_FKXL01000017",94,8.57e-58,226,150,141,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15460","NZ_FKWV01000005",94,8.57e-58,226,150,141,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15460","NZ_FKXF01000023",94,8.57e-58,226,150,141,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLWD01000035",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLXP01000026",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLUB01000021",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLTT01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRM01000021",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRF01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_FNOE01000002",94.558,8.5e-58,226,147,139.00026,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_FNPJ01000004",93.506,8.57e-58,226,154,143.99924,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_FKXL01000017",94.04,8.5e-58,226,151,142.0004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_FKWV01000005",94.04,8.5e-58,226,151,142.0004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_FKXF01000023",94.04,8.5e-58,226,151,142.0004,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLWD01000035",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLXP01000026",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLUB01000021",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLTT01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRM01000021",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRF01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLWD01000035",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLXP01000026",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLUB01000021",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLTT01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRM01000021",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRF01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLWD01000035",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLXP01000026",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLUB01000021",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLTT01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRM01000021",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRF01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLWD01000035",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLXP01000026",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLUB01000021",93.96,8.5e-58,226,149,140.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLTT01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRM01000021",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRF01000022",93.96,8.5e-58,226,149,140.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_FNPJ01000004",93.919,3.08e-57,224,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_FNPJ01000004",93.919,3.08e-57,224,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_FNPJ01000004",93.919,3.08e-57,224,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_FNPJ01000004",93.919,3.08e-57,224,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_FNOE01000002",93.919,3.06e-57,224,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_FNOE01000002",93.919,3.06e-57,224,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_MLWD01000035",94.558,3.06e-57,224,147,139.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_41991","NZ_FNOE01000002",94,3.06e-57,224,150,141,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31603","NZ_FKXL01000017",93.919,3.08e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31603","NZ_FKWV01000005",93.919,3.08e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31603","NZ_FKXF01000023",93.919,3.08e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31604","NZ_FKXL01000017",93.919,3.08e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31604","NZ_FKWV01000005",93.919,3.08e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31604","NZ_FKXF01000023",93.919,3.08e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLWD01000035",94.483,3.06e-57,224,145,137.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLXP01000026",94.483,3.06e-57,224,145,137.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLUB01000021",94.483,3.06e-57,224,145,137.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLTT01000022",94.483,3.06e-57,224,145,137.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRM01000021",94.483,3.06e-57,224,145,137.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRF01000022",94.483,3.06e-57,224,145,137.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17309","NZ_FKXL01000017",93.919,3.06e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17309","NZ_FKWV01000005",93.919,3.06e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17309","NZ_FKXF01000023",93.919,3.06e-57,224,148,139.00012,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_FNPJ01000004",93.919,3.06e-57,224,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_FNPJ01000004",93.464,3.06e-57,224,153,142.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39074","NZ_FKXL01000017",93.333,1.11e-56,222,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39074","NZ_FKWV01000005",93.333,1.11e-56,222,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39074","NZ_FKXF01000023",93.333,1.11e-56,222,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_FNOE01000002",93.333,1.11e-56,222,150,139.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_103891","NZ_FNPJ01000004",93.878,1.1e-56,222,147,138.00066,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_103892","NZ_FNPJ01000004",93.878,1.1e-56,222,147,138.00066,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_FNOE01000002",93.878,1.1e-56,222,147,138.00066,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_FNOE01000002",93.333,1.11e-56,222,150,139.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_FNOE01000002",93.333,1.11e-56,222,150,139.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20007","NZ_FKXL01000017",93.333,1.11e-56,222,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20007","NZ_FKWV01000005",93.333,1.11e-56,222,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20007","NZ_FKXF01000023",93.333,1.11e-56,222,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6672","NZ_FNOE01000002",93.878,1.09e-56,222,147,138.00066,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6880","NZ_FNOE01000002",93.919,1.09e-56,222,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39073","NZ_FKXL01000017",93.289,3.96e-56,220,149,139.00061,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39073","NZ_FKWV01000005",93.289,3.96e-56,220,149,139.00061,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39073","NZ_FKXF01000023",93.289,3.96e-56,220,149,139.00061,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_103890","NZ_FNPJ01000004",93.878,3.96e-56,220,147,138.00066,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_FNPJ01000004",93.289,3.99e-56,220,149,139.00061,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30489","NZ_FKXL01000017",94.444,3.96e-56,220,144,135.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30489","NZ_FKWV01000005",94.444,3.96e-56,220,144,135.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30489","NZ_FKXF01000023",94.444,3.96e-56,220,144,135.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_FKXL01000017",93.333,3.99e-56,220,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_FKWV01000005",93.333,3.99e-56,220,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_FKXF01000023",93.333,3.99e-56,220,150,139.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_FNOE01000002",93.919,3.96e-56,220,148,139.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_FNPJ01000004",92.903,3.99e-56,220,155,143.99965,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLWD01000035",93.289,3.96e-56,220,149,139.00061,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLXP01000026",93.289,3.96e-56,220,149,139.00061,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLUB01000021",93.289,3.96e-56,220,149,139.00061,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLTT01000022",93.289,3.96e-56,220,149,139.00061,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRM01000021",93.289,3.96e-56,220,149,139.00061,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRF01000022",93.289,3.96e-56,220,149,139.00061,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLWD01000035",93.836,3.89e-56,220,146,137.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLXP01000026",93.836,3.89e-56,220,146,137.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLUB01000021",93.836,3.89e-56,220,146,137.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLTT01000022",93.836,3.89e-56,220,146,137.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRM01000021",93.836,3.89e-56,220,146,137.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRF01000022",93.836,3.89e-56,220,146,137.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_FNPJ01000004",93.243,1.42e-55,219,148,137.99964,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_FNPJ01000004",93.243,1.42e-55,219,148,137.99964,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_49057","NZ_FKXL01000017",93.289,1.42e-55,219,149,139.00061,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_49057","NZ_FKWV01000005",93.289,1.42e-55,219,149,139.00061,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_49057","NZ_FKXF01000023",93.289,1.42e-55,219,149,139.00061,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31601","NZ_FKXL01000017",93.243,1.43e-55,219,148,137.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31601","NZ_FKWV01000005",93.243,1.43e-55,219,148,137.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31601","NZ_FKXF01000023",93.243,1.43e-55,219,148,137.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_14170","NZ_FNOE01000002",93.836,1.42e-55,219,146,137.00056,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17308","NZ_FKXL01000017",93.243,1.42e-55,219,148,137.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17308","NZ_FKWV01000005",93.243,1.42e-55,219,148,137.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17308","NZ_FKXF01000023",93.243,1.42e-55,219,148,137.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9388","NZ_FNPJ01000004",93.243,1.42e-55,219,148,137.99964,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39075","NZ_FKXL01000017",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39075","NZ_FKWV01000005",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39075","NZ_FKXF01000023",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLWD01000035",92.667,5.16e-55,217,150,139.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLXP01000026",92.667,5.16e-55,217,150,139.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLUB01000021",92.667,5.16e-55,217,150,139.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLTT01000022",92.667,5.16e-55,217,150,139.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRM01000021",92.667,5.16e-55,217,150,139.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRF01000022",92.667,5.16e-55,217,150,139.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_89693","NZ_FNOE01000002",94.928,5.16e-55,217,138,131.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_FNPJ01000004",93.197,5.12e-55,217,147,136.99959,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12696","NZ_FKXL01000017",93.197,5.16e-55,217,147,136.99959,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12696","NZ_FKWV01000005",93.197,5.16e-55,217,147,136.99959,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12696","NZ_FKXF01000023",93.197,5.16e-55,217,147,136.99959,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20004","NZ_FKXL01000017",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20004","NZ_FKWV01000005",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20004","NZ_FKXF01000023",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20005","NZ_FKXL01000017",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20005","NZ_FKWV01000005",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20005","NZ_FKXF01000023",92.667,5.16e-55,217,150,139.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26715","NZ_FNOE01000002",94.326,5.16e-55,217,141,132.99966,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26716","NZ_FNOE01000002",94.326,5.16e-55,217,141,132.99966,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLWD01000035",93.75,5.12e-55,217,144,135,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLXP01000026",93.75,5.12e-55,217,144,135,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLUB01000021",93.75,5.12e-55,217,144,135,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLTT01000022",93.75,5.12e-55,217,144,135,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRM01000021",93.75,5.12e-55,217,144,135,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRF01000022",93.75,5.12e-55,217,144,135,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_FNPJ01000004",93.75,5.12e-55,217,144,135,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_FNOE01000002",93.75,5.12e-55,217,144,135,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_FNPJ01000004",93.243,5.16e-55,217,148,137.99964,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_FNPJ01000004",92.667,5.16e-55,217,150,139.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_FNOE01000002",92.667,5.16e-55,217,150,139.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_FKXL01000017",94.964,4.7e-55,217,139,131.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_FKWV01000005",94.964,4.7e-55,217,139,131.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_FKXF01000023",94.964,4.7e-55,217,139,131.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_FNPJ01000004",93.197,5.12e-55,217,147,136.99959,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_MLWD01000035",92.617,1.84e-54,215,149,137.99933,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLWD01000035",93.706,1.78e-54,215,143,133.99958,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLXP01000026",93.706,1.78e-54,215,143,133.99958,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLUB01000021",93.706,1.78e-54,215,143,133.99958,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLTT01000022",93.706,1.78e-54,215,143,133.99958,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRM01000021",93.706,1.78e-54,215,143,133.99958,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRF01000022",93.706,1.78e-54,215,143,133.99958,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_FKXL01000017",92.617,1.84e-54,215,149,137.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_FKWV01000005",92.617,1.84e-54,215,149,137.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_FKXF01000023",92.617,1.84e-54,215,149,137.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_FNOE01000002",92.617,1.84e-54,215,149,137.99933,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_FNPJ01000004",93.197,1.86e-54,215,147,136.99959,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20152","NZ_FNPJ01000004",93.793,1.84e-54,215,145,135.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1642","NZ_FNOE01000002",93.151,1.86e-54,215,146,136.00046,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5017","NZ_FNPJ01000004",92.667,1.86e-54,215,150,139.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5017","NZ_FNOE01000002",92.667,1.86e-54,215,150,139.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18111","NZ_FNPJ01000004",94.891,1.86e-54,215,137,130.00067,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_FNPJ01000004",92.617,1.84e-54,215,149,137.99933,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_FNOE01000002",92.617,1.84e-54,215,149,137.99933,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15122","NZ_FNOE01000002",94.928,1.84e-54,215,138,131.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12986","NZ_FKXL01000017",92.617,6.62e-54,213,149,137.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12986","NZ_FKWV01000005",92.617,6.62e-54,213,149,137.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12986","NZ_FKXF01000023",92.617,6.62e-54,213,149,137.99933,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_FNOE01000002",92.568,6.67e-54,213,148,137.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLWD01000035",93.103,6.67e-54,213,145,134.99935,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLXP01000026",93.103,6.67e-54,213,145,134.99935,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLUB01000021",93.103,6.67e-54,213,145,134.99935,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLTT01000022",93.103,6.67e-54,213,145,134.99935,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRM01000021",93.103,6.67e-54,213,145,134.99935,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRF01000022",93.103,6.67e-54,213,145,134.99935,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLWD01000035",92.568,6.67e-54,213,148,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLXP01000026",92.568,6.67e-54,213,148,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLUB01000021",92.568,6.67e-54,213,148,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLTT01000022",92.568,6.67e-54,213,148,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRM01000021",92.568,6.67e-54,213,148,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRF01000022",92.568,6.67e-54,213,148,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4810","NZ_FKXL01000017",93.103,6.67e-54,213,145,134.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4810","NZ_FKWV01000005",93.103,6.67e-54,213,145,134.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4810","NZ_FKXF01000023",93.103,6.67e-54,213,145,134.99935,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16541","NZ_FNOE01000002",93.103,6.62e-54,213,145,134.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_14170","NZ_FNPJ01000004",92.568,6.62e-54,213,148,137.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_FNPJ01000004",93.151,6.62e-54,213,146,136.00046,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_FNOE01000002",93.151,6.62e-54,213,146,136.00046,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_MLWD01000035",92.617,6.62e-54,213,149,137.99933,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLWD01000035",92.568,6.62e-54,213,148,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLXP01000026",92.568,6.62e-54,213,148,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLUB01000021",92.568,6.62e-54,213,148,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLTT01000022",92.568,6.62e-54,213,148,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRM01000021",92.568,6.62e-54,213,148,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRF01000022",92.568,6.62e-54,213,148,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_FNOE01000002",92.568,6.62e-54,213,148,137.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_FNPJ01000004",92,2.4e-53,211,150,138,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLWD01000035",92,2.4e-53,211,150,138,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLXP01000026",92,2.4e-53,211,150,138,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLUB01000021",92,2.4e-53,211,150,138,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLTT01000022",92,2.4e-53,211,150,138,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRM01000021",92,2.4e-53,211,150,138,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRF01000022",92,2.4e-53,211,150,138,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_45443","NZ_FNOE01000002",94.203,2.4e-53,211,138,130.00014,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25933","NZ_FKXL01000017",92,2.4e-53,211,150,138,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25933","NZ_FKWV01000005",92,2.4e-53,211,150,138,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_25933","NZ_FKXF01000023",92,2.4e-53,211,150,138,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_FNPJ01000004",92.517,2.38e-53,211,147,135.99999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_FNOE01000002",92.517,2.38e-53,211,147,135.99999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_FNPJ01000004",92.517,2.38e-53,211,147,135.99999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_FNOE01000002",92.517,2.38e-53,211,147,135.99999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_FNPJ01000004",92.517,2.38e-53,211,147,135.99999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_FNOE01000002",92.517,2.38e-53,211,147,135.99999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40497","NZ_FNOE01000002",92.568,2.38e-53,211,148,137.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40498","NZ_FNOE01000002",92.568,2.38e-53,211,148,137.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21165","NZ_FNOE01000002",92,2.4e-53,211,150,138,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_FNPJ01000004",93.056,2.38e-53,211,144,134.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_FNOE01000002",93.056,2.38e-53,211,144,134.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9964","NZ_FNOE01000002",93.617,2.38e-53,211,141,131.99997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_MLWD01000035",92,8.56e-53,209,150,138,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10447","NZ_FNPJ01000004",92.105,8.56e-53,209,152,139.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10447","NZ_FNOE01000002",92.105,8.56e-53,209,152,139.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_FNPJ01000004",92.466,8.56e-53,209,146,135.00036,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_FNOE01000002",92.466,8.56e-53,209,146,135.00036,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_FNPJ01000004",93.571,8.63e-53,209,140,130.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_FNOE01000002",93.007,8.63e-53,209,143,133.00001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_FKXL01000017",91.946,8.56e-53,209,149,136.99954,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_FKWV01000005",91.946,8.56e-53,209,149,136.99954,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_FKXF01000023",91.946,8.56e-53,209,149,136.99954,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24594","NZ_FNOE01000002",91.946,8.56e-53,209,149,136.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20148","NZ_FNPJ01000004",93.103,8.56e-53,209,145,134.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20149","NZ_FNPJ01000004",93.103,8.56e-53,209,145,134.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20150","NZ_FNPJ01000004",93.103,8.56e-53,209,145,134.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20151","NZ_FNPJ01000004",93.103,8.56e-53,209,145,134.99935,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1641","NZ_FNOE01000002",92.466,8.63e-53,209,146,135.00036,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_FNOE01000002",93.007,8.42e-53,209,143,133.00001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_FNPJ01000004",91.946,8.56e-53,209,149,136.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_FNPJ01000004",91.946,8.56e-53,209,149,136.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9388","NZ_FNOE01000002",91.946,8.56e-53,209,149,136.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_FNPJ01000004",92,8.63e-53,209,150,138,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_FNOE01000002",91.892,3.1e-52,207,148,136.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_FNOE01000002",91.892,3.1e-52,207,148,136.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_FNOE01000002",91.892,3.1e-52,207,148,136.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_FNOE01000002",91.892,3.1e-52,207,148,136.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_54875","NZ_FNOE01000002",92.466,3.1e-52,207,146,135.00036,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16540","NZ_FNOE01000002",92.414,3.08e-52,207,145,134.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16541","NZ_FNPJ01000004",92.414,3.08e-52,207,145,134.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16542","NZ_FNOE01000002",92.414,3.08e-52,207,145,134.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLWD01000035",92.414,3.08e-52,207,145,134.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLXP01000026",92.414,3.08e-52,207,145,134.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLUB01000021",92.414,3.08e-52,207,145,134.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLTT01000022",92.414,3.08e-52,207,145,134.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRM01000021",92.414,3.08e-52,207,145,134.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRF01000022",92.414,3.08e-52,207,145,134.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLWD01000035",92.466,3.08e-52,207,146,135.00036,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLXP01000026",92.466,3.08e-52,207,146,135.00036,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLUB01000021",92.466,3.08e-52,207,146,135.00036,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLTT01000022",92.466,3.08e-52,207,146,135.00036,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRM01000021",92.466,3.08e-52,207,146,135.00036,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRF01000022",92.466,3.08e-52,207,146,135.00036,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_MLWD01000035",91.946,3.08e-52,207,149,136.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_MLWD01000035",91.946,3.08e-52,207,149,136.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15195","NZ_FNPJ01000004",94.737,3.03e-52,207,133,126.00021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_FNPJ01000004",92.958,3.03e-52,207,142,132.00036,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5016","NZ_FNPJ01000004",91.946,3.08e-52,207,149,136.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5016","NZ_FNOE01000002",91.946,3.08e-52,207,149,136.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLWD01000035",91.195,3.1e-52,207,159,145.00005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLXP01000026",91.195,3.1e-52,207,159,145.00005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLUB01000021",91.195,3.1e-52,207,159,145.00005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLTT01000022",91.195,3.1e-52,207,159,145.00005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRM01000021",91.195,3.1e-52,207,159,145.00005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRF01000022",91.195,3.1e-52,207,159,145.00005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43125","NZ_FNOE01000002",91.333,1.12e-51,206,150,136.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_FNPJ01000004",91.837,1.11e-51,206,147,135.00039,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_FNOE01000002",91.837,1.11e-51,206,147,135.00039,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40497","NZ_FNPJ01000004",91.837,1.11e-51,206,147,135.00039,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40498","NZ_FNPJ01000004",91.837,1.11e-51,206,147,135.00039,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_FNPJ01000004",91.892,1.12e-51,206,148,136.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3847","NZ_FNPJ01000004",91.447,1.11e-51,206,152,138.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21165","NZ_FNPJ01000004",91.333,1.12e-51,206,150,136.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLWD01000035",92.414,1.09e-51,206,145,134.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLXP01000026",92.414,1.09e-51,206,145,134.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLUB01000021",92.414,1.09e-51,206,145,134.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLTT01000022",92.414,1.09e-51,206,145,134.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRM01000021",92.414,1.09e-51,206,145,134.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRF01000022",92.414,1.09e-51,206,145,134.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLWD01000035",91.139,1.11e-51,206,158,143.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLXP01000026",91.139,1.11e-51,206,158,143.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLUB01000021",91.139,1.11e-51,206,158,143.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLTT01000022",91.139,1.11e-51,206,158,143.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRM01000021",91.139,1.11e-51,206,158,143.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRF01000022",91.139,1.11e-51,206,158,143.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLWD01000035",91.139,1.11e-51,206,158,143.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLXP01000026",91.139,1.11e-51,206,158,143.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLUB01000021",91.139,1.11e-51,206,158,143.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLTT01000022",91.139,1.11e-51,206,158,143.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRM01000021",91.139,1.11e-51,206,158,143.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRF01000022",91.139,1.11e-51,206,158,143.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLWD01000035",91.946,1.1e-51,206,149,136.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLXP01000026",91.946,1.1e-51,206,149,136.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLUB01000021",91.946,1.1e-51,206,149,136.99954,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLTT01000022",91.946,1.1e-51,206,149,136.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRM01000021",91.946,1.1e-51,206,149,136.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRF01000022",91.946,1.1e-51,206,149,136.99954,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10220","NZ_FNPJ01000004",94.737,1.1e-51,206,133,126.00021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12987","NZ_FKXL01000017",91.837,3.98e-51,204,147,135.00039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12987","NZ_FKWV01000005",91.837,3.98e-51,204,147,135.00039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12987","NZ_FKXF01000023",91.837,3.98e-51,204,147,135.00039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10446","NZ_FNPJ01000004",91.447,3.98e-51,204,152,138.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10446","NZ_FNOE01000002",91.447,3.98e-51,204,152,138.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10448","NZ_FNPJ01000004",91.447,3.98e-51,204,152,138.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10448","NZ_FNOE01000002",91.447,3.98e-51,204,152,138.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10449","NZ_FNPJ01000004",91.447,3.98e-51,204,152,138.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10449","NZ_FNOE01000002",91.447,3.98e-51,204,152,138.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLWD01000035",91.275,3.98e-51,204,149,135.99975,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLXP01000026",91.275,3.98e-51,204,149,135.99975,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLUB01000021",91.275,3.98e-51,204,149,135.99975,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLTT01000022",91.275,3.98e-51,204,149,135.99975,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRM01000021",91.275,3.98e-51,204,149,135.99975,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRF01000022",91.275,3.98e-51,204,149,135.99975,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_FNPJ01000004",91.275,3.98e-51,204,149,135.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_FKXL01000017",93.525,3.76e-51,204,139,129.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_FKWV01000005",93.525,3.76e-51,204,139,129.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_FKXF01000023",93.525,3.76e-51,204,139,129.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FNPJ01000004",92.308,3.82e-51,204,143,132.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FNOE01000002",92.308,3.82e-51,204,143,132.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_FNPJ01000004",91.275,3.98e-51,204,149,135.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1643","NZ_FKXL01000017",91.275,3.98e-51,204,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1643","NZ_FKWV01000005",91.275,3.98e-51,204,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1643","NZ_FKXF01000023",91.275,3.98e-51,204,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3396","NZ_FKXL01000017",91.275,3.98e-51,204,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3396","NZ_FKWV01000005",91.275,3.98e-51,204,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3396","NZ_FKXF01000023",91.275,3.98e-51,204,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11862","NZ_FNPJ01000004",91.333,3.98e-51,204,150,136.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40021","NZ_FNPJ01000004",94.656,1.27e-50,202,131,123.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_62727","NZ_FNPJ01000004",94.656,1.27e-50,202,131,123.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46057","NZ_FNPJ01000004",94.656,1.27e-50,202,131,123.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46058","NZ_FNPJ01000004",94.656,1.27e-50,202,131,123.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_62371","NZ_FNPJ01000004",94.656,1.27e-50,202,131,123.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24260","NZ_FNOE01000002",91.216,1.44e-50,202,148,134.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_FNOE01000002",91.724,1.44e-50,202,145,132.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_FNPJ01000004",91.781,1.44e-50,202,146,134.00026,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_54875","NZ_FNPJ01000004",91.724,1.44e-50,202,145,132.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLWD01000035",91.724,1.44e-50,202,145,132.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLXP01000026",91.724,1.44e-50,202,145,132.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLUB01000021",91.724,1.44e-50,202,145,132.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLTT01000022",91.724,1.44e-50,202,145,132.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRM01000021",91.724,1.44e-50,202,145,132.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRF01000022",91.724,1.44e-50,202,145,132.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16540","NZ_FNPJ01000004",91.724,1.43e-50,202,145,132.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16542","NZ_FNPJ01000004",91.724,1.43e-50,202,145,132.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLWD01000035",90.566,1.44e-50,202,159,143.99994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLXP01000026",90.566,1.44e-50,202,159,143.99994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLUB01000021",90.566,1.44e-50,202,159,143.99994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLTT01000022",90.566,1.44e-50,202,159,143.99994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRM01000021",90.566,1.44e-50,202,159,143.99994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRF01000022",90.566,1.44e-50,202,159,143.99994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLWD01000035",94.615,1.22e-50,202,130,122.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLXP01000026",94.615,1.22e-50,202,130,122.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLUB01000021",94.615,1.22e-50,202,130,122.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLTT01000022",94.615,1.22e-50,202,130,122.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRM01000021",94.615,1.22e-50,202,130,122.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRF01000022",94.615,1.22e-50,202,130,122.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLWD01000035",91.781,1.43e-50,202,146,134.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLXP01000026",91.781,1.43e-50,202,146,134.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLUB01000021",91.781,1.43e-50,202,146,134.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLTT01000022",91.781,1.43e-50,202,146,134.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRM01000021",91.781,1.43e-50,202,146,134.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRF01000022",91.781,1.43e-50,202,146,134.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLWD01000035",91.781,1.43e-50,202,146,134.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLXP01000026",91.781,1.43e-50,202,146,134.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLUB01000021",91.781,1.43e-50,202,146,134.00026,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLTT01000022",91.781,1.43e-50,202,146,134.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRM01000021",91.781,1.43e-50,202,146,134.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRF01000022",91.781,1.43e-50,202,146,134.00026,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15194","NZ_FNPJ01000004",93.985,1.41e-50,202,133,125.00005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_FNOE01000002",91.724,1.42e-50,202,145,132.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLWD01000035",90.566,1.44e-50,202,159,143.99994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLXP01000026",90.566,1.44e-50,202,159,143.99994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLUB01000021",90.566,1.44e-50,202,159,143.99994,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLTT01000022",90.566,1.44e-50,202,159,143.99994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRM01000021",90.566,1.44e-50,202,159,143.99994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRF01000022",90.566,1.44e-50,202,159,143.99994,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_MLWD01000035",94.656,1.43e-50,202,131,123.99936,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLWD01000035",90.667,5.2e-50,200,150,136.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLXP01000026",90.667,5.2e-50,200,150,136.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLUB01000021",90.667,5.2e-50,200,150,136.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLTT01000022",90.667,5.2e-50,200,150,136.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRM01000021",90.667,5.2e-50,200,150,136.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRF01000022",90.667,5.2e-50,200,150,136.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_45444","NZ_FNOE01000002",92.754,5.2e-50,200,138,128.00052,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_36053","NZ_FNPJ01000004",93.431,5.11e-50,200,137,128.00047,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_36054","NZ_FNPJ01000004",93.431,5.2e-50,200,137,128.00047,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLWD01000035",90.506,5.15e-50,200,158,142.99948,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLXP01000026",90.506,5.15e-50,200,158,142.99948,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLUB01000021",90.506,5.15e-50,200,158,142.99948,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLTT01000022",90.506,5.15e-50,200,158,142.99948,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRM01000021",90.506,5.15e-50,200,158,142.99948,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRF01000022",90.506,5.15e-50,200,158,142.99948,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_FNPJ01000004",91.216,5.2e-50,200,148,134.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_FNOE01000002",91.216,5.2e-50,200,148,134.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_FNPJ01000004",90.728,5.2e-50,200,151,136.99928,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_FNOE01000002",90.728,5.2e-50,200,151,136.99928,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3848","NZ_FNPJ01000004",90.789,5.15e-50,200,152,137.99928,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_MLWD01000035",90.728,5.2e-50,200,151,136.99928,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28282","NZ_FNPJ01000004",94.615,5.15e-50,200,130,122.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28282","NZ_FNOE01000002",94.615,5.15e-50,200,130,122.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_FNPJ01000004",91.216,5.11e-50,200,148,134.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_FKXL01000017",91.275,5.11e-50,200,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_FKWV01000005",91.275,5.11e-50,200,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_FKXF01000023",91.275,5.11e-50,200,149,135.99975,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_89693","NZ_FNPJ01000004",90.667,1.87e-49,198,150,136.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10445","NZ_FNPJ01000004",90.789,1.85e-49,198,152,137.99928,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10445","NZ_FNOE01000002",90.789,1.85e-49,198,152,137.99928,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLWD01000035",90.604,1.85e-49,198,149,134.99996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLXP01000026",90.604,1.85e-49,198,149,134.99996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLUB01000021",90.604,1.85e-49,198,149,134.99996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLTT01000022",90.604,1.85e-49,198,149,134.99996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRM01000021",90.604,1.85e-49,198,149,134.99996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRF01000022",90.604,1.85e-49,198,149,134.99996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_FNPJ01000004",90.604,1.85e-49,198,149,134.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_FNOE01000002",90.604,1.85e-49,198,149,134.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24260","NZ_FNPJ01000004",91.096,1.87e-49,198,146,133.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_FKXL01000017",91.724,1.79e-49,198,145,132.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_FKWV01000005",91.724,1.79e-49,198,145,132.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_FKXF01000023",91.724,1.79e-49,198,145,132.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27008","NZ_FNPJ01000004",90.604,1.85e-49,198,149,134.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_MLWD01000035",91.667,1.85e-49,198,144,132.00048,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_FNPJ01000004",90.604,1.85e-49,198,149,134.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_MLWD01000035",91.667,1.85e-49,198,144,132.00048,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_FNPJ01000004",92.701,1.85e-49,198,137,127.00037,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_FNOE01000002",92.701,1.85e-49,198,137,127.00037,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24398","NZ_FNOE01000002",92.199,1.73e-49,198,141,130.00059,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_FNOE01000002",90.604,1.85e-49,198,149,134.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27573","NZ_FNOE01000002",90.667,1.85e-49,198,150,136.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14629","NZ_FNPJ01000004",90.667,1.85e-49,198,150,136.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14629","NZ_FNOE01000002",90.667,1.85e-49,198,150,136.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_FKXL01000017",90.604,1.87e-49,198,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_FKWV01000005",90.604,1.87e-49,198,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_FKXF01000023",90.604,1.87e-49,198,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3395","NZ_FKXL01000017",90.604,1.85e-49,198,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3395","NZ_FKWV01000005",90.604,1.85e-49,198,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3395","NZ_FKXF01000023",90.604,1.85e-49,198,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_66017","NZ_FKXL01000017",90.604,6.67e-49,196,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_66017","NZ_FKWV01000005",90.604,6.67e-49,196,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_66017","NZ_FKXF01000023",90.604,6.67e-49,196,149,134.99996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_FNPJ01000004",92.086,6.72e-49,196,139,127.99954,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_FNOE01000002",91.096,6.72e-49,196,146,133.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLWD01000035",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLXP01000026",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLUB01000021",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLTT01000022",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRM01000021",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRF01000022",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLWD01000035",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLXP01000026",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLUB01000021",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLTT01000022",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRM01000021",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRF01000022",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLWD01000035",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLXP01000026",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLUB01000021",89.937,6.72e-49,196,159,142.99983,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLTT01000022",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRM01000021",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRF01000022",89.937,6.72e-49,196,159,142.99983,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6933","NZ_FNOE01000002",90.323,6.67e-49,196,155,140.00065,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6534","NZ_FNOE01000002",91.096,6.67e-49,196,146,133.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLWD01000035",93.846,5.68e-49,196,130,121.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLXP01000026",93.846,5.68e-49,196,130,121.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLUB01000021",93.846,5.68e-49,196,130,121.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLTT01000022",93.846,5.68e-49,196,130,121.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRM01000021",93.846,5.68e-49,196,130,121.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRF01000022",93.846,5.68e-49,196,130,121.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_FKXL01000017",92.806,6.23e-49,196,139,129.00034,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_FKWV01000005",92.806,6.23e-49,196,139,129.00034,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_FKXF01000023",92.806,6.23e-49,196,139,129.00034,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6076","NZ_FKXL01000017",93.846,6.67e-49,196,130,121.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6076","NZ_FKWV01000005",93.846,6.67e-49,196,130,121.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6076","NZ_FKXF01000023",93.846,6.67e-49,196,130,121.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_FNOE01000002",90.667,6.72e-49,196,150,136.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_45443","NZ_FNPJ01000004",90.066,2.42e-48,195,151,135.99966,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_36055","NZ_FNPJ01000004",92.701,2.42e-48,195,137,127.00037,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLWD01000035",89.873,2.4e-48,195,158,141.99934,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLXP01000026",89.873,2.4e-48,195,158,141.99934,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLUB01000021",89.873,2.4e-48,195,158,141.99934,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLTT01000022",89.873,2.4e-48,195,158,141.99934,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRM01000021",89.873,2.4e-48,195,158,141.99934,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRF01000022",89.873,2.4e-48,195,158,141.99934,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_FNPJ01000004",92.593,2.42e-48,195,135,125.00055,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_FNOE01000002",92.593,2.42e-48,195,135,125.00055,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42933","NZ_FNOE01000002",92.029,2.32e-48,195,138,127.00002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_FNOE01000002",90.541,2.42e-48,195,148,134.00068,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLWD01000035",90.132,2.42e-48,195,152,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLXP01000026",90.132,2.42e-48,195,152,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLUB01000021",90.132,2.42e-48,195,152,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLTT01000022",90.132,2.42e-48,195,152,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRM01000021",90.132,2.42e-48,195,152,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRF01000022",90.132,2.42e-48,195,152,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLWD01000035",90.132,2.42e-48,195,152,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLXP01000026",90.132,2.42e-48,195,152,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLUB01000021",90.132,2.42e-48,195,152,137.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLTT01000022",90.132,2.42e-48,195,152,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRM01000021",90.132,2.42e-48,195,152,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRF01000022",90.132,2.42e-48,195,152,137.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_FNPJ01000004",90,2.42e-48,195,150,135,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_FNOE01000002",90,2.42e-48,195,150,135,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6933","NZ_FNPJ01000004",90.196,2.4e-48,195,153,137.99988,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6534","NZ_FNPJ01000004",91.034,2.4e-48,195,145,131.9993,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_FNPJ01000004",90.604,2.4e-48,195,149,134.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_FKXL01000017",90,2.42e-48,195,150,135,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_FKWV01000005",90,2.42e-48,195,150,135,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_FKXF01000023",90,2.42e-48,195,150,135,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27573","NZ_FNPJ01000004",90.541,2.4e-48,195,148,134.00068,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLWD01000035",90.476,2.42e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLXP01000026",90.476,2.42e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLUB01000021",90.476,2.42e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLTT01000022",90.476,2.42e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRM01000021",90.476,2.42e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRF01000022",90.476,2.42e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLWD01000035",90.476,2.38e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLXP01000026",90.476,2.38e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLUB01000021",90.476,2.38e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLTT01000022",90.476,2.38e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRM01000021",90.476,2.38e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRF01000022",90.476,2.38e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLWD01000035",90.476,2.4e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLXP01000026",90.476,2.4e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLUB01000021",90.476,2.4e-48,195,147,132.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLTT01000022",90.476,2.4e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRM01000021",90.476,2.4e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRF01000022",90.476,2.4e-48,195,147,132.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_FNPJ01000004",89.933,8.62e-48,193,149,134.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_FNOE01000002",89.933,8.62e-48,193,149,134.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLWD01000035",89.933,8.62e-48,193,149,134.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLXP01000026",89.933,8.62e-48,193,149,134.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLUB01000021",89.933,8.62e-48,193,149,134.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLTT01000022",89.933,8.62e-48,193,149,134.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRM01000021",89.933,8.62e-48,193,149,134.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRF01000022",89.933,8.62e-48,193,149,134.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLWD01000035",91.034,8.62e-48,193,145,131.9993,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6409","NZ_FKXL01000017",89.933,8.62e-48,193,149,134.00017,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6409","NZ_FKWV01000005",89.933,8.62e-48,193,149,134.00017,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6409","NZ_FKXF01000023",89.933,8.62e-48,193,149,134.00017,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_FNOE01000002",91.971,8.62e-48,193,137,126.00027,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1642","NZ_FNPJ01000004",90.411,8.69e-48,193,146,132.00006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4081","NZ_FNPJ01000004",91.429,8.69e-48,193,140,128.0006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_24398","NZ_FNPJ01000004",91.429,8.06e-48,193,140,128.0006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_FNOE01000002",89.933,8.62e-48,193,149,134.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_FNOE01000002",89.933,8.62e-48,193,149,134.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_MLWD01000035",92.537,8.48e-48,193,134,123.99958,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLWD01000035",89.933,8.69e-48,193,149,134.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLXP01000026",89.933,8.69e-48,193,149,134.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLUB01000021",89.933,8.69e-48,193,149,134.00017,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLTT01000022",89.933,8.69e-48,193,149,134.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRM01000021",89.933,8.69e-48,193,149,134.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRF01000022",89.933,8.69e-48,193,149,134.00017,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14628","NZ_FNPJ01000004",90,8.62e-48,193,150,135,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14628","NZ_FNOE01000002",90,8.62e-48,193,150,135,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_FNOE01000002",90,8.62e-48,193,150,135,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_FNOE01000002",90.411,8.48e-48,193,146,132.00006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40021","NZ_FNOE01000002",92.537,2.75e-47,191,134,123.99958,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_62727","NZ_FNOE01000002",92.537,2.75e-47,191,134,123.99958,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46057","NZ_FNOE01000002",93.13,2.75e-47,191,131,122.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46058","NZ_FNOE01000002",92.537,2.75e-47,191,134,123.99958,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_62371","NZ_FNOE01000002",92.537,2.75e-47,191,134,123.99958,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_50498","NZ_FNOE01000002",91.367,3.13e-47,191,139,127.00013,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLWD01000035",89.308,3.13e-47,191,159,141.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLXP01000026",89.308,3.13e-47,191,159,141.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLUB01000021",89.308,3.13e-47,191,159,141.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLTT01000022",89.308,3.13e-47,191,159,141.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRM01000021",89.308,3.13e-47,191,159,141.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRF01000022",89.308,3.13e-47,191,159,141.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLWD01000035",89.308,3.13e-47,191,159,141.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLXP01000026",89.308,3.13e-47,191,159,141.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLUB01000021",89.308,3.13e-47,191,159,141.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLTT01000022",89.308,3.13e-47,191,159,141.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRM01000021",89.308,3.13e-47,191,159,141.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRF01000022",89.308,3.13e-47,191,159,141.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4205","NZ_FNOE01000002",91.912,3.1e-47,191,136,125.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_45444","NZ_FNPJ01000004",89.404,1.12e-46,189,151,135.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLWD01000035",89.333,1.12e-46,189,150,133.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLXP01000026",89.333,1.12e-46,189,150,133.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLUB01000021",89.333,1.12e-46,189,150,133.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLTT01000022",89.333,1.12e-46,189,150,133.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRM01000021",89.333,1.12e-46,189,150,133.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRF01000022",89.333,1.12e-46,189,150,133.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLWD01000035",90.411,1.08e-46,189,146,132.00006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLXP01000026",90.411,1.08e-46,189,146,132.00006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLUB01000021",90.411,1.08e-46,189,146,132.00006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLTT01000022",90.411,1.08e-46,189,146,132.00006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRM01000021",90.411,1.08e-46,189,146,132.00006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRF01000022",90.411,1.08e-46,189,146,132.00006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_FNPJ01000004",90.278,1.08e-46,189,144,130.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_FNOE01000002",90.278,1.08e-46,189,144,130.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42933","NZ_FNPJ01000004",90.278,1.08e-46,189,144,130.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_FKXL01000017",90.78,1.12e-46,189,141,127.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_FKWV01000005",90.78,1.12e-46,189,141,127.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_FKXF01000023",90.78,1.12e-46,189,141,127.9998,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_FKXL01000017",90.278,1.12e-46,189,144,130.00032,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_FKWV01000005",90.278,1.12e-46,189,144,130.00032,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_FKXF01000023",90.278,1.12e-46,189,144,130.00032,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLWD01000035",90.78,1.12e-46,189,141,127.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLXP01000026",90.78,1.12e-46,189,141,127.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLUB01000021",90.78,1.12e-46,189,141,127.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLTT01000022",90.78,1.12e-46,189,141,127.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRM01000021",90.78,1.12e-46,189,141,127.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRF01000022",90.78,1.12e-46,189,141,127.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16163","NZ_FNOE01000002",94.309,9.51e-47,189,123,116.00007,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_FNPJ01000004",90,1.12e-46,189,150,135,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_FNPJ01000004",89.796,1.11e-46,189,147,132.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_FNOE01000002",89.865,1.12e-46,189,148,133.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLWD01000035",89.796,1.12e-46,189,147,132.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLXP01000026",89.796,1.12e-46,189,147,132.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLUB01000021",89.796,1.12e-46,189,147,132.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLTT01000022",89.796,1.12e-46,189,147,132.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRM01000021",89.796,1.12e-46,189,147,132.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRF01000022",89.796,1.12e-46,189,147,132.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9964","NZ_FNPJ01000004",90.78,1.12e-46,189,141,127.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_FNOE01000002",89.262,4.01e-46,187,149,133.00038,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLWD01000035",89.262,4.01e-46,187,149,133.00038,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLXP01000026",89.262,4.01e-46,187,149,133.00038,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLUB01000021",89.262,4.01e-46,187,149,133.00038,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLTT01000022",89.262,4.01e-46,187,149,133.00038,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRM01000021",89.262,4.01e-46,187,149,133.00038,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRF01000022",89.262,4.01e-46,187,149,133.00038,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_FNOE01000002",89.796,4.04e-46,187,147,132.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLWD01000035",90.411,4.01e-46,187,146,132.00006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_MLWD01000035",94.958,4.01e-46,187,119,113.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1641","NZ_FNPJ01000004",89.726,4.04e-46,187,146,130.99996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_FNPJ01000004",90.541,4.01e-46,187,148,134.00068,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20119","NZ_FKXL01000017",94.262,4.04e-46,187,122,114.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20119","NZ_FKWV01000005",94.262,4.04e-46,187,122,114.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20119","NZ_FKXF01000023",94.262,4.04e-46,187,122,114.99964,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14863","NZ_FNOE01000002",89.474,4.01e-46,187,152,136.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15741","NZ_FKXL01000017",90.345,4.01e-46,187,145,131.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15741","NZ_FKWV01000005",90.345,4.01e-46,187,145,131.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15741","NZ_FKXF01000023",90.345,4.01e-46,187,145,131.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15742","NZ_FKXL01000017",90.345,4.01e-46,187,145,131.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15742","NZ_FKWV01000005",90.345,4.01e-46,187,145,131.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15742","NZ_FKXF01000023",90.345,4.01e-46,187,145,131.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_FNOE01000002",89.262,4.01e-46,187,149,133.00038,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLWD01000035",89.333,4.01e-46,187,150,133.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_50498","NZ_FNPJ01000004",90.647,1.45e-45,185,139,125.99933,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1491","NZ_FKXL01000017",91.034,1.44e-45,185,145,131.9993,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1491","NZ_FKWV01000005",91.034,1.44e-45,185,145,131.9993,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1491","NZ_FKXF01000023",91.034,1.44e-45,185,145,131.9993,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16163","NZ_FNPJ01000004",93.6,1.23e-45,185,125,117,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_FNPJ01000004",92.366,1.44e-45,185,131,120.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_FNPJ01000004",92.366,1.44e-45,185,131,120.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLWD01000035",89.189,1.45e-45,185,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLXP01000026",89.189,1.45e-45,185,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLUB01000021",89.189,1.45e-45,185,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLTT01000022",89.189,1.45e-45,185,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRM01000021",89.189,1.45e-45,185,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRF01000022",89.189,1.45e-45,185,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLWD01000035",89.189,1.44e-45,185,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLXP01000026",89.189,1.44e-45,185,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLUB01000021",89.189,1.44e-45,185,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLTT01000022",89.189,1.44e-45,185,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRM01000021",89.189,1.44e-45,185,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRF01000022",89.189,1.44e-45,185,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_FKXL01000017",88.742,5.23e-45,183,151,134.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_FKWV01000005",88.742,5.23e-45,183,151,134.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_FKXF01000023",88.742,5.23e-45,183,151,134.00042,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLWD01000035",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLXP01000026",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLUB01000021",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLTT01000022",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRM01000021",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRF01000022",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLWD01000035",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLXP01000026",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLUB01000021",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLTT01000022",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRM01000021",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRF01000022",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLWD01000035",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLXP01000026",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLUB01000021",89.189,5.19e-45,183,148,131.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLTT01000022",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRM01000021",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRF01000022",89.189,5.19e-45,183,148,131.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40096","NZ_FNPJ01000004",89.333,5.19e-45,183,150,133.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40096","NZ_FNOE01000002",89.333,5.19e-45,183,150,133.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_FNPJ01000004",90.071,5.19e-45,183,141,127.00011,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLWD01000035",92.913,5.19e-45,183,127,117.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLXP01000026",92.913,5.19e-45,183,127,117.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLUB01000021",92.913,5.19e-45,183,127,117.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLTT01000022",92.913,5.19e-45,183,127,117.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRM01000021",92.913,5.19e-45,183,127,117.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRF01000022",92.913,5.19e-45,183,127,117.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLWD01000035",92.913,5.19e-45,183,127,117.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLXP01000026",92.913,5.19e-45,183,127,117.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLUB01000021",92.913,5.19e-45,183,127,117.99951,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLTT01000022",92.913,5.19e-45,183,127,117.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRM01000021",92.913,5.19e-45,183,127,117.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRF01000022",92.913,5.19e-45,183,127,117.99951,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FNPJ01000004",94.215,5.23e-45,183,121,114.00015,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_FNPJ01000004",94.215,5.23e-45,183,121,114.00015,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_FNOE01000002",89.189,5.15e-45,183,148,131.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLWD01000035",88.608,5.19e-45,183,158,140.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLXP01000026",88.608,5.19e-45,183,158,140.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLUB01000021",88.608,5.19e-45,183,158,140.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLTT01000022",88.608,5.19e-45,183,158,140.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRM01000021",88.608,5.19e-45,183,158,140.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRF01000022",88.608,5.19e-45,183,158,140.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_86460","NZ_FNPJ01000004",89.116,1.87e-44,182,147,131.00052,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_FNOE01000002",92.188,1.87e-44,182,128,118.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_56610","NZ_FKXL01000017",88.199,1.87e-44,182,161,142.00039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_56610","NZ_FKWV01000005",88.199,1.87e-44,182,161,142.00039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_56610","NZ_FKXF01000023",88.199,1.87e-44,182,161,142.00039,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_FNPJ01000004",90.511,1.88e-44,182,137,124.00007,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_FNPJ01000004",90.345,1.87e-44,182,145,131.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_MLWD01000035",94.118,1.87e-44,182,119,112.00042,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_FNPJ01000004",89.865,1.87e-44,182,148,133.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLWD01000035",88.591,1.87e-44,182,149,132.00059,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLXP01000026",88.591,1.87e-44,182,149,132.00059,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLUB01000021",88.591,1.87e-44,182,149,132.00059,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLTT01000022",88.591,1.87e-44,182,149,132.00059,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRM01000021",88.591,1.87e-44,182,149,132.00059,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRF01000022",88.591,1.87e-44,182,149,132.00059,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_FNOE01000002",88.591,1.87e-44,182,149,132.00059,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_FNPJ01000004",88.591,1.87e-44,182,149,132.00059,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_58720","NZ_FNOE01000002",94.068,6.71e-44,180,118,111.00024,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_FNOE01000002",92.188,6.71e-44,180,128,118.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLWD01000035",88.05,6.77e-44,180,159,139.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLXP01000026",88.05,6.77e-44,180,159,139.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLUB01000021",88.05,6.77e-44,180,159,139.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLTT01000022",88.05,6.77e-44,180,159,139.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRM01000021",88.05,6.77e-44,180,159,139.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRF01000022",88.05,6.77e-44,180,159,139.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLWD01000035",90.441,6.71e-44,180,136,122.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLXP01000026",90.441,6.71e-44,180,136,122.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLUB01000021",90.441,6.71e-44,180,136,122.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLTT01000022",90.441,6.71e-44,180,136,122.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRM01000021",90.441,6.71e-44,180,136,122.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRF01000022",90.441,6.71e-44,180,136,122.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLWD01000035",92.126,6.71e-44,180,127,117.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLXP01000026",92.126,6.71e-44,180,127,117.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLUB01000021",92.126,6.71e-44,180,127,117.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLTT01000022",92.126,6.71e-44,180,127,117.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRM01000021",92.126,6.71e-44,180,127,117.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRF01000022",92.126,6.71e-44,180,127,117.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLWD01000035",92.126,6.77e-44,180,127,117.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLXP01000026",92.126,6.77e-44,180,127,117.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLUB01000021",92.126,6.77e-44,180,127,117.00002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLTT01000022",92.126,6.77e-44,180,127,117.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRM01000021",92.126,6.77e-44,180,127,117.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRF01000022",92.126,6.77e-44,180,127,117.00002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_FKXL01000017",88.514,6.77e-44,180,148,131.00072,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_FKWV01000005",88.514,6.77e-44,180,148,131.00072,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_FKXF01000023",88.514,6.77e-44,180,148,131.00072,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_FKXL01000017",88.079,2.43e-43,178,151,132.99929,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_FKWV01000005",88.079,2.43e-43,178,151,132.99929,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_FKXF01000023",88.079,2.43e-43,178,151,132.99929,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_58721","NZ_FNOE01000002",94.017,2.41e-43,178,117,109.99989,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLWD01000035",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLXP01000026",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLUB01000021",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLTT01000022",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRM01000021",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRF01000022",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLWD01000035",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLXP01000026",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLUB01000021",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLTT01000022",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRM01000021",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRF01000022",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLWD01000035",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLXP01000026",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLUB01000021",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLTT01000022",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRM01000021",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRF01000022",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLWD01000035",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLXP01000026",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLUB01000021",88.514,2.41e-43,178,148,131.00072,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLTT01000022",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRM01000021",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRF01000022",88.514,2.41e-43,178,148,131.00072,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_48790","NZ_FNPJ01000004",88.435,2.41e-43,178,147,129.99945,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12215","NZ_FNPJ01000004",91.473,2.43e-43,178,129,118.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_FNOE01000002",89.437,2.41e-43,178,142,127.00054,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10770","NZ_FNPJ01000004",89.583,2.43e-43,178,144,128.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30518","NZ_FNPJ01000004",88.158,2.43e-43,178,152,134.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30518","NZ_FNOE01000002",88.158,2.43e-43,178,152,134.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_FKXL01000017",88.435,2.41e-43,178,147,129.99945,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_FKWV01000005",88.435,2.41e-43,178,147,129.99945,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_FKXF01000023",88.435,2.41e-43,178,147,129.99945,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_FNPJ01000004",93.388,2.43e-43,178,121,112.99948,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_FNOE01000002",94.783,2.43e-43,178,115,109.00045,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_FNPJ01000004",88,2.43e-43,178,150,132,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLWD01000035",88.079,8.68e-43,176,151,132.99929,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLXP01000026",88.079,8.68e-43,176,151,132.99929,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLUB01000021",88.079,8.68e-43,176,151,132.99929,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLTT01000022",88.079,8.68e-43,176,151,132.99929,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRM01000021",88.079,8.68e-43,176,151,132.99929,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRF01000022",88.079,8.68e-43,176,151,132.99929,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_58720","NZ_FNPJ01000004",93.966,8.68e-43,176,116,109.00056,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_FKXL01000017",87.919,8.76e-43,176,149,130.99931,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_FKWV01000005",87.919,8.76e-43,176,149,130.99931,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_FKXF01000023",87.919,8.76e-43,176,149,130.99931,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_FNPJ01000004",91.473,8.68e-43,176,129,118.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_70535","NZ_FNOE01000002",91.406,8.76e-43,176,128,116.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1918","NZ_FNOE01000002",93.277,7.4e-43,176,119,110.99963,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_FNOE01000002",89.189,8.68e-43,176,148,131.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_10770","NZ_FNOE01000002",89.583,8.76e-43,176,144,128.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10653","NZ_FNPJ01000004",87.919,8.68e-43,176,149,130.99931,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4088","NZ_FNOE01000002",93.277,8.68e-43,176,119,110.99963,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14863","NZ_FNPJ01000004",88.079,8.68e-43,176,151,132.99929,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_FNPJ01000004",87.919,8.68e-43,176,149,130.99931,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_FNPJ01000004",89.362,8.68e-43,176,141,126.00042,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6675","NZ_FNOE01000002",93.277,8.68e-43,176,119,110.99963,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11862","NZ_FNOE01000002",88.235,8.68e-43,176,153,134.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_58721","NZ_FNPJ01000004",93.913,3.12e-42,174,115,107.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLWD01000035",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLXP01000026",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLUB01000021",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLTT01000022",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRM01000021",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRF01000022",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLWD01000035",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLXP01000026",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLUB01000021",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLTT01000022",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRM01000021",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRF01000022",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLWD01000035",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLXP01000026",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLUB01000021",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLTT01000022",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRM01000021",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRF01000022",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLWD01000035",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLXP01000026",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLUB01000021",87.421,3.15e-42,174,159,138.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLTT01000022",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRM01000021",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRF01000022",87.421,3.15e-42,174,159,138.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLWD01000035",89.209,3.12e-42,174,139,124.00051,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLXP01000026",89.209,3.12e-42,174,139,124.00051,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLUB01000021",89.209,3.12e-42,174,139,124.00051,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLTT01000022",89.209,3.12e-42,174,139,124.00051,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRM01000021",89.209,3.12e-42,174,139,124.00051,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRF01000022",89.209,3.12e-42,174,139,124.00051,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_FKXL01000017",87.838,3.12e-42,174,148,130.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_FKWV01000005",87.838,3.12e-42,174,148,130.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_FKXF01000023",87.838,3.12e-42,174,148,130.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_FKXL01000017",87.838,3.12e-42,174,148,130.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_FKWV01000005",87.838,3.12e-42,174,148,130.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_FKXF01000023",87.838,3.12e-42,174,148,130.00024,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLWD01000035",89.706,3.12e-42,174,136,122.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLXP01000026",89.706,3.12e-42,174,136,122.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLUB01000021",89.706,3.12e-42,174,136,122.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLTT01000022",89.706,3.12e-42,174,136,122.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRM01000021",89.706,3.12e-42,174,136,122.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRF01000022",89.706,3.12e-42,174,136,122.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLWD01000035",89.706,3.12e-42,174,136,122.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLXP01000026",89.706,3.12e-42,174,136,122.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLUB01000021",89.706,3.12e-42,174,136,122.00016,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLTT01000022",89.706,3.12e-42,174,136,122.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRM01000021",89.706,3.12e-42,174,136,122.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRF01000022",89.706,3.12e-42,174,136,122.00016,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2305","NZ_FNPJ01000004",88.276,3.15e-42,174,145,128.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10831","NZ_FNPJ01000004",93.333,2.36e-42,174,120,111.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10831","NZ_FNOE01000002",93.333,2.36e-42,174,120,111.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1918","NZ_FNPJ01000004",90.769,2.66e-42,174,130,117.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17248","NZ_FKXL01000017",90.226,3.15e-42,174,133,120.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17248","NZ_FKWV01000005",90.226,3.15e-42,174,133,120.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17248","NZ_FKXF01000023",90.226,3.15e-42,174,133,120.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_FKXL01000017",93.913,2.28e-42,174,115,107.99995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_FKWV01000005",93.913,2.28e-42,174,115,107.99995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_FKXF01000023",93.913,2.28e-42,174,115,107.99995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20413","NZ_FKXL01000017",90.226,3.12e-42,174,133,120.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20413","NZ_FKWV01000005",90.226,3.12e-42,174,133,120.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20413","NZ_FKXF01000023",90.226,3.12e-42,174,133,120.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLWD01000035",89.041,3.12e-42,174,146,129.99986,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLXP01000026",89.041,3.12e-42,174,146,129.99986,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLUB01000021",89.041,3.12e-42,174,146,129.99986,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLTT01000022",89.041,3.12e-42,174,146,129.99986,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRM01000021",89.041,3.12e-42,174,146,129.99986,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRF01000022",89.041,3.12e-42,174,146,129.99986,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3738","NZ_FNOE01000002",94.69,3.12e-42,174,113,106.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_FNPJ01000004",92,3.12e-42,174,125,115,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_FKXL01000017",87.5,1.13e-41,172,152,133,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_FKWV01000005",87.5,1.13e-41,172,152,133,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_FKXF01000023",87.5,1.13e-41,172,152,133,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLWD01000035",89.781,1.13e-41,172,137,122.99997,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLXP01000026",89.781,1.13e-41,172,137,122.99997,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLUB01000021",89.781,1.13e-41,172,137,122.99997,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLTT01000022",89.781,1.13e-41,172,137,122.99997,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRM01000021",89.781,1.13e-41,172,137,122.99997,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRF01000022",89.781,1.13e-41,172,137,122.99997,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_FKXL01000017",87.755,1.12e-41,172,147,128.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_FKWV01000005",87.755,1.12e-41,172,147,128.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_FKXF01000023",87.755,1.12e-41,172,147,128.99985,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLWD01000035",87.838,1.12e-41,172,148,130.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLXP01000026",87.838,1.12e-41,172,148,130.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLUB01000021",87.838,1.12e-41,172,148,130.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLTT01000022",87.838,1.12e-41,172,148,130.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRM01000021",87.838,1.12e-41,172,148,130.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRF01000022",87.838,1.12e-41,172,148,130.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLWD01000035",87.838,1.12e-41,172,148,130.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLXP01000026",87.838,1.12e-41,172,148,130.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLUB01000021",87.838,1.12e-41,172,148,130.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLTT01000022",87.838,1.12e-41,172,148,130.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRM01000021",87.838,1.12e-41,172,148,130.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRF01000022",87.838,1.12e-41,172,148,130.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_FKXL01000017",87.333,1.13e-41,172,150,130.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_FKWV01000005",87.333,1.13e-41,172,150,130.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_FKXF01000023",87.333,1.13e-41,172,150,130.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12215","NZ_FNOE01000002",90.698,1.13e-41,172,129,117.00042,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLWD01000035",89.63,1.12e-41,172,135,121.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLXP01000026",89.63,1.12e-41,172,135,121.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLUB01000021",89.63,1.12e-41,172,135,121.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLTT01000022",89.63,1.12e-41,172,135,121.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRM01000021",89.63,1.12e-41,172,135,121.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRF01000022",89.63,1.12e-41,172,135,121.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_FNOE01000002",91.27,1.13e-41,172,126,115.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_FNOE01000002",87.333,1.13e-41,172,150,130.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13638","NZ_FNPJ01000004",94.595,1.11e-41,172,111,105.00045,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLWD01000035",87.333,4.04e-41,171,150,130.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLXP01000026",87.333,4.04e-41,171,150,130.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLUB01000021",87.333,4.04e-41,171,150,130.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLTT01000022",87.333,4.04e-41,171,150,130.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRM01000021",87.333,4.04e-41,171,150,130.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRF01000022",87.333,4.04e-41,171,150,130.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39731","NZ_FKXL01000017",87.117,4.04e-41,171,163,142.00071,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39731","NZ_FKWV01000005",87.117,4.04e-41,171,163,142.00071,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39731","NZ_FKXF01000023",87.117,4.04e-41,171,163,142.00071,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_FKXL01000017",88.356,4.07e-41,171,146,128.99976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_FKWV01000005",88.356,4.07e-41,171,146,128.99976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_FKXF01000023",88.356,4.07e-41,171,146,128.99976,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_FNOE01000002",89.051,4.07e-41,171,137,121.99987,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17646","NZ_FNPJ01000004",87.755,4.04e-41,171,147,128.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17646","NZ_FNOE01000002",87.755,4.04e-41,171,147,128.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_FNOE01000002",88.514,4.04e-41,171,148,131.00072,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9062","NZ_FNPJ01000004",87.755,4.07e-41,171,147,128.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9062","NZ_FNOE01000002",87.755,4.07e-41,171,147,128.99985,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10311","NZ_FNPJ01000004",94.545,4.07e-41,171,110,103.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_FKXL01000017",87.333,4.07e-41,171,150,130.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_FKWV01000005",87.333,4.07e-41,171,150,130.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_FKXF01000023",87.333,4.07e-41,171,150,130.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_FKXL01000017",87.5,4.07e-41,171,152,133,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_FKWV01000005",87.5,4.07e-41,171,152,133,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_FKXF01000023",87.5,4.07e-41,171,152,133,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4088","NZ_FNPJ01000004",92.437,4.04e-41,171,119,110.00003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_FNOE01000002",91.2,4.04e-41,171,125,114,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28885","NZ_FNOE01000002",87.248,4.04e-41,171,149,129.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_FNPJ01000004",88.652,4.04e-41,171,141,124.99932,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6675","NZ_FNPJ01000004",92.437,4.04e-41,171,119,110.00003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17936","NZ_FNOE01000002",87.248,4.04e-41,171,149,129.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17938","NZ_FNOE01000002",87.248,4.04e-41,171,149,129.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLXP01000026",87.417,4.04e-41,171,151,131.99967,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLUB01000021",87.417,4.04e-41,171,151,131.99967,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLTT01000022",87.417,4.04e-41,171,151,131.99967,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRM01000021",87.417,4.04e-41,171,151,131.99967,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRF01000022",87.417,4.04e-41,171,151,131.99967,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLWD01000035",90.551,1.47e-40,169,127,114.99977,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLXP01000026",90.551,1.47e-40,169,127,114.99977,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLUB01000021",90.551,1.47e-40,169,127,114.99977,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLTT01000022",90.551,1.47e-40,169,127,114.99977,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRM01000021",90.551,1.47e-40,169,127,114.99977,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRF01000022",90.551,1.47e-40,169,127,114.99977,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLXP01000026",87.097,1.47e-40,169,155,135.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLUB01000021",87.097,1.47e-40,169,155,135.00035,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLTT01000022",87.097,1.47e-40,169,155,135.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRM01000021",87.097,1.47e-40,169,155,135.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRF01000022",87.097,1.47e-40,169,155,135.00035,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLWD01000035",88.489,1.45e-40,169,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLXP01000026",88.489,1.45e-40,169,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLUB01000021",88.489,1.45e-40,169,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLTT01000022",88.489,1.45e-40,169,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRM01000021",88.489,1.45e-40,169,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRF01000022",88.489,1.45e-40,169,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLWD01000035",88.489,1.45e-40,169,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLXP01000026",88.489,1.45e-40,169,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLUB01000021",88.489,1.45e-40,169,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLTT01000022",88.489,1.45e-40,169,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRM01000021",88.489,1.45e-40,169,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRF01000022",88.489,1.45e-40,169,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2409","NZ_FNOE01000002",93.75,1.45e-40,169,112,105,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1011","NZ_FNOE01000002",93.75,1.41e-40,169,112,105,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLWD01000035",88.971,1.45e-40,169,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLXP01000026",88.971,1.45e-40,169,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLUB01000021",88.971,1.45e-40,169,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLTT01000022",88.971,1.45e-40,169,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRM01000021",88.971,1.45e-40,169,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRF01000022",88.971,1.45e-40,169,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_70535","NZ_FNPJ01000004",90.551,1.47e-40,169,127,114.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLWD01000035",90.152,1.24e-40,169,132,119.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLXP01000026",90.152,1.24e-40,169,132,119.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLUB01000021",90.152,1.24e-40,169,132,119.00064,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLTT01000022",90.152,1.24e-40,169,132,119.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRM01000021",90.152,1.24e-40,169,132,119.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRF01000022",90.152,1.24e-40,169,132,119.00064,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_FKXL01000017",89.13,1.45e-40,169,138,122.9994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_FKWV01000005",89.13,1.45e-40,169,138,122.9994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_FKXF01000023",89.13,1.45e-40,169,138,122.9994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_FNOE01000002",90.625,1.45e-40,169,128,116,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_FNOE01000002",90.625,1.45e-40,169,128,116,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6859","NZ_FNOE01000002",88.028,1.43e-40,169,142,124.99976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3738","NZ_FNPJ01000004",94.495,1.45e-40,169,109,102.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_FKXL01000017",88.276,1.45e-40,169,145,128.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_FKWV01000005",88.276,1.45e-40,169,145,128.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_FKXF01000023",88.276,1.45e-40,169,145,128.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8713","NZ_FNOE01000002",93.75,1.45e-40,169,112,105,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8714","NZ_FNOE01000002",93.75,1.45e-40,169,112,105,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13637","NZ_FNOE01000002",93.75,1.44e-40,169,112,105,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLWD01000035",89.051,5.27e-40,167,137,121.99987,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLXP01000026",89.051,5.27e-40,167,137,121.99987,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLUB01000021",89.051,5.27e-40,167,137,121.99987,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLTT01000022",89.051,5.27e-40,167,137,121.99987,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRM01000021",89.051,5.27e-40,167,137,121.99987,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRF01000022",89.051,5.27e-40,167,137,121.99987,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_36613","NZ_FNPJ01000004",88.406,5.27e-40,167,138,122.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLWD01000035",94.545,5.27e-40,167,110,103.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_FNPJ01000004",87.5,5.27e-40,167,152,133,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLWD01000035",88.406,5.23e-40,167,138,122.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLXP01000026",88.406,5.23e-40,167,138,122.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLUB01000021",88.406,5.23e-40,167,138,122.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLTT01000022",88.406,5.23e-40,167,138,122.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRM01000021",88.406,5.23e-40,167,138,122.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRF01000022",88.406,5.23e-40,167,138,122.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2409","NZ_FNPJ01000004",93.694,5.23e-40,167,111,104.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1011","NZ_FNPJ01000004",93.694,5.06e-40,167,111,104.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLWD01000035",89.394,5.23e-40,167,132,118.00008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLXP01000026",89.394,5.23e-40,167,132,118.00008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLUB01000021",89.394,5.23e-40,167,132,118.00008,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLTT01000022",89.394,5.23e-40,167,132,118.00008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLRM01000021",89.394,5.23e-40,167,132,118.00008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLRF01000022",89.394,5.23e-40,167,132,118.00008,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9889","NZ_FNOE01000002",90.551,4.46e-40,167,127,114.99977,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_22858","NZ_FNPJ01000004",87.075,5.23e-40,167,147,128.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_22858","NZ_FNOE01000002",87.5,5.23e-40,167,144,126,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25338","NZ_FNPJ01000004",87.075,5.23e-40,167,147,128.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25338","NZ_FNOE01000002",87.5,5.23e-40,167,144,126,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_FNOE01000002",88.406,5.27e-40,167,138,122.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26109","NZ_FNPJ01000004",94.444,4.41e-40,167,108,101.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_FKXL01000017",88.276,5.23e-40,167,145,128.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_FKWV01000005",88.276,5.23e-40,167,145,128.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_FKXF01000023",88.276,5.23e-40,167,145,128.0002,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8713","NZ_FNPJ01000004",93.694,5.23e-40,167,111,104.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8714","NZ_FNPJ01000004",93.694,5.23e-40,167,111,104.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLWD01000035",87.075,5.27e-40,167,147,128.00025,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13637","NZ_FNPJ01000004",93.694,5.18e-40,167,111,104.00034,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_86460","NZ_FNOE01000002",87.248,1.88e-39,165,149,129.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLWD01000035",86.667,1.88e-39,165,150,130.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLXP01000026",86.667,1.88e-39,165,150,130.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLUB01000021",86.667,1.88e-39,165,150,130.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLTT01000022",86.667,1.88e-39,165,150,130.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRM01000021",86.667,1.88e-39,165,150,130.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRF01000022",86.667,1.88e-39,165,150,130.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLWD01000035",88.971,1.88e-39,165,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLXP01000026",88.971,1.88e-39,165,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLUB01000021",88.971,1.88e-39,165,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLTT01000022",88.971,1.88e-39,165,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRM01000021",88.971,1.88e-39,165,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRF01000022",88.971,1.88e-39,165,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46170","NZ_FNPJ01000004",89.313,1.88e-39,165,131,117.00003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27008","NZ_FNOE01000002",86.842,1.88e-39,165,152,131.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39732","NZ_FKXL01000017",86.503,1.88e-39,165,163,140.99989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39732","NZ_FKWV01000005",86.503,1.88e-39,165,163,140.99989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39732","NZ_FKXF01000023",86.503,1.88e-39,165,163,140.99989,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_FKXL01000017",86.667,1.88e-39,165,150,130.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_FKWV01000005",86.667,1.88e-39,165,150,130.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_FKXF01000023",86.667,1.88e-39,165,150,130.0005,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLWD01000035",88.489,1.9e-39,165,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLXP01000026",88.489,1.9e-39,165,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLUB01000021",88.489,1.9e-39,165,139,122.99971,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLTT01000022",88.489,1.9e-39,165,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRM01000021",88.489,1.9e-39,165,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRF01000022",88.489,1.9e-39,165,139,122.99971,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLWD01000035",88.971,1.88e-39,165,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLXP01000026",88.971,1.88e-39,165,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLUB01000021",88.971,1.88e-39,165,136,121.00056,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLTT01000022",88.971,1.88e-39,165,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRM01000021",88.971,1.88e-39,165,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRF01000022",88.971,1.88e-39,165,136,121.00056,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17641","NZ_FNPJ01000004",87.075,1.88e-39,165,147,128.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17641","NZ_FNOE01000002",87.075,1.88e-39,165,147,128.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_FKXL01000017",92.241,1.88e-39,165,116,106.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_FKWV01000005",92.241,1.88e-39,165,116,106.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_FKXF01000023",92.241,1.88e-39,165,116,106.99956,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7398","NZ_FNOE01000002",87.333,1.88e-39,165,150,130.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8149","NZ_FNPJ01000004",86.577,1.88e-39,165,149,128.99973,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_FNOE01000002",86.667,1.88e-39,165,150,130.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_FNOE01000002",87.5,1.88e-39,165,144,126,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17937","NZ_FNOE01000002",86.577,1.88e-39,165,149,128.99973,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_FNPJ01000004",86.667,1.88e-39,165,150,130.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21944","NZ_FNPJ01000004",86.486,6.76e-39,163,148,127.99928,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLWD01000035",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLXP01000026",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLUB01000021",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLTT01000022",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRM01000021",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRF01000022",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLWD01000035",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXP01000026",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLUB01000021",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLTT01000022",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRM01000021",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRF01000022",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLWD01000035",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLXP01000026",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLUB01000021",89.764,6.82e-39,163,127,114.00028,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLTT01000022",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRM01000021",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRF01000022",89.764,6.82e-39,163,127,114.00028,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_FKXL01000017",90,6.76e-39,163,130,117,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_FKWV01000005",90,6.76e-39,163,130,117,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_FKXF01000023",90,6.76e-39,163,130,117,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_FNOE01000002",89.844,6.76e-39,163,128,115.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLWD01000035",86.275,6.82e-39,163,153,132.00075,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_FKXL01000017",87.77,6.82e-39,163,139,122.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_FKWV01000005",87.77,6.82e-39,163,139,122.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_FKXF01000023",87.77,6.82e-39,163,139,122.0003,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLWD01000035",90.909,5.54e-39,163,121,109.99989,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLXP01000026",90.909,5.54e-39,163,121,109.99989,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLUB01000021",90.909,5.54e-39,163,121,109.99989,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLTT01000022",90.909,5.54e-39,163,121,109.99989,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRM01000021",90.909,5.54e-39,163,121,109.99989,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRF01000022",90.909,5.54e-39,163,121,109.99989,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_FNPJ01000004",90.909,5.54e-39,163,121,109.99989,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_FKXL01000017",88.406,6.76e-39,163,138,122.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_FKWV01000005",88.406,6.76e-39,163,138,122.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_FKXF01000023",88.406,6.76e-39,163,138,122.00028,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLWD01000035",87.671,6.76e-39,163,146,127.99966,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLXP01000026",87.671,6.76e-39,163,146,127.99966,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLUB01000021",87.671,6.76e-39,163,146,127.99966,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLTT01000022",87.671,6.76e-39,163,146,127.99966,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRM01000021",87.671,6.76e-39,163,146,127.99966,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRF01000022",87.671,6.76e-39,163,146,127.99966,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_FKXL01000017",87.586,6.76e-39,163,145,126.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_FKWV01000005",87.586,6.76e-39,163,145,126.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_FKXF01000023",87.586,6.76e-39,163,145,126.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_FKXL01000017",87.586,6.76e-39,163,145,126.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_FKWV01000005",87.586,6.76e-39,163,145,126.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_FKXF01000023",87.586,6.76e-39,163,145,126.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_FNOE01000002",89.844,6.76e-39,163,128,115.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_FNPJ01000004",86.486,6.76e-39,163,148,127.99928,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13638","NZ_FNOE01000002",92.857,6.71e-39,163,112,103.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_FNOE01000002",86.364,2.45e-38,161,154,133.00056,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1850","NZ_FKXL01000017",88.722,2.35e-38,161,133,118.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1850","NZ_FKWV01000005",88.722,2.35e-38,161,133,118.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1850","NZ_FKXF01000023",88.722,2.35e-38,161,133,118.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_33258","NZ_FNPJ01000004",88.722,2.35e-38,161,133,118.00026,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_33259","NZ_FNPJ01000004",90.909,2.35e-38,161,121,109.99989,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_FKXL01000017",87.5,2.45e-38,161,144,126,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_FKWV01000005",87.5,2.45e-38,161,144,126,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_FKXF01000023",87.5,2.45e-38,161,144,126,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_FKXL01000017",87.5,2.45e-38,161,144,126,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_FKWV01000005",87.5,2.45e-38,161,144,126,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_FKXF01000023",87.5,2.45e-38,161,144,126,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28802","NZ_FNPJ01000004",90.833,2.43e-38,161,120,108.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28802","NZ_FNOE01000002",90.833,2.43e-38,161,120,108.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28803","NZ_FNPJ01000004",90.833,2.45e-38,161,120,108.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28803","NZ_FNOE01000002",90.833,2.45e-38,161,120,108.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLWD01000035",86.395,2.43e-38,161,147,127.00065,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLXP01000026",86.395,2.43e-38,161,147,127.00065,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLUB01000021",86.395,2.43e-38,161,147,127.00065,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLTT01000022",86.395,2.43e-38,161,147,127.00065,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRM01000021",86.395,2.43e-38,161,147,127.00065,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRF01000022",86.395,2.43e-38,161,147,127.00065,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9889","NZ_FNPJ01000004",89.764,2.07e-38,161,127,114.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLWD01000035",89.313,2.07e-38,161,131,117.00003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLXP01000026",89.313,2.07e-38,161,131,117.00003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLUB01000021",89.313,2.07e-38,161,131,117.00003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLTT01000022",89.313,2.07e-38,161,131,117.00003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRM01000021",89.313,2.07e-38,161,131,117.00003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRF01000022",89.313,2.07e-38,161,131,117.00003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLWD01000035",89.313,2.07e-38,161,131,117.00003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLXP01000026",89.313,2.07e-38,161,131,117.00003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLUB01000021",89.313,2.07e-38,161,131,117.00003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLTT01000022",89.313,2.07e-38,161,131,117.00003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRM01000021",89.313,2.07e-38,161,131,117.00003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRF01000022",89.313,2.07e-38,161,131,117.00003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_FNPJ01000004",89.764,2.45e-38,161,127,114.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLWD01000035",86.184,2.43e-38,161,152,130.99968,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46168","NZ_FNPJ01000004",88.55,8.75e-38,159,131,116.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46169","NZ_FNPJ01000004",88.55,8.75e-38,159,131,116.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43252","NZ_FNOE01000002",86,8.82e-38,159,150,129,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27902","NZ_FKXL01000017",87.324,8.82e-38,159,142,124.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27902","NZ_FKWV01000005",87.324,8.82e-38,159,142,124.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27902","NZ_FKXF01000023",87.324,8.82e-38,159,142,124.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27904","NZ_FKXL01000017",87.324,8.82e-38,159,142,124.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27904","NZ_FKWV01000005",87.324,8.82e-38,159,142,124.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27904","NZ_FKXF01000023",87.324,8.82e-38,159,142,124.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17011","NZ_FNPJ01000004",90.164,8.75e-38,159,122,110.00008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11338","NZ_FNOE01000002",86.301,8.75e-38,159,146,125.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_FNPJ01000004",89.683,8.75e-38,159,126,113.00058,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_FNOE01000002",86.806,8.75e-38,159,144,125.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_FKXL01000017",86.301,3.17e-37,158,146,125.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_FKWV01000005",86.301,3.17e-37,158,146,125.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_FKXF01000023",86.301,3.17e-37,158,146,125.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18803","NZ_FNOE01000002",85.714,3.17e-37,158,154,131.99956,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_FKXL01000017",87.234,3.15e-37,158,141,122.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_FKWV01000005",87.234,3.15e-37,158,141,122.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_FKXF01000023",87.234,3.15e-37,158,141,122.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_FNPJ01000004",88.06,3.09e-37,158,134,118.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_FNOE01000002",88.148,3.09e-37,158,135,118.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2907","NZ_FNOE01000002",88.462,3.15e-37,158,130,115.0006,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_FKXL01000017",86.897,3.12e-37,158,145,126.00065,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_FKWV01000005",86.897,3.12e-37,158,145,126.00065,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_FKXF01000023",86.897,3.12e-37,158,145,126.00065,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_FNOE01000002",85.811,3.15e-37,158,148,127.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_FKXL01000017",86.207,1.13e-36,156,145,125.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_FKWV01000005",86.207,1.13e-36,156,145,125.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_FKXF01000023",86.207,1.13e-36,156,145,125.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43252","NZ_FNPJ01000004",85.43,1.14e-36,156,151,128.9993,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_FKXL01000017",86.806,1.14e-36,156,144,125.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_FKWV01000005",86.806,1.14e-36,156,144,125.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_FKXF01000023",86.806,1.14e-36,156,144,125.00064,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_FKXL01000017",86.207,1.13e-36,156,145,125.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_FKWV01000005",86.207,1.13e-36,156,145,125.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_FKXF01000023",86.207,1.13e-36,156,145,125.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8106","NZ_FNOE01000002",86.111,1.14e-36,156,144,123.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8107","NZ_FNOE01000002",86.111,1.14e-36,156,144,123.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7398","NZ_FKXL01000017",86,1.13e-36,156,150,129,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7398","NZ_FKWV01000005",86,1.13e-36,156,150,129,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7398","NZ_FKXF01000023",86,1.13e-36,156,150,129,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLWD01000035",85.714,1.12e-36,156,147,125.99958,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLXP01000026",85.714,1.12e-36,156,147,125.99958,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLUB01000021",85.714,1.12e-36,156,147,125.99958,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLTT01000022",85.714,1.12e-36,156,147,125.99958,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRM01000021",85.714,1.12e-36,156,147,125.99958,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRF01000022",85.714,1.12e-36,156,147,125.99958,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_FNPJ01000004",86.957,1.14e-36,156,138,120.00066,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_FKXL01000017",85.443,1.13e-36,156,158,134.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_FKWV01000005",85.443,1.13e-36,156,158,134.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_FKXF01000023",85.443,1.13e-36,156,158,134.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLWD01000035",90.517,4.07e-36,154,116,104.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLXP01000026",90.517,4.07e-36,154,116,104.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLUB01000021",90.517,4.07e-36,154,116,104.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLTT01000022",90.517,4.07e-36,154,116,104.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRM01000021",90.517,4.07e-36,154,116,104.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRF01000022",90.517,4.07e-36,154,116,104.99972,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLWD01000035",86.861,4.1e-36,154,137,118.99957,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLXP01000026",86.861,4.1e-36,154,137,118.99957,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLUB01000021",86.861,4.1e-36,154,137,118.99957,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLTT01000022",86.861,4.1e-36,154,137,118.99957,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRM01000021",86.861,4.1e-36,154,137,118.99957,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRF01000022",86.861,4.1e-36,154,137,118.99957,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43251","NZ_FNOE01000002",85.333,4.1e-36,154,150,127.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_51177","NZ_FNPJ01000004",87.786,4.1e-36,154,131,114.99966,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9782","NZ_FNOE01000002",86.62,4.07e-36,154,142,123.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_FNOE01000002",94.898,4.07e-36,154,98,93.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLWD01000035",86.957,4.1e-36,154,138,120.00066,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLXP01000026",86.957,4.1e-36,154,138,120.00066,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLUB01000021",86.957,4.1e-36,154,138,120.00066,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLTT01000022",86.957,4.1e-36,154,138,120.00066,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRM01000021",86.957,4.1e-36,154,138,120.00066,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRF01000022",86.957,4.1e-36,154,138,120.00066,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_FNOE01000002",94.898,3.47e-36,154,98,93.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_FKXL01000017",88.462,4.07e-36,154,130,115.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_FKWV01000005",88.462,4.07e-36,154,130,115.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_FKXF01000023",88.462,4.07e-36,154,130,115.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLWD01000035",85.621,4.1e-36,154,153,131.00013,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20661","NZ_FNPJ01000004",89.344,4.1e-36,154,122,108.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20661","NZ_FNOE01000002",89.344,4.1e-36,154,122,108.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_MLWD01000035",86.111,3.9e-36,154,144,123.99984,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2908","NZ_FNOE01000002",93.269,4.07e-36,154,104,96.99976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_FNOE01000002",86.111,4.04e-36,154,144,123.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_FNPJ01000004",86.301,4.07e-36,154,146,125.99946,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLWD01000035",86.765,1.48e-35,152,136,118.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLXP01000026",86.765,1.48e-35,152,136,118.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLUB01000021",86.765,1.48e-35,152,136,118.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLTT01000022",86.765,1.48e-35,152,136,118.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRM01000021",86.765,1.48e-35,152,136,118.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRF01000022",86.765,1.48e-35,152,136,118.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8606","NZ_FKXL01000017",86.429,1.48e-35,152,140,121.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8606","NZ_FKWV01000005",86.429,1.48e-35,152,140,121.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8606","NZ_FKXF01000023",86.429,1.48e-35,152,140,121.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26940","NZ_FKXL01000017",85.714,1.48e-35,152,147,125.99958,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26940","NZ_FKWV01000005",85.714,1.48e-35,152,147,125.99958,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26940","NZ_FKXF01000023",85.714,1.48e-35,152,147,125.99958,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_FKXL01000017",84.906,1.48e-35,152,159,135.00054,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_FKWV01000005",84.906,1.48e-35,152,159,135.00054,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_FKXF01000023",84.906,1.48e-35,152,159,135.00054,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_FKXL01000017",84.906,1.48e-35,152,159,135.00054,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_FKWV01000005",84.906,1.48e-35,152,159,135.00054,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_FKXF01000023",84.906,1.48e-35,152,159,135.00054,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18803","NZ_FNPJ01000004",85.161,1.48e-35,152,155,131.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_FNOE01000002",92.453,1.2e-35,152,106,98.00018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_FKXL01000017",86.525,1.46e-35,152,141,122.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_FKWV01000005",86.525,1.46e-35,152,141,122.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_FKXF01000023",86.525,1.46e-35,152,141,122.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_FKXL01000017",86.525,1.46e-35,152,141,122.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_FKWV01000005",86.525,1.46e-35,152,141,122.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_FKXF01000023",86.525,1.46e-35,152,141,122.00025,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLWD01000035",85.526,1.46e-35,152,152,129.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2906","NZ_FNOE01000002",87.692,1.46e-35,152,130,113.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2907","NZ_FNPJ01000004",87.692,1.46e-35,152,130,113.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_FKXL01000017",86.301,5.31e-35,150,146,125.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_FKWV01000005",86.301,5.31e-35,150,146,125.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_FKXF01000023",86.301,5.31e-35,150,146,125.99946,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_FNPJ01000004",84.667,5.31e-35,150,150,127.0005,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8105","NZ_FNOE01000002",85.417,5.31e-35,150,144,123.00048,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8644","NZ_FNOE01000002",85.333,5.31e-35,150,150,127.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLWD01000035",85.065,5.31e-35,150,154,131.0001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLWD01000035",89.256,5.31e-35,150,121,107.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLXP01000026",89.256,5.31e-35,150,121,107.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLUB01000021",89.256,5.31e-35,150,121,107.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLTT01000022",89.256,5.31e-35,150,121,107.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRM01000021",89.256,5.31e-35,150,121,107.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRF01000022",89.256,5.31e-35,150,121,107.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLWD01000035",89.256,5.31e-35,150,121,107.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLXP01000026",89.256,5.31e-35,150,121,107.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLUB01000021",89.256,5.31e-35,150,121,107.99976,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLTT01000022",89.256,5.31e-35,150,121,107.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRM01000021",89.256,5.31e-35,150,121,107.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRF01000022",89.256,5.31e-35,150,121,107.99976,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_MLWD01000035",87.786,1.89e-34,148,131,114.99966,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLWD01000035",86.131,1.91e-34,148,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLXP01000026",86.131,1.91e-34,148,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLUB01000021",86.131,1.91e-34,148,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLTT01000022",86.131,1.91e-34,148,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRM01000021",86.131,1.91e-34,148,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRF01000022",86.131,1.91e-34,148,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLWD01000035",86.131,1.91e-34,148,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLXP01000026",86.131,1.91e-34,148,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLUB01000021",86.131,1.91e-34,148,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLTT01000022",86.131,1.91e-34,148,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRM01000021",86.131,1.91e-34,148,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRF01000022",86.131,1.91e-34,148,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2050","NZ_FKXL01000017",84.568,1.89e-34,148,162,137.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2050","NZ_FKWV01000005",84.568,1.89e-34,148,162,137.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2050","NZ_FKXF01000023",84.568,1.89e-34,148,162,137.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_51178","NZ_FNPJ01000004",87.023,1.91e-34,148,131,114.00013,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_FKXL01000017",84.932,1.91e-34,148,146,124.00072,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_FKWV01000005",84.932,1.91e-34,148,146,124.00072,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_FKXF01000023",84.932,1.91e-34,148,146,124.00072,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2908","NZ_FNPJ01000004",92.308,1.89e-34,148,104,96.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10246","NZ_FNOE01000002",84.868,1.89e-34,148,152,128.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_FKXL01000017",84.828,6.86e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_FKWV01000005",84.828,6.86e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_FKXF01000023",84.828,6.86e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_FKXL01000017",87.692,6.81e-34,147,130,113.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_FKWV01000005",87.692,6.81e-34,147,130,113.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_FKXF01000023",87.692,6.81e-34,147,130,113.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_843","NZ_FKXL01000017",90.909,6.59e-34,147,110,99.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_843","NZ_FKWV01000005",90.909,6.59e-34,147,110,99.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_843","NZ_FKXF01000023",90.909,6.59e-34,147,110,99.9999,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_FKXL01000017",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_FKWV01000005",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_FKXF01000023",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_FKXL01000017",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_FKWV01000005",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_FKXF01000023",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_FKXL01000017",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_FKWV01000005",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_FKXF01000023",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_FKXL01000017",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_FKWV01000005",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_FKXF01000023",84.828,6.81e-34,147,145,123.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11010","NZ_FNPJ01000004",89.076,5.8e-34,147,119,106.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11010","NZ_FNOE01000002",89.076,5.8e-34,147,119,106.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11011","NZ_FNPJ01000004",89.076,5.8e-34,147,119,106.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11011","NZ_FNOE01000002",89.076,5.8e-34,147,119,106.00044,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLWD01000035",86.131,6.14e-34,147,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLXP01000026",86.131,6.14e-34,147,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLUB01000021",86.131,6.14e-34,147,137,117.99947,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLTT01000022",86.131,6.14e-34,147,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRM01000021",86.131,6.14e-34,147,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRF01000022",86.131,6.14e-34,147,137,117.99947,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2905","NZ_FNOE01000002",92.308,6.81e-34,147,104,96.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2906","NZ_FNPJ01000004",86.923,6.81e-34,147,130,112.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_FNOE01000002",85.315,2.45e-33,145,143,122.00045,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_FKXL01000017",85.211,2.45e-33,145,142,120.99962,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_FKWV01000005",85.211,2.45e-33,145,142,120.99962,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_FKXF01000023",85.211,2.45e-33,145,142,120.99962,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_FNPJ01000004",92.157,2.47e-33,145,102,94.00014,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLWD01000035",85.417,2.37e-33,145,144,123.00048,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLXP01000026",85.417,2.37e-33,145,144,123.00048,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLUB01000021",85.417,2.37e-33,145,144,123.00048,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLTT01000022",85.417,2.37e-33,145,144,123.00048,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRM01000021",85.417,2.37e-33,145,144,123.00048,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRF01000022",85.417,2.37e-33,145,144,123.00048,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_FKXL01000017",87.302,2.45e-33,145,126,110.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_FKWV01000005",87.302,2.45e-33,145,126,110.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_FKXF01000023",87.302,2.45e-33,145,126,110.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_FKXL01000017",85.616,2.47e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_FKWV01000005",85.616,2.47e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_FKXF01000023",85.616,2.47e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_FKXL01000017",85.616,2.47e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_FKWV01000005",85.616,2.47e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_FKXF01000023",85.616,2.47e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_FNOE01000002",84,2.47e-33,145,150,126,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_FKXL01000017",85.507,2.47e-33,145,138,117.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_FKWV01000005",85.507,2.47e-33,145,138,117.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_FKXF01000023",85.507,2.47e-33,145,138,117.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11033","NZ_FKXL01000017",85.616,2.45e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11033","NZ_FKWV01000005",85.616,2.45e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11033","NZ_FKXF01000023",85.616,2.45e-33,145,146,124.99936,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_FNOE01000002",85.315,2.35e-33,145,143,122.00045,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLWD01000035",88.43,2.47e-33,145,121,107.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLXP01000026",88.43,2.47e-33,145,121,107.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLUB01000021",88.43,2.47e-33,145,121,107.0003,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLTT01000022",88.43,2.47e-33,145,121,107.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRM01000021",88.43,2.47e-33,145,121,107.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRF01000022",88.43,2.47e-33,145,121,107.0003,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FKXL01000017",87.302,2.35e-33,145,126,110.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FKWV01000005",87.302,2.35e-33,145,126,110.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FKXF01000023",87.302,2.35e-33,145,126,110.00052,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_FKXL01000017",85.507,2.45e-33,145,138,117.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_FKWV01000005",85.507,2.45e-33,145,138,117.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_FKXF01000023",85.507,2.45e-33,145,138,117.99966,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_MLWD01000035",87.023,8.81e-33,143,131,114.00013,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_FNPJ01000004",83.893,8.88e-33,143,149,125.00057,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_FNPJ01000004",83.893,8.88e-33,143,149,125.00057,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLWD01000035",85.401,8.88e-33,143,137,116.99937,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLXP01000026",85.401,8.88e-33,143,137,116.99937,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLUB01000021",85.401,8.88e-33,143,137,116.99937,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLTT01000022",85.401,8.88e-33,143,137,116.99937,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRM01000021",85.401,8.88e-33,143,137,116.99937,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRF01000022",85.401,8.88e-33,143,137,116.99937,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLWD01000035",85.401,8.88e-33,143,137,116.99937,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLXP01000026",85.401,8.88e-33,143,137,116.99937,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLUB01000021",85.401,8.88e-33,143,137,116.99937,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLTT01000022",85.401,8.88e-33,143,137,116.99937,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRM01000021",85.401,8.88e-33,143,137,116.99937,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRF01000022",85.401,8.88e-33,143,137,116.99937,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_FKXL01000017",86.822,8.81e-33,143,129,112.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_FKWV01000005",86.822,8.81e-33,143,129,112.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_FKXF01000023",86.822,8.81e-33,143,129,112.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22444","NZ_FNPJ01000004",86.822,7.51e-33,143,129,112.00038,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22444","NZ_FNOE01000002",86.822,7.51e-33,143,129,112.00038,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_FNPJ01000004",94.565,4.77e-33,143,92,86.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_FNOE01000002",94.565,4.77e-33,143,92,86.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2909","NZ_FNOE01000002",91.346,8.81e-33,143,104,94.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_FNOE01000002",84.932,8.81e-33,143,146,124.00072,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10246","NZ_FNPJ01000004",84.416,8.81e-33,143,154,130.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_FKXL01000017",84.138,3.19e-32,141,145,122.0001,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_FKWV01000005",84.138,3.19e-32,141,145,122.0001,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_FKXF01000023",84.138,3.19e-32,141,145,122.0001,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLWD01000035",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLXP01000026",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLUB01000021",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLTT01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRM01000021",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRF01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLWD01000035",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLXP01000026",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLUB01000021",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLTT01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRM01000021",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRF01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLWD01000035",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLXP01000026",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLUB01000021",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLTT01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRM01000021",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRF01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLWD01000035",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLXP01000026",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLUB01000021",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLTT01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRM01000021",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRF01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLWD01000035",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLXP01000026",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLUB01000021",86.614,3.17e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLTT01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRM01000021",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRF01000022",86.614,3.17e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48265","NZ_FNPJ01000004",83.784,3.17e-32,141,148,124.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLWD01000035",86.614,3.04e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXP01000026",86.614,3.04e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLUB01000021",86.614,3.04e-32,141,127,109.99978,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLTT01000022",86.614,3.04e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRM01000021",86.614,3.04e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRF01000022",86.614,3.04e-32,141,127,109.99978,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_2905","NZ_FNPJ01000004",91.346,3.17e-32,141,104,94.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLWD01000035",85.211,3.14e-32,141,142,120.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLXP01000026",85.211,3.14e-32,141,142,120.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLUB01000021",85.211,3.14e-32,141,142,120.99962,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLTT01000022",85.211,3.14e-32,141,142,120.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRM01000021",85.211,3.14e-32,141,142,120.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRF01000022",85.211,3.14e-32,141,142,120.99962,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FNOE01000002",84.615,1.14e-31,139,143,120.99945,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_FKXL01000017",84.397,1.14e-31,139,141,118.99977,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_FKWV01000005",84.397,1.14e-31,139,141,118.99977,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_FKXF01000023",84.397,1.14e-31,139,141,118.99977,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_FKXL01000017",84.507,1.14e-31,139,142,119.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_FKWV01000005",84.507,1.14e-31,139,142,119.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_FKXF01000023",84.507,1.14e-31,139,142,119.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_FKXL01000017",84.507,1.14e-31,139,142,119.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_FKWV01000005",84.507,1.14e-31,139,142,119.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_FKXF01000023",84.507,1.14e-31,139,142,119.99994,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32166","NZ_FNPJ01000004",86.992,1.14e-31,139,123,107.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_FNOE01000002",91.176,1.15e-31,139,102,92.99952,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_49158","NZ_FKXL01000017",86.429,1.1e-31,139,140,121.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_49158","NZ_FKWV01000005",86.429,1.1e-31,139,140,121.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_49158","NZ_FKXF01000023",86.429,1.1e-31,139,140,121.0006,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_FKXL01000017",83.444,1.15e-31,139,151,126.00044,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_FKWV01000005",83.444,1.15e-31,139,151,126.00044,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_FKXF01000023",83.444,1.15e-31,139,151,126.00044,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5187","NZ_FNOE01000002",89.815,1.14e-31,139,108,97.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLWD01000035",86.154,9.71e-32,139,130,112.0002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLXP01000026",86.154,9.71e-32,139,130,112.0002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLUB01000021",86.154,9.71e-32,139,130,112.0002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLTT01000022",86.154,9.71e-32,139,130,112.0002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRM01000021",86.154,9.71e-32,139,130,112.0002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRF01000022",86.154,9.71e-32,139,130,112.0002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLWD01000035",86.26,9.71e-32,139,131,113.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLXP01000026",86.26,9.71e-32,139,131,113.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLUB01000021",86.26,9.71e-32,139,131,113.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLTT01000022",86.26,9.71e-32,139,131,113.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRM01000021",86.26,9.71e-32,139,131,113.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRF01000022",86.26,9.71e-32,139,131,113.0006,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_FKXL01000017",83.544,1.15e-31,139,158,131.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_FKWV01000005",83.544,1.15e-31,139,158,131.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_FKXF01000023",83.544,1.15e-31,139,158,131.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_FKXL01000017",83.893,1.14e-31,139,149,125.00057,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_FKWV01000005",83.893,1.14e-31,139,149,125.00057,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_FKXF01000023",83.893,1.14e-31,139,149,125.00057,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLWD01000035",83.333,4.1e-31,137,150,124.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLXP01000026",83.333,4.1e-31,137,150,124.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLUB01000021",83.333,4.1e-31,137,150,124.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLTT01000022",83.333,4.1e-31,137,150,124.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRM01000021",83.333,4.1e-31,137,150,124.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRF01000022",83.333,4.1e-31,137,150,124.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_MLWD01000035",86.26,4.1e-31,137,131,113.0006,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_FNPJ01000004",83.221,4.13e-31,137,149,123.99929,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46170","NZ_FNOE01000002",85.606,4.1e-31,137,132,112.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48264","NZ_FNPJ01000004",83.562,4.1e-31,137,146,122.00052,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLWD01000035",83.333,4.1e-31,137,150,124.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLXP01000026",83.333,4.1e-31,137,150,124.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLUB01000021",83.333,4.1e-31,137,150,124.9995,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLTT01000022",83.333,4.1e-31,137,150,124.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRM01000021",83.333,4.1e-31,137,150,124.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRF01000022",83.333,4.1e-31,137,150,124.9995,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_51177","NZ_FNOE01000002",85.606,4.13e-31,137,132,112.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLWD01000035",86.4,4.13e-31,137,125,108,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLXP01000026",86.4,4.13e-31,137,125,108,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLUB01000021",86.4,4.13e-31,137,125,108,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLTT01000022",86.4,4.13e-31,137,125,108,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRM01000021",86.4,4.13e-31,137,125,108,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRF01000022",86.4,4.13e-31,137,125,108,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLXP01000026",88.496,4.1e-31,137,113,100.00048,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLUB01000021",88.496,4.1e-31,137,113,100.00048,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLTT01000022",88.496,4.1e-31,137,113,100.00048,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRM01000021",88.496,4.1e-31,137,113,100.00048,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRF01000022",88.496,4.1e-31,137,113,100.00048,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLWD01000035",90.476,3.49e-31,137,105,94.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLXP01000026",90.476,3.49e-31,137,105,94.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLUB01000021",90.476,3.49e-31,137,105,94.9998,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLTT01000022",90.476,3.49e-31,137,105,94.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRM01000021",90.476,3.49e-31,137,105,94.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRF01000022",90.476,3.49e-31,137,105,94.9998,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_FKXL01000017",85.401,4.03e-31,137,137,116.99937,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_FKWV01000005",85.401,4.03e-31,137,137,116.99937,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_FKXF01000023",85.401,4.03e-31,137,137,116.99937,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_FKXL01000017",85.211,4.13e-31,137,142,120.99962,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_FKWV01000005",85.211,4.13e-31,137,142,120.99962,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_FKXF01000023",85.211,4.13e-31,137,142,120.99962,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_FKXL01000017",83.439,4.1e-31,137,157,130.99923,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_FKWV01000005",83.439,4.1e-31,137,157,130.99923,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_FKXF01000023",83.439,4.1e-31,137,157,130.99923,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4024","NZ_FNPJ01000004",85.938,4.1e-31,137,128,110.00064,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLWD01000035",86.4,4.1e-31,137,125,108,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLXP01000026",86.4,4.1e-31,137,125,108,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLUB01000021",86.4,4.1e-31,137,125,108,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLTT01000022",86.4,4.1e-31,137,125,108,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRM01000021",86.4,4.1e-31,137,125,108,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRF01000022",86.4,4.1e-31,137,125,108,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_FKXL01000017",83.448,1.49e-30,135,145,120.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_FKWV01000005",83.448,1.49e-30,135,145,120.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_FKXF01000023",83.448,1.49e-30,135,145,120.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FKXL01000017",83.448,1.49e-30,135,145,120.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FKWV01000005",83.448,1.49e-30,135,145,120.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FKXF01000023",83.448,1.49e-30,135,145,120.9996,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_FNOE01000002",86.777,1.47e-30,135,121,105.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_FNOE01000002",86.777,1.47e-30,135,121,105.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_FNOE01000002",86.777,1.47e-30,135,121,105.00017,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_FNOE01000002",86.885,1.47e-30,135,122,105.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_34731","NZ_FNOE01000002",87.097,1.47e-30,135,124,108.00028,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_23854","NZ_FNPJ01000004",85.606,1.26e-30,135,132,112.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLWD01000035",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLXP01000026",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLUB01000021",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLTT01000022",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRM01000021",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRF01000022",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLWD01000035",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLXP01000026",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLUB01000021",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLTT01000022",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRM01000021",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRF01000022",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FKXL01000017",87.288,1.49e-30,135,118,102.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FKWV01000005",87.288,1.49e-30,135,118,102.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FKXF01000023",87.288,1.49e-30,135,118,102.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_FKXL01000017",87.288,1.49e-30,135,118,102.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_FKWV01000005",87.288,1.49e-30,135,118,102.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_FKXF01000023",87.288,1.49e-30,135,118,102.99984,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLWD01000035",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLXP01000026",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLUB01000021",92.632,9.18e-31,135,95,88.0004,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLTT01000022",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRM01000021",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRF01000022",92.632,9.18e-31,135,95,88.0004,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FNOE01000002",83.916,5.3e-30,134,143,119.99988,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_FKXL01000017",84.615,5.3e-30,134,143,120.99945,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_FKWV01000005",84.615,5.3e-30,134,143,120.99945,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_FKXF01000023",84.615,5.3e-30,134,143,120.99945,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_FKXL01000017",83.803,5.3e-30,134,142,119.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_FKWV01000005",83.803,5.3e-30,134,142,119.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_FKXF01000023",83.803,5.3e-30,134,142,119.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_44640","NZ_FNPJ01000004",84.444,5.34e-30,134,135,113.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_FNOE01000002",83.221,5.34e-30,134,149,123.99929,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_52681","NZ_FNPJ01000004",84.444,5.34e-30,134,135,113.9994,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5186","NZ_FNOE01000002",88.889,5.3e-30,134,108,96.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5187","NZ_FNPJ01000004",89.524,5.3e-30,134,105,94.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5188","NZ_FNOE01000002",88.889,5.3e-30,134,108,96.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6910","NZ_FNOE01000002",89.524,5.34e-30,134,105,94.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLXP01000026",90.909,5.34e-30,134,99,89.99991,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLUB01000021",90.909,5.34e-30,134,99,89.99991,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLTT01000022",90.909,5.34e-30,134,99,89.99991,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLRM01000021",90.909,5.34e-30,134,99,89.99991,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLRF01000022",90.909,5.34e-30,134,99,89.99991,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLWD01000035",83.942,1.92e-29,132,137,115.00054,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLXP01000026",83.942,1.92e-29,132,137,115.00054,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLUB01000021",83.942,1.92e-29,132,137,115.00054,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLTT01000022",83.942,1.92e-29,132,137,115.00054,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRM01000021",83.942,1.92e-29,132,137,115.00054,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRF01000022",83.942,1.92e-29,132,137,115.00054,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46168","NZ_FNOE01000002",84.848,1.91e-29,132,132,111.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46169","NZ_FNOE01000002",84.848,1.91e-29,132,132,111.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLWD01000035",82.667,1.91e-29,132,150,124.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLXP01000026",82.667,1.91e-29,132,150,124.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLUB01000021",82.667,1.91e-29,132,150,124.0005,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLTT01000022",82.667,1.91e-29,132,150,124.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRM01000021",82.667,1.91e-29,132,150,124.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRF01000022",82.667,1.91e-29,132,150,124.0005,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13907","NZ_FNPJ01000004",90.099,1.92e-29,132,101,90.99999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLXP01000026",88.182,1.92e-29,132,110,97.0002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLUB01000021",88.182,1.92e-29,132,110,97.0002,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLTT01000022",88.182,1.92e-29,132,110,97.0002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRM01000021",88.182,1.92e-29,132,110,97.0002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRF01000022",88.182,1.92e-29,132,110,97.0002,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_FNPJ01000004",90.909,1.19e-29,132,99,89.99991,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_FNPJ01000004",90.909,1.19e-29,132,99,89.99991,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_FNPJ01000004",90.909,1.19e-29,132,99,89.99991,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_FKXL01000017",82.803,1.91e-29,132,157,130.00071,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_FKWV01000005",82.803,1.91e-29,132,157,130.00071,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_FKXF01000023",82.803,1.91e-29,132,157,130.00071,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLWD01000035",84.733,1.75e-29,132,131,111.00023,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLXP01000026",84.733,1.75e-29,132,131,111.00023,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLUB01000021",84.733,1.75e-29,132,131,111.00023,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLTT01000022",84.733,1.75e-29,132,131,111.00023,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRM01000021",84.733,1.75e-29,132,131,111.00023,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRF01000022",84.733,1.75e-29,132,131,111.00023,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_FKXL01000017",83.217,1.91e-29,132,143,119.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_FKWV01000005",83.217,1.91e-29,132,143,119.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_FKXF01000023",83.217,1.91e-29,132,143,119.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLXP01000026",83.333,1.91e-29,132,144,119.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLUB01000021",83.333,1.91e-29,132,144,119.99952,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLTT01000022",83.333,1.91e-29,132,144,119.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRM01000021",83.333,1.91e-29,132,144,119.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRF01000022",83.333,1.91e-29,132,144,119.99952,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_FKXL01000017",83.333,6.91e-29,130,144,119.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_FKWV01000005",83.333,6.91e-29,130,144,119.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_FKXF01000023",83.333,6.91e-29,130,144,119.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_33303","NZ_FNOE01000002",88.288,6.86e-29,130,111,97.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_33304","NZ_FNOE01000002",88.288,6.86e-29,130,111,97.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9713","NZ_FNPJ01000004",88.679,6.86e-29,130,106,93.99974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9714","NZ_FNPJ01000004",88.679,6.86e-29,130,106,93.99974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_23853","NZ_FNPJ01000004",84.848,5.85e-29,130,132,111.99936,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLWD01000035",84.733,6.46e-29,130,131,111.00023,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLXP01000026",84.733,6.46e-29,130,131,111.00023,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLUB01000021",84.733,6.46e-29,130,131,111.00023,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLTT01000022",84.733,6.46e-29,130,131,111.00023,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRM01000021",84.733,6.46e-29,130,131,111.00023,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRF01000022",84.733,6.46e-29,130,131,111.00023,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_FKXL01000017",86.441,6.91e-29,130,118,102.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_FKWV01000005",86.441,6.91e-29,130,118,102.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_FKXF01000023",86.441,6.91e-29,130,118,102.00038,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLWD01000035",83.217,6.86e-29,130,143,119.00031,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_FKXL01000017",86.179,6.86e-29,130,123,106.00017,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_FKWV01000005",86.179,6.86e-29,130,123,106.00017,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_FKXF01000023",86.179,6.86e-29,130,123,106.00017,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_FKXL01000017",83.916,2.47e-28,128,143,119.99988,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_FKWV01000005",83.916,2.47e-28,128,143,119.99988,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_FKXF01000023",83.916,2.47e-28,128,143,119.99988,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_FNOE01000002",87.387,2.47e-28,128,111,96.99957,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_FKXL01000017",83.099,2.47e-28,128,142,118.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_FKWV01000005",83.099,2.47e-28,128,142,118.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_FKXF01000023",83.099,2.47e-28,128,142,118.00058,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_44639","NZ_FNPJ01000004",83.704,2.49e-28,128,135,113.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_FNOE01000002",82.55,2.49e-28,128,149,122.9995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_FNPJ01000004",82.237,2.49e-28,128,152,125.00024,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5186","NZ_FNPJ01000004",88.571,2.47e-28,128,105,92.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5188","NZ_FNPJ01000004",88.571,2.47e-28,128,105,92.99955,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17502","NZ_FNPJ01000004",84.921,2.35e-28,128,126,107.00046,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6910","NZ_FNPJ01000004",89.216,2.49e-28,128,102,91.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_23854","NZ_FNOE01000002",84.733,2.1e-28,128,131,111.00023,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1736","NZ_FNPJ01000004",87.5,2.49e-28,128,112,98,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1737","NZ_FNPJ01000004",87.5,2.47e-28,128,112,98,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_MLWD01000035",94.048,1.17e-28,128,84,79.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_FNPJ01000004",94.118,1.17e-28,128,85,80.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLWD01000035",83.099,2.49e-28,128,142,118.00058,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLXP01000026",83.099,2.49e-28,128,142,118.00058,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLUB01000021",83.099,2.49e-28,128,142,118.00058,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLTT01000022",83.099,2.49e-28,128,142,118.00058,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRM01000021",83.099,2.49e-28,128,142,118.00058,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRF01000022",83.099,2.49e-28,128,142,118.00058,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLXP01000026",89.216,2.49e-28,128,102,91.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLUB01000021",89.216,2.49e-28,128,102,91.00032,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLTT01000022",89.216,2.49e-28,128,102,91.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRM01000021",89.216,2.49e-28,128,102,91.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRF01000022",89.216,2.49e-28,128,102,91.00032,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLWD01000035",86.726,8.87e-28,126,113,98.00038,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLWD01000035",88.571,8.87e-28,126,105,92.99955,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLXP01000026",88.571,8.87e-28,126,105,92.99955,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLUB01000021",88.571,8.87e-28,126,105,92.99955,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLTT01000022",88.571,8.87e-28,126,105,92.99955,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRM01000021",88.571,8.87e-28,126,105,92.99955,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRF01000022",88.571,8.87e-28,126,105,92.99955,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_FNPJ01000004",95,4.07e-28,126,80,76,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_FNOE01000002",95,4.07e-28,126,80,76,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_33303","NZ_FNPJ01000004",87.5,3.19e-27,124,112,98,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_33304","NZ_FNPJ01000004",87.5,3.19e-27,124,112,98,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6147","NZ_FNOE01000002",84.496,2.96e-27,124,129,108.99984,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_FNOE01000002",90.625,2.72e-27,124,96,87,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_FNPJ01000004",85.124,2.72e-27,124,121,103.00004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_FNOE01000002",90.625,2.72e-27,124,96,87,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_23852","NZ_FNPJ01000004",84.091,2.72e-27,124,132,111.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_FNPJ01000004",81.579,1.16e-26,122,152,124.00008,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_FNOE01000002",83.099,1.15e-26,122,142,118.00058,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_FNOE01000002",83.099,1.16e-26,122,142,118.00058,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_FNPJ01000004",91.111,6.3e-27,122,90,81.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLWD01000035",83.969,1.07e-26,122,131,109.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLXP01000026",83.969,1.07e-26,122,131,109.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLUB01000021",83.969,1.07e-26,122,131,109.99939,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLTT01000022",83.969,1.07e-26,122,131,109.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRM01000021",83.969,1.07e-26,122,131,109.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRF01000022",83.969,1.07e-26,122,131,109.99939,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3204","NZ_FNPJ01000004",89.691,1.16e-26,122,97,87.00027,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8334","NZ_FNPJ01000004",90.323,6.77e-27,122,93,84.00039,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17744","NZ_FNOE01000002",94.872,5.27e-27,122,78,74.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7639","NZ_FKXL01000017",88.235,4.13e-26,121,102,89.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7639","NZ_FKWV01000005",88.235,4.13e-26,121,102,89.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7639","NZ_FKXF01000023",88.235,4.13e-26,121,102,89.9997,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1078","NZ_FNOE01000002",83.721,3.52e-26,121,129,108.00009,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_FNPJ01000004",91.765,1.13e-25,119,85,78.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48265","NZ_FNOE01000002",81.457,1.48e-25,119,151,123.00007,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_FKXL01000017",81.25,1.5e-25,119,160,130,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_FKWV01000005",81.25,1.5e-25,119,160,130,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_FKXF01000023",81.25,1.5e-25,119,160,130,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_FNPJ01000004",84.298,1.27e-25,119,121,102.00058,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLWD01000035",94.737,6.33e-26,119,76,72.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLXP01000026",94.737,6.33e-26,119,76,72.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLUB01000021",94.737,6.33e-26,119,76,72.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLTT01000022",94.737,6.33e-26,119,76,72.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRM01000021",94.737,6.33e-26,119,76,72.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRF01000022",94.737,6.33e-26,119,76,72.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_FNPJ01000004",94.737,6.33e-26,119,76,72.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_FNOE01000002",82.576,5.38e-25,117,132,109.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_FKXL01000017",81.333,5.3e-25,117,150,121.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_FKWV01000005",81.333,5.3e-25,117,150,121.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_FKXF01000023",81.333,5.3e-25,117,150,121.9995,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17744","NZ_FNPJ01000004",93.59,2.45e-25,117,78,73.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLWD01000035",87.255,5.38e-25,117,102,89.0001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_FKXL01000017",84.615,1.92e-24,115,117,98.99955,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_FKWV01000005",84.615,1.92e-24,115,117,98.99955,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_FKXF01000023",84.615,1.92e-24,115,117,98.99955,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_FKXL01000017",80.892,1.94e-24,115,157,127.00044,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_FKWV01000005",80.892,1.94e-24,115,157,127.00044,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_FKXF01000023",80.892,1.94e-24,115,157,127.00044,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42380","NZ_FNPJ01000004",87.755,1.86e-24,115,98,85.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42381","NZ_FNPJ01000004",87.755,1.86e-24,115,98,85.9999,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48264","NZ_FNOE01000002",81.208,1.92e-24,115,149,120.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64347","NZ_FKXL01000017",82.707,1.94e-24,115,133,110.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64347","NZ_FKWV01000005",82.707,1.94e-24,115,133,110.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64347","NZ_FKXF01000023",82.707,1.94e-24,115,133,110.00031,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71729","NZ_FNPJ01000004",88.421,1.94e-24,115,95,83.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_FKXL01000017",85.714,1.92e-24,115,112,95.99968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_FKWV01000005",85.714,1.92e-24,115,112,95.99968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_FKXF01000023",85.714,1.92e-24,115,112,95.99968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLWD01000035",85.714,1.94e-24,115,112,95.99968,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1736","NZ_FNOE01000002",85.714,1.94e-24,115,112,95.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1737","NZ_FNOE01000002",85.714,1.92e-24,115,112,95.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8334","NZ_FNOE01000002",89.13,1.13e-24,115,92,81.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_70393","NZ_FNPJ01000004",85.714,4.59e-24,113,112,95.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_70393","NZ_FNOE01000002",85.714,4.59e-24,113,112,95.99968,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_FKXL01000017",86.667,6.96e-24,113,105,91.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_FKWV01000005",86.667,6.96e-24,113,105,91.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_FKXF01000023",86.667,6.96e-24,113,105,91.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7225","NZ_MLWD01000035",80.519,6.96e-24,113,154,123.99926,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_FKXL01000017",80,2.5e-23,111,150,120,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_FKWV01000005",80,2.5e-23,111,150,120,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_FKXF01000023",80,2.5e-23,111,150,120,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_FNOE01000002",81.818,2.5e-23,111,132,107.99976,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_FNOE01000002",82.927,2.5e-23,111,123,102.00021,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64349","NZ_FKXL01000017",83.2,2.5e-23,111,125,104,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64349","NZ_FKWV01000005",83.2,2.5e-23,111,125,104,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64349","NZ_FKXF01000023",83.2,2.5e-23,111,125,104,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLWD01000035",92.308,2.5e-23,111,78,72.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLXP01000026",92.308,2.5e-23,111,78,72.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLUB01000021",92.308,2.5e-23,111,78,72.00024,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLTT01000022",92.308,2.5e-23,111,78,72.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRM01000021",92.308,2.5e-23,111,78,72.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRF01000022",92.308,2.5e-23,111,78,72.00024,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_FKXL01000017",80.255,9.01e-23,110,157,126.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_FKWV01000005",80.255,9.01e-23,110,157,126.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_FKXF01000023",80.255,9.01e-23,110,157,126.00035,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9050","NZ_FNPJ01000004",80.851,9.01e-23,110,141,113.99991,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_FKXL01000017",84.821,8.93e-23,110,112,94.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_FKWV01000005",84.821,8.93e-23,110,112,94.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_FKXF01000023",84.821,8.93e-23,110,112,94.99952,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLWD01000035",91.25,4.83e-23,110,80,73,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLXP01000026",91.25,4.83e-23,110,80,73,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLUB01000021",91.25,4.83e-23,110,80,73,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLTT01000022",91.25,4.83e-23,110,80,73,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRM01000021",91.25,4.83e-23,110,80,73,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRF01000022",91.25,4.83e-23,110,80,73,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4024","NZ_FNOE01000002",82.308,8.93e-23,110,130,107.0004,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLWD01000035",83.761,2.34e-22,108,117,98.00037,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLXP01000026",83.761,2.34e-22,108,117,98.00037,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLUB01000021",83.761,2.34e-22,108,117,98.00037,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLTT01000022",83.761,2.34e-22,108,117,98.00037,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRM01000021",83.761,2.34e-22,108,117,98.00037,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRF01000022",83.761,2.34e-22,108,117,98.00037,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_52016","NZ_FNPJ01000004",85.859,1.17e-21,106,99,85.00041,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_52016","NZ_FNOE01000002",84.071,1.17e-21,106,113,95.00023,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_52017","NZ_FNPJ01000004",85.859,1.17e-21,106,99,85.00041,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_52017","NZ_FNOE01000002",84.071,1.17e-21,106,113,95.00023,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_52018","NZ_FNPJ01000004",85.859,1.17e-21,106,99,85.00041,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38374","NZ_FKXL01000017",85.577,1.12e-21,106,104,89.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38374","NZ_FKWV01000005",85.577,1.12e-21,106,104,89.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_38374","NZ_FKXF01000023",85.577,1.12e-21,106,104,89.00008,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_72138","NZ_FNOE01000002",81.89,1.17e-21,106,127,104.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_MLWD01000035",94.203,6.35e-22,106,69,65.00007,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8417","NZ_FNPJ01000004",87.912,6.35e-22,106,91,79.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT03RTmix_EKRN25H000089-1A_22TV32LT4_L4.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5608","NZ_FNPJ01000004",87.912,6.35e-22,106,91,79.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11012","NZ_FNPJ01000004",84.762,9.85e-22,106,105,89.0001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11012","NZ_FNOE01000002",85.437,9.85e-22,106,103,88.00011,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11013","NZ_FNPJ01000004",84.762,9.85e-22,106,105,89.0001,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11013","NZ_FNOE01000002",85.437,9.85e-22,106,103,88.00011,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_FKXL01000017",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_FKWV01000005",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_FKXF01000023",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_FKXL01000017",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_FKWV01000005",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_FKXF01000023",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_FKXL01000017",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_FKWV01000005",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_FKXF01000023",79.618,4.19e-21,104,157,125.00026,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLWD01000035",79.605,4.19e-21,104,152,120.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLXP01000026",79.605,4.19e-21,104,152,120.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLUB01000021",79.605,4.19e-21,104,152,120.9996,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLTT01000022",79.605,4.19e-21,104,152,120.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRM01000021",79.605,4.19e-21,104,152,120.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRF01000022",79.605,4.19e-21,104,152,120.9996,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_72137","NZ_FNOE01000002",85.714,4.16e-21,104,98,83.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_FKXL01000017",79.195,4.19e-21,104,149,118.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_FKWV01000005",79.195,4.19e-21,104,149,118.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_FKXF01000023",79.195,4.19e-21,104,149,118.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11844","NZ_FNOE01000002",79.72,4.19e-21,104,143,113.9996,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_FKXL01000017",79.195,4.16e-21,104,149,118.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_FKWV01000005",79.195,4.16e-21,104,149,118.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_FKXF01000023",79.195,4.16e-21,104,149,118.00055,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42380","NZ_FNOE01000002",91.781,1.45e-20,102,73,67.00013,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42381","NZ_FNOE01000002",91.781,1.45e-20,102,73,67.00013,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9713","NZ_FNOE01000002",84.259,1.49e-20,102,108,90.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9714","NZ_FNOE01000002",84.259,1.49e-20,102,108,90.99972,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_71729","NZ_FNOE01000002",91.781,1.51e-20,102,73,67.00013,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15915","NZ_FNPJ01000004",79.054,1.49e-20,102,148,116.99992,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_MLWD01000035",84.259,1.49e-20,102,108,90.99972,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_FKXL01000017",91.781,6.86e-21,102,73,67.00013,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_FKWV01000005",91.781,6.86e-21,102,73,67.00013,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_FKXF01000023",91.781,6.86e-21,102,73,67.00013,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_52018","NZ_FNOE01000002",83.186,5.42e-20,100,113,94.00018,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6147","NZ_FNPJ01000004",86.813,4.98e-20,100,91,78.99983,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20346","NZ_FNPJ01000004",93.939,1.85e-20,100,66,61.99974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12649","NZ_FNPJ01000004",93.939,1.85e-20,100,66,61.99974,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_FKXL01000017",88.372,2.56e-20,100,86,75.99992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_FKWV01000005",88.372,2.56e-20,100,86,75.99992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_FKXF01000023",88.372,2.56e-20,100,86,75.99992,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_FNPJ01000004",89.744,2.29e-20,100,78,70.00032,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_FNOE01000002",90.667,2.29e-20,100,75,68.00025,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_FNOE01000002",81.301,5.38e-20,100,123,100.00023,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLWD01000035",78.947,1.95e-19,99,152,119.99944,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLXP01000026",78.947,1.95e-19,99,152,119.99944,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLUB01000021",78.947,1.95e-19,99,152,119.99944,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLTT01000022",78.947,1.95e-19,99,152,119.99944,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRM01000021",78.947,1.95e-19,99,152,119.99944,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRF01000022",78.947,1.95e-19,99,152,119.99944,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15913","NZ_FNPJ01000004",78.378,6.96e-19,97.1,148,115.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15914","NZ_FNPJ01000004",78.378,6.96e-19,97.1,148,115.99944,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17979","NZ_FNOE01000002",87.952,3.19e-19,97.1,83,73.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17980","NZ_FNOE01000002",87.952,3.19e-19,97.1,83,73.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_FKXL01000017",90.278,9.64e-19,95.3,72,65.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_FKWV01000005",90.278,9.64e-19,95.3,72,65.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_FKXF01000023",90.278,9.64e-19,95.3,72,65.00016,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLWD01000035",95,2.8e-18,93.5,60,57,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLXP01000026",95,2.8e-18,93.5,60,57,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLUB01000021",95,2.8e-18,93.5,60,57,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLTT01000022",95,2.8e-18,93.5,60,57,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRM01000021",95,2.8e-18,93.5,60,57,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRF01000022",95,2.8e-18,93.5,60,57,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLWD01000035",95,2.8e-18,93.5,60,57,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLXP01000026",95,2.8e-18,93.5,60,57,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLUB01000021",95,2.8e-18,93.5,60,57,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLTT01000022",95,2.8e-18,93.5,60,57,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRM01000021",95,2.8e-18,93.5,60,57,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRF01000022",95,2.8e-18,93.5,60,57,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_FNOE01000002",84.694,9e-18,93.5,98,83.00012,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16215","NZ_FNPJ01000004",79.699,7.67e-18,93.5,133,105.99967,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_FNPJ01000004",79.699,7.67e-18,93.5,133,105.99967,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_FKXL01000017",91.176,4.87e-18,93.5,68,61.99968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_FKWV01000005",91.176,4.87e-18,93.5,68,61.99968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_FKXF01000023",91.176,4.87e-18,93.5,68,61.99968,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_FNOE01000002",80,3.26e-17,91.6,130,104,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLWD01000035",86.747,1.49e-17,91.6,83,72.00001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLXP01000026",86.747,1.49e-17,91.6,83,72.00001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLUB01000021",86.747,1.49e-17,91.6,83,72.00001,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLTT01000022",86.747,1.49e-17,91.6,83,72.00001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRM01000021",86.747,1.49e-17,91.6,83,72.00001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRF01000022",86.747,1.49e-17,91.6,83,72.00001,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17979","NZ_FNPJ01000004",86.585,5.34e-17,89.8,82,70.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17980","NZ_FNPJ01000004",86.585,5.34e-17,89.8,82,70.9997,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_FNPJ01000004",93.333,1.3e-16,87.9,60,55.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_FNOE01000002",93.333,1.3e-16,87.9,60,55.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_FNPJ01000004",93.333,1.3e-16,87.9,60,55.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_FNOE01000002",93.333,1.3e-16,87.9,60,55.9998,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_FNOE01000002",79.231,1.52e-15,86.1,130,103.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16215","NZ_FNOE01000002",78.788,1.28e-15,86.1,132,104.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_FNOE01000002",78.788,1.28e-15,86.1,132,104.00016,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5306","NZ_FKXL01000017",78.417,1.49e-15,86.1,139,108.99963,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5306","NZ_FKWV01000005",78.417,1.49e-15,86.1,139,108.99963,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5306","NZ_FKXF01000023",78.417,1.49e-15,86.1,139,108.99963,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8556","NZ_FKXL01000017",78.417,1.51e-15,86.1,139,108.99963,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8556","NZ_FKWV01000005",78.417,1.51e-15,86.1,139,108.99963,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8556","NZ_FKXF01000023",78.417,1.51e-15,86.1,139,108.99963,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLWD01000035",85.366,6.91e-16,86.1,82,70.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLXP01000026",85.366,6.91e-16,86.1,82,70.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLUB01000021",85.366,6.91e-16,86.1,82,70.00012,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLTT01000022",85.366,6.91e-16,86.1,82,70.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRM01000021",85.366,6.91e-16,86.1,82,70.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRF01000022",85.366,6.91e-16,86.1,82,70.00012,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLXP01000026",90.476,5.46e-15,84.2,63,56.99988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLUB01000021",90.476,5.46e-15,84.2,63,56.99988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLTT01000022",90.476,5.46e-15,84.2,63,56.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLRM01000021",90.476,5.46e-15,84.2,63,56.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLRF01000022",90.476,5.46e-15,84.2,63,56.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12242","NZ_FNPJ01000004",86.42,2.31e-15,84.2,81,70.0002,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16034","NZ_FNOE01000002",78.519,4.62e-15,84.2,135,106.00065,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3168","NZ_FNPJ01000004",94.545,2.26e-15,84.2,55,51.99975,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLXP01000026",90.476,5.41e-15,84.2,63,56.99988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLUB01000021",90.476,5.41e-15,84.2,63,56.99988,"Streptococcus mutans","Oral cancer; Head and neck cancer; Esophageal cancer","IL-6 production; EMT induction; myeloid-derived suppressor cell recruitment","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLTT01000022",90.476,5.41e-15,84.2,63,56.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLRM01000021",90.476,5.41e-15,84.2,63,56.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLRF01000022",90.476,5.41e-15,84.2,63,56.99988,"Peptostreptococcus anaerobius","Colorectal cancer; Liver metastases","Butyrate metabolism disruption; immune evasion","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_FKXL01000017",89.231,2.18e-14,80.5,65,58.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_FKWV01000005",89.231,2.18e-14,80.5,65,58.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_FKXF01000023",89.231,2.18e-14,80.5,65,58.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_FKXL01000017",89.231,2.18e-14,80.5,65,58.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_FKWV01000005",89.231,2.18e-14,80.5,65,58.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_FKXF01000023",89.231,2.18e-14,80.5,65,58.00015,"Fusobacterium nucleatum subtype Fna C2","Colorectal cancer","Specific virulence factors; enhanced tumor microenvironment modulation","Emerging Strong","2_Strong","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16034","NZ_FNPJ01000004",77.778,2.15e-13,78.7,135,105.0003,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15478","NZ_FNOE01000002",90,1.05e-13,78.7,60,54,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7534","NZ_FNPJ01000004",94,1.93e-13,76.8,50,47,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16031","NZ_FNPJ01000004",94,1.93e-13,76.8,50,47,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3168","NZ_FNOE01000002",90.909,4.9e-12,73.1,55,49.99995,"Acinetobacter baumannii","Cancer mortality in immunocompromised; ICU cancer patients","Multi-drug resistance; immune suppression in cancer patients","Emerging Strong","2_Strong","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRZ01000037",100,2.33e-73,278,150,150,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLXR01000021",100,2.33e-73,278,150,150,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRJ01000019",100,2.33e-73,278,150,150,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLWB01000035",100,2.33e-73,278,150,150,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLZF01000029",100,2.33e-73,278,150,150,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLXZ01000020",100,2.33e-73,278,150,150,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_JBGJJV010000032",100,2.33e-73,278,150,150,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_FLBI01000046",100,2.33e-73,278,150,150,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_FLBN01000099",100,2.33e-73,278,150,150,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_FLCN01000004",100,2.33e-73,278,150,150,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_FLBI01000046",100,2.33e-73,278,150,150,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_FLBN01000099",100,2.33e-73,278,150,150,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_FLCN01000004",100,2.33e-73,278,150,150,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRI01000021",100,8.32e-73,276,149,149,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRZ01000037",100,8.32e-73,276,149,149,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRO01000021",100,8.32e-73,276,149,149,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLXR01000021",100,8.32e-73,276,149,149,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRG01000021",100,8.32e-73,276,149,149,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLYG01000019",100,8.32e-73,276,149,149,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRJ01000019",100,8.32e-73,276,149,149,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLSM01000018",100,8.32e-73,276,149,149,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLSQ01000022",100,8.32e-73,276,149,149,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLXY01000024",100,8.32e-73,276,149,149,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLXS01000025",100,8.32e-73,276,149,149,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLWB01000035",100,8.32e-73,276,149,149,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLUD01000021",100,8.32e-73,276,149,149,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRC01000027",100,8.32e-73,276,149,149,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLYZ01000021",100,8.32e-73,276,149,149,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLSP01000022",100,8.32e-73,276,149,149,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLZF01000029",100,8.32e-73,276,149,149,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLSH01000020",100,8.32e-73,276,149,149,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLYY01000023",100,8.32e-73,276,149,149,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLYC01000020",100,8.32e-73,276,149,149,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLXZ01000020",100,8.32e-73,276,149,149,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_JBGJJV010000032",100,8.32e-73,276,149,149,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_FLBI01000046",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_FLBN01000099",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_FLCN01000004",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_FLBI01000046",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_FLBN01000099",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_FLCN01000004",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_FLBI01000046",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_FLBN01000099",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_FLCN01000004",100,8.32e-73,276,149,149,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_MLRZ01000037",100,8.32e-73,276,149,149,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_MLWB01000035",100,8.32e-73,276,149,149,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_MLZF01000029",100,8.32e-73,276,149,149,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_JBGJJV010000032",100,8.32e-73,276,149,149,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_FLBI01000046",100,3.02e-72,274,148,148,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_FLBI01000046",100,2.99e-72,274,148,148,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_FLBN01000099",100,2.99e-72,274,148,148,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_FLCN01000004",100,2.99e-72,274,148,148,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_JBGJJV010000032",100,2.99e-72,274,148,148,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRZ01000037",99.333,1.09e-71,272,150,148.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLXR01000021",99.333,1.09e-71,272,150,148.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRJ01000019",99.333,1.09e-71,272,150,148.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLWB01000035",99.333,1.09e-71,272,150,148.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLZF01000029",99.333,1.09e-71,272,150,148.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLXZ01000020",99.333,1.09e-71,272,150,148.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_JBGJJV010000032",99.333,1.09e-71,272,150,148.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_FLBI01000046",99.333,1.09e-71,272,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_FLBN01000099",99.333,1.09e-71,272,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRI01000021",99.333,1.09e-71,272,150,148.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_FLCN01000004",99.333,1.09e-71,272,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRO01000021",99.333,1.09e-71,272,150,148.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRG01000021",99.333,1.09e-71,272,150,148.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLYG01000019",99.333,1.09e-71,272,150,148.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLSM01000018",99.333,1.09e-71,272,150,148.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLSQ01000022",99.333,1.09e-71,272,150,148.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLXY01000024",99.333,1.09e-71,272,150,148.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLXS01000025",99.333,1.09e-71,272,150,148.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLUD01000021",99.333,1.09e-71,272,150,148.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRC01000027",99.333,1.09e-71,272,150,148.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLYZ01000021",99.333,1.09e-71,272,150,148.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLSP01000022",99.333,1.09e-71,272,150,148.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLSH01000020",99.333,1.09e-71,272,150,148.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLYY01000023",99.333,1.09e-71,272,150,148.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLYC01000020",99.333,1.09e-71,272,150,148.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRE01000049",99.333,1.09e-71,272,150,148.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_FLBI01000046",99.333,1.09e-71,272,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_FLBN01000099",99.333,1.09e-71,272,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_FLCN01000004",99.333,1.09e-71,272,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRI01000021",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRZ01000037",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRO01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLXR01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRG01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLYG01000019",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRJ01000019",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLSM01000018",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLSQ01000022",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLXY01000024",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLXS01000025",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLWB01000035",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLUD01000021",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRC01000027",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLYZ01000021",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLSP01000022",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLZF01000029",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLSH01000020",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLYY01000023",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLYC01000020",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLXZ01000020",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_JBGJJV010000032",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRI01000021",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRZ01000037",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRO01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLXR01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRG01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLYG01000019",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRJ01000019",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLSM01000018",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLSQ01000022",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLXY01000024",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLXS01000025",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLWB01000035",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLUD01000021",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRC01000027",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLYZ01000021",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLSP01000022",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLZF01000029",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLSH01000020",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLYY01000023",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLYC01000020",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLXZ01000020",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_JBGJJV010000032",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRI01000021",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRZ01000037",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRO01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLXR01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRG01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLYG01000019",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRJ01000019",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLSM01000018",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLSQ01000022",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLXY01000024",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLXS01000025",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLWB01000035",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLUD01000021",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRC01000027",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLYZ01000021",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLSP01000022",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLZF01000029",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLSH01000020",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLYY01000023",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLYC01000020",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLXZ01000020",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_JBGJJV010000032",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_FLBI01000046",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_FLBN01000099",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLRE01000049",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_FLCN01000004",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_JAUEGY010000142",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRI01000021",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRZ01000037",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRO01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLXR01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRG01000021",99.329,3.87e-71,270,149,148.00021,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLYG01000019",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRJ01000019",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLSM01000018",99.329,3.87e-71,270,149,148.00021,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLSQ01000022",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLXY01000024",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLXS01000025",99.329,3.87e-71,270,149,148.00021,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLWB01000035",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLUD01000021",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRC01000027",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLYZ01000021",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLSP01000022",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLZF01000029",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLSH01000020",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLYY01000023",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLYC01000020",99.329,3.87e-71,270,149,148.00021,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLXZ01000020",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_JBGJJV010000032",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_JBGJJV010000032",100,3.9e-71,270,146,146,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRE01000049",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_FLBI01000046",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_FLBN01000099",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_FLCN01000004",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_MLRZ01000037",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_MLWB01000035",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_MLZF01000029",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_JBGJJV010000032",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_FLBI01000046",99.333,3.87e-71,270,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_FLBN01000099",99.333,3.87e-71,270,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_FLCN01000004",99.333,3.87e-71,270,150,148.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_MLRZ01000037",99.333,3.87e-71,270,150,148.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_MLWB01000035",99.333,3.87e-71,270,150,148.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_MLZF01000029",99.333,3.87e-71,270,150,148.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_JBGJJV010000032",99.333,3.87e-71,270,150,148.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_FLBI01000046",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_FLBN01000099",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_FLCN01000004",99.329,3.87e-71,270,149,148.00021,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_MLRZ01000037",99.329,3.87e-71,270,149,148.00021,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_MLWB01000035",99.329,3.87e-71,270,149,148.00021,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_MLZF01000029",99.329,3.87e-71,270,149,148.00021,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_JBGJJV010000032",99.329,3.87e-71,270,149,148.00021,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRI01000021",100,1.4e-70,268,145,145,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRE01000049",100,1.4e-70,268,145,145,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRZ01000037",100,1.4e-70,268,145,145,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRO01000021",100,1.4e-70,268,145,145,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLXR01000021",100,1.4e-70,268,145,145,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRG01000021",100,1.4e-70,268,145,145,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLYG01000019",100,1.4e-70,268,145,145,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRJ01000019",100,1.4e-70,268,145,145,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLSM01000018",100,1.4e-70,268,145,145,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLSQ01000022",100,1.4e-70,268,145,145,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLXY01000024",100,1.4e-70,268,145,145,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLXS01000025",100,1.4e-70,268,145,145,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLWB01000035",100,1.4e-70,268,145,145,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLUD01000021",100,1.4e-70,268,145,145,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLRC01000027",100,1.4e-70,268,145,145,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLYZ01000021",100,1.4e-70,268,145,145,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLSP01000022",100,1.4e-70,268,145,145,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLZF01000029",100,1.4e-70,268,145,145,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLSH01000020",100,1.4e-70,268,145,145,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLYY01000023",100,1.4e-70,268,145,145,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLYC01000020",100,1.4e-70,268,145,145,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLXZ01000020",100,1.4e-70,268,145,145,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_JBGJJV010000032",99.324,1.39e-70,268,148,146.99952,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_FLBI01000046",99.324,1.4e-70,268,148,146.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_FLBI01000046",98.667,5.05e-70,267,150,148.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_FLBN01000099",98.667,5.05e-70,267,150,148.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRI01000021",98.667,5.05e-70,267,150,148.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_FLCN01000004",98.667,5.05e-70,267,150,148.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRO01000021",98.667,5.05e-70,267,150,148.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRG01000021",98.667,5.05e-70,267,150,148.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLYG01000019",98.667,5.05e-70,267,150,148.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLSM01000018",98.667,5.05e-70,267,150,148.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLSQ01000022",98.667,5.05e-70,267,150,148.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLXY01000024",98.667,5.05e-70,267,150,148.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLXS01000025",98.667,5.05e-70,267,150,148.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLUD01000021",98.667,5.05e-70,267,150,148.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRC01000027",98.667,5.05e-70,267,150,148.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLYZ01000021",98.667,5.05e-70,267,150,148.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLSP01000022",98.667,5.05e-70,267,150,148.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLSH01000020",98.667,5.05e-70,267,150,148.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLYY01000023",98.667,5.05e-70,267,150,148.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLYC01000020",98.667,5.05e-70,267,150,148.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLRE01000049",98.667,5.05e-70,267,150,148.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_JAUEGY010000142",98.667,5.05e-70,267,150,148.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_FLBI01000046",100,5.05e-70,267,144,144,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_FLCN01000004",100,5.05e-70,267,144,144,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRE01000049",98.667,5.05e-70,267,150,148.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_FLBI01000046",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_FLBN01000099",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLRE01000049",98.658,1.8e-69,265,149,147.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_FLCN01000004",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_JAUEGY010000142",98.658,1.8e-69,265,149,147.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_FLBI01000046",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_FLBN01000099",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLRE01000049",98.658,1.8e-69,265,149,147.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_FLCN01000004",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_JAUEGY010000142",98.658,1.8e-69,265,149,147.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_FLBI01000046",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_FLBN01000099",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLRE01000049",98.658,1.8e-69,265,149,147.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_FLCN01000004",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_JAUEGY010000142",98.658,1.8e-69,265,149,147.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRI01000021",98.658,1.8e-69,265,149,147.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRZ01000037",98.658,1.8e-69,265,149,147.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRO01000021",98.658,1.8e-69,265,149,147.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLXR01000021",98.658,1.8e-69,265,149,147.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRG01000021",98.658,1.8e-69,265,149,147.00042,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLYG01000019",98.658,1.8e-69,265,149,147.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRJ01000019",98.658,1.8e-69,265,149,147.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLSM01000018",98.658,1.8e-69,265,149,147.00042,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLSQ01000022",98.658,1.8e-69,265,149,147.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLXY01000024",98.658,1.8e-69,265,149,147.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLXS01000025",98.658,1.8e-69,265,149,147.00042,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLWB01000035",98.658,1.8e-69,265,149,147.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLUD01000021",98.658,1.8e-69,265,149,147.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRC01000027",98.658,1.8e-69,265,149,147.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLYZ01000021",98.658,1.8e-69,265,149,147.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLSP01000022",98.658,1.8e-69,265,149,147.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLZF01000029",98.658,1.8e-69,265,149,147.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLSH01000020",98.658,1.8e-69,265,149,147.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLYY01000023",98.658,1.8e-69,265,149,147.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLYC01000020",98.658,1.8e-69,265,149,147.00042,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLXZ01000020",98.658,1.8e-69,265,149,147.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_JBGJJV010000032",98.658,1.8e-69,265,149,147.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_FLBI01000046",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_FLBN01000099",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLRE01000049",98.658,1.8e-69,265,149,147.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_FLCN01000004",98.658,1.8e-69,265,149,147.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_JAUEGY010000142",98.658,1.8e-69,265,149,147.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_JBGJJV010000032",98.649,6.48e-69,263,148,146.00052,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_FLBN01000099",98.649,6.53e-69,263,148,146.00052,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_FLCN01000004",98.649,6.53e-69,263,148,146.00052,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRI01000021",98.649,6.48e-69,263,148,146.00052,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRE01000049",98.649,6.48e-69,263,148,146.00052,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRZ01000037",98.649,6.48e-69,263,148,146.00052,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRO01000021",98.649,6.48e-69,263,148,146.00052,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLXR01000021",98.649,6.48e-69,263,148,146.00052,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRG01000021",98.649,6.48e-69,263,148,146.00052,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLYG01000019",98.649,6.48e-69,263,148,146.00052,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRJ01000019",98.649,6.48e-69,263,148,146.00052,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLSM01000018",98.649,6.48e-69,263,148,146.00052,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLSQ01000022",98.649,6.48e-69,263,148,146.00052,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLXY01000024",98.649,6.48e-69,263,148,146.00052,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLXS01000025",98.649,6.48e-69,263,148,146.00052,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLWB01000035",98.649,6.48e-69,263,148,146.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLUD01000021",98.649,6.48e-69,263,148,146.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLRC01000027",98.649,6.48e-69,263,148,146.00052,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLYZ01000021",98.649,6.48e-69,263,148,146.00052,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLSP01000022",98.649,6.48e-69,263,148,146.00052,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLZF01000029",98.649,6.48e-69,263,148,146.00052,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLSH01000020",98.649,6.48e-69,263,148,146.00052,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLYY01000023",98.649,6.48e-69,263,148,146.00052,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLYC01000020",98.649,6.48e-69,263,148,146.00052,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLXZ01000020",98.649,6.48e-69,263,148,146.00052,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLRE01000049",98,2.35e-68,261,150,147,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_JAUEGY010000142",98,2.35e-68,261,150,147,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRZ01000037",98,2.35e-68,261,150,147,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLXR01000021",98,2.35e-68,261,150,147,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRJ01000019",98,2.35e-68,261,150,147,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLWB01000035",98,2.35e-68,261,150,147,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLZF01000029",98,2.35e-68,261,150,147,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLXZ01000020",98,2.35e-68,261,150,147,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_JBGJJV010000032",98,2.35e-68,261,150,147,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_FLBN01000099",99.306,2.35e-68,261,144,143.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_JBGJJV010000032",98,2.35e-68,261,150,147,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRI01000021",98,2.35e-68,261,150,147,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRZ01000037",98,2.35e-68,261,150,147,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRO01000021",98,2.35e-68,261,150,147,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLXR01000021",98,2.35e-68,261,150,147,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRG01000021",98,2.35e-68,261,150,147,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLYG01000019",98,2.35e-68,261,150,147,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRJ01000019",98,2.35e-68,261,150,147,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLSM01000018",98,2.35e-68,261,150,147,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLSQ01000022",98,2.35e-68,261,150,147,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLXY01000024",98,2.35e-68,261,150,147,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLXS01000025",98,2.35e-68,261,150,147,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLWB01000035",98,2.35e-68,261,150,147,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLUD01000021",98,2.35e-68,261,150,147,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLRC01000027",98,2.35e-68,261,150,147,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLYZ01000021",98,2.35e-68,261,150,147,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLSP01000022",98,2.35e-68,261,150,147,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLZF01000029",98,2.35e-68,261,150,147,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLSH01000020",98,2.35e-68,261,150,147,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLYY01000023",98,2.35e-68,261,150,147,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLYC01000020",98,2.35e-68,261,150,147,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLXZ01000020",98,2.35e-68,261,150,147,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_FLBI01000046",98,2.35e-68,261,150,147,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_FLBN01000099",98,2.35e-68,261,150,147,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRI01000021",98,2.35e-68,261,150,147,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRE01000049",98,2.35e-68,261,150,147,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_FLCN01000004",98,2.35e-68,261,150,147,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRZ01000037",98,2.35e-68,261,150,147,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRO01000021",98,2.35e-68,261,150,147,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLXR01000021",98,2.35e-68,261,150,147,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRG01000021",98,2.35e-68,261,150,147,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLYG01000019",98,2.35e-68,261,150,147,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRJ01000019",98,2.35e-68,261,150,147,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLSM01000018",98,2.35e-68,261,150,147,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLSQ01000022",98,2.35e-68,261,150,147,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLXY01000024",98,2.35e-68,261,150,147,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLXS01000025",98,2.35e-68,261,150,147,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLWB01000035",98,2.35e-68,261,150,147,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLUD01000021",98,2.35e-68,261,150,147,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLRC01000027",98,2.35e-68,261,150,147,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLYZ01000021",98,2.35e-68,261,150,147,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLSP01000022",98,2.35e-68,261,150,147,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLZF01000029",98,2.35e-68,261,150,147,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLSH01000020",98,2.35e-68,261,150,147,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLYY01000023",98,2.35e-68,261,150,147,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLYC01000020",98,2.35e-68,261,150,147,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLXZ01000020",98,2.35e-68,261,150,147,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_JBGJJV010000032",98,2.35e-68,261,150,147,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_JAUEGY010000142",98,2.35e-68,261,150,147,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_FLBI01000046",98.639,2.31e-68,261,147,144.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_FLBN01000099",98.639,2.31e-68,261,147,144.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_FLCN01000004",98.639,2.31e-68,261,147,144.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_MLRZ01000037",98.639,2.31e-68,261,147,144.99933,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_MLWB01000035",98.639,2.31e-68,261,147,144.99933,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_MLZF01000029",98.639,2.31e-68,261,147,144.99933,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_JBGJJV010000032",98.639,2.31e-68,261,147,144.99933,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRI01000021",97.987,8.38e-68,259,149,146.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRZ01000037",97.987,8.38e-68,259,149,146.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRO01000021",97.987,8.38e-68,259,149,146.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLXR01000021",97.987,8.38e-68,259,149,146.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRG01000021",97.987,8.38e-68,259,149,146.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLYG01000019",97.987,8.38e-68,259,149,146.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRJ01000019",97.987,8.38e-68,259,149,146.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLSM01000018",97.987,8.38e-68,259,149,146.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLSQ01000022",97.987,8.38e-68,259,149,146.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLXY01000024",97.987,8.38e-68,259,149,146.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLXS01000025",97.987,8.38e-68,259,149,146.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLWB01000035",97.987,8.38e-68,259,149,146.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLUD01000021",97.987,8.38e-68,259,149,146.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRC01000027",97.987,8.38e-68,259,149,146.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLYZ01000021",97.987,8.38e-68,259,149,146.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLSP01000022",97.987,8.38e-68,259,149,146.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLZF01000029",97.987,8.38e-68,259,149,146.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLSH01000020",97.987,8.38e-68,259,149,146.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLYY01000023",97.987,8.38e-68,259,149,146.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLYC01000020",97.987,8.38e-68,259,149,146.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLXZ01000020",97.987,8.38e-68,259,149,146.00063,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_JBGJJV010000032",97.987,8.38e-68,259,149,146.00063,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_FLBI01000046",97.987,8.38e-68,259,149,146.00063,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_FLBN01000099",97.987,8.38e-68,259,149,146.00063,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLRE01000049",97.987,8.38e-68,259,149,146.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_FLCN01000004",97.987,8.38e-68,259,149,146.00063,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_JAUEGY010000142",97.987,8.38e-68,259,149,146.00063,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_JBGJJV010000032",97.987,8.38e-68,259,149,146.00063,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRI01000021",97.987,8.38e-68,259,149,146.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRZ01000037",97.987,8.38e-68,259,149,146.00063,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRO01000021",97.987,8.38e-68,259,149,146.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLXR01000021",97.987,8.38e-68,259,149,146.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRG01000021",97.987,8.38e-68,259,149,146.00063,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLYG01000019",97.987,8.38e-68,259,149,146.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRJ01000019",97.987,8.38e-68,259,149,146.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLSM01000018",97.987,8.38e-68,259,149,146.00063,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLSQ01000022",97.987,8.38e-68,259,149,146.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLXY01000024",97.987,8.38e-68,259,149,146.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLXS01000025",97.987,8.38e-68,259,149,146.00063,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLWB01000035",97.987,8.38e-68,259,149,146.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLUD01000021",97.987,8.38e-68,259,149,146.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLRC01000027",97.987,8.38e-68,259,149,146.00063,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLYZ01000021",97.987,8.38e-68,259,149,146.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLSP01000022",97.987,8.38e-68,259,149,146.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLZF01000029",97.987,8.38e-68,259,149,146.00063,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLSH01000020",97.987,8.38e-68,259,149,146.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLYY01000023",97.987,8.38e-68,259,149,146.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLYC01000020",97.987,8.38e-68,259,149,146.00063,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLXZ01000020",97.987,8.38e-68,259,149,146.00063,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_FLBN01000099",97.973,3.04e-67,257,148,145.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_FLCN01000004",97.973,3.04e-67,257,148,145.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_FLBI01000046",97.973,3.01e-67,257,148,145.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_FLBN01000099",97.973,3.01e-67,257,148,145.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_FLCN01000004",97.973,3.01e-67,257,148,145.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_JBGJJV010000032",97.973,3.01e-67,257,148,145.00004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_FLBI01000046",97.333,1.09e-66,255,150,145.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_FLBN01000099",97.333,1.09e-66,255,150,145.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRI01000021",97.333,1.09e-66,255,150,145.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_FLCN01000004",97.333,1.09e-66,255,150,145.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRO01000021",97.333,1.09e-66,255,150,145.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRG01000021",97.333,1.09e-66,255,150,145.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLYG01000019",97.333,1.09e-66,255,150,145.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLSM01000018",97.333,1.09e-66,255,150,145.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLSQ01000022",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLXY01000024",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLXS01000025",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLUD01000021",97.333,1.09e-66,255,150,145.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRC01000027",97.333,1.09e-66,255,150,145.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLYZ01000021",97.333,1.09e-66,255,150,145.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLSP01000022",97.333,1.09e-66,255,150,145.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLSH01000020",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLYY01000023",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLYC01000020",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRI01000021",97.333,1.09e-66,255,150,145.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRE01000049",97.333,1.09e-66,255,150,145.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRZ01000037",97.333,1.09e-66,255,150,145.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRO01000021",97.333,1.09e-66,255,150,145.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLXR01000021",97.333,1.09e-66,255,150,145.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRG01000021",97.333,1.09e-66,255,150,145.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLYG01000019",97.333,1.09e-66,255,150,145.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRJ01000019",97.333,1.09e-66,255,150,145.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLSM01000018",97.333,1.09e-66,255,150,145.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLSQ01000022",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLXY01000024",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLXS01000025",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLWB01000035",97.333,1.09e-66,255,150,145.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLUD01000021",97.333,1.09e-66,255,150,145.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLRC01000027",97.333,1.09e-66,255,150,145.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLYZ01000021",97.333,1.09e-66,255,150,145.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLSP01000022",97.333,1.09e-66,255,150,145.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLZF01000029",97.333,1.09e-66,255,150,145.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLSH01000020",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLYY01000023",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLYC01000020",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLXZ01000020",97.333,1.09e-66,255,150,145.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_JBGJJV010000032",97.333,1.09e-66,255,150,145.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRI01000021",97.333,1.09e-66,255,150,145.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRZ01000037",97.333,1.09e-66,255,150,145.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRO01000021",97.333,1.09e-66,255,150,145.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLXR01000021",97.333,1.09e-66,255,150,145.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRG01000021",97.333,1.09e-66,255,150,145.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLYG01000019",97.333,1.09e-66,255,150,145.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRJ01000019",97.333,1.09e-66,255,150,145.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLSM01000018",97.333,1.09e-66,255,150,145.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLSQ01000022",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLXY01000024",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLXS01000025",97.333,1.09e-66,255,150,145.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLWB01000035",97.333,1.09e-66,255,150,145.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLUD01000021",97.333,1.09e-66,255,150,145.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLRC01000027",97.333,1.09e-66,255,150,145.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLYZ01000021",97.333,1.09e-66,255,150,145.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLSP01000022",97.333,1.09e-66,255,150,145.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLZF01000029",97.333,1.09e-66,255,150,145.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLSH01000020",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLYY01000023",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLYC01000020",97.333,1.09e-66,255,150,145.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLXZ01000020",97.333,1.09e-66,255,150,145.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_FLBI01000046",97.315,3.9e-66,254,149,144.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_FLBN01000099",97.315,3.9e-66,254,149,144.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLRE01000049",97.315,3.9e-66,254,149,144.99935,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_FLCN01000004",97.315,3.9e-66,254,149,144.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_JAUEGY010000142",97.315,3.9e-66,254,149,144.99935,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRI01000021",97.315,3.9e-66,254,149,144.99935,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRE01000049",97.315,3.9e-66,254,149,144.99935,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRZ01000037",97.315,3.9e-66,254,149,144.99935,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRO01000021",97.315,3.9e-66,254,149,144.99935,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLXR01000021",97.315,3.9e-66,254,149,144.99935,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRG01000021",97.315,3.9e-66,254,149,144.99935,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLYG01000019",97.315,3.9e-66,254,149,144.99935,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRJ01000019",97.315,3.9e-66,254,149,144.99935,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLSM01000018",97.315,3.9e-66,254,149,144.99935,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLSQ01000022",97.315,3.9e-66,254,149,144.99935,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLXY01000024",97.315,3.9e-66,254,149,144.99935,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLXS01000025",97.315,3.9e-66,254,149,144.99935,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLWB01000035",97.315,3.9e-66,254,149,144.99935,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLUD01000021",97.315,3.9e-66,254,149,144.99935,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLRC01000027",97.315,3.9e-66,254,149,144.99935,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLYZ01000021",97.315,3.9e-66,254,149,144.99935,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLSP01000022",97.315,3.9e-66,254,149,144.99935,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLZF01000029",97.315,3.9e-66,254,149,144.99935,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLSH01000020",97.315,3.9e-66,254,149,144.99935,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLYY01000023",97.315,3.9e-66,254,149,144.99935,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLYC01000020",97.315,3.9e-66,254,149,144.99935,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLXZ01000020",97.315,3.9e-66,254,149,144.99935,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_JBGJJV010000032",97.315,3.9e-66,254,149,144.99935,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_FLBI01000046",97.297,1.41e-65,252,148,143.99956,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLRE01000049",96.667,5.09e-65,250,150,145.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_JAUEGY010000142",96.667,5.09e-65,250,150,145.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_JBGJJV010000032",96.667,5.09e-65,250,150,145.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_FLBI01000046",96.667,5.09e-65,250,150,145.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_FLBN01000099",96.667,5.09e-65,250,150,145.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRI01000021",96.667,5.09e-65,250,150,145.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRE01000049",96.667,5.09e-65,250,150,145.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_FLCN01000004",96.667,5.09e-65,250,150,145.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRZ01000037",96.667,5.09e-65,250,150,145.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRO01000021",96.667,5.09e-65,250,150,145.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLXR01000021",96.667,5.09e-65,250,150,145.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRG01000021",96.667,5.09e-65,250,150,145.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLYG01000019",96.667,5.09e-65,250,150,145.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRJ01000019",96.667,5.09e-65,250,150,145.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLSM01000018",96.667,5.09e-65,250,150,145.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLSQ01000022",96.667,5.09e-65,250,150,145.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLXY01000024",96.667,5.09e-65,250,150,145.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLXS01000025",96.667,5.09e-65,250,150,145.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLWB01000035",96.667,5.09e-65,250,150,145.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLUD01000021",96.667,5.09e-65,250,150,145.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLRC01000027",96.667,5.09e-65,250,150,145.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLYZ01000021",96.667,5.09e-65,250,150,145.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLSP01000022",96.667,5.09e-65,250,150,145.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLZF01000029",96.667,5.09e-65,250,150,145.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLSH01000020",96.667,5.09e-65,250,150,145.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLYY01000023",96.667,5.09e-65,250,150,145.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLYC01000020",96.667,5.09e-65,250,150,145.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLXZ01000020",96.667,5.09e-65,250,150,145.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_JBGJJV010000032",96.667,5.09e-65,250,150,145.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_JBGJJV010000032",96.622,6.58e-64,246,148,143.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRI01000021",96.622,6.53e-64,246,148,143.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRE01000049",96.622,6.53e-64,246,148,143.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRZ01000037",96.622,6.53e-64,246,148,143.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRO01000021",96.622,6.53e-64,246,148,143.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLXR01000021",96.622,6.53e-64,246,148,143.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRG01000021",96.622,6.53e-64,246,148,143.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLYG01000019",96.622,6.53e-64,246,148,143.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRJ01000019",96.622,6.53e-64,246,148,143.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLSM01000018",96.622,6.53e-64,246,148,143.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLSQ01000022",96.622,6.53e-64,246,148,143.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLXY01000024",96.622,6.53e-64,246,148,143.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLXS01000025",96.622,6.53e-64,246,148,143.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLWB01000035",96.622,6.53e-64,246,148,143.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLUD01000021",96.622,6.53e-64,246,148,143.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLRC01000027",96.622,6.53e-64,246,148,143.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLYZ01000021",96.622,6.53e-64,246,148,143.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLSP01000022",96.622,6.53e-64,246,148,143.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLZF01000029",96.622,6.53e-64,246,148,143.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLSH01000020",96.622,6.53e-64,246,148,143.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLYY01000023",96.622,6.53e-64,246,148,143.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLYC01000020",96.622,6.53e-64,246,148,143.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLXZ01000020",96.622,6.53e-64,246,148,143.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_FLBI01000046",96.599,2.35e-63,244,147,142.00053,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_FLBN01000099",96.599,2.35e-63,244,147,142.00053,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRI01000021",96.599,2.35e-63,244,147,142.00053,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRE01000049",96.599,2.35e-63,244,147,142.00053,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_FLCN01000004",96.599,2.35e-63,244,147,142.00053,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRZ01000037",96.599,2.35e-63,244,147,142.00053,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRO01000021",96.599,2.35e-63,244,147,142.00053,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLXR01000021",96.599,2.35e-63,244,147,142.00053,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRG01000021",96.599,2.35e-63,244,147,142.00053,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLYG01000019",96.599,2.35e-63,244,147,142.00053,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRJ01000019",96.599,2.35e-63,244,147,142.00053,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLSM01000018",96.599,2.35e-63,244,147,142.00053,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLSQ01000022",96.599,2.35e-63,244,147,142.00053,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLXY01000024",96.599,2.35e-63,244,147,142.00053,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLXS01000025",96.599,2.35e-63,244,147,142.00053,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLWB01000035",96.599,2.35e-63,244,147,142.00053,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLUD01000021",96.599,2.35e-63,244,147,142.00053,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLRC01000027",96.599,2.35e-63,244,147,142.00053,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLYZ01000021",96.599,2.35e-63,244,147,142.00053,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLSP01000022",96.599,2.35e-63,244,147,142.00053,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLZF01000029",96.599,2.35e-63,244,147,142.00053,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLSH01000020",96.599,2.35e-63,244,147,142.00053,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLYY01000023",96.599,2.35e-63,244,147,142.00053,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLYC01000020",96.599,2.35e-63,244,147,142.00053,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLXZ01000020",96.599,2.35e-63,244,147,142.00053,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_JBGJJV010000032",96.599,2.35e-63,244,147,142.00053,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_JAUEGY010000142",96.599,2.35e-63,244,147,142.00053,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_FLBI01000046",96.599,2.35e-63,244,147,142.00053,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_FLBN01000099",96.599,2.35e-63,244,147,142.00053,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRI01000021",96.599,2.35e-63,244,147,142.00053,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRE01000049",96.599,2.35e-63,244,147,142.00053,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_FLCN01000004",96.599,2.35e-63,244,147,142.00053,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRZ01000037",96.599,2.35e-63,244,147,142.00053,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRO01000021",96.599,2.35e-63,244,147,142.00053,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLXR01000021",96.599,2.35e-63,244,147,142.00053,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRG01000021",96.599,2.35e-63,244,147,142.00053,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLYG01000019",96.599,2.35e-63,244,147,142.00053,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRJ01000019",96.599,2.35e-63,244,147,142.00053,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLSM01000018",96.599,2.35e-63,244,147,142.00053,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLSQ01000022",96.599,2.35e-63,244,147,142.00053,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLXY01000024",96.599,2.35e-63,244,147,142.00053,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLXS01000025",96.599,2.35e-63,244,147,142.00053,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLWB01000035",96.599,2.35e-63,244,147,142.00053,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLUD01000021",96.599,2.35e-63,244,147,142.00053,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLRC01000027",96.599,2.35e-63,244,147,142.00053,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLYZ01000021",96.599,2.35e-63,244,147,142.00053,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLSP01000022",96.599,2.35e-63,244,147,142.00053,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLZF01000029",96.599,2.35e-63,244,147,142.00053,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLSH01000020",96.599,2.35e-63,244,147,142.00053,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLYY01000023",96.599,2.35e-63,244,147,142.00053,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLYC01000020",96.599,2.35e-63,244,147,142.00053,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLXZ01000020",96.599,2.35e-63,244,147,142.00053,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_JBGJJV010000032",96.599,2.35e-63,244,147,142.00053,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_JAUEGY010000142",96.599,2.35e-63,244,147,142.00053,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_FLBI01000046",96,2.37e-63,244,150,144,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_FLBN01000099",96,2.37e-63,244,150,144,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_FLCN01000004",96,2.37e-63,244,150,144,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_MLRZ01000037",96,2.37e-63,244,150,144,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_MLWB01000035",96,2.37e-63,244,150,144,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_MLZF01000029",96,2.37e-63,244,150,144,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_JBGJJV010000032",96,2.37e-63,244,150,144,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_JBGJJV010000032",96.599,8.44e-63,243,147,142.00053,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_JBGJJV010000032",96,8.44e-63,243,150,144,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_JBGJJV010000032",95.395,3.06e-62,241,152,145.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRE01000049",95.946,3.06e-62,241,148,142.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_JBGJJV010000032",95.946,3.06e-62,241,148,142.00008,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_FLBN01000099",95.946,3.06e-62,241,148,142.00008,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_FLCN01000004",95.946,3.06e-62,241,148,142.00008,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRE01000049",95.946,3.06e-62,241,148,142.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_FLBI01000046",95.946,3.06e-62,241,148,142.00008,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_FLBN01000099",95.946,3.06e-62,241,148,142.00008,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_FLCN01000004",95.946,3.06e-62,241,148,142.00008,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_MLRZ01000037",95.946,3.06e-62,241,148,142.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_MLWB01000035",95.946,3.06e-62,241,148,142.00008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_MLZF01000029",95.946,3.06e-62,241,148,142.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_JBGJJV010000032",95.946,3.06e-62,241,148,142.00008,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_FLBI01000046",95.333,1.1e-61,239,150,142.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_FLBN01000099",95.333,1.1e-61,239,150,142.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_FLCN01000004",95.333,1.1e-61,239,150,142.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_MLRZ01000037",95.333,1.1e-61,239,150,142.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_MLWB01000035",95.333,1.1e-61,239,150,142.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_MLZF01000029",95.333,1.1e-61,239,150,142.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_JBGJJV010000032",95.333,1.1e-61,239,150,142.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_FLBI01000046",96.503,3.96e-61,237,143,137.99929,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_FLBN01000099",96.503,3.96e-61,237,143,137.99929,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRI01000021",96.503,3.96e-61,237,143,137.99929,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRE01000049",96.503,3.96e-61,237,143,137.99929,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_FLCN01000004",96.503,3.96e-61,237,143,137.99929,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRZ01000037",96.503,3.96e-61,237,143,137.99929,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRO01000021",96.503,3.96e-61,237,143,137.99929,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLXR01000021",96.503,3.96e-61,237,143,137.99929,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRG01000021",96.503,3.96e-61,237,143,137.99929,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLYG01000019",96.503,3.96e-61,237,143,137.99929,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRJ01000019",96.503,3.96e-61,237,143,137.99929,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLSM01000018",96.503,3.96e-61,237,143,137.99929,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLSQ01000022",96.503,3.96e-61,237,143,137.99929,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLXY01000024",96.503,3.96e-61,237,143,137.99929,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLXS01000025",96.503,3.96e-61,237,143,137.99929,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLWB01000035",96.503,3.96e-61,237,143,137.99929,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLUD01000021",96.503,3.96e-61,237,143,137.99929,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLRC01000027",96.503,3.96e-61,237,143,137.99929,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLYZ01000021",96.503,3.96e-61,237,143,137.99929,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLSP01000022",96.503,3.96e-61,237,143,137.99929,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLZF01000029",96.503,3.96e-61,237,143,137.99929,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLSH01000020",96.503,3.96e-61,237,143,137.99929,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLYY01000023",96.503,3.96e-61,237,143,137.99929,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLYC01000020",96.503,3.96e-61,237,143,137.99929,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLXZ01000020",96.503,3.96e-61,237,143,137.99929,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_JBGJJV010000032",96.503,3.96e-61,237,143,137.99929,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_JAUEGY010000142",96.503,3.96e-61,237,143,137.99929,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_FLBI01000046",95.302,3.93e-61,237,149,141.99998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_FLBN01000099",95.302,3.93e-61,237,149,141.99998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRI01000021",95.302,3.93e-61,237,149,141.99998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRE01000049",95.302,3.93e-61,237,149,141.99998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_FLCN01000004",95.302,3.93e-61,237,149,141.99998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRZ01000037",95.302,3.93e-61,237,149,141.99998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRO01000021",95.302,3.93e-61,237,149,141.99998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLXR01000021",95.302,3.93e-61,237,149,141.99998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRG01000021",95.302,3.93e-61,237,149,141.99998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLYG01000019",95.302,3.93e-61,237,149,141.99998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRJ01000019",95.302,3.93e-61,237,149,141.99998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLSM01000018",95.302,3.93e-61,237,149,141.99998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLSQ01000022",95.302,3.93e-61,237,149,141.99998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLXY01000024",95.302,3.93e-61,237,149,141.99998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLXS01000025",95.302,3.93e-61,237,149,141.99998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLWB01000035",95.302,3.93e-61,237,149,141.99998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLUD01000021",95.302,3.93e-61,237,149,141.99998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLRC01000027",95.302,3.93e-61,237,149,141.99998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLYZ01000021",95.302,3.93e-61,237,149,141.99998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLSP01000022",95.302,3.93e-61,237,149,141.99998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLZF01000029",95.302,3.93e-61,237,149,141.99998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLSH01000020",95.302,3.93e-61,237,149,141.99998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLYY01000023",95.302,3.93e-61,237,149,141.99998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLYC01000020",95.302,3.93e-61,237,149,141.99998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLXZ01000020",95.302,3.93e-61,237,149,141.99998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_JBGJJV010000032",95.302,3.93e-61,237,149,141.99998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_JAUEGY010000142",95.302,3.93e-61,237,149,141.99998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_JBGJJV010000032",95.333,3.93e-61,237,150,142.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_FLBI01000046",96.479,1.41e-60,235,142,137.00018,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_FLBN01000099",96.479,1.41e-60,235,142,137.00018,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRI01000021",96.479,1.41e-60,235,142,137.00018,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRE01000049",96.479,1.41e-60,235,142,137.00018,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_FLCN01000004",96.479,1.41e-60,235,142,137.00018,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRZ01000037",96.479,1.41e-60,235,142,137.00018,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRO01000021",96.479,1.41e-60,235,142,137.00018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLXR01000021",96.479,1.41e-60,235,142,137.00018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRG01000021",96.479,1.41e-60,235,142,137.00018,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLYG01000019",96.479,1.41e-60,235,142,137.00018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRJ01000019",96.479,1.41e-60,235,142,137.00018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLSM01000018",96.479,1.41e-60,235,142,137.00018,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLSQ01000022",96.479,1.41e-60,235,142,137.00018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLXY01000024",96.479,1.41e-60,235,142,137.00018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLXS01000025",96.479,1.41e-60,235,142,137.00018,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLWB01000035",96.479,1.41e-60,235,142,137.00018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLUD01000021",96.479,1.41e-60,235,142,137.00018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLRC01000027",96.479,1.41e-60,235,142,137.00018,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLYZ01000021",96.479,1.41e-60,235,142,137.00018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLSP01000022",96.479,1.41e-60,235,142,137.00018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLZF01000029",96.479,1.41e-60,235,142,137.00018,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLSH01000020",96.479,1.41e-60,235,142,137.00018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLYY01000023",96.479,1.41e-60,235,142,137.00018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLYC01000020",96.479,1.41e-60,235,142,137.00018,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLXZ01000020",96.479,1.41e-60,235,142,137.00018,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_JBGJJV010000032",96.479,1.41e-60,235,142,137.00018,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_JAUEGY010000142",96.479,1.41e-60,235,142,137.00018,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRI01000021",95.27,1.41e-60,235,148,140.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRE01000049",95.27,1.41e-60,235,148,140.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRZ01000037",95.27,1.41e-60,235,148,140.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRO01000021",95.27,1.41e-60,235,148,140.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLXR01000021",95.27,1.41e-60,235,148,140.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRG01000021",95.27,1.41e-60,235,148,140.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLYG01000019",95.27,1.41e-60,235,148,140.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRJ01000019",95.27,1.41e-60,235,148,140.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLSM01000018",95.27,1.41e-60,235,148,140.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLSQ01000022",95.27,1.41e-60,235,148,140.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLXY01000024",95.27,1.41e-60,235,148,140.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLXS01000025",95.27,1.41e-60,235,148,140.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLWB01000035",95.27,1.41e-60,235,148,140.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLUD01000021",95.27,1.41e-60,235,148,140.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLRC01000027",95.27,1.41e-60,235,148,140.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLYZ01000021",95.27,1.41e-60,235,148,140.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLSP01000022",95.27,1.41e-60,235,148,140.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLZF01000029",95.27,1.41e-60,235,148,140.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLSH01000020",95.27,1.41e-60,235,148,140.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLYY01000023",95.27,1.41e-60,235,148,140.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLYC01000020",95.27,1.41e-60,235,148,140.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLXZ01000020",95.27,1.41e-60,235,148,140.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_FLBI01000046",95.27,1.42e-60,235,148,140.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_FLBN01000099",95.27,1.42e-60,235,148,140.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRI01000021",95.27,1.42e-60,235,148,140.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRE01000049",95.27,1.42e-60,235,148,140.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_FLCN01000004",95.27,1.42e-60,235,148,140.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRZ01000037",95.27,1.42e-60,235,148,140.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRO01000021",95.27,1.42e-60,235,148,140.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLXR01000021",95.27,1.42e-60,235,148,140.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRG01000021",95.27,1.42e-60,235,148,140.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLYG01000019",95.27,1.42e-60,235,148,140.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRJ01000019",95.27,1.42e-60,235,148,140.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLSM01000018",95.27,1.42e-60,235,148,140.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLSQ01000022",95.27,1.42e-60,235,148,140.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLXY01000024",95.27,1.42e-60,235,148,140.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLXS01000025",95.27,1.42e-60,235,148,140.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLWB01000035",95.27,1.42e-60,235,148,140.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLUD01000021",95.27,1.42e-60,235,148,140.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLRC01000027",95.27,1.42e-60,235,148,140.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLYZ01000021",95.27,1.42e-60,235,148,140.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLSP01000022",95.27,1.42e-60,235,148,140.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLZF01000029",95.27,1.42e-60,235,148,140.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLSH01000020",95.27,1.42e-60,235,148,140.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLYY01000023",95.27,1.42e-60,235,148,140.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLYC01000020",95.27,1.42e-60,235,148,140.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLXZ01000020",95.27,1.42e-60,235,148,140.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_JBGJJV010000032",95.27,1.42e-60,235,148,140.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_JAUEGY010000142",95.27,1.42e-60,235,148,140.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_FLBI01000046",95.238,5.08e-60,233,147,139.99986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_FLBN01000099",95.238,5.08e-60,233,147,139.99986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRI01000021",95.238,5.08e-60,233,147,139.99986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRE01000049",95.238,5.08e-60,233,147,139.99986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_FLCN01000004",95.238,5.08e-60,233,147,139.99986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRZ01000037",95.238,5.08e-60,233,147,139.99986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRO01000021",95.238,5.08e-60,233,147,139.99986,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLXR01000021",95.238,5.08e-60,233,147,139.99986,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRG01000021",95.238,5.08e-60,233,147,139.99986,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLYG01000019",95.238,5.08e-60,233,147,139.99986,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRJ01000019",95.238,5.08e-60,233,147,139.99986,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLSM01000018",95.238,5.08e-60,233,147,139.99986,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLSQ01000022",95.238,5.08e-60,233,147,139.99986,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLXY01000024",95.238,5.08e-60,233,147,139.99986,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLXS01000025",95.238,5.08e-60,233,147,139.99986,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLWB01000035",95.238,5.08e-60,233,147,139.99986,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLUD01000021",95.238,5.08e-60,233,147,139.99986,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLRC01000027",95.238,5.08e-60,233,147,139.99986,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLYZ01000021",95.238,5.08e-60,233,147,139.99986,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLSP01000022",95.238,5.08e-60,233,147,139.99986,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLZF01000029",95.238,5.08e-60,233,147,139.99986,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLSH01000020",95.238,5.08e-60,233,147,139.99986,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLYY01000023",95.238,5.08e-60,233,147,139.99986,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLYC01000020",95.238,5.08e-60,233,147,139.99986,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLXZ01000020",95.238,5.08e-60,233,147,139.99986,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_JBGJJV010000032",95.238,5.08e-60,233,147,139.99986,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_JAUEGY010000142",95.238,5.08e-60,233,147,139.99986,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_FLBI01000046",96.85,6.62e-54,213,127,122.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_FLBN01000099",96.85,6.62e-54,213,127,122.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_FLCN01000004",96.85,6.62e-54,213,127,122.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_FLBI01000046",96.063,1.11e-51,206,127,122.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_FLBN01000099",96.063,1.11e-51,206,127,122.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_FLCN01000004",96.063,1.11e-51,206,127,122.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLRI01000021",96.032,1.12e-51,206,126,121.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLRZ01000037",96.032,1.12e-51,206,126,121.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLRO01000021",96.032,1.12e-51,206,126,121.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLXR01000021",96.032,1.12e-51,206,126,121.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLRG01000021",96.032,1.12e-51,206,126,121.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLYG01000019",96.032,1.12e-51,206,126,121.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLRJ01000019",96.032,1.12e-51,206,126,121.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLSM01000018",96.032,1.12e-51,206,126,121.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLSQ01000022",96.032,1.12e-51,206,126,121.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLXY01000024",96.032,1.12e-51,206,126,121.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLXS01000025",96.032,1.12e-51,206,126,121.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLWB01000035",96.032,1.12e-51,206,126,121.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLUD01000021",96.032,1.12e-51,206,126,121.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLRC01000027",96.032,1.12e-51,206,126,121.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLYZ01000021",96.032,1.12e-51,206,126,121.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLSP01000022",96.032,1.12e-51,206,126,121.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLZF01000029",96.032,1.12e-51,206,126,121.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLSH01000020",96.032,1.12e-51,206,126,121.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLYY01000023",96.032,1.12e-51,206,126,121.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLYC01000020",96.032,1.12e-51,206,126,121.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLXZ01000020",96.032,1.12e-51,206,126,121.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLRI01000021",96,3.98e-51,204,125,120,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLRZ01000037",96,3.98e-51,204,125,120,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLRO01000021",96,3.98e-51,204,125,120,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLXR01000021",96,3.98e-51,204,125,120,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLRG01000021",96,3.98e-51,204,125,120,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLYG01000019",96,3.98e-51,204,125,120,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLRJ01000019",96,3.98e-51,204,125,120,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLSM01000018",96,3.98e-51,204,125,120,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLSQ01000022",96,3.98e-51,204,125,120,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLXY01000024",96,3.98e-51,204,125,120,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLXS01000025",96,3.98e-51,204,125,120,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLWB01000035",96,3.98e-51,204,125,120,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLUD01000021",96,3.98e-51,204,125,120,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLRC01000027",96,3.98e-51,204,125,120,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLYZ01000021",96,3.98e-51,204,125,120,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLSP01000022",96,3.98e-51,204,125,120,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLZF01000029",96,3.98e-51,204,125,120,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLSH01000020",96,3.98e-51,204,125,120,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLYY01000023",96,3.98e-51,204,125,120,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLYC01000020",96,3.98e-51,204,125,120,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLXZ01000020",96,3.98e-51,204,125,120,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_JBGJJV010000032",95.238,5.2e-50,200,126,119.99988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRI01000021",95.902,1.58e-49,198,122,117.00044,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRE01000049",95.902,1.58e-49,198,122,117.00044,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRZ01000037",95.902,1.58e-49,198,122,117.00044,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRO01000021",95.902,1.58e-49,198,122,117.00044,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLXR01000021",95.902,1.58e-49,198,122,117.00044,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRG01000021",95.902,1.58e-49,198,122,117.00044,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLYG01000019",95.902,1.58e-49,198,122,117.00044,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRJ01000019",95.902,1.58e-49,198,122,117.00044,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLSM01000018",95.902,1.58e-49,198,122,117.00044,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLSQ01000022",95.902,1.58e-49,198,122,117.00044,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLXY01000024",95.902,1.58e-49,198,122,117.00044,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLXS01000025",95.902,1.58e-49,198,122,117.00044,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLWB01000035",95.902,1.58e-49,198,122,117.00044,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLUD01000021",95.902,1.58e-49,198,122,117.00044,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLRC01000027",95.902,1.58e-49,198,122,117.00044,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLYZ01000021",95.902,1.58e-49,198,122,117.00044,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLSP01000022",95.902,1.58e-49,198,122,117.00044,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLZF01000029",95.902,1.58e-49,198,122,117.00044,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLSH01000020",95.902,1.58e-49,198,122,117.00044,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLYY01000023",95.902,1.58e-49,198,122,117.00044,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLYC01000020",95.902,1.58e-49,198,122,117.00044,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLXZ01000020",95.902,1.58e-49,198,122,117.00044,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_JBGJJV010000032",95.2,1.85e-49,198,125,119,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_JBGJJV010000032",95.161,2.04e-48,195,124,117.99964,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_FLBI01000046",95.652,1.44e-45,185,115,109.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_FLBN01000099",95.652,1.44e-45,185,115,109.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRI01000021",95.652,1.44e-45,185,115,109.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRE01000049",95.652,1.44e-45,185,115,109.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_FLCN01000004",95.652,1.44e-45,185,115,109.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRZ01000037",95.652,1.44e-45,185,115,109.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRO01000021",95.652,1.44e-45,185,115,109.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLXR01000021",95.652,1.44e-45,185,115,109.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRG01000021",95.652,1.44e-45,185,115,109.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLYG01000019",95.652,1.44e-45,185,115,109.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRJ01000019",95.652,1.44e-45,185,115,109.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLSM01000018",95.652,1.44e-45,185,115,109.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLSQ01000022",95.652,1.44e-45,185,115,109.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLXY01000024",95.652,1.44e-45,185,115,109.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLXS01000025",95.652,1.44e-45,185,115,109.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLWB01000035",95.652,1.44e-45,185,115,109.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLUD01000021",95.652,1.44e-45,185,115,109.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLRC01000027",95.652,1.44e-45,185,115,109.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLYZ01000021",95.652,1.44e-45,185,115,109.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLSP01000022",95.652,1.44e-45,185,115,109.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLZF01000029",95.652,1.44e-45,185,115,109.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLSH01000020",95.652,1.44e-45,185,115,109.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLYY01000023",95.652,1.44e-45,185,115,109.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLYC01000020",95.652,1.44e-45,185,115,109.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLXZ01000020",95.652,1.44e-45,185,115,109.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_JBGJJV010000032",95.652,1.44e-45,185,115,109.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_FLBI01000046",95.652,1.44e-45,185,115,109.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_FLBN01000099",95.652,1.44e-45,185,115,109.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRI01000021",95.652,1.44e-45,185,115,109.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRE01000049",95.652,1.44e-45,185,115,109.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_FLCN01000004",95.652,1.44e-45,185,115,109.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRZ01000037",95.652,1.44e-45,185,115,109.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRO01000021",95.652,1.44e-45,185,115,109.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLXR01000021",95.652,1.44e-45,185,115,109.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRG01000021",95.652,1.44e-45,185,115,109.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLYG01000019",95.652,1.44e-45,185,115,109.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRJ01000019",95.652,1.44e-45,185,115,109.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLSM01000018",95.652,1.44e-45,185,115,109.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLSQ01000022",95.652,1.44e-45,185,115,109.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLXY01000024",95.652,1.44e-45,185,115,109.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLXS01000025",95.652,1.44e-45,185,115,109.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLWB01000035",95.652,1.44e-45,185,115,109.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLUD01000021",95.652,1.44e-45,185,115,109.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLRC01000027",95.652,1.44e-45,185,115,109.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLYZ01000021",95.652,1.44e-45,185,115,109.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLSP01000022",95.652,1.44e-45,185,115,109.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLZF01000029",95.652,1.44e-45,185,115,109.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLSH01000020",95.652,1.44e-45,185,115,109.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLYY01000023",95.652,1.44e-45,185,115,109.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLYC01000020",95.652,1.44e-45,185,115,109.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLXZ01000020",95.652,1.44e-45,185,115,109.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_JBGJJV010000032",95.652,1.44e-45,185,115,109.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_MLRZ01000037",98.058,6.77e-44,180,103,100.99974,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_MLWB01000035",98.058,6.77e-44,180,103,100.99974,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_MLZF01000029",98.058,6.77e-44,180,103,100.99974,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRI01000021",95.413,3.12e-42,174,109,104.00017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRE01000049",95.413,3.12e-42,174,109,104.00017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRZ01000037",95.413,3.12e-42,174,109,104.00017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRO01000021",95.413,3.12e-42,174,109,104.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLXR01000021",95.413,3.12e-42,174,109,104.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRG01000021",95.413,3.12e-42,174,109,104.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLYG01000019",95.413,3.12e-42,174,109,104.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRJ01000019",95.413,3.12e-42,174,109,104.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLSM01000018",95.413,3.12e-42,174,109,104.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLSQ01000022",95.413,3.12e-42,174,109,104.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLXY01000024",95.413,3.12e-42,174,109,104.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLXS01000025",95.413,3.12e-42,174,109,104.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLWB01000035",95.413,3.12e-42,174,109,104.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLUD01000021",95.413,3.12e-42,174,109,104.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLRC01000027",95.413,3.12e-42,174,109,104.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLYZ01000021",95.413,3.12e-42,174,109,104.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLSP01000022",95.413,3.12e-42,174,109,104.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLZF01000029",95.413,3.12e-42,174,109,104.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLSH01000020",95.413,3.12e-42,174,109,104.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLYY01000023",95.413,3.12e-42,174,109,104.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLYC01000020",95.413,3.12e-42,174,109,104.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLXZ01000020",95.413,3.12e-42,174,109,104.00017,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_FLBI01000046",97.826,7.46e-38,159,92,89.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_FLBN01000099",97.826,7.46e-38,159,92,89.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRI01000021",96.842,7.46e-38,159,95,91.9999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRE01000049",96.842,7.46e-38,159,95,91.9999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_FLCN01000004",97.826,7.46e-38,159,92,89.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRZ01000037",96.842,7.46e-38,159,95,91.9999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRO01000021",96.842,7.46e-38,159,95,91.9999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLXR01000021",96.842,7.46e-38,159,95,91.9999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRG01000021",96.842,7.46e-38,159,95,91.9999,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLYG01000019",96.842,7.46e-38,159,95,91.9999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRJ01000019",96.842,7.46e-38,159,95,91.9999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLSM01000018",96.842,7.46e-38,159,95,91.9999,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLSQ01000022",96.842,7.46e-38,159,95,91.9999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLXY01000024",96.842,7.46e-38,159,95,91.9999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLXS01000025",96.842,7.46e-38,159,95,91.9999,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLWB01000035",96.842,7.46e-38,159,95,91.9999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLUD01000021",96.842,7.46e-38,159,95,91.9999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLRC01000027",96.842,7.46e-38,159,95,91.9999,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLYZ01000021",96.842,7.46e-38,159,95,91.9999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLSP01000022",96.842,7.46e-38,159,95,91.9999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLZF01000029",96.842,7.46e-38,159,95,91.9999,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLSH01000020",96.842,7.46e-38,159,95,91.9999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLYY01000023",96.842,7.46e-38,159,95,91.9999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLYC01000020",96.842,7.46e-38,159,95,91.9999,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLXZ01000020",96.842,7.46e-38,159,95,91.9999,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_JBGJJV010000032",97.826,7.46e-38,159,92,89.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_FLBI01000046",98.824,7.08e-36,152,85,84.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_FLBN01000099",98.824,7.08e-36,152,85,84.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRI01000021",98.824,7.08e-36,152,85,84.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRE01000049",98.824,7.08e-36,152,85,84.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_FLCN01000004",98.824,7.08e-36,152,85,84.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRZ01000037",98.824,7.08e-36,152,85,84.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRO01000021",98.824,7.08e-36,152,85,84.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLXR01000021",98.824,7.08e-36,152,85,84.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRG01000021",98.824,7.08e-36,152,85,84.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLYG01000019",98.824,7.08e-36,152,85,84.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRJ01000019",98.824,7.08e-36,152,85,84.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLSM01000018",98.824,7.08e-36,152,85,84.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLSQ01000022",98.824,7.08e-36,152,85,84.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLXY01000024",98.824,7.08e-36,152,85,84.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLXS01000025",98.824,7.08e-36,152,85,84.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLWB01000035",98.824,7.08e-36,152,85,84.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLUD01000021",98.824,7.08e-36,152,85,84.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLRC01000027",98.824,7.08e-36,152,85,84.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLYZ01000021",98.824,7.08e-36,152,85,84.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLSP01000022",98.824,7.08e-36,152,85,84.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLZF01000029",98.824,7.08e-36,152,85,84.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLSH01000020",98.824,7.08e-36,152,85,84.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLYY01000023",98.824,7.08e-36,152,85,84.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLYC01000020",98.824,7.08e-36,152,85,84.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLXZ01000020",98.824,7.08e-36,152,85,84.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_JBGJJV010000032",98.824,7.08e-36,152,85,84.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_MLRZ01000037",97.674,1.44e-34,148,86,83.99964,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_MLWB01000035",97.674,1.44e-34,148,86,83.99964,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_MLZF01000029",97.674,1.44e-34,148,86,83.99964,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_JBGJJV010000032",97.674,1.44e-34,148,86,83.99964,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_FLBI01000046",97.647,3.29e-34,147,85,82.99995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_FLBN01000099",97.647,3.29e-34,147,85,82.99995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRI01000021",97.647,3.29e-34,147,85,82.99995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRE01000049",97.647,3.29e-34,147,85,82.99995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_FLCN01000004",97.647,3.29e-34,147,85,82.99995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRZ01000037",97.647,3.29e-34,147,85,82.99995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRO01000021",97.647,3.29e-34,147,85,82.99995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLXR01000021",97.647,3.29e-34,147,85,82.99995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRG01000021",97.647,3.29e-34,147,85,82.99995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLYG01000019",97.647,3.29e-34,147,85,82.99995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRJ01000019",97.647,3.29e-34,147,85,82.99995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLSM01000018",97.647,3.29e-34,147,85,82.99995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLSQ01000022",97.647,3.29e-34,147,85,82.99995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLXY01000024",97.647,3.29e-34,147,85,82.99995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLXS01000025",97.647,3.29e-34,147,85,82.99995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLWB01000035",97.647,3.29e-34,147,85,82.99995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLUD01000021",97.647,3.29e-34,147,85,82.99995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLRC01000027",97.647,3.29e-34,147,85,82.99995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLYZ01000021",97.647,3.29e-34,147,85,82.99995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLSP01000022",97.647,3.29e-34,147,85,82.99995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLZF01000029",97.647,3.29e-34,147,85,82.99995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLSH01000020",97.647,3.29e-34,147,85,82.99995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLYY01000023",97.647,3.29e-34,147,85,82.99995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLYC01000020",97.647,3.29e-34,147,85,82.99995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLXZ01000020",97.647,3.29e-34,147,85,82.99995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_JBGJJV010000032",97.647,3.29e-34,147,85,82.99995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_MLRZ01000037",96.512,6.71e-33,143,86,83.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_MLWB01000035",96.512,6.71e-33,143,86,83.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_MLZF01000029",96.512,6.71e-33,143,86,83.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_JBGJJV010000032",96.512,6.71e-33,143,86,83.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_FLBI01000046",97.5,1.88e-31,137,80,78,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_FLBN01000099",97.5,1.88e-31,137,80,78,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRI01000021",97.5,1.88e-31,137,80,78,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRE01000049",97.5,1.88e-31,137,80,78,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_FLCN01000004",97.5,1.88e-31,137,80,78,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRZ01000037",97.5,1.88e-31,137,80,78,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRO01000021",97.5,1.88e-31,137,80,78,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLXR01000021",97.5,1.88e-31,137,80,78,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRG01000021",97.5,1.88e-31,137,80,78,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLYG01000019",97.5,1.88e-31,137,80,78,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRJ01000019",97.5,1.88e-31,137,80,78,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLSM01000018",97.5,1.88e-31,137,80,78,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLSQ01000022",97.5,1.88e-31,137,80,78,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLXY01000024",97.5,1.88e-31,137,80,78,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLXS01000025",97.5,1.88e-31,137,80,78,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLWB01000035",97.5,1.88e-31,137,80,78,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLUD01000021",97.5,1.88e-31,137,80,78,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLRC01000027",97.5,1.88e-31,137,80,78,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLYZ01000021",97.5,1.88e-31,137,80,78,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLSP01000022",97.5,1.88e-31,137,80,78,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLZF01000029",97.5,1.88e-31,137,80,78,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLSH01000020",97.5,1.88e-31,137,80,78,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLYY01000023",97.5,1.88e-31,137,80,78,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLYC01000020",97.5,1.88e-31,137,80,78,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLXZ01000020",97.5,1.88e-31,137,80,78,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_JBGJJV010000032",97.5,1.88e-31,137,80,78,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_JAUEGY010000142",97.5,1.88e-31,137,80,78,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_FLBI01000046",95.062,1.17e-28,128,81,77.00022,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_FLBN01000099",95.062,1.17e-28,128,81,77.00022,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_FLCN01000004",95.062,1.17e-28,128,81,77.00022,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_JBGJJV010000032",95.062,1.17e-28,128,81,77.00022,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_FLBI01000046",96.154,1.05e-28,128,78,75.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_FLBN01000099",96.154,1.05e-28,128,78,75.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRI01000021",96.154,1.05e-28,128,78,75.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRE01000049",96.154,1.05e-28,128,78,75.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_FLCN01000004",96.154,1.05e-28,128,78,75.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRZ01000037",96.154,1.05e-28,128,78,75.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRO01000021",96.154,1.05e-28,128,78,75.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLXR01000021",96.154,1.05e-28,128,78,75.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRG01000021",96.154,1.05e-28,128,78,75.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLYG01000019",96.154,1.05e-28,128,78,75.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRJ01000019",96.154,1.05e-28,128,78,75.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLSM01000018",96.154,1.05e-28,128,78,75.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLSQ01000022",96.154,1.05e-28,128,78,75.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLXY01000024",96.154,1.05e-28,128,78,75.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLXS01000025",96.154,1.05e-28,128,78,75.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLWB01000035",96.154,1.05e-28,128,78,75.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLUD01000021",96.154,1.05e-28,128,78,75.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLRC01000027",96.154,1.05e-28,128,78,75.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLYZ01000021",96.154,1.05e-28,128,78,75.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLSP01000022",96.154,1.05e-28,128,78,75.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLZF01000029",96.154,1.05e-28,128,78,75.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLSH01000020",96.154,1.05e-28,128,78,75.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLYY01000023",96.154,1.05e-28,128,78,75.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLYC01000020",96.154,1.05e-28,128,78,75.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLXZ01000020",96.154,1.05e-28,128,78,75.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_JBGJJV010000032",96.154,1.05e-28,128,78,75.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_JAUEGY010000142",97.101,5.38e-25,117,69,66.99969,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_JAUEGY010000142",97.101,5.38e-25,117,69,66.99969,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_JAUEGY010000142",97.101,5.38e-25,117,69,66.99969,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_JAUEGY010000142",95.652,2.5e-23,111,69,65.99988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_JAUEGY010000142",95.652,2.5e-23,111,69,65.99988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_JAUEGY010000142",95.652,2.5e-23,111,69,65.99988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_JAUEGY010000142",95.588,9.01e-23,110,68,64.99984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_FLBI01000046",96.875,1.24e-22,108,64,62,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_FLBN01000099",96.875,1.24e-22,108,64,62,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRI01000021",96.875,1.24e-22,108,64,62,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRE01000049",96.875,1.24e-22,108,64,62,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_FLCN01000004",96.875,1.24e-22,108,64,62,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRZ01000037",96.875,1.24e-22,108,64,62,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRO01000021",96.875,1.24e-22,108,64,62,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLXR01000021",96.875,1.24e-22,108,64,62,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRG01000021",96.875,1.24e-22,108,64,62,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLYG01000019",96.875,1.24e-22,108,64,62,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRJ01000019",96.875,1.24e-22,108,64,62,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLSM01000018",96.875,1.24e-22,108,64,62,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLSQ01000022",96.875,1.24e-22,108,64,62,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLXY01000024",96.875,1.24e-22,108,64,62,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLXS01000025",96.875,1.24e-22,108,64,62,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLWB01000035",96.875,1.24e-22,108,64,62,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLUD01000021",96.875,1.24e-22,108,64,62,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLRC01000027",96.875,1.24e-22,108,64,62,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLYZ01000021",96.875,1.24e-22,108,64,62,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLSP01000022",96.875,1.24e-22,108,64,62,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLZF01000029",96.875,1.24e-22,108,64,62,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLSH01000020",96.875,1.24e-22,108,64,62,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLYY01000023",96.875,1.24e-22,108,64,62,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLYC01000020",96.875,1.24e-22,108,64,62,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLXZ01000020",96.875,1.24e-22,108,64,62,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_JBGJJV010000032",96.875,1.24e-22,108,64,62,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_JAUEGY010000142",96.875,1.24e-22,108,64,62,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLRI01000021",100,4.22e-11,71.3,38,38,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLRO01000021",100,4.22e-11,71.3,38,38,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLXR01000021",100,4.22e-11,71.3,38,38,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLRG01000021",100,4.22e-11,71.3,38,38,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLYG01000019",100,4.22e-11,71.3,38,38,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLRJ01000019",100,4.22e-11,71.3,38,38,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLSM01000018",100,4.22e-11,71.3,38,38,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLSQ01000022",100,4.22e-11,71.3,38,38,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLXY01000024",100,4.22e-11,71.3,38,38,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLXS01000025",100,4.22e-11,71.3,38,38,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLUD01000021",100,4.22e-11,71.3,38,38,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLRC01000027",100,4.22e-11,71.3,38,38,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLYZ01000021",100,4.22e-11,71.3,38,38,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLSP01000022",100,4.22e-11,71.3,38,38,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLSH01000020",100,4.22e-11,71.3,38,38,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLYY01000023",100,4.22e-11,71.3,38,38,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLYC01000020",100,4.22e-11,71.3,38,38,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLXZ01000020",100,4.22e-11,71.3,38,38,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLRI01000021",100,4.22e-11,71.3,38,38,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLRO01000021",100,4.22e-11,71.3,38,38,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLXR01000021",100,4.22e-11,71.3,38,38,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLRG01000021",100,4.22e-11,71.3,38,38,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLYG01000019",100,4.22e-11,71.3,38,38,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLRJ01000019",100,4.22e-11,71.3,38,38,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLSM01000018",100,4.22e-11,71.3,38,38,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLSQ01000022",100,4.22e-11,71.3,38,38,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLXY01000024",100,4.22e-11,71.3,38,38,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLXS01000025",100,4.22e-11,71.3,38,38,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLUD01000021",100,4.22e-11,71.3,38,38,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLRC01000027",100,4.22e-11,71.3,38,38,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLYZ01000021",100,4.22e-11,71.3,38,38,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLSP01000022",100,4.22e-11,71.3,38,38,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLSH01000020",100,4.22e-11,71.3,38,38,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLYY01000023",100,4.22e-11,71.3,38,38,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLYC01000020",100,4.22e-11,71.3,38,38,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLXZ01000020",100,4.22e-11,71.3,38,38,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLRI01000021",95.349,1.53e-10,69.4,43,41.00007,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLRO01000021",95.349,1.53e-10,69.4,43,41.00007,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLXR01000021",95.349,1.53e-10,69.4,43,41.00007,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLRG01000021",95.349,1.53e-10,69.4,43,41.00007,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLYG01000019",95.349,1.53e-10,69.4,43,41.00007,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLRJ01000019",95.349,1.53e-10,69.4,43,41.00007,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLSM01000018",95.349,1.53e-10,69.4,43,41.00007,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLSQ01000022",95.349,1.53e-10,69.4,43,41.00007,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLXY01000024",95.349,1.53e-10,69.4,43,41.00007,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLXS01000025",95.349,1.53e-10,69.4,43,41.00007,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLUD01000021",95.349,1.53e-10,69.4,43,41.00007,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLRC01000027",95.349,1.53e-10,69.4,43,41.00007,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLYZ01000021",95.349,1.53e-10,69.4,43,41.00007,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLSP01000022",95.349,1.53e-10,69.4,43,41.00007,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLSH01000020",95.349,1.53e-10,69.4,43,41.00007,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLYY01000023",95.349,1.53e-10,69.4,43,41.00007,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLYC01000020",95.349,1.53e-10,69.4,43,41.00007,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLXZ01000020",95.349,1.53e-10,69.4,43,41.00007,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLRI01000021",95.238,5.5e-10,67.6,42,39.99996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLRO01000021",95.238,5.5e-10,67.6,42,39.99996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLXR01000021",95.238,5.5e-10,67.6,42,39.99996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLRG01000021",95.238,5.5e-10,67.6,42,39.99996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLYG01000019",95.238,5.5e-10,67.6,42,39.99996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLRJ01000019",95.238,5.5e-10,67.6,42,39.99996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLSM01000018",95.238,5.5e-10,67.6,42,39.99996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLSQ01000022",95.238,5.5e-10,67.6,42,39.99996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLXY01000024",95.238,5.5e-10,67.6,42,39.99996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLXS01000025",95.238,5.5e-10,67.6,42,39.99996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLUD01000021",95.238,5.5e-10,67.6,42,39.99996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLRC01000027",95.238,5.5e-10,67.6,42,39.99996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLYZ01000021",95.238,5.5e-10,67.6,42,39.99996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLSP01000022",95.238,5.5e-10,67.6,42,39.99996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLSH01000020",95.238,5.5e-10,67.6,42,39.99996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLYY01000023",95.238,5.5e-10,67.6,42,39.99996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLYC01000020",95.238,5.5e-10,67.6,42,39.99996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLXZ01000020",95.238,5.5e-10,67.6,42,39.99996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLRI01000021",95.122,1.96e-09,65.8,41,39.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLRO01000021",95.122,1.96e-09,65.8,41,39.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLXR01000021",95.122,1.96e-09,65.8,41,39.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLRG01000021",95.122,1.96e-09,65.8,41,39.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLYG01000019",95.122,1.96e-09,65.8,41,39.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLRJ01000019",95.122,1.96e-09,65.8,41,39.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLSM01000018",95.122,1.96e-09,65.8,41,39.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLSQ01000022",95.122,1.96e-09,65.8,41,39.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLXY01000024",95.122,1.96e-09,65.8,41,39.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLXS01000025",95.122,1.96e-09,65.8,41,39.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLUD01000021",95.122,1.96e-09,65.8,41,39.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLRC01000027",95.122,1.96e-09,65.8,41,39.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLYZ01000021",95.122,1.96e-09,65.8,41,39.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLSP01000022",95.122,1.96e-09,65.8,41,39.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLSH01000020",95.122,1.96e-09,65.8,41,39.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLYY01000023",95.122,1.96e-09,65.8,41,39.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLYC01000020",95.122,1.96e-09,65.8,41,39.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Medium"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLXZ01000020",95.122,1.96e-09,65.8,41,39.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Medium"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRI01000021",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRE01000049",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRZ01000037",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRO01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLXR01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRG01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLYG01000019",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRJ01000019",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLSM01000018",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLSQ01000022",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLXY01000024",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLXS01000025",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLWB01000035",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLUD01000021",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLRC01000027",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLYZ01000021",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLSP01000022",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLZF01000029",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLSH01000020",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLYY01000023",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLYC01000020",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLXZ01000020",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_FLBI01000046",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_FLBN01000099",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRI01000021",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRE01000049",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_FLCN01000004",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRZ01000037",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRO01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLXR01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRG01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLYG01000019",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRJ01000019",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLSM01000018",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLSQ01000022",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLXY01000024",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLXS01000025",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLWB01000035",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLUD01000021",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLRC01000027",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLYZ01000021",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLSP01000022",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLZF01000029",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLSH01000020",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLYY01000023",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLYC01000020",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLXZ01000020",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_JBGJJV010000032",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_JAUEGY010000142",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_FLBI01000046",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_FLBN01000099",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRI01000021",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRE01000049",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_FLCN01000004",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRZ01000037",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRO01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLXR01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRG01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLYG01000019",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRJ01000019",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLSM01000018",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLSQ01000022",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLXY01000024",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLXS01000025",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLWB01000035",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLUD01000021",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLRC01000027",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLYZ01000021",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLSP01000022",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLZF01000029",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLSH01000020",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLYY01000023",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLYC01000020",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLXZ01000020",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_JBGJJV010000032",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_JAUEGY010000142",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_FLBI01000046",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_FLBN01000099",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRI01000021",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRE01000049",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_FLCN01000004",94.667,5.12e-60,233,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRZ01000037",94.667,5.12e-60,233,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRO01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLXR01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRG01000021",94.667,5.12e-60,233,150,142.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLYG01000019",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRJ01000019",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLSM01000018",94.667,5.12e-60,233,150,142.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLSQ01000022",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLXY01000024",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLXS01000025",94.667,5.12e-60,233,150,142.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLWB01000035",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLUD01000021",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLRC01000027",94.667,5.12e-60,233,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLYZ01000021",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLSP01000022",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLZF01000029",94.667,5.12e-60,233,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLSH01000020",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLYY01000023",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLYC01000020",94.667,5.12e-60,233,150,142.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLXZ01000020",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_JBGJJV010000032",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_JAUEGY010000142",94.667,5.12e-60,233,150,142.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_FLBI01000046",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_FLBN01000099",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRI01000021",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRE01000049",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_FLCN01000004",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRZ01000037",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRO01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLXR01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRG01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLYG01000019",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRJ01000019",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLSM01000018",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLSQ01000022",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLXY01000024",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLXS01000025",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLWB01000035",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLUD01000021",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLRC01000027",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLYZ01000021",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLSP01000022",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLZF01000029",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLSH01000020",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLYY01000023",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLYC01000020",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLXZ01000020",94.631,1.83e-59,231,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_JBGJJV010000032",94.631,1.83e-59,231,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_JAUEGY010000142",94.631,1.83e-59,231,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_FLBI01000046",94.667,1.83e-59,231,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_FLBN01000099",94.667,1.83e-59,231,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_FLCN01000004",94.667,1.83e-59,231,150,142.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_FLBI01000046",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_FLBN01000099",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRI01000021",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRE01000049",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_FLCN01000004",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRZ01000037",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRO01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLXR01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRG01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLYG01000019",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRJ01000019",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLSM01000018",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLSQ01000022",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLXY01000024",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLXS01000025",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLWB01000035",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLUD01000021",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLRC01000027",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLYZ01000021",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLSP01000022",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLZF01000029",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLSH01000020",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLYY01000023",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLYC01000020",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLXZ01000020",94.631,1.83e-59,231,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_JBGJJV010000032",94.631,1.83e-59,231,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_FLBI01000046",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_FLBN01000099",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRI01000021",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRE01000049",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_FLCN01000004",94.631,1.83e-59,231,149,141.00019,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRZ01000037",94.631,1.83e-59,231,149,141.00019,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRO01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLXR01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRG01000021",94.631,1.83e-59,231,149,141.00019,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLYG01000019",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRJ01000019",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLSM01000018",94.631,1.83e-59,231,149,141.00019,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLSQ01000022",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLXY01000024",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLXS01000025",94.631,1.83e-59,231,149,141.00019,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLWB01000035",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLUD01000021",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLRC01000027",94.631,1.83e-59,231,149,141.00019,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLYZ01000021",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLSP01000022",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLZF01000029",94.631,1.83e-59,231,149,141.00019,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLSH01000020",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLYY01000023",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLYC01000020",94.631,1.83e-59,231,149,141.00019,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLXZ01000020",94.631,1.83e-59,231,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_JBGJJV010000032",94.631,1.83e-59,231,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_JAUEGY010000142",94.631,1.83e-59,231,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_JBGJJV010000032",94.631,6.57e-59,230,149,141.00019,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_FLBI01000046",94.079,6.63e-59,230,152,143.00008,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_FLBN01000099",94.079,6.63e-59,230,152,143.00008,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_FLCN01000004",94.079,6.63e-59,230,152,143.00008,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_MLRZ01000037",94.667,6.57e-59,230,150,142.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_MLWB01000035",94.667,6.57e-59,230,150,142.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_MLZF01000029",94.667,6.57e-59,230,150,142.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRI01000021",94.595,6.63e-59,230,148,140.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRZ01000037",94.595,6.63e-59,230,148,140.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRO01000021",94.595,6.63e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLXR01000021",94.595,6.63e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRG01000021",94.595,6.63e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLYG01000019",94.595,6.63e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRJ01000019",94.595,6.63e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLSM01000018",94.595,6.63e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLSQ01000022",94.595,6.63e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLXY01000024",94.595,6.63e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLXS01000025",94.595,6.63e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLWB01000035",94.595,6.63e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLUD01000021",94.595,6.63e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLRC01000027",94.595,6.63e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLYZ01000021",94.595,6.63e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLSP01000022",94.595,6.63e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLZF01000029",94.595,6.63e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLSH01000020",94.595,6.63e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLYY01000023",94.595,6.63e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLYC01000020",94.595,6.63e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLXZ01000020",94.595,6.63e-59,230,148,140.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_JBGJJV010000032",94.595,6.63e-59,230,148,140.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRI01000021",94.595,6.63e-59,230,148,140.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRZ01000037",94.595,6.63e-59,230,148,140.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRO01000021",94.595,6.63e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLXR01000021",94.595,6.63e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRG01000021",94.595,6.63e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLYG01000019",94.595,6.63e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRJ01000019",94.595,6.63e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLSM01000018",94.595,6.63e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLSQ01000022",94.595,6.63e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLXY01000024",94.595,6.63e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLXS01000025",94.595,6.63e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLWB01000035",94.595,6.63e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLUD01000021",94.595,6.63e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLRC01000027",94.595,6.63e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLYZ01000021",94.595,6.63e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLSP01000022",94.595,6.63e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLZF01000029",94.595,6.63e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLSH01000020",94.595,6.63e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLYY01000023",94.595,6.63e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLYC01000020",94.595,6.63e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLXZ01000020",94.595,6.63e-59,230,148,140.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRI01000021",94.595,6.57e-59,230,148,140.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRE01000049",94.595,6.57e-59,230,148,140.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRZ01000037",94.595,6.57e-59,230,148,140.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRO01000021",94.595,6.57e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLXR01000021",94.595,6.57e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRG01000021",94.595,6.57e-59,230,148,140.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLYG01000019",94.595,6.57e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRJ01000019",94.595,6.57e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLSM01000018",94.595,6.57e-59,230,148,140.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLSQ01000022",94.595,6.57e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLXY01000024",94.595,6.57e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLXS01000025",94.595,6.57e-59,230,148,140.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLWB01000035",94.595,6.57e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLUD01000021",94.595,6.57e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLRC01000027",94.595,6.57e-59,230,148,140.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLYZ01000021",94.595,6.57e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLSP01000022",94.595,6.57e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLZF01000029",94.595,6.57e-59,230,148,140.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLSH01000020",94.595,6.57e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLYY01000023",94.595,6.57e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLYC01000020",94.595,6.57e-59,230,148,140.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLXZ01000020",94.595,6.57e-59,230,148,140.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_FLBI01000046",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_FLBN01000099",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_FLCN01000004",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_MLRZ01000037",94,2.38e-58,228,150,141,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_MLWB01000035",94,2.38e-58,228,150,141,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_MLZF01000029",94,2.38e-58,228,150,141,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_JBGJJV010000032",94,2.38e-58,228,150,141,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_FLBI01000046",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_FLBN01000099",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRI01000021",94,2.38e-58,228,150,141,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRE01000049",94,2.38e-58,228,150,141,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_FLCN01000004",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRZ01000037",94,2.38e-58,228,150,141,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRO01000021",94,2.38e-58,228,150,141,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLXR01000021",94,2.38e-58,228,150,141,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRG01000021",94,2.38e-58,228,150,141,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLYG01000019",94,2.38e-58,228,150,141,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRJ01000019",94,2.38e-58,228,150,141,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLSM01000018",94,2.38e-58,228,150,141,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLSQ01000022",94,2.38e-58,228,150,141,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLXY01000024",94,2.38e-58,228,150,141,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLXS01000025",94,2.38e-58,228,150,141,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLWB01000035",94,2.38e-58,228,150,141,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLUD01000021",94,2.38e-58,228,150,141,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLRC01000027",94,2.38e-58,228,150,141,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLYZ01000021",94,2.38e-58,228,150,141,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLSP01000022",94,2.38e-58,228,150,141,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLZF01000029",94,2.38e-58,228,150,141,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLSH01000020",94,2.38e-58,228,150,141,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLYY01000023",94,2.38e-58,228,150,141,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLYC01000020",94,2.38e-58,228,150,141,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLXZ01000020",94,2.38e-58,228,150,141,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_JBGJJV010000032",94,2.38e-58,228,150,141,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_JAUEGY010000142",94,2.38e-58,228,150,141,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_FLBI01000046",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_FLBN01000099",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_FLCN01000004",94,2.38e-58,228,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_MLRZ01000037",94,2.38e-58,228,150,141,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_MLWB01000035",94,2.38e-58,228,150,141,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_MLZF01000029",94,2.38e-58,228,150,141,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_JBGJJV010000032",94,2.38e-58,228,150,141,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_JBGJJV010000032",94,8.5e-58,226,150,141,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_FLBI01000046",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_FLBN01000099",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRI01000021",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRE01000049",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_FLCN01000004",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRZ01000037",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRO01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLXR01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRG01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLYG01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRJ01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLSM01000018",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLSQ01000022",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLXY01000024",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLXS01000025",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLWB01000035",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLUD01000021",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLRC01000027",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLYZ01000021",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLSP01000022",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLZF01000029",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLSH01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLYY01000023",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLYC01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLXZ01000020",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_JBGJJV010000032",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_FLBI01000046",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_FLBN01000099",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRI01000021",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRE01000049",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_FLCN01000004",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRZ01000037",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRO01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLXR01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRG01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLYG01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRJ01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLSM01000018",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLSQ01000022",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLXY01000024",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLXS01000025",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLWB01000035",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLUD01000021",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLRC01000027",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLYZ01000021",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLSP01000022",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLZF01000029",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLSH01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLYY01000023",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLYC01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLXZ01000020",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_JBGJJV010000032",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_JAUEGY010000142",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_FLBI01000046",94.558,8.5e-58,226,147,139.00026,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_FLBN01000099",94.558,8.5e-58,226,147,139.00026,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_FLCN01000004",94.558,8.5e-58,226,147,139.00026,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_FLBI01000046",94,8.5e-58,226,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_FLBN01000099",94,8.5e-58,226,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_FLCN01000004",94,8.5e-58,226,150,141,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_FLBI01000046",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_FLBN01000099",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRI01000021",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRE01000049",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_FLCN01000004",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRZ01000037",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRO01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLXR01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRG01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLYG01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRJ01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLSM01000018",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLSQ01000022",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLXY01000024",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLXS01000025",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLWB01000035",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLUD01000021",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLRC01000027",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLYZ01000021",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLSP01000022",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLZF01000029",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLSH01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLYY01000023",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLYC01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLXZ01000020",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_JBGJJV010000032",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_FLBI01000046",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_FLBN01000099",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRI01000021",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRE01000049",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_FLCN01000004",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRZ01000037",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRO01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLXR01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRG01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLYG01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRJ01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLSM01000018",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLSQ01000022",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLXY01000024",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLXS01000025",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLWB01000035",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLUD01000021",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLRC01000027",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLYZ01000021",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLSP01000022",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLZF01000029",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLSH01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLYY01000023",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLYC01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLXZ01000020",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_JBGJJV010000032",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_FLBI01000046",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_FLBN01000099",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRI01000021",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRE01000049",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_FLCN01000004",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRZ01000037",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRO01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLXR01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRG01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLYG01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRJ01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLSM01000018",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLSQ01000022",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLXY01000024",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLXS01000025",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLWB01000035",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLUD01000021",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLRC01000027",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLYZ01000021",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLSP01000022",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLZF01000029",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLSH01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLYY01000023",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLYC01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLXZ01000020",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_JBGJJV010000032",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_FLBI01000046",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_FLBN01000099",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRI01000021",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRE01000049",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_FLCN01000004",93.96,8.5e-58,226,149,140.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRZ01000037",93.96,8.5e-58,226,149,140.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRO01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLXR01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRG01000021",93.96,8.5e-58,226,149,140.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLYG01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRJ01000019",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLSM01000018",93.96,8.5e-58,226,149,140.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLSQ01000022",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLXY01000024",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLXS01000025",93.96,8.5e-58,226,149,140.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLWB01000035",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLUD01000021",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLRC01000027",93.96,8.5e-58,226,149,140.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLYZ01000021",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLSP01000022",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLZF01000029",93.96,8.5e-58,226,149,140.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLSH01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLYY01000023",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLYC01000020",93.96,8.5e-58,226,149,140.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLXZ01000020",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_JBGJJV010000032",93.96,8.5e-58,226,149,140.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_MLRZ01000037",94.558,3.06e-57,224,147,139.00026,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_MLWB01000035",94.558,3.06e-57,224,147,139.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_MLZF01000029",94.558,3.06e-57,224,147,139.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRI01000021",94.483,3.06e-57,224,145,137.00035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRE01000049",94.483,3.06e-57,224,145,137.00035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRZ01000037",94.483,3.06e-57,224,145,137.00035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRO01000021",94.483,3.06e-57,224,145,137.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLXR01000021",94.483,3.06e-57,224,145,137.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRG01000021",94.483,3.06e-57,224,145,137.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLYG01000019",94.483,3.06e-57,224,145,137.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRJ01000019",94.483,3.06e-57,224,145,137.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLSM01000018",94.483,3.06e-57,224,145,137.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLSQ01000022",94.483,3.06e-57,224,145,137.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLXY01000024",94.483,3.06e-57,224,145,137.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLXS01000025",94.483,3.06e-57,224,145,137.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLWB01000035",94.483,3.06e-57,224,145,137.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLUD01000021",94.483,3.06e-57,224,145,137.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLRC01000027",94.483,3.06e-57,224,145,137.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLYZ01000021",94.483,3.06e-57,224,145,137.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLSP01000022",94.483,3.06e-57,224,145,137.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLZF01000029",94.483,3.06e-57,224,145,137.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLSH01000020",94.483,3.06e-57,224,145,137.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLYY01000023",94.483,3.06e-57,224,145,137.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLYC01000020",94.483,3.06e-57,224,145,137.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLXZ01000020",94.483,3.06e-57,224,145,137.00035,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_FLBI01000046",93.333,1.11e-56,222,150,139.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_FLBN01000099",93.333,1.11e-56,222,150,139.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRE01000049",93.333,1.11e-56,222,150,139.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_FLCN01000004",93.333,1.11e-56,222,150,139.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_JAUEGY010000142",93.333,1.11e-56,222,150,139.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_FLBI01000046",93.289,3.96e-56,220,149,139.00061,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_FLBN01000099",93.289,3.96e-56,220,149,139.00061,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRI01000021",93.289,3.96e-56,220,149,139.00061,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRE01000049",93.289,3.96e-56,220,149,139.00061,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_FLCN01000004",93.289,3.96e-56,220,149,139.00061,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRZ01000037",93.289,3.96e-56,220,149,139.00061,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRO01000021",93.289,3.96e-56,220,149,139.00061,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLXR01000021",93.289,3.96e-56,220,149,139.00061,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRG01000021",93.289,3.96e-56,220,149,139.00061,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLYG01000019",93.289,3.96e-56,220,149,139.00061,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRJ01000019",93.289,3.96e-56,220,149,139.00061,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLSM01000018",93.289,3.96e-56,220,149,139.00061,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLSQ01000022",93.289,3.96e-56,220,149,139.00061,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLXY01000024",93.289,3.96e-56,220,149,139.00061,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLXS01000025",93.289,3.96e-56,220,149,139.00061,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLWB01000035",93.289,3.96e-56,220,149,139.00061,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLUD01000021",93.289,3.96e-56,220,149,139.00061,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLRC01000027",93.289,3.96e-56,220,149,139.00061,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLYZ01000021",93.289,3.96e-56,220,149,139.00061,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLSP01000022",93.289,3.96e-56,220,149,139.00061,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLZF01000029",93.289,3.96e-56,220,149,139.00061,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLSH01000020",93.289,3.96e-56,220,149,139.00061,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLYY01000023",93.289,3.96e-56,220,149,139.00061,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLYC01000020",93.289,3.96e-56,220,149,139.00061,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLXZ01000020",93.289,3.96e-56,220,149,139.00061,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_JBGJJV010000032",93.289,3.96e-56,220,149,139.00061,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_FLBI01000046",93.836,3.89e-56,220,146,137.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_FLBN01000099",93.836,3.89e-56,220,146,137.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRI01000021",93.836,3.89e-56,220,146,137.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRE01000049",93.836,3.89e-56,220,146,137.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_FLCN01000004",93.836,3.89e-56,220,146,137.00056,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRZ01000037",93.836,3.89e-56,220,146,137.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRO01000021",93.836,3.89e-56,220,146,137.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLXR01000021",93.836,3.89e-56,220,146,137.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRG01000021",93.836,3.89e-56,220,146,137.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLYG01000019",93.836,3.89e-56,220,146,137.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRJ01000019",93.836,3.89e-56,220,146,137.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLSM01000018",93.836,3.89e-56,220,146,137.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLSQ01000022",93.836,3.89e-56,220,146,137.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLXY01000024",93.836,3.89e-56,220,146,137.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLXS01000025",93.836,3.89e-56,220,146,137.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLWB01000035",93.836,3.89e-56,220,146,137.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLUD01000021",93.836,3.89e-56,220,146,137.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLRC01000027",93.836,3.89e-56,220,146,137.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLYZ01000021",93.836,3.89e-56,220,146,137.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLSP01000022",93.836,3.89e-56,220,146,137.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLZF01000029",93.836,3.89e-56,220,146,137.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLSH01000020",93.836,3.89e-56,220,146,137.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLYY01000023",93.836,3.89e-56,220,146,137.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLYC01000020",93.836,3.89e-56,220,146,137.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLXZ01000020",93.836,3.89e-56,220,146,137.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_JBGJJV010000032",93.836,3.89e-56,220,146,137.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRE01000049",93.243,1.43e-55,219,148,137.99964,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRI01000021",92.667,5.16e-55,217,150,139.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRZ01000037",92.667,5.16e-55,217,150,139.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRO01000021",92.667,5.16e-55,217,150,139.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLXR01000021",92.667,5.16e-55,217,150,139.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRG01000021",92.667,5.16e-55,217,150,139.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLYG01000019",92.667,5.16e-55,217,150,139.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRJ01000019",92.667,5.16e-55,217,150,139.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLSM01000018",92.667,5.16e-55,217,150,139.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLSQ01000022",92.667,5.16e-55,217,150,139.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLXY01000024",92.667,5.16e-55,217,150,139.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLXS01000025",92.667,5.16e-55,217,150,139.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLWB01000035",92.667,5.16e-55,217,150,139.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLUD01000021",92.667,5.16e-55,217,150,139.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLRC01000027",92.667,5.16e-55,217,150,139.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLYZ01000021",92.667,5.16e-55,217,150,139.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLSP01000022",92.667,5.16e-55,217,150,139.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLZF01000029",92.667,5.16e-55,217,150,139.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLSH01000020",92.667,5.16e-55,217,150,139.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLYY01000023",92.667,5.16e-55,217,150,139.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLYC01000020",92.667,5.16e-55,217,150,139.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLXZ01000020",92.667,5.16e-55,217,150,139.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_JBGJJV010000032",92.667,5.16e-55,217,150,139.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_FLBI01000046",92.667,5.16e-55,217,150,139.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_FLBN01000099",92.667,5.16e-55,217,150,139.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRE01000049",92.667,5.16e-55,217,150,139.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_FLCN01000004",92.667,5.16e-55,217,150,139.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_JAUEGY010000142",92.667,5.16e-55,217,150,139.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_FLBI01000046",93.75,5.12e-55,217,144,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_FLBN01000099",93.75,5.12e-55,217,144,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRI01000021",93.75,5.12e-55,217,144,135,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRE01000049",93.75,5.12e-55,217,144,135,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_FLCN01000004",93.75,5.12e-55,217,144,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRZ01000037",93.75,5.12e-55,217,144,135,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRO01000021",93.75,5.12e-55,217,144,135,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLXR01000021",93.75,5.12e-55,217,144,135,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRG01000021",93.75,5.12e-55,217,144,135,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLYG01000019",93.75,5.12e-55,217,144,135,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRJ01000019",93.75,5.12e-55,217,144,135,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLSM01000018",93.75,5.12e-55,217,144,135,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLSQ01000022",93.75,5.12e-55,217,144,135,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLXY01000024",93.75,5.12e-55,217,144,135,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLXS01000025",93.75,5.12e-55,217,144,135,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLWB01000035",93.75,5.12e-55,217,144,135,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLUD01000021",93.75,5.12e-55,217,144,135,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLRC01000027",93.75,5.12e-55,217,144,135,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLYZ01000021",93.75,5.12e-55,217,144,135,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLSP01000022",93.75,5.12e-55,217,144,135,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLZF01000029",93.75,5.12e-55,217,144,135,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLSH01000020",93.75,5.12e-55,217,144,135,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLYY01000023",93.75,5.12e-55,217,144,135,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLYC01000020",93.75,5.12e-55,217,144,135,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLXZ01000020",93.75,5.12e-55,217,144,135,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_JBGJJV010000032",93.75,5.12e-55,217,144,135,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_JAUEGY010000142",93.75,5.12e-55,217,144,135,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_MLRZ01000037",92.617,1.84e-54,215,149,137.99933,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_MLWB01000035",92.617,1.84e-54,215,149,137.99933,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_MLZF01000029",92.617,1.84e-54,215,149,137.99933,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_FLBI01000046",93.706,1.78e-54,215,143,133.99958,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_FLBN01000099",93.706,1.78e-54,215,143,133.99958,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRI01000021",93.706,1.78e-54,215,143,133.99958,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRE01000049",93.706,1.78e-54,215,143,133.99958,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_FLCN01000004",93.706,1.78e-54,215,143,133.99958,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRZ01000037",93.706,1.78e-54,215,143,133.99958,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRO01000021",93.706,1.78e-54,215,143,133.99958,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLXR01000021",93.706,1.78e-54,215,143,133.99958,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRG01000021",93.706,1.78e-54,215,143,133.99958,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLYG01000019",93.706,1.78e-54,215,143,133.99958,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRJ01000019",93.706,1.78e-54,215,143,133.99958,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLSM01000018",93.706,1.78e-54,215,143,133.99958,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLSQ01000022",93.706,1.78e-54,215,143,133.99958,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLXY01000024",93.706,1.78e-54,215,143,133.99958,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLXS01000025",93.706,1.78e-54,215,143,133.99958,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLWB01000035",93.706,1.78e-54,215,143,133.99958,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLUD01000021",93.706,1.78e-54,215,143,133.99958,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLRC01000027",93.706,1.78e-54,215,143,133.99958,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLYZ01000021",93.706,1.78e-54,215,143,133.99958,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLSP01000022",93.706,1.78e-54,215,143,133.99958,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLZF01000029",93.706,1.78e-54,215,143,133.99958,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLSH01000020",93.706,1.78e-54,215,143,133.99958,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLYY01000023",93.706,1.78e-54,215,143,133.99958,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLYC01000020",93.706,1.78e-54,215,143,133.99958,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLXZ01000020",93.706,1.78e-54,215,143,133.99958,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_JBGJJV010000032",93.706,1.78e-54,215,143,133.99958,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_JAUEGY010000142",93.706,1.78e-54,215,143,133.99958,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_FLBI01000046",93.103,6.67e-54,213,145,134.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_FLBN01000099",93.103,6.67e-54,213,145,134.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRI01000021",93.103,6.67e-54,213,145,134.99935,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRE01000049",93.103,6.67e-54,213,145,134.99935,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_FLCN01000004",93.103,6.67e-54,213,145,134.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRZ01000037",93.103,6.67e-54,213,145,134.99935,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRO01000021",93.103,6.67e-54,213,145,134.99935,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLXR01000021",93.103,6.67e-54,213,145,134.99935,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRG01000021",93.103,6.67e-54,213,145,134.99935,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLYG01000019",93.103,6.67e-54,213,145,134.99935,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRJ01000019",93.103,6.67e-54,213,145,134.99935,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLSM01000018",93.103,6.67e-54,213,145,134.99935,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLSQ01000022",93.103,6.67e-54,213,145,134.99935,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLXY01000024",93.103,6.67e-54,213,145,134.99935,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLXS01000025",93.103,6.67e-54,213,145,134.99935,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLWB01000035",93.103,6.67e-54,213,145,134.99935,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLUD01000021",93.103,6.67e-54,213,145,134.99935,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLRC01000027",93.103,6.67e-54,213,145,134.99935,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLYZ01000021",93.103,6.67e-54,213,145,134.99935,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLSP01000022",93.103,6.67e-54,213,145,134.99935,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLZF01000029",93.103,6.67e-54,213,145,134.99935,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLSH01000020",93.103,6.67e-54,213,145,134.99935,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLYY01000023",93.103,6.67e-54,213,145,134.99935,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLYC01000020",93.103,6.67e-54,213,145,134.99935,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLXZ01000020",93.103,6.67e-54,213,145,134.99935,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_JBGJJV010000032",93.103,6.67e-54,213,145,134.99935,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_JAUEGY010000142",93.103,6.67e-54,213,145,134.99935,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRI01000021",92.568,6.67e-54,213,148,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRZ01000037",92.568,6.67e-54,213,148,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRO01000021",92.568,6.67e-54,213,148,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLXR01000021",92.568,6.67e-54,213,148,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRG01000021",92.568,6.67e-54,213,148,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLYG01000019",92.568,6.67e-54,213,148,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRJ01000019",92.568,6.67e-54,213,148,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLSM01000018",92.568,6.67e-54,213,148,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLSQ01000022",92.568,6.67e-54,213,148,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLXY01000024",92.568,6.67e-54,213,148,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLXS01000025",92.568,6.67e-54,213,148,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLWB01000035",92.568,6.67e-54,213,148,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLUD01000021",92.568,6.67e-54,213,148,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLRC01000027",92.568,6.67e-54,213,148,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLYZ01000021",92.568,6.67e-54,213,148,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLSP01000022",92.568,6.67e-54,213,148,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLZF01000029",92.568,6.67e-54,213,148,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLSH01000020",92.568,6.67e-54,213,148,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLYY01000023",92.568,6.67e-54,213,148,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLYC01000020",92.568,6.67e-54,213,148,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLXZ01000020",92.568,6.67e-54,213,148,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_FLBI01000046",93.151,6.62e-54,213,146,136.00046,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_FLBN01000099",93.151,6.62e-54,213,146,136.00046,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_FLCN01000004",93.151,6.62e-54,213,146,136.00046,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_FLBI01000046",92.617,6.62e-54,213,149,137.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_FLBN01000099",92.617,6.62e-54,213,149,137.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_FLCN01000004",92.617,6.62e-54,213,149,137.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_MLRZ01000037",92.617,6.62e-54,213,149,137.99933,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_MLWB01000035",92.617,6.62e-54,213,149,137.99933,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_MLZF01000029",92.617,6.62e-54,213,149,137.99933,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_JBGJJV010000032",92.617,6.62e-54,213,149,137.99933,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_FLBI01000046",92.568,6.62e-54,213,148,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_FLBN01000099",92.568,6.62e-54,213,148,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRI01000021",92.568,6.62e-54,213,148,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRE01000049",92.568,6.62e-54,213,148,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_FLCN01000004",92.568,6.62e-54,213,148,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRZ01000037",92.568,6.62e-54,213,148,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRO01000021",92.568,6.62e-54,213,148,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLXR01000021",92.568,6.62e-54,213,148,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRG01000021",92.568,6.62e-54,213,148,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLYG01000019",92.568,6.62e-54,213,148,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRJ01000019",92.568,6.62e-54,213,148,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLSM01000018",92.568,6.62e-54,213,148,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLSQ01000022",92.568,6.62e-54,213,148,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLXY01000024",92.568,6.62e-54,213,148,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLXS01000025",92.568,6.62e-54,213,148,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLWB01000035",92.568,6.62e-54,213,148,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLUD01000021",92.568,6.62e-54,213,148,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLRC01000027",92.568,6.62e-54,213,148,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLYZ01000021",92.568,6.62e-54,213,148,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLSP01000022",92.568,6.62e-54,213,148,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLZF01000029",92.568,6.62e-54,213,148,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLSH01000020",92.568,6.62e-54,213,148,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLYY01000023",92.568,6.62e-54,213,148,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLYC01000020",92.568,6.62e-54,213,148,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLXZ01000020",92.568,6.62e-54,213,148,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_JBGJJV010000032",92.568,6.62e-54,213,148,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRI01000021",92,2.4e-53,211,150,138,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRZ01000037",92,2.4e-53,211,150,138,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRO01000021",92,2.4e-53,211,150,138,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLXR01000021",92,2.4e-53,211,150,138,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRG01000021",92,2.4e-53,211,150,138,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLYG01000019",92,2.4e-53,211,150,138,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRJ01000019",92,2.4e-53,211,150,138,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLSM01000018",92,2.4e-53,211,150,138,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLSQ01000022",92,2.4e-53,211,150,138,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLXY01000024",92,2.4e-53,211,150,138,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLXS01000025",92,2.4e-53,211,150,138,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLWB01000035",92,2.4e-53,211,150,138,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLUD01000021",92,2.4e-53,211,150,138,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLRC01000027",92,2.4e-53,211,150,138,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLYZ01000021",92,2.4e-53,211,150,138,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLSP01000022",92,2.4e-53,211,150,138,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLZF01000029",92,2.4e-53,211,150,138,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLSH01000020",92,2.4e-53,211,150,138,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLYY01000023",92,2.4e-53,211,150,138,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLYC01000020",92,2.4e-53,211,150,138,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLXZ01000020",92,2.4e-53,211,150,138,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_JBGJJV010000032",92,2.4e-53,211,150,138,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_MLRZ01000037",92,8.56e-53,209,150,138,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_MLWB01000035",92,8.56e-53,209,150,138,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_MLZF01000029",92,8.56e-53,209,150,138,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_FLBI01000046",92.414,3.08e-52,207,145,134.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_FLBN01000099",92.414,3.08e-52,207,145,134.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRI01000021",92.414,3.08e-52,207,145,134.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRE01000049",92.414,3.08e-52,207,145,134.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_FLCN01000004",92.414,3.08e-52,207,145,134.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRZ01000037",92.414,3.08e-52,207,145,134.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRO01000021",92.414,3.08e-52,207,145,134.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLXR01000021",92.414,3.08e-52,207,145,134.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRG01000021",92.414,3.08e-52,207,145,134.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLYG01000019",92.414,3.08e-52,207,145,134.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRJ01000019",92.414,3.08e-52,207,145,134.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLSM01000018",92.414,3.08e-52,207,145,134.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLSQ01000022",92.414,3.08e-52,207,145,134.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLXY01000024",92.414,3.08e-52,207,145,134.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLXS01000025",92.414,3.08e-52,207,145,134.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLWB01000035",92.414,3.08e-52,207,145,134.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLUD01000021",92.414,3.08e-52,207,145,134.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLRC01000027",92.414,3.08e-52,207,145,134.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLYZ01000021",92.414,3.08e-52,207,145,134.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLSP01000022",92.414,3.08e-52,207,145,134.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLZF01000029",92.414,3.08e-52,207,145,134.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLSH01000020",92.414,3.08e-52,207,145,134.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLYY01000023",92.414,3.08e-52,207,145,134.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLYC01000020",92.414,3.08e-52,207,145,134.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLXZ01000020",92.414,3.08e-52,207,145,134.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_JBGJJV010000032",92.414,3.08e-52,207,145,134.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_FLBI01000046",92.466,3.08e-52,207,146,135.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_FLBN01000099",92.466,3.08e-52,207,146,135.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_FLCN01000004",92.466,3.08e-52,207,146,135.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRI01000021",92.466,3.08e-52,207,146,135.00036,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRE01000049",92.466,3.08e-52,207,146,135.00036,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRZ01000037",92.466,3.08e-52,207,146,135.00036,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRO01000021",92.466,3.08e-52,207,146,135.00036,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLXR01000021",92.466,3.08e-52,207,146,135.00036,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRG01000021",92.466,3.08e-52,207,146,135.00036,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLYG01000019",92.466,3.08e-52,207,146,135.00036,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRJ01000019",92.466,3.08e-52,207,146,135.00036,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLSM01000018",92.466,3.08e-52,207,146,135.00036,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLSQ01000022",92.466,3.08e-52,207,146,135.00036,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLXY01000024",92.466,3.08e-52,207,146,135.00036,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLXS01000025",92.466,3.08e-52,207,146,135.00036,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLWB01000035",92.466,3.08e-52,207,146,135.00036,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLUD01000021",92.466,3.08e-52,207,146,135.00036,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLRC01000027",92.466,3.08e-52,207,146,135.00036,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLYZ01000021",92.466,3.08e-52,207,146,135.00036,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLSP01000022",92.466,3.08e-52,207,146,135.00036,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLZF01000029",92.466,3.08e-52,207,146,135.00036,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLSH01000020",92.466,3.08e-52,207,146,135.00036,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLYY01000023",92.466,3.08e-52,207,146,135.00036,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLYC01000020",92.466,3.08e-52,207,146,135.00036,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLXZ01000020",92.466,3.08e-52,207,146,135.00036,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_JBGJJV010000032",92.466,3.08e-52,207,146,135.00036,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_FLBI01000046",92.466,3.08e-52,207,146,135.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_FLBN01000099",92.466,3.08e-52,207,146,135.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_FLCN01000004",92.466,3.08e-52,207,146,135.00036,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_FLBI01000046",91.946,3.08e-52,207,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_FLBN01000099",91.946,3.08e-52,207,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_FLCN01000004",91.946,3.08e-52,207,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_MLRZ01000037",91.946,3.08e-52,207,149,136.99954,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_MLWB01000035",91.946,3.08e-52,207,149,136.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_MLZF01000029",91.946,3.08e-52,207,149,136.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_JBGJJV010000032",91.946,3.08e-52,207,149,136.99954,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_FLBI01000046",91.946,3.08e-52,207,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_FLBN01000099",91.946,3.08e-52,207,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_FLCN01000004",91.946,3.08e-52,207,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_MLRZ01000037",91.946,3.08e-52,207,149,136.99954,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_MLWB01000035",91.946,3.08e-52,207,149,136.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_MLZF01000029",91.946,3.08e-52,207,149,136.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_JBGJJV010000032",91.946,3.08e-52,207,149,136.99954,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRI01000021",91.195,3.1e-52,207,159,145.00005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRE01000049",91.195,3.1e-52,207,159,145.00005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRZ01000037",91.195,3.1e-52,207,159,145.00005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRO01000021",91.195,3.1e-52,207,159,145.00005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLXR01000021",91.195,3.1e-52,207,159,145.00005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRG01000021",91.195,3.1e-52,207,159,145.00005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLYG01000019",91.195,3.1e-52,207,159,145.00005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRJ01000019",91.195,3.1e-52,207,159,145.00005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLSM01000018",91.195,3.1e-52,207,159,145.00005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLSQ01000022",91.195,3.1e-52,207,159,145.00005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLXY01000024",91.195,3.1e-52,207,159,145.00005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLXS01000025",91.195,3.1e-52,207,159,145.00005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLWB01000035",91.195,3.1e-52,207,159,145.00005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLUD01000021",91.195,3.1e-52,207,159,145.00005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLRC01000027",91.195,3.1e-52,207,159,145.00005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLYZ01000021",91.195,3.1e-52,207,159,145.00005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLSP01000022",91.195,3.1e-52,207,159,145.00005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLZF01000029",91.195,3.1e-52,207,159,145.00005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLSH01000020",91.195,3.1e-52,207,159,145.00005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLYY01000023",91.195,3.1e-52,207,159,145.00005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLYC01000020",91.195,3.1e-52,207,159,145.00005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLXZ01000020",91.195,3.1e-52,207,159,145.00005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_FLBI01000046",91.333,1.12e-51,206,150,136.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_FLBN01000099",91.333,1.12e-51,206,150,136.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRE01000049",91.333,1.12e-51,206,150,136.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_FLCN01000004",91.333,1.12e-51,206,150,136.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_JAUEGY010000142",91.333,1.12e-51,206,150,136.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_FLBI01000046",92.414,1.09e-51,206,145,134.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_FLBN01000099",92.414,1.09e-51,206,145,134.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRI01000021",92.414,1.09e-51,206,145,134.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRE01000049",92.414,1.09e-51,206,145,134.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_FLCN01000004",92.414,1.09e-51,206,145,134.0003,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRZ01000037",92.414,1.09e-51,206,145,134.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRO01000021",92.414,1.09e-51,206,145,134.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLXR01000021",92.414,1.09e-51,206,145,134.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRG01000021",92.414,1.09e-51,206,145,134.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLYG01000019",92.414,1.09e-51,206,145,134.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRJ01000019",92.414,1.09e-51,206,145,134.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLSM01000018",92.414,1.09e-51,206,145,134.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLSQ01000022",92.414,1.09e-51,206,145,134.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLXY01000024",92.414,1.09e-51,206,145,134.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLXS01000025",92.414,1.09e-51,206,145,134.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLWB01000035",92.414,1.09e-51,206,145,134.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLUD01000021",92.414,1.09e-51,206,145,134.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLRC01000027",92.414,1.09e-51,206,145,134.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLYZ01000021",92.414,1.09e-51,206,145,134.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLSP01000022",92.414,1.09e-51,206,145,134.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLZF01000029",92.414,1.09e-51,206,145,134.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLSH01000020",92.414,1.09e-51,206,145,134.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLYY01000023",92.414,1.09e-51,206,145,134.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLYC01000020",92.414,1.09e-51,206,145,134.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLXZ01000020",92.414,1.09e-51,206,145,134.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_JBGJJV010000032",92.414,1.09e-51,206,145,134.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_JAUEGY010000142",92.414,1.09e-51,206,145,134.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRI01000021",91.139,1.11e-51,206,158,143.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRE01000049",91.139,1.11e-51,206,158,143.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRZ01000037",91.139,1.11e-51,206,158,143.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRO01000021",91.139,1.11e-51,206,158,143.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLXR01000021",91.139,1.11e-51,206,158,143.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRG01000021",91.139,1.11e-51,206,158,143.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLYG01000019",91.139,1.11e-51,206,158,143.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRJ01000019",91.139,1.11e-51,206,158,143.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLSM01000018",91.139,1.11e-51,206,158,143.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLSQ01000022",91.139,1.11e-51,206,158,143.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLXY01000024",91.139,1.11e-51,206,158,143.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLXS01000025",91.139,1.11e-51,206,158,143.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLWB01000035",91.139,1.11e-51,206,158,143.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLUD01000021",91.139,1.11e-51,206,158,143.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLRC01000027",91.139,1.11e-51,206,158,143.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLYZ01000021",91.139,1.11e-51,206,158,143.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLSP01000022",91.139,1.11e-51,206,158,143.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLZF01000029",91.139,1.11e-51,206,158,143.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLSH01000020",91.139,1.11e-51,206,158,143.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLYY01000023",91.139,1.11e-51,206,158,143.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLYC01000020",91.139,1.11e-51,206,158,143.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLXZ01000020",91.139,1.11e-51,206,158,143.99962,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRI01000021",91.139,1.11e-51,206,158,143.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRE01000049",91.139,1.11e-51,206,158,143.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRZ01000037",91.139,1.11e-51,206,158,143.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRO01000021",91.139,1.11e-51,206,158,143.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLXR01000021",91.139,1.11e-51,206,158,143.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRG01000021",91.139,1.11e-51,206,158,143.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLYG01000019",91.139,1.11e-51,206,158,143.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRJ01000019",91.139,1.11e-51,206,158,143.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLSM01000018",91.139,1.11e-51,206,158,143.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLSQ01000022",91.139,1.11e-51,206,158,143.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLXY01000024",91.139,1.11e-51,206,158,143.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLXS01000025",91.139,1.11e-51,206,158,143.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLWB01000035",91.139,1.11e-51,206,158,143.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLUD01000021",91.139,1.11e-51,206,158,143.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLRC01000027",91.139,1.11e-51,206,158,143.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLYZ01000021",91.139,1.11e-51,206,158,143.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLSP01000022",91.139,1.11e-51,206,158,143.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLZF01000029",91.139,1.11e-51,206,158,143.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLSH01000020",91.139,1.11e-51,206,158,143.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLYY01000023",91.139,1.11e-51,206,158,143.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLYC01000020",91.139,1.11e-51,206,158,143.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLXZ01000020",91.139,1.11e-51,206,158,143.99962,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_FLBI01000046",91.946,1.1e-51,206,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_FLBN01000099",91.946,1.1e-51,206,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRI01000021",91.946,1.1e-51,206,149,136.99954,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRE01000049",91.946,1.1e-51,206,149,136.99954,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_FLCN01000004",91.946,1.1e-51,206,149,136.99954,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRZ01000037",91.946,1.1e-51,206,149,136.99954,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRO01000021",91.946,1.1e-51,206,149,136.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLXR01000021",91.946,1.1e-51,206,149,136.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRG01000021",91.946,1.1e-51,206,149,136.99954,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLYG01000019",91.946,1.1e-51,206,149,136.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRJ01000019",91.946,1.1e-51,206,149,136.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLSM01000018",91.946,1.1e-51,206,149,136.99954,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLSQ01000022",91.946,1.1e-51,206,149,136.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLXY01000024",91.946,1.1e-51,206,149,136.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLXS01000025",91.946,1.1e-51,206,149,136.99954,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLWB01000035",91.946,1.1e-51,206,149,136.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLUD01000021",91.946,1.1e-51,206,149,136.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLRC01000027",91.946,1.1e-51,206,149,136.99954,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLYZ01000021",91.946,1.1e-51,206,149,136.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLSP01000022",91.946,1.1e-51,206,149,136.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLZF01000029",91.946,1.1e-51,206,149,136.99954,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLSH01000020",91.946,1.1e-51,206,149,136.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLYY01000023",91.946,1.1e-51,206,149,136.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLYC01000020",91.946,1.1e-51,206,149,136.99954,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLXZ01000020",91.946,1.1e-51,206,149,136.99954,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_JBGJJV010000032",91.946,1.1e-51,206,149,136.99954,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_FLBI01000046",91.275,3.98e-51,204,149,135.99975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_FLBN01000099",91.275,3.98e-51,204,149,135.99975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRI01000021",91.275,3.98e-51,204,149,135.99975,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRE01000049",91.275,3.98e-51,204,149,135.99975,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_FLCN01000004",91.275,3.98e-51,204,149,135.99975,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRZ01000037",91.275,3.98e-51,204,149,135.99975,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRO01000021",91.275,3.98e-51,204,149,135.99975,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLXR01000021",91.275,3.98e-51,204,149,135.99975,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRG01000021",91.275,3.98e-51,204,149,135.99975,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLYG01000019",91.275,3.98e-51,204,149,135.99975,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRJ01000019",91.275,3.98e-51,204,149,135.99975,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLSM01000018",91.275,3.98e-51,204,149,135.99975,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLSQ01000022",91.275,3.98e-51,204,149,135.99975,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLXY01000024",91.275,3.98e-51,204,149,135.99975,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLXS01000025",91.275,3.98e-51,204,149,135.99975,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLWB01000035",91.275,3.98e-51,204,149,135.99975,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLUD01000021",91.275,3.98e-51,204,149,135.99975,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLRC01000027",91.275,3.98e-51,204,149,135.99975,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLYZ01000021",91.275,3.98e-51,204,149,135.99975,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLSP01000022",91.275,3.98e-51,204,149,135.99975,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLZF01000029",91.275,3.98e-51,204,149,135.99975,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLSH01000020",91.275,3.98e-51,204,149,135.99975,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLYY01000023",91.275,3.98e-51,204,149,135.99975,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLYC01000020",91.275,3.98e-51,204,149,135.99975,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLXZ01000020",91.275,3.98e-51,204,149,135.99975,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_JBGJJV010000032",91.275,3.98e-51,204,149,135.99975,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_JAUEGY010000142",91.275,3.98e-51,204,149,135.99975,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_JBGJJV010000032",90.683,4.02e-51,204,161,145.99963,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_FLBI01000046",91.724,1.44e-50,202,145,132.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_FLBN01000099",91.724,1.44e-50,202,145,132.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRI01000021",91.724,1.44e-50,202,145,132.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRE01000049",91.724,1.44e-50,202,145,132.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_FLCN01000004",91.724,1.44e-50,202,145,132.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRZ01000037",91.724,1.44e-50,202,145,132.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRO01000021",91.724,1.44e-50,202,145,132.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLXR01000021",91.724,1.44e-50,202,145,132.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRG01000021",91.724,1.44e-50,202,145,132.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLYG01000019",91.724,1.44e-50,202,145,132.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRJ01000019",91.724,1.44e-50,202,145,132.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLSM01000018",91.724,1.44e-50,202,145,132.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLSQ01000022",91.724,1.44e-50,202,145,132.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLXY01000024",91.724,1.44e-50,202,145,132.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLXS01000025",91.724,1.44e-50,202,145,132.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLWB01000035",91.724,1.44e-50,202,145,132.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLUD01000021",91.724,1.44e-50,202,145,132.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLRC01000027",91.724,1.44e-50,202,145,132.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLYZ01000021",91.724,1.44e-50,202,145,132.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLSP01000022",91.724,1.44e-50,202,145,132.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLZF01000029",91.724,1.44e-50,202,145,132.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLSH01000020",91.724,1.44e-50,202,145,132.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLYY01000023",91.724,1.44e-50,202,145,132.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLYC01000020",91.724,1.44e-50,202,145,132.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLXZ01000020",91.724,1.44e-50,202,145,132.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_JBGJJV010000032",91.724,1.44e-50,202,145,132.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRI01000021",90.566,1.44e-50,202,159,143.99994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRE01000049",90.566,1.44e-50,202,159,143.99994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRZ01000037",90.566,1.44e-50,202,159,143.99994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRO01000021",90.566,1.44e-50,202,159,143.99994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLXR01000021",90.566,1.44e-50,202,159,143.99994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRG01000021",90.566,1.44e-50,202,159,143.99994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLYG01000019",90.566,1.44e-50,202,159,143.99994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRJ01000019",90.566,1.44e-50,202,159,143.99994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLSM01000018",90.566,1.44e-50,202,159,143.99994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLSQ01000022",90.566,1.44e-50,202,159,143.99994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLXY01000024",90.566,1.44e-50,202,159,143.99994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLXS01000025",90.566,1.44e-50,202,159,143.99994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLWB01000035",90.566,1.44e-50,202,159,143.99994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLUD01000021",90.566,1.44e-50,202,159,143.99994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLRC01000027",90.566,1.44e-50,202,159,143.99994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLYZ01000021",90.566,1.44e-50,202,159,143.99994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLSP01000022",90.566,1.44e-50,202,159,143.99994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLZF01000029",90.566,1.44e-50,202,159,143.99994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLSH01000020",90.566,1.44e-50,202,159,143.99994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLYY01000023",90.566,1.44e-50,202,159,143.99994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLYC01000020",90.566,1.44e-50,202,159,143.99994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLXZ01000020",90.566,1.44e-50,202,159,143.99994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_FLBI01000046",94.615,1.22e-50,202,130,122.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_FLBN01000099",94.615,1.22e-50,202,130,122.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRI01000021",94.615,1.22e-50,202,130,122.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRE01000049",94.615,1.22e-50,202,130,122.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_FLCN01000004",94.615,1.22e-50,202,130,122.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRZ01000037",94.615,1.22e-50,202,130,122.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRO01000021",94.615,1.22e-50,202,130,122.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLXR01000021",94.615,1.22e-50,202,130,122.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRG01000021",94.615,1.22e-50,202,130,122.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLYG01000019",94.615,1.22e-50,202,130,122.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRJ01000019",94.615,1.22e-50,202,130,122.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLSM01000018",94.615,1.22e-50,202,130,122.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLSQ01000022",94.615,1.22e-50,202,130,122.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLXY01000024",94.615,1.22e-50,202,130,122.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLXS01000025",94.615,1.22e-50,202,130,122.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLWB01000035",94.615,1.22e-50,202,130,122.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLUD01000021",94.615,1.22e-50,202,130,122.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLRC01000027",94.615,1.22e-50,202,130,122.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLYZ01000021",94.615,1.22e-50,202,130,122.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLSP01000022",94.615,1.22e-50,202,130,122.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLZF01000029",94.615,1.22e-50,202,130,122.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLSH01000020",94.615,1.22e-50,202,130,122.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLYY01000023",94.615,1.22e-50,202,130,122.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLYC01000020",94.615,1.22e-50,202,130,122.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLXZ01000020",94.615,1.22e-50,202,130,122.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_JBGJJV010000032",94.615,1.22e-50,202,130,122.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_JAUEGY010000142",94.615,1.22e-50,202,130,122.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_FLBI01000046",92.308,1.43e-50,202,143,132.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_FLBN01000099",92.308,1.43e-50,202,143,132.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_FLCN01000004",92.308,1.43e-50,202,143,132.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_JBGJJV010000032",92.361,1.43e-50,202,144,132.99984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRI01000021",91.781,1.43e-50,202,146,134.00026,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRE01000049",91.781,1.43e-50,202,146,134.00026,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRZ01000037",91.781,1.43e-50,202,146,134.00026,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRO01000021",91.781,1.43e-50,202,146,134.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLXR01000021",91.781,1.43e-50,202,146,134.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRG01000021",91.781,1.43e-50,202,146,134.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLYG01000019",91.781,1.43e-50,202,146,134.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRJ01000019",91.781,1.43e-50,202,146,134.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLSM01000018",91.781,1.43e-50,202,146,134.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLSQ01000022",91.781,1.43e-50,202,146,134.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLXY01000024",91.781,1.43e-50,202,146,134.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLXS01000025",91.781,1.43e-50,202,146,134.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLWB01000035",91.781,1.43e-50,202,146,134.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLUD01000021",91.781,1.43e-50,202,146,134.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLRC01000027",91.781,1.43e-50,202,146,134.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLYZ01000021",91.781,1.43e-50,202,146,134.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLSP01000022",91.781,1.43e-50,202,146,134.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLZF01000029",91.781,1.43e-50,202,146,134.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLSH01000020",91.781,1.43e-50,202,146,134.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLYY01000023",91.781,1.43e-50,202,146,134.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLYC01000020",91.781,1.43e-50,202,146,134.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLXZ01000020",91.781,1.43e-50,202,146,134.00026,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_JBGJJV010000032",91.781,1.43e-50,202,146,134.00026,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRI01000021",91.781,1.43e-50,202,146,134.00026,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRE01000049",91.781,1.43e-50,202,146,134.00026,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRZ01000037",91.781,1.43e-50,202,146,134.00026,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRO01000021",91.781,1.43e-50,202,146,134.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLXR01000021",91.781,1.43e-50,202,146,134.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRG01000021",91.781,1.43e-50,202,146,134.00026,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLYG01000019",91.781,1.43e-50,202,146,134.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRJ01000019",91.781,1.43e-50,202,146,134.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLSM01000018",91.781,1.43e-50,202,146,134.00026,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLSQ01000022",91.781,1.43e-50,202,146,134.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLXY01000024",91.781,1.43e-50,202,146,134.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLXS01000025",91.781,1.43e-50,202,146,134.00026,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLWB01000035",91.781,1.43e-50,202,146,134.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLUD01000021",91.781,1.43e-50,202,146,134.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLRC01000027",91.781,1.43e-50,202,146,134.00026,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLYZ01000021",91.781,1.43e-50,202,146,134.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLSP01000022",91.781,1.43e-50,202,146,134.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLZF01000029",91.781,1.43e-50,202,146,134.00026,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLSH01000020",91.781,1.43e-50,202,146,134.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLYY01000023",91.781,1.43e-50,202,146,134.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLYC01000020",91.781,1.43e-50,202,146,134.00026,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLXZ01000020",91.781,1.43e-50,202,146,134.00026,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_JBGJJV010000032",91.781,1.43e-50,202,146,134.00026,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRI01000021",90.566,1.44e-50,202,159,143.99994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRE01000049",90.566,1.44e-50,202,159,143.99994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRZ01000037",90.566,1.44e-50,202,159,143.99994,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRO01000021",90.566,1.44e-50,202,159,143.99994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLXR01000021",90.566,1.44e-50,202,159,143.99994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRG01000021",90.566,1.44e-50,202,159,143.99994,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLYG01000019",90.566,1.44e-50,202,159,143.99994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRJ01000019",90.566,1.44e-50,202,159,143.99994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLSM01000018",90.566,1.44e-50,202,159,143.99994,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLSQ01000022",90.566,1.44e-50,202,159,143.99994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLXY01000024",90.566,1.44e-50,202,159,143.99994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLXS01000025",90.566,1.44e-50,202,159,143.99994,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLWB01000035",90.566,1.44e-50,202,159,143.99994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLUD01000021",90.566,1.44e-50,202,159,143.99994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLRC01000027",90.566,1.44e-50,202,159,143.99994,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLYZ01000021",90.566,1.44e-50,202,159,143.99994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLSP01000022",90.566,1.44e-50,202,159,143.99994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLZF01000029",90.566,1.44e-50,202,159,143.99994,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLSH01000020",90.566,1.44e-50,202,159,143.99994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLYY01000023",90.566,1.44e-50,202,159,143.99994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLYC01000020",90.566,1.44e-50,202,159,143.99994,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLXZ01000020",90.566,1.44e-50,202,159,143.99994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_JBGJJV010000032",90.625,1.43e-50,202,160,145,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_JBGJJV010000032",90.625,1.43e-50,202,160,145,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_FLBI01000046",94.656,1.43e-50,202,131,123.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_FLBN01000099",94.656,1.43e-50,202,131,123.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_FLCN01000004",94.656,1.43e-50,202,131,123.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_MLRZ01000037",94.656,1.43e-50,202,131,123.99936,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_MLWB01000035",94.656,1.43e-50,202,131,123.99936,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_MLZF01000029",94.656,1.43e-50,202,131,123.99936,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_JBGJJV010000032",94.656,1.43e-50,202,131,123.99936,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRI01000021",90.667,5.2e-50,200,150,136.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRZ01000037",90.667,5.2e-50,200,150,136.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRO01000021",90.667,5.2e-50,200,150,136.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLXR01000021",90.667,5.2e-50,200,150,136.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRG01000021",90.667,5.2e-50,200,150,136.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLYG01000019",90.667,5.2e-50,200,150,136.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRJ01000019",90.667,5.2e-50,200,150,136.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLSM01000018",90.667,5.2e-50,200,150,136.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLSQ01000022",90.667,5.2e-50,200,150,136.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLXY01000024",90.667,5.2e-50,200,150,136.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLXS01000025",90.667,5.2e-50,200,150,136.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLWB01000035",90.667,5.2e-50,200,150,136.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLUD01000021",90.667,5.2e-50,200,150,136.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLRC01000027",90.667,5.2e-50,200,150,136.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLYZ01000021",90.667,5.2e-50,200,150,136.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLSP01000022",90.667,5.2e-50,200,150,136.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLZF01000029",90.667,5.2e-50,200,150,136.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLSH01000020",90.667,5.2e-50,200,150,136.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLYY01000023",90.667,5.2e-50,200,150,136.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLYC01000020",90.667,5.2e-50,200,150,136.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLXZ01000020",90.667,5.2e-50,200,150,136.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_JBGJJV010000032",90.667,5.2e-50,200,150,136.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRI01000021",90.506,5.15e-50,200,158,142.99948,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRE01000049",90.506,5.15e-50,200,158,142.99948,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRZ01000037",90.506,5.15e-50,200,158,142.99948,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRO01000021",90.506,5.15e-50,200,158,142.99948,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLXR01000021",90.506,5.15e-50,200,158,142.99948,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRG01000021",90.506,5.15e-50,200,158,142.99948,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLYG01000019",90.506,5.15e-50,200,158,142.99948,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRJ01000019",90.506,5.15e-50,200,158,142.99948,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLSM01000018",90.506,5.15e-50,200,158,142.99948,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLSQ01000022",90.506,5.15e-50,200,158,142.99948,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLXY01000024",90.506,5.15e-50,200,158,142.99948,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLXS01000025",90.506,5.15e-50,200,158,142.99948,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLWB01000035",90.506,5.15e-50,200,158,142.99948,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLUD01000021",90.506,5.15e-50,200,158,142.99948,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLRC01000027",90.506,5.15e-50,200,158,142.99948,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLYZ01000021",90.506,5.15e-50,200,158,142.99948,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLSP01000022",90.506,5.15e-50,200,158,142.99948,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLZF01000029",90.506,5.15e-50,200,158,142.99948,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLSH01000020",90.506,5.15e-50,200,158,142.99948,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLYY01000023",90.506,5.15e-50,200,158,142.99948,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLYC01000020",90.506,5.15e-50,200,158,142.99948,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLXZ01000020",90.506,5.15e-50,200,158,142.99948,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_FLBI01000046",90.728,5.2e-50,200,151,136.99928,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_FLBN01000099",90.728,5.2e-50,200,151,136.99928,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_FLCN01000004",90.728,5.2e-50,200,151,136.99928,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_MLRZ01000037",90.728,5.2e-50,200,151,136.99928,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_MLWB01000035",90.728,5.2e-50,200,151,136.99928,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_MLZF01000029",90.728,5.2e-50,200,151,136.99928,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_JBGJJV010000032",90.728,5.2e-50,200,151,136.99928,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_FLBI01000046",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_FLBN01000099",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_FLCN01000004",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_FLBI01000046",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_FLBN01000099",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_FLCN01000004",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_FLBI01000046",90.604,1.85e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_FLBN01000099",90.604,1.85e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRI01000021",90.604,1.85e-49,198,149,134.99996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRE01000049",90.604,1.85e-49,198,149,134.99996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_FLCN01000004",90.604,1.85e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRZ01000037",90.604,1.85e-49,198,149,134.99996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRO01000021",90.604,1.85e-49,198,149,134.99996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLXR01000021",90.604,1.85e-49,198,149,134.99996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRG01000021",90.604,1.85e-49,198,149,134.99996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLYG01000019",90.604,1.85e-49,198,149,134.99996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRJ01000019",90.604,1.85e-49,198,149,134.99996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLSM01000018",90.604,1.85e-49,198,149,134.99996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLSQ01000022",90.604,1.85e-49,198,149,134.99996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLXY01000024",90.604,1.85e-49,198,149,134.99996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLXS01000025",90.604,1.85e-49,198,149,134.99996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLWB01000035",90.604,1.85e-49,198,149,134.99996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLUD01000021",90.604,1.85e-49,198,149,134.99996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLRC01000027",90.604,1.85e-49,198,149,134.99996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLYZ01000021",90.604,1.85e-49,198,149,134.99996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLSP01000022",90.604,1.85e-49,198,149,134.99996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLZF01000029",90.604,1.85e-49,198,149,134.99996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLSH01000020",90.604,1.85e-49,198,149,134.99996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLYY01000023",90.604,1.85e-49,198,149,134.99996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLYC01000020",90.604,1.85e-49,198,149,134.99996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLXZ01000020",90.604,1.85e-49,198,149,134.99996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_JBGJJV010000032",90.604,1.85e-49,198,149,134.99996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_JAUEGY010000142",90.604,1.85e-49,198,149,134.99996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_FLBI01000046",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_FLBN01000099",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_FLCN01000004",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_MLRZ01000037",91.667,1.85e-49,198,144,132.00048,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_MLWB01000035",91.667,1.85e-49,198,144,132.00048,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_MLZF01000029",91.667,1.85e-49,198,144,132.00048,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_JBGJJV010000032",90.667,1.85e-49,198,150,136.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_JBGJJV010000032",90.062,1.87e-49,198,161,144.99982,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_JBGJJV010000032",90.062,1.87e-49,198,161,144.99982,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_FLBI01000046",90.604,1.85e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_FLBN01000099",90.604,1.85e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRE01000049",90.604,1.85e-49,198,149,134.99996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_FLCN01000004",90.604,1.85e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_JAUEGY010000142",90.604,1.85e-49,198,149,134.99996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_FLBI01000046",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_FLBN01000099",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_FLCN01000004",90.667,1.85e-49,198,150,136.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_MLRZ01000037",91.667,1.85e-49,198,144,132.00048,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_MLWB01000035",91.667,1.85e-49,198,144,132.00048,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_MLZF01000029",91.667,1.85e-49,198,144,132.00048,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_JBGJJV010000032",90.667,1.85e-49,198,150,136.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_JBGJJV010000032",91.724,1.85e-49,198,145,132.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_FLBI01000046",90.062,1.87e-49,198,161,144.99982,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_FLBN01000099",90.062,1.87e-49,198,161,144.99982,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_FLCN01000004",90.062,1.87e-49,198,161,144.99982,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_JBGJJV010000032",90.062,1.87e-49,198,161,144.99982,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_FLBI01000046",90.604,1.87e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_FLBN01000099",90.604,1.87e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRE01000049",90.604,1.87e-49,198,149,134.99996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_FLCN01000004",90.604,1.87e-49,198,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_JAUEGY010000142",90.604,1.87e-49,198,149,134.99996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_JBGJJV010000032",90,6.67e-49,196,160,144,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_FLBI01000046",90.604,6.67e-49,196,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_FLBN01000099",90.604,6.67e-49,196,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_FLCN01000004",90.604,6.67e-49,196,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRI01000021",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRE01000049",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRZ01000037",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRO01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLXR01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRG01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLYG01000019",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRJ01000019",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLSM01000018",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLSQ01000022",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLXY01000024",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLXS01000025",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLWB01000035",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLUD01000021",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLRC01000027",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLYZ01000021",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLSP01000022",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLZF01000029",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLSH01000020",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLYY01000023",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLYC01000020",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLXZ01000020",89.937,6.72e-49,196,159,142.99983,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRI01000021",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRE01000049",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRZ01000037",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRO01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLXR01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRG01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLYG01000019",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRJ01000019",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLSM01000018",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLSQ01000022",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLXY01000024",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLXS01000025",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLWB01000035",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLUD01000021",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLRC01000027",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLYZ01000021",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLSP01000022",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLZF01000029",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLSH01000020",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLYY01000023",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLYC01000020",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLXZ01000020",89.937,6.72e-49,196,159,142.99983,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRI01000021",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRE01000049",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRZ01000037",89.937,6.72e-49,196,159,142.99983,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRO01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLXR01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRG01000021",89.937,6.72e-49,196,159,142.99983,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLYG01000019",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRJ01000019",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLSM01000018",89.937,6.72e-49,196,159,142.99983,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLSQ01000022",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLXY01000024",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLXS01000025",89.937,6.72e-49,196,159,142.99983,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLWB01000035",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLUD01000021",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLRC01000027",89.937,6.72e-49,196,159,142.99983,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLYZ01000021",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLSP01000022",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLZF01000029",89.937,6.72e-49,196,159,142.99983,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLSH01000020",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLYY01000023",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLYC01000020",89.937,6.72e-49,196,159,142.99983,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLXZ01000020",89.937,6.72e-49,196,159,142.99983,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_FLBI01000046",93.846,5.68e-49,196,130,121.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_FLBN01000099",93.846,5.68e-49,196,130,121.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRI01000021",93.846,5.68e-49,196,130,121.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRE01000049",93.846,5.68e-49,196,130,121.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_FLCN01000004",93.846,5.68e-49,196,130,121.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRZ01000037",93.846,5.68e-49,196,130,121.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRO01000021",93.846,5.68e-49,196,130,121.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLXR01000021",93.846,5.68e-49,196,130,121.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRG01000021",93.846,5.68e-49,196,130,121.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLYG01000019",93.846,5.68e-49,196,130,121.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRJ01000019",93.846,5.68e-49,196,130,121.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLSM01000018",93.846,5.68e-49,196,130,121.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLSQ01000022",93.846,5.68e-49,196,130,121.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLXY01000024",93.846,5.68e-49,196,130,121.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLXS01000025",93.846,5.68e-49,196,130,121.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLWB01000035",93.846,5.68e-49,196,130,121.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLUD01000021",93.846,5.68e-49,196,130,121.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLRC01000027",93.846,5.68e-49,196,130,121.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLYZ01000021",93.846,5.68e-49,196,130,121.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLSP01000022",93.846,5.68e-49,196,130,121.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLZF01000029",93.846,5.68e-49,196,130,121.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLSH01000020",93.846,5.68e-49,196,130,121.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLYY01000023",93.846,5.68e-49,196,130,121.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLYC01000020",93.846,5.68e-49,196,130,121.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLXZ01000020",93.846,5.68e-49,196,130,121.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_JBGJJV010000032",93.846,5.68e-49,196,130,121.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_JAUEGY010000142",93.846,5.68e-49,196,130,121.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_FLBI01000046",91.667,6.67e-49,196,144,132.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_FLBN01000099",91.667,6.67e-49,196,144,132.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_FLCN01000004",91.667,6.67e-49,196,144,132.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_FLBI01000046",90,6.67e-49,196,160,144,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_FLBN01000099",90,6.67e-49,196,160,144,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_FLCN01000004",90,6.67e-49,196,160,144,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRI01000021",89.873,2.4e-48,195,158,141.99934,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRE01000049",89.873,2.4e-48,195,158,141.99934,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRZ01000037",89.873,2.4e-48,195,158,141.99934,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRO01000021",89.873,2.4e-48,195,158,141.99934,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLXR01000021",89.873,2.4e-48,195,158,141.99934,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRG01000021",89.873,2.4e-48,195,158,141.99934,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLYG01000019",89.873,2.4e-48,195,158,141.99934,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRJ01000019",89.873,2.4e-48,195,158,141.99934,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLSM01000018",89.873,2.4e-48,195,158,141.99934,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLSQ01000022",89.873,2.4e-48,195,158,141.99934,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLXY01000024",89.873,2.4e-48,195,158,141.99934,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLXS01000025",89.873,2.4e-48,195,158,141.99934,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLWB01000035",89.873,2.4e-48,195,158,141.99934,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLUD01000021",89.873,2.4e-48,195,158,141.99934,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLRC01000027",89.873,2.4e-48,195,158,141.99934,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLYZ01000021",89.873,2.4e-48,195,158,141.99934,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLSP01000022",89.873,2.4e-48,195,158,141.99934,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLZF01000029",89.873,2.4e-48,195,158,141.99934,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLSH01000020",89.873,2.4e-48,195,158,141.99934,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLYY01000023",89.873,2.4e-48,195,158,141.99934,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLYC01000020",89.873,2.4e-48,195,158,141.99934,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLXZ01000020",89.873,2.4e-48,195,158,141.99934,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRE01000049",90.541,2.4e-48,195,148,134.00068,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRE01000049",90.541,2.4e-48,195,148,134.00068,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRE01000049",90.541,2.4e-48,195,148,134.00068,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_FLBI01000046",90.132,2.42e-48,195,152,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_FLBN01000099",90.132,2.42e-48,195,152,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRI01000021",90.132,2.42e-48,195,152,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRE01000049",90.132,2.42e-48,195,152,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_FLCN01000004",90.132,2.42e-48,195,152,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRZ01000037",90.132,2.42e-48,195,152,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRO01000021",90.132,2.42e-48,195,152,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLXR01000021",90.132,2.42e-48,195,152,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRG01000021",90.132,2.42e-48,195,152,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLYG01000019",90.132,2.42e-48,195,152,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRJ01000019",90.132,2.42e-48,195,152,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLSM01000018",90.132,2.42e-48,195,152,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLSQ01000022",90.132,2.42e-48,195,152,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLXY01000024",90.132,2.42e-48,195,152,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLXS01000025",90.132,2.42e-48,195,152,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLWB01000035",90.132,2.42e-48,195,152,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLUD01000021",90.132,2.42e-48,195,152,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLRC01000027",90.132,2.42e-48,195,152,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLYZ01000021",90.132,2.42e-48,195,152,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLSP01000022",90.132,2.42e-48,195,152,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLZF01000029",90.132,2.42e-48,195,152,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLSH01000020",90.132,2.42e-48,195,152,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLYY01000023",90.132,2.42e-48,195,152,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLYC01000020",90.132,2.42e-48,195,152,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLXZ01000020",90.132,2.42e-48,195,152,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_JBGJJV010000032",90.132,2.42e-48,195,152,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_JAUEGY010000142",90.132,2.42e-48,195,152,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_FLBI01000046",90.132,2.42e-48,195,152,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_FLBN01000099",90.132,2.42e-48,195,152,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRI01000021",90.132,2.42e-48,195,152,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRE01000049",90.132,2.42e-48,195,152,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_FLCN01000004",90.132,2.42e-48,195,152,137.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRZ01000037",90.132,2.42e-48,195,152,137.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRO01000021",90.132,2.42e-48,195,152,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLXR01000021",90.132,2.42e-48,195,152,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRG01000021",90.132,2.42e-48,195,152,137.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLYG01000019",90.132,2.42e-48,195,152,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRJ01000019",90.132,2.42e-48,195,152,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLSM01000018",90.132,2.42e-48,195,152,137.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLSQ01000022",90.132,2.42e-48,195,152,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLXY01000024",90.132,2.42e-48,195,152,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLXS01000025",90.132,2.42e-48,195,152,137.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLWB01000035",90.132,2.42e-48,195,152,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLUD01000021",90.132,2.42e-48,195,152,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLRC01000027",90.132,2.42e-48,195,152,137.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLYZ01000021",90.132,2.42e-48,195,152,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLSP01000022",90.132,2.42e-48,195,152,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLZF01000029",90.132,2.42e-48,195,152,137.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLSH01000020",90.132,2.42e-48,195,152,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLYY01000023",90.132,2.42e-48,195,152,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLYC01000020",90.132,2.42e-48,195,152,137.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLXZ01000020",90.132,2.42e-48,195,152,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_JBGJJV010000032",90.132,2.42e-48,195,152,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_JAUEGY010000142",90.132,2.42e-48,195,152,137.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_FLBI01000046",91.489,2.4e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_FLBN01000099",91.489,2.4e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_FLCN01000004",91.489,2.4e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_FLBI01000046",94.444,2.42e-48,195,126,118.99944,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_FLBN01000099",94.444,2.42e-48,195,126,118.99944,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_FLCN01000004",94.444,2.42e-48,195,126,118.99944,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_FLBI01000046",91.489,2.42e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_FLBN01000099",91.489,2.42e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRI01000021",90.476,2.42e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRE01000049",90.476,2.42e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_FLCN01000004",91.489,2.42e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRZ01000037",90.476,2.42e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRO01000021",90.476,2.42e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLXR01000021",90.476,2.42e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRG01000021",90.476,2.42e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLYG01000019",90.476,2.42e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRJ01000019",90.476,2.42e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLSM01000018",90.476,2.42e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLSQ01000022",90.476,2.42e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLXY01000024",90.476,2.42e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLXS01000025",90.476,2.42e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLWB01000035",90.476,2.42e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLUD01000021",90.476,2.42e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLRC01000027",90.476,2.42e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLYZ01000021",90.476,2.42e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLSP01000022",90.476,2.42e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLZF01000029",90.476,2.42e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLSH01000020",90.476,2.42e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLYY01000023",90.476,2.42e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLYC01000020",90.476,2.42e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLXZ01000020",90.476,2.42e-48,195,147,132.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_JBGJJV010000032",91.489,2.42e-48,195,141,128.99949,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_JAUEGY010000142",91.489,2.42e-48,195,141,128.99949,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_FLBI01000046",91.489,2.38e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_FLBN01000099",91.489,2.38e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRI01000021",90.476,2.38e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRE01000049",90.476,2.38e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_FLCN01000004",91.489,2.38e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRZ01000037",90.476,2.38e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRO01000021",90.476,2.38e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLXR01000021",90.476,2.38e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRG01000021",90.476,2.38e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLYG01000019",90.476,2.38e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRJ01000019",90.476,2.38e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLSM01000018",90.476,2.38e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLSQ01000022",90.476,2.38e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLXY01000024",90.476,2.38e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLXS01000025",90.476,2.38e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLWB01000035",90.476,2.38e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLUD01000021",90.476,2.38e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLRC01000027",90.476,2.38e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLYZ01000021",90.476,2.38e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLSP01000022",90.476,2.38e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLZF01000029",90.476,2.38e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLSH01000020",90.476,2.38e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLYY01000023",90.476,2.38e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLYC01000020",90.476,2.38e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLXZ01000020",90.476,2.38e-48,195,147,132.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_JBGJJV010000032",91.489,2.38e-48,195,141,128.99949,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_JAUEGY010000142",91.489,2.38e-48,195,141,128.99949,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_FLBI01000046",91.489,2.4e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_FLBN01000099",91.489,2.4e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRI01000021",90.476,2.4e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRE01000049",90.476,2.4e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_FLCN01000004",91.489,2.4e-48,195,141,128.99949,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRZ01000037",90.476,2.4e-48,195,147,132.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRO01000021",90.476,2.4e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLXR01000021",90.476,2.4e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRG01000021",90.476,2.4e-48,195,147,132.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLYG01000019",90.476,2.4e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRJ01000019",90.476,2.4e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLSM01000018",90.476,2.4e-48,195,147,132.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLSQ01000022",90.476,2.4e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLXY01000024",90.476,2.4e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLXS01000025",90.476,2.4e-48,195,147,132.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLWB01000035",90.476,2.4e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLUD01000021",90.476,2.4e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLRC01000027",90.476,2.4e-48,195,147,132.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLYZ01000021",90.476,2.4e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLSP01000022",90.476,2.4e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLZF01000029",90.476,2.4e-48,195,147,132.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLSH01000020",90.476,2.4e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLYY01000023",90.476,2.4e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLYC01000020",90.476,2.4e-48,195,147,132.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLXZ01000020",90.476,2.4e-48,195,147,132.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_JBGJJV010000032",91.489,2.4e-48,195,141,128.99949,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_JAUEGY010000142",91.489,2.4e-48,195,141,128.99949,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_FLBI01000046",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_FLBN01000099",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_FLCN01000004",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_FLBI01000046",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_FLBN01000099",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_FLCN01000004",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_FLBI01000046",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_FLBN01000099",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_FLCN01000004",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_FLBI01000046",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_FLBN01000099",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_FLCN01000004",90,8.62e-48,193,150,135,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_JBGJJV010000032",89.441,8.69e-48,193,161,144.00001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_FLBI01000046",89.441,8.69e-48,193,161,144.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_FLBN01000099",89.441,8.69e-48,193,161,144.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_FLCN01000004",89.441,8.69e-48,193,161,144.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRI01000021",89.933,8.62e-48,193,149,134.00017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRZ01000037",89.933,8.62e-48,193,149,134.00017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRO01000021",89.933,8.62e-48,193,149,134.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLXR01000021",89.933,8.62e-48,193,149,134.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRG01000021",89.933,8.62e-48,193,149,134.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLYG01000019",89.933,8.62e-48,193,149,134.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRJ01000019",89.933,8.62e-48,193,149,134.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLSM01000018",89.933,8.62e-48,193,149,134.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLSQ01000022",89.933,8.62e-48,193,149,134.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLXY01000024",89.933,8.62e-48,193,149,134.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLXS01000025",89.933,8.62e-48,193,149,134.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLWB01000035",89.933,8.62e-48,193,149,134.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLUD01000021",89.933,8.62e-48,193,149,134.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLRC01000027",89.933,8.62e-48,193,149,134.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLYZ01000021",89.933,8.62e-48,193,149,134.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLSP01000022",89.933,8.62e-48,193,149,134.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLZF01000029",89.933,8.62e-48,193,149,134.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLSH01000020",89.933,8.62e-48,193,149,134.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLYY01000023",89.933,8.62e-48,193,149,134.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLYC01000020",89.933,8.62e-48,193,149,134.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLXZ01000020",89.933,8.62e-48,193,149,134.00017,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_JBGJJV010000032",89.933,8.62e-48,193,149,134.00017,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_JBGJJV010000032",89.441,8.69e-48,193,161,144.00001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLRZ01000037",91.034,8.62e-48,193,145,131.9993,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLWB01000035",91.034,8.62e-48,193,145,131.9993,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLZF01000029",91.034,8.62e-48,193,145,131.9993,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_FLBI01000046",92.537,8.48e-48,193,134,123.99958,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_FLBN01000099",92.537,8.48e-48,193,134,123.99958,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_FLCN01000004",92.537,8.48e-48,193,134,123.99958,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_MLRZ01000037",92.537,8.48e-48,193,134,123.99958,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_MLWB01000035",92.537,8.48e-48,193,134,123.99958,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_MLZF01000029",92.537,8.48e-48,193,134,123.99958,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_JBGJJV010000032",92.537,8.48e-48,193,134,123.99958,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_FLBI01000046",89.441,8.69e-48,193,161,144.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_FLBN01000099",89.441,8.69e-48,193,161,144.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_FLCN01000004",89.441,8.69e-48,193,161,144.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRI01000021",89.933,8.69e-48,193,149,134.00017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRZ01000037",89.933,8.69e-48,193,149,134.00017,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRO01000021",89.933,8.69e-48,193,149,134.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLXR01000021",89.933,8.69e-48,193,149,134.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRG01000021",89.933,8.69e-48,193,149,134.00017,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLYG01000019",89.933,8.69e-48,193,149,134.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRJ01000019",89.933,8.69e-48,193,149,134.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLSM01000018",89.933,8.69e-48,193,149,134.00017,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLSQ01000022",89.933,8.69e-48,193,149,134.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLXY01000024",89.933,8.69e-48,193,149,134.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLXS01000025",89.933,8.69e-48,193,149,134.00017,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLWB01000035",89.933,8.69e-48,193,149,134.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLUD01000021",89.933,8.69e-48,193,149,134.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLRC01000027",89.933,8.69e-48,193,149,134.00017,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLYZ01000021",89.933,8.69e-48,193,149,134.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLSP01000022",89.933,8.69e-48,193,149,134.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLZF01000029",89.933,8.69e-48,193,149,134.00017,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLSH01000020",89.933,8.69e-48,193,149,134.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLYY01000023",89.933,8.69e-48,193,149,134.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLYC01000020",89.933,8.69e-48,193,149,134.00017,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLXZ01000020",89.933,8.69e-48,193,149,134.00017,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_JBGJJV010000032",89.933,8.69e-48,193,149,134.00017,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_FLBI01000046",94.4,8.62e-48,193,125,118,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_FLBN01000099",94.4,8.62e-48,193,125,118,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_FLCN01000004",94.4,8.62e-48,193,125,118,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_JBGJJV010000032",89.375,3.1e-47,191,160,143,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_FLBI01000046",89.375,3.1e-47,191,160,143,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_FLBN01000099",89.375,3.1e-47,191,160,143,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_FLCN01000004",89.375,3.1e-47,191,160,143,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_FLBI01000046",90.604,3.13e-47,191,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_FLBN01000099",90.604,3.13e-47,191,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_FLCN01000004",90.604,3.13e-47,191,149,134.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRI01000021",89.308,3.13e-47,191,159,141.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRE01000049",89.308,3.13e-47,191,159,141.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRZ01000037",89.308,3.13e-47,191,159,141.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRO01000021",89.308,3.13e-47,191,159,141.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLXR01000021",89.308,3.13e-47,191,159,141.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRG01000021",89.308,3.13e-47,191,159,141.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLYG01000019",89.308,3.13e-47,191,159,141.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRJ01000019",89.308,3.13e-47,191,159,141.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLSM01000018",89.308,3.13e-47,191,159,141.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLSQ01000022",89.308,3.13e-47,191,159,141.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLXY01000024",89.308,3.13e-47,191,159,141.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLXS01000025",89.308,3.13e-47,191,159,141.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLWB01000035",89.308,3.13e-47,191,159,141.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLUD01000021",89.308,3.13e-47,191,159,141.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLRC01000027",89.308,3.13e-47,191,159,141.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLYZ01000021",89.308,3.13e-47,191,159,141.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLSP01000022",89.308,3.13e-47,191,159,141.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLZF01000029",89.308,3.13e-47,191,159,141.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLSH01000020",89.308,3.13e-47,191,159,141.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLYY01000023",89.308,3.13e-47,191,159,141.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLYC01000020",89.308,3.13e-47,191,159,141.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLXZ01000020",89.308,3.13e-47,191,159,141.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRI01000021",89.308,3.13e-47,191,159,141.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRE01000049",89.308,3.13e-47,191,159,141.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRZ01000037",89.308,3.13e-47,191,159,141.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRO01000021",89.308,3.13e-47,191,159,141.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLXR01000021",89.308,3.13e-47,191,159,141.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRG01000021",89.308,3.13e-47,191,159,141.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLYG01000019",89.308,3.13e-47,191,159,141.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRJ01000019",89.308,3.13e-47,191,159,141.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLSM01000018",89.308,3.13e-47,191,159,141.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLSQ01000022",89.308,3.13e-47,191,159,141.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLXY01000024",89.308,3.13e-47,191,159,141.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLXS01000025",89.308,3.13e-47,191,159,141.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLWB01000035",89.308,3.13e-47,191,159,141.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLUD01000021",89.308,3.13e-47,191,159,141.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLRC01000027",89.308,3.13e-47,191,159,141.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLYZ01000021",89.308,3.13e-47,191,159,141.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLSP01000022",89.308,3.13e-47,191,159,141.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLZF01000029",89.308,3.13e-47,191,159,141.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLSH01000020",89.308,3.13e-47,191,159,141.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLYY01000023",89.308,3.13e-47,191,159,141.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLYC01000020",89.308,3.13e-47,191,159,141.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLXZ01000020",89.308,3.13e-47,191,159,141.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_FLBI01000046",89.375,3.1e-47,191,160,143,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_FLBN01000099",89.375,3.1e-47,191,160,143,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_FLCN01000004",89.375,3.1e-47,191,160,143,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_FLBI01000046",89.333,1.12e-46,189,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_FLBN01000099",89.333,1.12e-46,189,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRI01000021",89.333,1.12e-46,189,150,133.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRE01000049",89.333,1.12e-46,189,150,133.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_FLCN01000004",89.333,1.12e-46,189,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRZ01000037",89.333,1.12e-46,189,150,133.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRO01000021",89.333,1.12e-46,189,150,133.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLXR01000021",89.333,1.12e-46,189,150,133.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRG01000021",89.333,1.12e-46,189,150,133.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLYG01000019",89.333,1.12e-46,189,150,133.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRJ01000019",89.333,1.12e-46,189,150,133.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLSM01000018",89.333,1.12e-46,189,150,133.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLSQ01000022",89.333,1.12e-46,189,150,133.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLXY01000024",89.333,1.12e-46,189,150,133.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLXS01000025",89.333,1.12e-46,189,150,133.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLWB01000035",89.333,1.12e-46,189,150,133.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLUD01000021",89.333,1.12e-46,189,150,133.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLRC01000027",89.333,1.12e-46,189,150,133.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLYZ01000021",89.333,1.12e-46,189,150,133.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLSP01000022",89.333,1.12e-46,189,150,133.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLZF01000029",89.333,1.12e-46,189,150,133.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLSH01000020",89.333,1.12e-46,189,150,133.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLYY01000023",89.333,1.12e-46,189,150,133.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLYC01000020",89.333,1.12e-46,189,150,133.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLXZ01000020",89.333,1.12e-46,189,150,133.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_JBGJJV010000032",89.333,1.12e-46,189,150,133.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRE01000049",89.865,1.12e-46,189,148,133.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRE01000049",89.865,1.12e-46,189,148,133.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRE01000049",89.865,1.12e-46,189,148,133.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRE01000049",89.865,1.12e-46,189,148,133.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_FLBI01000046",90.411,1.08e-46,189,146,132.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_FLBN01000099",90.411,1.08e-46,189,146,132.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRI01000021",90.411,1.08e-46,189,146,132.00006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRE01000049",90.411,1.08e-46,189,146,132.00006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_FLCN01000004",90.411,1.08e-46,189,146,132.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRZ01000037",90.411,1.08e-46,189,146,132.00006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRO01000021",90.411,1.08e-46,189,146,132.00006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLXR01000021",90.411,1.08e-46,189,146,132.00006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRG01000021",90.411,1.08e-46,189,146,132.00006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLYG01000019",90.411,1.08e-46,189,146,132.00006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRJ01000019",90.411,1.08e-46,189,146,132.00006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLSM01000018",90.411,1.08e-46,189,146,132.00006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLSQ01000022",90.411,1.08e-46,189,146,132.00006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLXY01000024",90.411,1.08e-46,189,146,132.00006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLXS01000025",90.411,1.08e-46,189,146,132.00006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLWB01000035",90.411,1.08e-46,189,146,132.00006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLUD01000021",90.411,1.08e-46,189,146,132.00006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLRC01000027",90.411,1.08e-46,189,146,132.00006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLYZ01000021",90.411,1.08e-46,189,146,132.00006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLSP01000022",90.411,1.08e-46,189,146,132.00006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLZF01000029",90.411,1.08e-46,189,146,132.00006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLSH01000020",90.411,1.08e-46,189,146,132.00006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLYY01000023",90.411,1.08e-46,189,146,132.00006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLYC01000020",90.411,1.08e-46,189,146,132.00006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLXZ01000020",90.411,1.08e-46,189,146,132.00006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_JBGJJV010000032",90.411,1.08e-46,189,146,132.00006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_JAUEGY010000142",90.411,1.08e-46,189,146,132.00006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRI01000021",90.78,1.12e-46,189,141,127.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRE01000049",90.78,1.12e-46,189,141,127.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRZ01000037",90.78,1.12e-46,189,141,127.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRO01000021",90.78,1.12e-46,189,141,127.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLXR01000021",90.78,1.12e-46,189,141,127.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRG01000021",90.78,1.12e-46,189,141,127.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLYG01000019",90.78,1.12e-46,189,141,127.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRJ01000019",90.78,1.12e-46,189,141,127.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLSM01000018",90.78,1.12e-46,189,141,127.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLSQ01000022",90.78,1.12e-46,189,141,127.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLXY01000024",90.78,1.12e-46,189,141,127.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLXS01000025",90.78,1.12e-46,189,141,127.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLWB01000035",90.78,1.12e-46,189,141,127.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLUD01000021",90.78,1.12e-46,189,141,127.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLRC01000027",90.78,1.12e-46,189,141,127.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLYZ01000021",90.78,1.12e-46,189,141,127.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLSP01000022",90.78,1.12e-46,189,141,127.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLZF01000029",90.78,1.12e-46,189,141,127.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLSH01000020",90.78,1.12e-46,189,141,127.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLYY01000023",90.78,1.12e-46,189,141,127.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLYC01000020",90.78,1.12e-46,189,141,127.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLXZ01000020",90.78,1.12e-46,189,141,127.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_JBGJJV010000032",90.78,1.12e-46,189,141,127.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_FLBI01000046",90.78,1.12e-46,189,141,127.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_FLBN01000099",90.78,1.12e-46,189,141,127.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRI01000021",89.796,1.12e-46,189,147,132.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRE01000049",89.796,1.12e-46,189,147,132.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_FLCN01000004",90.78,1.12e-46,189,141,127.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRZ01000037",89.796,1.12e-46,189,147,132.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRO01000021",89.796,1.12e-46,189,147,132.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLXR01000021",89.796,1.12e-46,189,147,132.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRG01000021",89.796,1.12e-46,189,147,132.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLYG01000019",89.796,1.12e-46,189,147,132.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRJ01000019",89.796,1.12e-46,189,147,132.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLSM01000018",89.796,1.12e-46,189,147,132.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLSQ01000022",89.796,1.12e-46,189,147,132.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLXY01000024",89.796,1.12e-46,189,147,132.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLXS01000025",89.796,1.12e-46,189,147,132.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLWB01000035",89.796,1.12e-46,189,147,132.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLUD01000021",89.796,1.12e-46,189,147,132.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLRC01000027",89.796,1.12e-46,189,147,132.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLYZ01000021",89.796,1.12e-46,189,147,132.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLSP01000022",89.796,1.12e-46,189,147,132.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLZF01000029",89.796,1.12e-46,189,147,132.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLSH01000020",89.796,1.12e-46,189,147,132.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLYY01000023",89.796,1.12e-46,189,147,132.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLYC01000020",89.796,1.12e-46,189,147,132.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLXZ01000020",89.796,1.12e-46,189,147,132.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_JBGJJV010000032",90.78,1.12e-46,189,141,127.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_JAUEGY010000142",90.78,1.12e-46,189,141,127.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_FLBI01000046",89.404,4.01e-46,187,151,135.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_FLBN01000099",89.404,4.01e-46,187,151,135.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_FLCN01000004",89.404,4.01e-46,187,151,135.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_FLBI01000046",89.333,4.01e-46,187,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_FLBN01000099",89.333,4.01e-46,187,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_FLCN01000004",89.333,4.01e-46,187,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_FLBI01000046",89.333,4.01e-46,187,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_FLBN01000099",89.333,4.01e-46,187,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_FLCN01000004",89.333,4.01e-46,187,150,133.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRI01000021",89.262,4.01e-46,187,149,133.00038,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRE01000049",89.262,4.01e-46,187,149,133.00038,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRZ01000037",89.262,4.01e-46,187,149,133.00038,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRO01000021",89.262,4.01e-46,187,149,133.00038,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLXR01000021",89.262,4.01e-46,187,149,133.00038,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRG01000021",89.262,4.01e-46,187,149,133.00038,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLYG01000019",89.262,4.01e-46,187,149,133.00038,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRJ01000019",89.262,4.01e-46,187,149,133.00038,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLSM01000018",89.262,4.01e-46,187,149,133.00038,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLSQ01000022",89.262,4.01e-46,187,149,133.00038,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLXY01000024",89.262,4.01e-46,187,149,133.00038,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLXS01000025",89.262,4.01e-46,187,149,133.00038,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLWB01000035",89.262,4.01e-46,187,149,133.00038,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLUD01000021",89.262,4.01e-46,187,149,133.00038,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLRC01000027",89.262,4.01e-46,187,149,133.00038,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLYZ01000021",89.262,4.01e-46,187,149,133.00038,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLSP01000022",89.262,4.01e-46,187,149,133.00038,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLZF01000029",89.262,4.01e-46,187,149,133.00038,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLSH01000020",89.262,4.01e-46,187,149,133.00038,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLYY01000023",89.262,4.01e-46,187,149,133.00038,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLYC01000020",89.262,4.01e-46,187,149,133.00038,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLXZ01000020",89.262,4.01e-46,187,149,133.00038,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_JBGJJV010000032",88.82,4.04e-46,187,161,143.0002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_JBGJJV010000032",88.82,4.04e-46,187,161,143.0002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_FLBI01000046",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_FLBN01000099",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_FLCN01000004",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_FLBI01000046",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_FLBN01000099",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_FLCN01000004",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_FLBI01000046",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_FLBN01000099",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_FLCN01000004",88.82,4.04e-46,187,161,143.0002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLRZ01000037",90.411,4.01e-46,187,146,132.00006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLWB01000035",90.411,4.01e-46,187,146,132.00006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLZF01000029",90.411,4.01e-46,187,146,132.00006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_FLBI01000046",94.958,4.01e-46,187,119,113.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_FLBN01000099",94.958,4.01e-46,187,119,113.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_FLCN01000004",94.958,4.01e-46,187,119,113.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_MLRZ01000037",94.958,4.01e-46,187,119,113.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_MLWB01000035",94.958,4.01e-46,187,119,113.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_MLZF01000029",94.958,4.01e-46,187,119,113.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_JBGJJV010000032",94.958,4.01e-46,187,119,113.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRZ01000037",89.333,4.01e-46,187,150,133.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLWB01000035",89.333,4.01e-46,187,150,133.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLZF01000029",89.333,4.01e-46,187,150,133.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_FLBI01000046",88.75,1.44e-45,185,160,142,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_FLBN01000099",88.75,1.44e-45,185,160,142,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_FLCN01000004",88.75,1.44e-45,185,160,142,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_JBGJJV010000032",89.865,1.45e-45,185,148,133.0002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_FLBI01000046",89.189,1.45e-45,185,148,131.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_FLBN01000099",89.189,1.45e-45,185,148,131.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRI01000021",89.189,1.45e-45,185,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRE01000049",89.189,1.45e-45,185,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_FLCN01000004",89.189,1.45e-45,185,148,131.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRZ01000037",89.189,1.45e-45,185,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRO01000021",89.189,1.45e-45,185,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLXR01000021",89.189,1.45e-45,185,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRG01000021",89.189,1.45e-45,185,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLYG01000019",89.189,1.45e-45,185,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRJ01000019",89.189,1.45e-45,185,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLSM01000018",89.189,1.45e-45,185,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLSQ01000022",89.189,1.45e-45,185,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLXY01000024",89.189,1.45e-45,185,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLXS01000025",89.189,1.45e-45,185,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLWB01000035",89.189,1.45e-45,185,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLUD01000021",89.189,1.45e-45,185,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLRC01000027",89.189,1.45e-45,185,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLYZ01000021",89.189,1.45e-45,185,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLSP01000022",89.189,1.45e-45,185,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLZF01000029",89.189,1.45e-45,185,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLSH01000020",89.189,1.45e-45,185,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLYY01000023",89.189,1.45e-45,185,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLYC01000020",89.189,1.45e-45,185,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLXZ01000020",89.189,1.45e-45,185,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_JBGJJV010000032",89.189,1.45e-45,185,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_FLBI01000046",89.189,1.44e-45,185,148,131.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_FLBN01000099",89.189,1.44e-45,185,148,131.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRI01000021",89.189,1.44e-45,185,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRE01000049",89.189,1.44e-45,185,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_FLCN01000004",89.189,1.44e-45,185,148,131.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRZ01000037",89.189,1.44e-45,185,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRO01000021",89.189,1.44e-45,185,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLXR01000021",89.189,1.44e-45,185,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRG01000021",89.189,1.44e-45,185,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLYG01000019",89.189,1.44e-45,185,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRJ01000019",89.189,1.44e-45,185,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLSM01000018",89.189,1.44e-45,185,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLSQ01000022",89.189,1.44e-45,185,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLXY01000024",89.189,1.44e-45,185,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLXS01000025",89.189,1.44e-45,185,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLWB01000035",89.189,1.44e-45,185,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLUD01000021",89.189,1.44e-45,185,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLRC01000027",89.189,1.44e-45,185,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLYZ01000021",89.189,1.44e-45,185,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLSP01000022",89.189,1.44e-45,185,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLZF01000029",89.189,1.44e-45,185,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLSH01000020",89.189,1.44e-45,185,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLYY01000023",89.189,1.44e-45,185,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLYC01000020",89.189,1.44e-45,185,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLXZ01000020",89.189,1.44e-45,185,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_JBGJJV010000032",89.189,1.44e-45,185,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_FLBI01000046",93.651,1.44e-45,185,126,118.00026,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_FLBN01000099",93.651,1.44e-45,185,126,118.00026,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_FLCN01000004",93.651,1.44e-45,185,126,118.00026,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_FLBI01000046",91.176,5.23e-45,183,136,123.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_FLBN01000099",91.176,5.23e-45,183,136,123.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_FLCN01000004",91.176,5.23e-45,183,136,123.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRI01000021",89.189,5.19e-45,183,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRZ01000037",89.189,5.19e-45,183,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRO01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLXR01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRG01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLYG01000019",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRJ01000019",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLSM01000018",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLSQ01000022",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLXY01000024",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLXS01000025",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLWB01000035",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLUD01000021",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLRC01000027",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLYZ01000021",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLSP01000022",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLZF01000029",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLSH01000020",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLYY01000023",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLYC01000020",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLXZ01000020",89.189,5.19e-45,183,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_JBGJJV010000032",89.189,5.19e-45,183,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRI01000021",89.189,5.19e-45,183,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRZ01000037",89.189,5.19e-45,183,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRO01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLXR01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRG01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLYG01000019",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRJ01000019",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLSM01000018",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLSQ01000022",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLXY01000024",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLXS01000025",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLWB01000035",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLUD01000021",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLRC01000027",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLYZ01000021",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLSP01000022",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLZF01000029",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLSH01000020",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLYY01000023",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLYC01000020",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLXZ01000020",89.189,5.19e-45,183,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_JBGJJV010000032",89.189,5.19e-45,183,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRE01000049",89.189,5.19e-45,183,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRI01000021",89.189,5.19e-45,183,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRZ01000037",89.189,5.19e-45,183,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRO01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLXR01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRG01000021",89.189,5.19e-45,183,148,131.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLYG01000019",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRJ01000019",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLSM01000018",89.189,5.19e-45,183,148,131.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLSQ01000022",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLXY01000024",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLXS01000025",89.189,5.19e-45,183,148,131.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLWB01000035",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLUD01000021",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLRC01000027",89.189,5.19e-45,183,148,131.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLYZ01000021",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLSP01000022",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLZF01000029",89.189,5.19e-45,183,148,131.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLSH01000020",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLYY01000023",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLYC01000020",89.189,5.19e-45,183,148,131.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLXZ01000020",89.189,5.19e-45,183,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_JBGJJV010000032",89.189,5.19e-45,183,148,131.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRE01000049",89.189,5.19e-45,183,148,131.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64954","NZ_FLCN01000004",89.189,5.23e-45,183,148,131.99972,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_FLBI01000046",93.548,4.42e-45,183,124,115.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_FLBN01000099",93.548,4.42e-45,183,124,115.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_FLCN01000004",93.548,4.42e-45,183,124,115.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_FLBI01000046",92.913,5.19e-45,183,127,117.99951,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_FLBN01000099",92.913,5.19e-45,183,127,117.99951,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRI01000021",92.913,5.19e-45,183,127,117.99951,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRE01000049",92.913,5.19e-45,183,127,117.99951,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_FLCN01000004",92.913,5.19e-45,183,127,117.99951,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRZ01000037",92.913,5.19e-45,183,127,117.99951,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRO01000021",92.913,5.19e-45,183,127,117.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLXR01000021",92.913,5.19e-45,183,127,117.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRG01000021",92.913,5.19e-45,183,127,117.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLYG01000019",92.913,5.19e-45,183,127,117.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRJ01000019",92.913,5.19e-45,183,127,117.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLSM01000018",92.913,5.19e-45,183,127,117.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLSQ01000022",92.913,5.19e-45,183,127,117.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLXY01000024",92.913,5.19e-45,183,127,117.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLXS01000025",92.913,5.19e-45,183,127,117.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLWB01000035",92.913,5.19e-45,183,127,117.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLUD01000021",92.913,5.19e-45,183,127,117.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLRC01000027",92.913,5.19e-45,183,127,117.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLYZ01000021",92.913,5.19e-45,183,127,117.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLSP01000022",92.913,5.19e-45,183,127,117.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLZF01000029",92.913,5.19e-45,183,127,117.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLSH01000020",92.913,5.19e-45,183,127,117.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLYY01000023",92.913,5.19e-45,183,127,117.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLYC01000020",92.913,5.19e-45,183,127,117.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLXZ01000020",92.913,5.19e-45,183,127,117.99951,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_JBGJJV010000032",92.913,5.19e-45,183,127,117.99951,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_FLBI01000046",92.913,5.19e-45,183,127,117.99951,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_FLBN01000099",92.913,5.19e-45,183,127,117.99951,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRI01000021",92.913,5.19e-45,183,127,117.99951,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRE01000049",92.913,5.19e-45,183,127,117.99951,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_FLCN01000004",92.913,5.19e-45,183,127,117.99951,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRZ01000037",92.913,5.19e-45,183,127,117.99951,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRO01000021",92.913,5.19e-45,183,127,117.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLXR01000021",92.913,5.19e-45,183,127,117.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRG01000021",92.913,5.19e-45,183,127,117.99951,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLYG01000019",92.913,5.19e-45,183,127,117.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRJ01000019",92.913,5.19e-45,183,127,117.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLSM01000018",92.913,5.19e-45,183,127,117.99951,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLSQ01000022",92.913,5.19e-45,183,127,117.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLXY01000024",92.913,5.19e-45,183,127,117.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLXS01000025",92.913,5.19e-45,183,127,117.99951,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLWB01000035",92.913,5.19e-45,183,127,117.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLUD01000021",92.913,5.19e-45,183,127,117.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLRC01000027",92.913,5.19e-45,183,127,117.99951,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLYZ01000021",92.913,5.19e-45,183,127,117.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLSP01000022",92.913,5.19e-45,183,127,117.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLZF01000029",92.913,5.19e-45,183,127,117.99951,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLSH01000020",92.913,5.19e-45,183,127,117.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLYY01000023",92.913,5.19e-45,183,127,117.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLYC01000020",92.913,5.19e-45,183,127,117.99951,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLXZ01000020",92.913,5.19e-45,183,127,117.99951,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_JBGJJV010000032",92.913,5.19e-45,183,127,117.99951,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRI01000021",88.608,5.19e-45,183,158,140.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRE01000049",88.608,5.19e-45,183,158,140.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRZ01000037",88.608,5.19e-45,183,158,140.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRO01000021",88.608,5.19e-45,183,158,140.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLXR01000021",88.608,5.19e-45,183,158,140.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRG01000021",88.608,5.19e-45,183,158,140.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLYG01000019",88.608,5.19e-45,183,158,140.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRJ01000019",88.608,5.19e-45,183,158,140.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLSM01000018",88.608,5.19e-45,183,158,140.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLSQ01000022",88.608,5.19e-45,183,158,140.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLXY01000024",88.608,5.19e-45,183,158,140.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLXS01000025",88.608,5.19e-45,183,158,140.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLWB01000035",88.608,5.19e-45,183,158,140.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLUD01000021",88.608,5.19e-45,183,158,140.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLRC01000027",88.608,5.19e-45,183,158,140.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLYZ01000021",88.608,5.19e-45,183,158,140.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLSP01000022",88.608,5.19e-45,183,158,140.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLZF01000029",88.608,5.19e-45,183,158,140.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLSH01000020",88.608,5.19e-45,183,158,140.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLYY01000023",88.608,5.19e-45,183,158,140.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLYC01000020",88.608,5.19e-45,183,158,140.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLXZ01000020",88.608,5.19e-45,183,158,140.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_FLBI01000046",90.647,1.87e-44,182,139,125.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_FLBN01000099",90.647,1.87e-44,182,139,125.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_FLCN01000004",90.647,1.87e-44,182,139,125.99933,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_FLBI01000046",89.041,1.87e-44,182,146,129.99986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_FLBN01000099",89.041,1.87e-44,182,146,129.99986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_FLCN01000004",89.041,1.87e-44,182,146,129.99986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_JBGJJV010000032",89.041,1.87e-44,182,146,129.99986,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_FLBI01000046",88.199,1.88e-44,182,161,142.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_FLBN01000099",88.199,1.88e-44,182,161,142.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_FLCN01000004",88.199,1.88e-44,182,161,142.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_FLBI01000046",88.199,1.88e-44,182,161,142.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_FLBN01000099",88.199,1.88e-44,182,161,142.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_FLCN01000004",88.199,1.88e-44,182,161,142.00039,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_FLBI01000046",94.118,1.87e-44,182,119,112.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_FLBN01000099",94.118,1.87e-44,182,119,112.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_FLCN01000004",94.118,1.87e-44,182,119,112.00042,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_MLRZ01000037",94.118,1.87e-44,182,119,112.00042,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_MLWB01000035",94.118,1.87e-44,182,119,112.00042,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_MLZF01000029",94.118,1.87e-44,182,119,112.00042,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_JBGJJV010000032",94.118,1.87e-44,182,119,112.00042,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_FLBI01000046",88.591,1.87e-44,182,149,132.00059,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_FLBN01000099",88.591,1.87e-44,182,149,132.00059,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRI01000021",88.591,1.87e-44,182,149,132.00059,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRE01000049",88.591,1.87e-44,182,149,132.00059,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_FLCN01000004",88.591,1.87e-44,182,149,132.00059,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRZ01000037",88.591,1.87e-44,182,149,132.00059,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRO01000021",88.591,1.87e-44,182,149,132.00059,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLXR01000021",88.591,1.87e-44,182,149,132.00059,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRG01000021",88.591,1.87e-44,182,149,132.00059,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLYG01000019",88.591,1.87e-44,182,149,132.00059,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRJ01000019",88.591,1.87e-44,182,149,132.00059,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLSM01000018",88.591,1.87e-44,182,149,132.00059,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLSQ01000022",88.591,1.87e-44,182,149,132.00059,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLXY01000024",88.591,1.87e-44,182,149,132.00059,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLXS01000025",88.591,1.87e-44,182,149,132.00059,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLWB01000035",88.591,1.87e-44,182,149,132.00059,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLUD01000021",88.591,1.87e-44,182,149,132.00059,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLRC01000027",88.591,1.87e-44,182,149,132.00059,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLYZ01000021",88.591,1.87e-44,182,149,132.00059,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLSP01000022",88.591,1.87e-44,182,149,132.00059,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLZF01000029",88.591,1.87e-44,182,149,132.00059,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLSH01000020",88.591,1.87e-44,182,149,132.00059,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLYY01000023",88.591,1.87e-44,182,149,132.00059,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLYC01000020",88.591,1.87e-44,182,149,132.00059,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLXZ01000020",88.591,1.87e-44,182,149,132.00059,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_JBGJJV010000032",88.591,1.87e-44,182,149,132.00059,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_FLBI01000046",88.667,1.87e-44,182,150,133.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_FLBN01000099",88.816,1.87e-44,182,152,135.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_FLCN01000004",88.816,1.87e-44,182,152,135.00032,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_JBGJJV010000032",88.816,1.87e-44,182,152,135.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_JBGJJV010000032",88.667,1.88e-44,182,150,133.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_JBGJJV010000032",88.591,6.77e-44,180,149,132.00059,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRI01000021",88.05,6.77e-44,180,159,139.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRE01000049",88.05,6.77e-44,180,159,139.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRZ01000037",88.05,6.77e-44,180,159,139.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRO01000021",88.05,6.77e-44,180,159,139.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLXR01000021",88.05,6.77e-44,180,159,139.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRG01000021",88.05,6.77e-44,180,159,139.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLYG01000019",88.05,6.77e-44,180,159,139.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRJ01000019",88.05,6.77e-44,180,159,139.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLSM01000018",88.05,6.77e-44,180,159,139.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLSQ01000022",88.05,6.77e-44,180,159,139.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLXY01000024",88.05,6.77e-44,180,159,139.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLXS01000025",88.05,6.77e-44,180,159,139.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLWB01000035",88.05,6.77e-44,180,159,139.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLUD01000021",88.05,6.77e-44,180,159,139.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLRC01000027",88.05,6.77e-44,180,159,139.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLYZ01000021",88.05,6.77e-44,180,159,139.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLSP01000022",88.05,6.77e-44,180,159,139.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLZF01000029",88.05,6.77e-44,180,159,139.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLSH01000020",88.05,6.77e-44,180,159,139.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLYY01000023",88.05,6.77e-44,180,159,139.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLYC01000020",88.05,6.77e-44,180,159,139.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLXZ01000020",88.05,6.77e-44,180,159,139.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_FLBI01000046",89.928,6.71e-44,180,139,124.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_FLBN01000099",89.928,6.71e-44,180,139,124.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_FLCN01000004",89.928,6.71e-44,180,139,124.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_JBGJJV010000032",89.928,6.71e-44,180,139,124.99992,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_FLBI01000046",88.591,6.71e-44,180,149,132.00059,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_FLBN01000099",88.591,6.71e-44,180,149,132.00059,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_FLCN01000004",88.591,6.71e-44,180,149,132.00059,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_FLBI01000046",91.538,6.71e-44,180,130,118.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_FLBN01000099",91.538,6.71e-44,180,130,118.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRI01000021",90.441,6.71e-44,180,136,122.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRE01000049",90.441,6.71e-44,180,136,122.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_FLCN01000004",91.538,6.71e-44,180,130,118.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRZ01000037",90.441,6.71e-44,180,136,122.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRO01000021",90.441,6.71e-44,180,136,122.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLXR01000021",90.441,6.71e-44,180,136,122.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRG01000021",90.441,6.71e-44,180,136,122.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLYG01000019",90.441,6.71e-44,180,136,122.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRJ01000019",90.441,6.71e-44,180,136,122.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLSM01000018",90.441,6.71e-44,180,136,122.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLSQ01000022",90.441,6.71e-44,180,136,122.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLXY01000024",90.441,6.71e-44,180,136,122.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLXS01000025",90.441,6.71e-44,180,136,122.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLWB01000035",90.441,6.71e-44,180,136,122.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLUD01000021",90.441,6.71e-44,180,136,122.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLRC01000027",90.441,6.71e-44,180,136,122.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLYZ01000021",90.441,6.71e-44,180,136,122.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLSP01000022",90.441,6.71e-44,180,136,122.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLZF01000029",90.441,6.71e-44,180,136,122.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLSH01000020",90.441,6.71e-44,180,136,122.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLYY01000023",90.441,6.71e-44,180,136,122.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLYC01000020",90.441,6.71e-44,180,136,122.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLXZ01000020",90.441,6.71e-44,180,136,122.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_JBGJJV010000032",91.538,6.71e-44,180,130,118.9994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_JAUEGY010000142",91.538,6.71e-44,180,130,118.9994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_FLBI01000046",91.667,5.72e-44,180,132,121.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_FLBN01000099",91.667,5.72e-44,180,132,121.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_FLCN01000004",91.667,5.72e-44,180,132,121.00044,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_FLBI01000046",93.443,6.71e-44,180,122,114.00046,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_FLBN01000099",93.443,6.71e-44,180,122,114.00046,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_FLCN01000004",93.443,6.71e-44,180,122,114.00046,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_JBGJJV010000032",93.443,6.71e-44,180,122,114.00046,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_FLBI01000046",92.126,6.71e-44,180,127,117.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_FLBN01000099",92.126,6.71e-44,180,127,117.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRI01000021",92.126,6.71e-44,180,127,117.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRE01000049",92.126,6.71e-44,180,127,117.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_FLCN01000004",92.126,6.71e-44,180,127,117.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRZ01000037",92.126,6.71e-44,180,127,117.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRO01000021",92.126,6.71e-44,180,127,117.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLXR01000021",92.126,6.71e-44,180,127,117.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRG01000021",92.126,6.71e-44,180,127,117.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLYG01000019",92.126,6.71e-44,180,127,117.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRJ01000019",92.126,6.71e-44,180,127,117.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLSM01000018",92.126,6.71e-44,180,127,117.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLSQ01000022",92.126,6.71e-44,180,127,117.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLXY01000024",92.126,6.71e-44,180,127,117.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLXS01000025",92.126,6.71e-44,180,127,117.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLWB01000035",92.126,6.71e-44,180,127,117.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLUD01000021",92.126,6.71e-44,180,127,117.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLRC01000027",92.126,6.71e-44,180,127,117.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLYZ01000021",92.126,6.71e-44,180,127,117.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLSP01000022",92.126,6.71e-44,180,127,117.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLZF01000029",92.126,6.71e-44,180,127,117.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLSH01000020",92.126,6.71e-44,180,127,117.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLYY01000023",92.126,6.71e-44,180,127,117.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLYC01000020",92.126,6.71e-44,180,127,117.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLXZ01000020",92.126,6.71e-44,180,127,117.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_JBGJJV010000032",92.126,6.71e-44,180,127,117.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_JAUEGY010000142",92.126,6.71e-44,180,127,117.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_FLBI01000046",92.126,6.77e-44,180,127,117.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_FLBN01000099",92.126,6.77e-44,180,127,117.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRI01000021",92.126,6.77e-44,180,127,117.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRE01000049",92.126,6.77e-44,180,127,117.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_FLCN01000004",92.126,6.77e-44,180,127,117.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRZ01000037",92.126,6.77e-44,180,127,117.00002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRO01000021",92.126,6.77e-44,180,127,117.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLXR01000021",92.126,6.77e-44,180,127,117.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRG01000021",92.126,6.77e-44,180,127,117.00002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLYG01000019",92.126,6.77e-44,180,127,117.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRJ01000019",92.126,6.77e-44,180,127,117.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLSM01000018",92.126,6.77e-44,180,127,117.00002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLSQ01000022",92.126,6.77e-44,180,127,117.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLXY01000024",92.126,6.77e-44,180,127,117.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLXS01000025",92.126,6.77e-44,180,127,117.00002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLWB01000035",92.126,6.77e-44,180,127,117.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLUD01000021",92.126,6.77e-44,180,127,117.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLRC01000027",92.126,6.77e-44,180,127,117.00002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLYZ01000021",92.126,6.77e-44,180,127,117.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLSP01000022",92.126,6.77e-44,180,127,117.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLZF01000029",92.126,6.77e-44,180,127,117.00002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLSH01000020",92.126,6.77e-44,180,127,117.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLYY01000023",92.126,6.77e-44,180,127,117.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLYC01000020",92.126,6.77e-44,180,127,117.00002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLXZ01000020",92.126,6.77e-44,180,127,117.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_JBGJJV010000032",92.126,6.77e-44,180,127,117.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_JAUEGY010000142",92.126,6.77e-44,180,127,117.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_JBGJJV010000032",88.125,6.71e-44,180,160,141,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_FLBI01000046",90.441,2.43e-43,178,136,122.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_FLBN01000099",90.441,2.43e-43,178,136,122.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_FLCN01000004",90.441,2.43e-43,178,136,122.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_JBGJJV010000032",90.511,2.43e-43,178,137,124.00007,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRI01000021",88.514,2.41e-43,178,148,131.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRZ01000037",88.514,2.41e-43,178,148,131.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRO01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLXR01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRG01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLYG01000019",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRJ01000019",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLSM01000018",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLSQ01000022",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLXY01000024",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLXS01000025",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLWB01000035",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLUD01000021",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLRC01000027",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLYZ01000021",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLSP01000022",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLZF01000029",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLSH01000020",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLYY01000023",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLYC01000020",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLXZ01000020",88.514,2.41e-43,178,148,131.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_JBGJJV010000032",90.441,2.41e-43,178,136,122.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRI01000021",88.514,2.41e-43,178,148,131.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRZ01000037",88.514,2.41e-43,178,148,131.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRO01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLXR01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRG01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLYG01000019",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRJ01000019",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLSM01000018",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLSQ01000022",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLXY01000024",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLXS01000025",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLWB01000035",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLUD01000021",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLRC01000027",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLYZ01000021",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLSP01000022",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLZF01000029",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLSH01000020",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLYY01000023",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLYC01000020",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLXZ01000020",88.514,2.41e-43,178,148,131.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_JBGJJV010000032",88.514,2.41e-43,178,148,131.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRI01000021",88.514,2.41e-43,178,148,131.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRZ01000037",88.514,2.41e-43,178,148,131.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRO01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLXR01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRG01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLYG01000019",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRJ01000019",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLSM01000018",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLSQ01000022",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLXY01000024",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLXS01000025",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLWB01000035",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLUD01000021",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLRC01000027",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLYZ01000021",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLSP01000022",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLZF01000029",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLSH01000020",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLYY01000023",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLYC01000020",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLXZ01000020",88.514,2.41e-43,178,148,131.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_JBGJJV010000032",88.514,2.41e-43,178,148,131.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRI01000021",88.514,2.41e-43,178,148,131.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRZ01000037",88.514,2.41e-43,178,148,131.00072,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRO01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLXR01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRG01000021",88.514,2.41e-43,178,148,131.00072,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLYG01000019",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRJ01000019",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLSM01000018",88.514,2.41e-43,178,148,131.00072,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLSQ01000022",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLXY01000024",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLXS01000025",88.514,2.41e-43,178,148,131.00072,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLWB01000035",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLUD01000021",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLRC01000027",88.514,2.41e-43,178,148,131.00072,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLYZ01000021",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLSP01000022",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLZF01000029",88.514,2.41e-43,178,148,131.00072,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLSH01000020",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLYY01000023",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLYC01000020",88.514,2.41e-43,178,148,131.00072,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLXZ01000020",88.514,2.41e-43,178,148,131.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_JBGJJV010000032",88.514,2.41e-43,178,148,131.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_JBGJJV010000032",88.514,2.41e-43,178,148,131.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRI01000021",88.079,8.68e-43,176,151,132.99929,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRE01000049",88.079,8.68e-43,176,151,132.99929,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRZ01000037",88.079,8.68e-43,176,151,132.99929,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRO01000021",88.079,8.68e-43,176,151,132.99929,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLXR01000021",88.079,8.68e-43,176,151,132.99929,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRG01000021",88.079,8.68e-43,176,151,132.99929,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLYG01000019",88.079,8.68e-43,176,151,132.99929,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRJ01000019",88.079,8.68e-43,176,151,132.99929,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLSM01000018",88.079,8.68e-43,176,151,132.99929,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLSQ01000022",88.079,8.68e-43,176,151,132.99929,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLXY01000024",88.079,8.68e-43,176,151,132.99929,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLXS01000025",88.079,8.68e-43,176,151,132.99929,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLWB01000035",88.079,8.68e-43,176,151,132.99929,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLUD01000021",88.079,8.68e-43,176,151,132.99929,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLRC01000027",88.079,8.68e-43,176,151,132.99929,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLYZ01000021",88.079,8.68e-43,176,151,132.99929,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLSP01000022",88.079,8.68e-43,176,151,132.99929,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLZF01000029",88.079,8.68e-43,176,151,132.99929,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLSH01000020",88.079,8.68e-43,176,151,132.99929,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLYY01000023",88.079,8.68e-43,176,151,132.99929,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLYC01000020",88.079,8.68e-43,176,151,132.99929,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLXZ01000020",88.079,8.68e-43,176,151,132.99929,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_FLBI01000046",88,8.68e-43,176,150,132,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_FLBN01000099",88,8.68e-43,176,150,132,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRE01000049",88,8.68e-43,176,150,132,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_FLCN01000004",88,8.68e-43,176,150,132,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_JAUEGY010000142",88,8.68e-43,176,150,132,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_JBGJJV010000032",87.578,8.76e-43,176,161,141.00058,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_JBGJJV010000032",87.578,8.76e-43,176,161,141.00058,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_FLBI01000046",87.919,8.68e-43,176,149,130.99931,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_FLBN01000099",87.919,8.68e-43,176,149,130.99931,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRE01000049",87.919,8.68e-43,176,149,130.99931,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_FLCN01000004",87.919,8.68e-43,176,149,130.99931,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_JAUEGY010000142",87.919,8.68e-43,176,149,130.99931,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRI01000021",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRE01000049",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRZ01000037",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRO01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLXR01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRG01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLYG01000019",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRJ01000019",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLSM01000018",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLSQ01000022",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLXY01000024",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLXS01000025",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLWB01000035",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLUD01000021",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLRC01000027",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLYZ01000021",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLSP01000022",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLZF01000029",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLSH01000020",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLYY01000023",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLYC01000020",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLXZ01000020",87.421,3.15e-42,174,159,138.99939,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRI01000021",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRE01000049",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRZ01000037",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRO01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLXR01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRG01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLYG01000019",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRJ01000019",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLSM01000018",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLSQ01000022",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLXY01000024",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLXS01000025",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLWB01000035",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLUD01000021",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLRC01000027",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLYZ01000021",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLSP01000022",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLZF01000029",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLSH01000020",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLYY01000023",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLYC01000020",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLXZ01000020",87.421,3.15e-42,174,159,138.99939,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRI01000021",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRE01000049",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRZ01000037",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRO01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLXR01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRG01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLYG01000019",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRJ01000019",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLSM01000018",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLSQ01000022",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLXY01000024",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLXS01000025",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLWB01000035",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLUD01000021",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLRC01000027",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLYZ01000021",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLSP01000022",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLZF01000029",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLSH01000020",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLYY01000023",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLYC01000020",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLXZ01000020",87.421,3.15e-42,174,159,138.99939,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRI01000021",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRE01000049",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRZ01000037",87.421,3.15e-42,174,159,138.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRO01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLXR01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRG01000021",87.421,3.15e-42,174,159,138.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLYG01000019",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRJ01000019",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLSM01000018",87.421,3.15e-42,174,159,138.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLSQ01000022",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLXY01000024",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLXS01000025",87.421,3.15e-42,174,159,138.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLWB01000035",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLUD01000021",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLRC01000027",87.421,3.15e-42,174,159,138.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLYZ01000021",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLSP01000022",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLZF01000029",87.421,3.15e-42,174,159,138.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLSH01000020",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLYY01000023",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLYC01000020",87.421,3.15e-42,174,159,138.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLXZ01000020",87.421,3.15e-42,174,159,138.99939,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_FLBI01000046",89.209,3.12e-42,174,139,124.00051,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_FLBN01000099",89.209,3.12e-42,174,139,124.00051,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_FLCN01000004",89.209,3.12e-42,174,139,124.00051,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_JBGJJV010000032",89.209,3.12e-42,174,139,124.00051,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_FLBI01000046",89.209,3.12e-42,174,139,124.00051,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_FLBN01000099",89.209,3.12e-42,174,139,124.00051,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_FLCN01000004",89.209,3.12e-42,174,139,124.00051,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_JBGJJV010000032",89.209,3.12e-42,174,139,124.00051,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRI01000021",89.209,3.12e-42,174,139,124.00051,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRE01000049",89.209,3.12e-42,174,139,124.00051,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRZ01000037",89.209,3.12e-42,174,139,124.00051,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRO01000021",89.209,3.12e-42,174,139,124.00051,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLXR01000021",89.209,3.12e-42,174,139,124.00051,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRG01000021",89.209,3.12e-42,174,139,124.00051,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLYG01000019",89.209,3.12e-42,174,139,124.00051,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRJ01000019",89.209,3.12e-42,174,139,124.00051,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLSM01000018",89.209,3.12e-42,174,139,124.00051,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLSQ01000022",89.209,3.12e-42,174,139,124.00051,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLXY01000024",89.209,3.12e-42,174,139,124.00051,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLXS01000025",89.209,3.12e-42,174,139,124.00051,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLWB01000035",89.209,3.12e-42,174,139,124.00051,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLUD01000021",89.209,3.12e-42,174,139,124.00051,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLRC01000027",89.209,3.12e-42,174,139,124.00051,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLYZ01000021",89.209,3.12e-42,174,139,124.00051,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLSP01000022",89.209,3.12e-42,174,139,124.00051,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLZF01000029",89.209,3.12e-42,174,139,124.00051,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLSH01000020",89.209,3.12e-42,174,139,124.00051,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLYY01000023",89.209,3.12e-42,174,139,124.00051,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLYC01000020",89.209,3.12e-42,174,139,124.00051,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLXZ01000020",89.209,3.12e-42,174,139,124.00051,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_FLBI01000046",87.919,3.12e-42,174,149,130.99931,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_FLBN01000099",87.919,3.12e-42,174,149,130.99931,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_FLCN01000004",87.919,3.12e-42,174,149,130.99931,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRI01000021",89.706,3.12e-42,174,136,122.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRZ01000037",89.706,3.12e-42,174,136,122.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRO01000021",89.706,3.12e-42,174,136,122.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLXR01000021",89.706,3.12e-42,174,136,122.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRG01000021",89.706,3.12e-42,174,136,122.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLYG01000019",89.706,3.12e-42,174,136,122.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRJ01000019",89.706,3.12e-42,174,136,122.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLSM01000018",89.706,3.12e-42,174,136,122.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLSQ01000022",89.706,3.12e-42,174,136,122.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLXY01000024",89.706,3.12e-42,174,136,122.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLXS01000025",89.706,3.12e-42,174,136,122.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLWB01000035",89.706,3.12e-42,174,136,122.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLUD01000021",89.706,3.12e-42,174,136,122.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLRC01000027",89.706,3.12e-42,174,136,122.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLYZ01000021",89.706,3.12e-42,174,136,122.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLSP01000022",89.706,3.12e-42,174,136,122.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLZF01000029",89.706,3.12e-42,174,136,122.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLSH01000020",89.706,3.12e-42,174,136,122.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLYY01000023",89.706,3.12e-42,174,136,122.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLYC01000020",89.706,3.12e-42,174,136,122.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLXZ01000020",89.706,3.12e-42,174,136,122.00016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_JBGJJV010000032",89.706,3.12e-42,174,136,122.00016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_FLBI01000046",87.838,3.12e-42,174,148,130.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_FLBN01000099",87.838,3.12e-42,174,148,130.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRE01000049",87.838,3.12e-42,174,148,130.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_FLCN01000004",87.838,3.12e-42,174,148,130.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_JAUEGY010000142",87.838,3.12e-42,174,148,130.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_FLBI01000046",90.769,3.12e-42,174,130,117.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_FLBN01000099",90.769,3.12e-42,174,130,117.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRI01000021",89.706,3.12e-42,174,136,122.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRE01000049",89.706,3.12e-42,174,136,122.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_FLCN01000004",90.769,3.12e-42,174,130,117.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRZ01000037",89.706,3.12e-42,174,136,122.00016,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRO01000021",89.706,3.12e-42,174,136,122.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLXR01000021",89.706,3.12e-42,174,136,122.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRG01000021",89.706,3.12e-42,174,136,122.00016,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLYG01000019",89.706,3.12e-42,174,136,122.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRJ01000019",89.706,3.12e-42,174,136,122.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLSM01000018",89.706,3.12e-42,174,136,122.00016,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLSQ01000022",89.706,3.12e-42,174,136,122.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLXY01000024",89.706,3.12e-42,174,136,122.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLXS01000025",89.706,3.12e-42,174,136,122.00016,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLWB01000035",89.706,3.12e-42,174,136,122.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLUD01000021",89.706,3.12e-42,174,136,122.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLRC01000027",89.706,3.12e-42,174,136,122.00016,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLYZ01000021",89.706,3.12e-42,174,136,122.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLSP01000022",89.706,3.12e-42,174,136,122.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLZF01000029",89.706,3.12e-42,174,136,122.00016,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLSH01000020",89.706,3.12e-42,174,136,122.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLYY01000023",89.706,3.12e-42,174,136,122.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLYC01000020",89.706,3.12e-42,174,136,122.00016,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLXZ01000020",89.706,3.12e-42,174,136,122.00016,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_JBGJJV010000032",90.769,3.12e-42,174,130,117.9997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_JAUEGY010000142",90.769,3.12e-42,174,130,117.9997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_FLBI01000046",92.063,3.12e-42,174,126,115.99938,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_FLBN01000099",92.063,3.12e-42,174,126,115.99938,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_FLCN01000004",92.063,3.12e-42,174,126,115.99938,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRI01000021",89.041,3.12e-42,174,146,129.99986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRE01000049",89.041,3.12e-42,174,146,129.99986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRZ01000037",89.041,3.12e-42,174,146,129.99986,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRO01000021",89.041,3.12e-42,174,146,129.99986,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLXR01000021",89.041,3.12e-42,174,146,129.99986,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRG01000021",89.041,3.12e-42,174,146,129.99986,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLYG01000019",89.041,3.12e-42,174,146,129.99986,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRJ01000019",89.041,3.12e-42,174,146,129.99986,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLSM01000018",89.041,3.12e-42,174,146,129.99986,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLSQ01000022",89.041,3.12e-42,174,146,129.99986,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLXY01000024",89.041,3.12e-42,174,146,129.99986,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLXS01000025",89.041,3.12e-42,174,146,129.99986,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLWB01000035",89.041,3.12e-42,174,146,129.99986,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLUD01000021",89.041,3.12e-42,174,146,129.99986,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLRC01000027",89.041,3.12e-42,174,146,129.99986,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLYZ01000021",89.041,3.12e-42,174,146,129.99986,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLSP01000022",89.041,3.12e-42,174,146,129.99986,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLZF01000029",89.041,3.12e-42,174,146,129.99986,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLSH01000020",89.041,3.12e-42,174,146,129.99986,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLYY01000023",89.041,3.12e-42,174,146,129.99986,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLYC01000020",89.041,3.12e-42,174,146,129.99986,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLXZ01000020",89.041,3.12e-42,174,146,129.99986,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_FLBI01000046",87.5,3.12e-42,174,160,140,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_FLBN01000099",87.5,3.12e-42,174,160,140,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_FLCN01000004",87.5,3.12e-42,174,160,140,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_JBGJJV010000032",89.781,1.13e-41,172,137,122.99997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRI01000021",89.781,1.13e-41,172,137,122.99997,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRE01000049",89.781,1.13e-41,172,137,122.99997,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRZ01000037",89.781,1.13e-41,172,137,122.99997,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRO01000021",89.781,1.13e-41,172,137,122.99997,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLXR01000021",89.781,1.13e-41,172,137,122.99997,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRG01000021",89.781,1.13e-41,172,137,122.99997,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLYG01000019",89.781,1.13e-41,172,137,122.99997,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRJ01000019",89.781,1.13e-41,172,137,122.99997,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLSM01000018",89.781,1.13e-41,172,137,122.99997,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLSQ01000022",89.781,1.13e-41,172,137,122.99997,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLXY01000024",89.781,1.13e-41,172,137,122.99997,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLXS01000025",89.781,1.13e-41,172,137,122.99997,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLWB01000035",89.781,1.13e-41,172,137,122.99997,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLUD01000021",89.781,1.13e-41,172,137,122.99997,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLRC01000027",89.781,1.13e-41,172,137,122.99997,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLYZ01000021",89.781,1.13e-41,172,137,122.99997,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLSP01000022",89.781,1.13e-41,172,137,122.99997,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLZF01000029",89.781,1.13e-41,172,137,122.99997,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLSH01000020",89.781,1.13e-41,172,137,122.99997,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLYY01000023",89.781,1.13e-41,172,137,122.99997,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLYC01000020",89.781,1.13e-41,172,137,122.99997,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLXZ01000020",89.781,1.13e-41,172,137,122.99997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_FLBI01000046",89.13,1.12e-41,172,138,122.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_FLBN01000099",89.13,1.12e-41,172,138,122.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_FLCN01000004",89.13,1.12e-41,172,138,122.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_JBGJJV010000032",89.13,1.12e-41,172,138,122.9994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRI01000021",87.838,1.12e-41,172,148,130.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRZ01000037",87.838,1.12e-41,172,148,130.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRO01000021",87.838,1.12e-41,172,148,130.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLXR01000021",87.838,1.12e-41,172,148,130.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRG01000021",87.838,1.12e-41,172,148,130.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLYG01000019",87.838,1.12e-41,172,148,130.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRJ01000019",87.838,1.12e-41,172,148,130.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLSM01000018",87.838,1.12e-41,172,148,130.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLSQ01000022",87.838,1.12e-41,172,148,130.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLXY01000024",87.838,1.12e-41,172,148,130.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLXS01000025",87.838,1.12e-41,172,148,130.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLWB01000035",87.838,1.12e-41,172,148,130.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLUD01000021",87.838,1.12e-41,172,148,130.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLRC01000027",87.838,1.12e-41,172,148,130.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLYZ01000021",87.838,1.12e-41,172,148,130.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLSP01000022",87.838,1.12e-41,172,148,130.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLZF01000029",87.838,1.12e-41,172,148,130.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLSH01000020",87.838,1.12e-41,172,148,130.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLYY01000023",87.838,1.12e-41,172,148,130.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLYC01000020",87.838,1.12e-41,172,148,130.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLXZ01000020",87.838,1.12e-41,172,148,130.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_JBGJJV010000032",87.838,1.12e-41,172,148,130.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRI01000021",87.838,1.12e-41,172,148,130.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRZ01000037",87.838,1.12e-41,172,148,130.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRO01000021",87.838,1.12e-41,172,148,130.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLXR01000021",87.838,1.12e-41,172,148,130.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRG01000021",87.838,1.12e-41,172,148,130.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLYG01000019",87.838,1.12e-41,172,148,130.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRJ01000019",87.838,1.12e-41,172,148,130.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLSM01000018",87.838,1.12e-41,172,148,130.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLSQ01000022",87.838,1.12e-41,172,148,130.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLXY01000024",87.838,1.12e-41,172,148,130.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLXS01000025",87.838,1.12e-41,172,148,130.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLWB01000035",87.838,1.12e-41,172,148,130.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLUD01000021",87.838,1.12e-41,172,148,130.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLRC01000027",87.838,1.12e-41,172,148,130.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLYZ01000021",87.838,1.12e-41,172,148,130.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLSP01000022",87.838,1.12e-41,172,148,130.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLZF01000029",87.838,1.12e-41,172,148,130.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLSH01000020",87.838,1.12e-41,172,148,130.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLYY01000023",87.838,1.12e-41,172,148,130.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLYC01000020",87.838,1.12e-41,172,148,130.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLXZ01000020",87.838,1.12e-41,172,148,130.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_JBGJJV010000032",87.838,1.12e-41,172,148,130.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRI01000021",89.63,1.12e-41,172,135,121.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRZ01000037",89.63,1.12e-41,172,135,121.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRO01000021",89.63,1.12e-41,172,135,121.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLXR01000021",89.63,1.12e-41,172,135,121.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRG01000021",89.63,1.12e-41,172,135,121.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLYG01000019",89.63,1.12e-41,172,135,121.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRJ01000019",89.63,1.12e-41,172,135,121.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLSM01000018",89.63,1.12e-41,172,135,121.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLSQ01000022",89.63,1.12e-41,172,135,121.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLXY01000024",89.63,1.12e-41,172,135,121.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLXS01000025",89.63,1.12e-41,172,135,121.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLWB01000035",89.63,1.12e-41,172,135,121.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLUD01000021",89.63,1.12e-41,172,135,121.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLRC01000027",89.63,1.12e-41,172,135,121.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLYZ01000021",89.63,1.12e-41,172,135,121.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLSP01000022",89.63,1.12e-41,172,135,121.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLZF01000029",89.63,1.12e-41,172,135,121.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLSH01000020",89.63,1.12e-41,172,135,121.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLYY01000023",89.63,1.12e-41,172,135,121.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLYC01000020",89.63,1.12e-41,172,135,121.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLXZ01000020",89.63,1.12e-41,172,135,121.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_JBGJJV010000032",89.63,1.12e-41,172,135,121.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_FLBI01000046",87.755,1.11e-41,172,147,128.99985,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_FLBN01000099",87.755,1.11e-41,172,147,128.99985,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_FLCN01000004",87.755,1.11e-41,172,147,128.99985,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRI01000021",87.333,4.04e-41,171,150,130.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRZ01000037",87.333,4.04e-41,171,150,130.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRO01000021",87.333,4.04e-41,171,150,130.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLXR01000021",87.333,4.04e-41,171,150,130.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRG01000021",87.333,4.04e-41,171,150,130.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLYG01000019",87.333,4.04e-41,171,150,130.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRJ01000019",87.333,4.04e-41,171,150,130.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLSM01000018",87.333,4.04e-41,171,150,130.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLSQ01000022",87.333,4.04e-41,171,150,130.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLXY01000024",87.333,4.04e-41,171,150,130.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLXS01000025",87.333,4.04e-41,171,150,130.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLWB01000035",87.333,4.04e-41,171,150,130.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLUD01000021",87.333,4.04e-41,171,150,130.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLRC01000027",87.333,4.04e-41,171,150,130.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLYZ01000021",87.333,4.04e-41,171,150,130.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLSP01000022",87.333,4.04e-41,171,150,130.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLZF01000029",87.333,4.04e-41,171,150,130.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLSH01000020",87.333,4.04e-41,171,150,130.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLYY01000023",87.333,4.04e-41,171,150,130.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLYC01000020",87.333,4.04e-41,171,150,130.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLXZ01000020",87.333,4.04e-41,171,150,130.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_JBGJJV010000032",87.333,4.04e-41,171,150,130.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_FLBI01000046",87.333,4.04e-41,171,150,130.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_FLBN01000099",87.333,4.04e-41,171,150,130.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRE01000049",87.333,4.04e-41,171,150,130.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_FLCN01000004",87.333,4.04e-41,171,150,130.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_JAUEGY010000142",87.333,4.04e-41,171,150,130.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_FLBI01000046",86.957,4.07e-41,171,161,140.00077,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_FLBN01000099",86.957,4.07e-41,171,161,140.00077,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_FLCN01000004",86.957,4.07e-41,171,161,140.00077,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_JBGJJV010000032",86.957,4.07e-41,171,161,140.00077,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_FLBI01000046",86.957,4.07e-41,171,161,140.00077,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_FLBN01000099",86.957,4.07e-41,171,161,140.00077,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_FLCN01000004",86.957,4.07e-41,171,161,140.00077,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_JBGJJV010000032",86.957,4.07e-41,171,161,140.00077,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_JBGJJV010000032",86.957,4.07e-41,171,161,140.00077,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_FLBI01000046",87.248,4.04e-41,171,149,129.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_FLBN01000099",87.248,4.04e-41,171,149,129.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRE01000049",87.248,4.04e-41,171,149,129.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_FLCN01000004",87.248,4.04e-41,171,149,129.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_JAUEGY010000142",87.248,4.04e-41,171,149,129.99952,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_JBGJJV010000032",89.209,4.07e-41,171,139,124.00051,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRI01000021",87.417,4.04e-41,171,151,131.99967,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRO01000021",87.417,4.04e-41,171,151,131.99967,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLXR01000021",87.417,4.04e-41,171,151,131.99967,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRG01000021",87.417,4.04e-41,171,151,131.99967,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLYG01000019",87.417,4.04e-41,171,151,131.99967,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRJ01000019",87.417,4.04e-41,171,151,131.99967,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLSM01000018",87.417,4.04e-41,171,151,131.99967,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLSQ01000022",87.417,4.04e-41,171,151,131.99967,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLXY01000024",87.417,4.04e-41,171,151,131.99967,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLXS01000025",87.417,4.04e-41,171,151,131.99967,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLUD01000021",87.417,4.04e-41,171,151,131.99967,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRC01000027",87.417,4.04e-41,171,151,131.99967,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLYZ01000021",87.417,4.04e-41,171,151,131.99967,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLSP01000022",87.417,4.04e-41,171,151,131.99967,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLSH01000020",87.417,4.04e-41,171,151,131.99967,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLYY01000023",87.417,4.04e-41,171,151,131.99967,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLYC01000020",87.417,4.04e-41,171,151,131.99967,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLXZ01000020",87.417,4.04e-41,171,151,131.99967,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_FLBI01000046",87.586,1.47e-40,169,145,126.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_FLBN01000099",87.586,1.47e-40,169,145,126.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRI01000021",90.551,1.47e-40,169,127,114.99977,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRE01000049",90.551,1.47e-40,169,127,114.99977,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_FLCN01000004",87.586,1.47e-40,169,145,126.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRZ01000037",90.551,1.47e-40,169,127,114.99977,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRO01000021",90.551,1.47e-40,169,127,114.99977,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLXR01000021",90.551,1.47e-40,169,127,114.99977,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRG01000021",90.551,1.47e-40,169,127,114.99977,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLYG01000019",90.551,1.47e-40,169,127,114.99977,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRJ01000019",90.551,1.47e-40,169,127,114.99977,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLSM01000018",90.551,1.47e-40,169,127,114.99977,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLSQ01000022",90.551,1.47e-40,169,127,114.99977,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLXY01000024",90.551,1.47e-40,169,127,114.99977,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLXS01000025",90.551,1.47e-40,169,127,114.99977,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLWB01000035",90.551,1.47e-40,169,127,114.99977,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLUD01000021",90.551,1.47e-40,169,127,114.99977,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLRC01000027",90.551,1.47e-40,169,127,114.99977,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLYZ01000021",90.551,1.47e-40,169,127,114.99977,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLSP01000022",90.551,1.47e-40,169,127,114.99977,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLZF01000029",90.551,1.47e-40,169,127,114.99977,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLSH01000020",90.551,1.47e-40,169,127,114.99977,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLYY01000023",90.551,1.47e-40,169,127,114.99977,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLYC01000020",90.551,1.47e-40,169,127,114.99977,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLXZ01000020",90.551,1.47e-40,169,127,114.99977,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_JBGJJV010000032",87.586,1.47e-40,169,145,126.9997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_JAUEGY010000142",87.586,1.47e-40,169,145,126.9997,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRI01000021",87.097,1.47e-40,169,155,135.00035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRE01000049",87.097,1.47e-40,169,155,135.00035,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRO01000021",87.097,1.47e-40,169,155,135.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLXR01000021",87.097,1.47e-40,169,155,135.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRG01000021",87.097,1.47e-40,169,155,135.00035,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLYG01000019",87.097,1.47e-40,169,155,135.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRJ01000019",87.097,1.47e-40,169,155,135.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLSM01000018",87.097,1.47e-40,169,155,135.00035,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLSQ01000022",87.097,1.47e-40,169,155,135.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLXY01000024",87.097,1.47e-40,169,155,135.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLXS01000025",87.097,1.47e-40,169,155,135.00035,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLUD01000021",87.097,1.47e-40,169,155,135.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRC01000027",87.097,1.47e-40,169,155,135.00035,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLYZ01000021",87.097,1.47e-40,169,155,135.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLSP01000022",87.097,1.47e-40,169,155,135.00035,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLSH01000020",87.097,1.47e-40,169,155,135.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLYY01000023",87.097,1.47e-40,169,155,135.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLYC01000020",87.097,1.47e-40,169,155,135.00035,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLXZ01000020",87.097,1.47e-40,169,155,135.00035,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRI01000021",88.489,1.45e-40,169,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRE01000049",88.489,1.45e-40,169,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRZ01000037",88.489,1.45e-40,169,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRO01000021",88.489,1.45e-40,169,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLXR01000021",88.489,1.45e-40,169,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRG01000021",88.489,1.45e-40,169,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLYG01000019",88.489,1.45e-40,169,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRJ01000019",88.489,1.45e-40,169,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLSM01000018",88.489,1.45e-40,169,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLSQ01000022",88.489,1.45e-40,169,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLXY01000024",88.489,1.45e-40,169,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLXS01000025",88.489,1.45e-40,169,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLWB01000035",88.489,1.45e-40,169,139,122.99971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLUD01000021",88.489,1.45e-40,169,139,122.99971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLRC01000027",88.489,1.45e-40,169,139,122.99971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLYZ01000021",88.489,1.45e-40,169,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLSP01000022",88.489,1.45e-40,169,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLZF01000029",88.489,1.45e-40,169,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLSH01000020",88.489,1.45e-40,169,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLYY01000023",88.489,1.45e-40,169,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLYC01000020",88.489,1.45e-40,169,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLXZ01000020",88.489,1.45e-40,169,139,122.99971,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRI01000021",88.489,1.45e-40,169,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRE01000049",88.489,1.45e-40,169,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRZ01000037",88.489,1.45e-40,169,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRO01000021",88.489,1.45e-40,169,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLXR01000021",88.489,1.45e-40,169,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRG01000021",88.489,1.45e-40,169,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLYG01000019",88.489,1.45e-40,169,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRJ01000019",88.489,1.45e-40,169,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLSM01000018",88.489,1.45e-40,169,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLSQ01000022",88.489,1.45e-40,169,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLXY01000024",88.489,1.45e-40,169,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLXS01000025",88.489,1.45e-40,169,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLWB01000035",88.489,1.45e-40,169,139,122.99971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLUD01000021",88.489,1.45e-40,169,139,122.99971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLRC01000027",88.489,1.45e-40,169,139,122.99971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLYZ01000021",88.489,1.45e-40,169,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLSP01000022",88.489,1.45e-40,169,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLZF01000029",88.489,1.45e-40,169,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLSH01000020",88.489,1.45e-40,169,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLYY01000023",88.489,1.45e-40,169,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLYC01000020",88.489,1.45e-40,169,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLXZ01000020",88.489,1.45e-40,169,139,122.99971,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRI01000021",88.971,1.45e-40,169,136,121.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRZ01000037",88.971,1.45e-40,169,136,121.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRO01000021",88.971,1.45e-40,169,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLXR01000021",88.971,1.45e-40,169,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRG01000021",88.971,1.45e-40,169,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLYG01000019",88.971,1.45e-40,169,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRJ01000019",88.971,1.45e-40,169,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLSM01000018",88.971,1.45e-40,169,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLSQ01000022",88.971,1.45e-40,169,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLXY01000024",88.971,1.45e-40,169,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLXS01000025",88.971,1.45e-40,169,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLWB01000035",88.971,1.45e-40,169,136,121.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLUD01000021",88.971,1.45e-40,169,136,121.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLRC01000027",88.971,1.45e-40,169,136,121.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLYZ01000021",88.971,1.45e-40,169,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLSP01000022",88.971,1.45e-40,169,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLZF01000029",88.971,1.45e-40,169,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLSH01000020",88.971,1.45e-40,169,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLYY01000023",88.971,1.45e-40,169,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLYC01000020",88.971,1.45e-40,169,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLXZ01000020",88.971,1.45e-40,169,136,121.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_JBGJJV010000032",88.971,1.45e-40,169,136,121.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRI01000021",90.152,1.24e-40,169,132,119.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRE01000049",90.152,1.24e-40,169,132,119.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRZ01000037",90.152,1.24e-40,169,132,119.00064,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRO01000021",90.152,1.24e-40,169,132,119.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLXR01000021",90.152,1.24e-40,169,132,119.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRG01000021",90.152,1.24e-40,169,132,119.00064,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLYG01000019",90.152,1.24e-40,169,132,119.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRJ01000019",90.152,1.24e-40,169,132,119.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLSM01000018",90.152,1.24e-40,169,132,119.00064,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLSQ01000022",90.152,1.24e-40,169,132,119.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLXY01000024",90.152,1.24e-40,169,132,119.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLXS01000025",90.152,1.24e-40,169,132,119.00064,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLWB01000035",90.152,1.24e-40,169,132,119.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLUD01000021",90.152,1.24e-40,169,132,119.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLRC01000027",90.152,1.24e-40,169,132,119.00064,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLYZ01000021",90.152,1.24e-40,169,132,119.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLSP01000022",90.152,1.24e-40,169,132,119.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLZF01000029",90.152,1.24e-40,169,132,119.00064,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLSH01000020",90.152,1.24e-40,169,132,119.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLYY01000023",90.152,1.24e-40,169,132,119.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLYC01000020",90.152,1.24e-40,169,132,119.00064,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLXZ01000020",90.152,1.24e-40,169,132,119.00064,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_FLBI01000046",91.129,1.19e-40,169,124,112.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_FLBN01000099",91.129,1.19e-40,169,124,112.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_FLCN01000004",91.129,1.19e-40,169,124,112.99996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRI01000021",89.051,5.27e-40,167,137,121.99987,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRE01000049",89.051,5.27e-40,167,137,121.99987,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRZ01000037",89.051,5.27e-40,167,137,121.99987,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRO01000021",89.051,5.27e-40,167,137,121.99987,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLXR01000021",89.051,5.27e-40,167,137,121.99987,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRG01000021",89.051,5.27e-40,167,137,121.99987,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLYG01000019",89.051,5.27e-40,167,137,121.99987,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRJ01000019",89.051,5.27e-40,167,137,121.99987,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLSM01000018",89.051,5.27e-40,167,137,121.99987,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLSQ01000022",89.051,5.27e-40,167,137,121.99987,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLXY01000024",89.051,5.27e-40,167,137,121.99987,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLXS01000025",89.051,5.27e-40,167,137,121.99987,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLWB01000035",89.051,5.27e-40,167,137,121.99987,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLUD01000021",89.051,5.27e-40,167,137,121.99987,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLRC01000027",89.051,5.27e-40,167,137,121.99987,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLYZ01000021",89.051,5.27e-40,167,137,121.99987,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLSP01000022",89.051,5.27e-40,167,137,121.99987,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLZF01000029",89.051,5.27e-40,167,137,121.99987,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLSH01000020",89.051,5.27e-40,167,137,121.99987,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLYY01000023",89.051,5.27e-40,167,137,121.99987,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLYC01000020",89.051,5.27e-40,167,137,121.99987,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLXZ01000020",89.051,5.27e-40,167,137,121.99987,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_FLBI01000046",86.755,5.27e-40,167,151,131.00005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_FLBN01000099",86.755,5.27e-40,167,151,131.00005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_FLCN01000004",86.755,5.27e-40,167,151,131.00005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_FLBI01000046",94.545,5.27e-40,167,110,103.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_FLBN01000099",94.545,5.27e-40,167,110,103.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_FLCN01000004",94.545,5.27e-40,167,110,103.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLRZ01000037",94.545,5.27e-40,167,110,103.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLWB01000035",94.545,5.27e-40,167,110,103.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLZF01000029",94.545,5.27e-40,167,110,103.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_JBGJJV010000032",94.545,5.27e-40,167,110,103.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRI01000021",88.406,5.23e-40,167,138,122.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRE01000049",88.406,5.23e-40,167,138,122.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRZ01000037",88.406,5.23e-40,167,138,122.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRO01000021",88.406,5.23e-40,167,138,122.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLXR01000021",88.406,5.23e-40,167,138,122.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRG01000021",88.406,5.23e-40,167,138,122.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLYG01000019",88.406,5.23e-40,167,138,122.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRJ01000019",88.406,5.23e-40,167,138,122.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLSM01000018",88.406,5.23e-40,167,138,122.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLSQ01000022",88.406,5.23e-40,167,138,122.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLXY01000024",88.406,5.23e-40,167,138,122.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLXS01000025",88.406,5.23e-40,167,138,122.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLWB01000035",88.406,5.23e-40,167,138,122.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLUD01000021",88.406,5.23e-40,167,138,122.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLRC01000027",88.406,5.23e-40,167,138,122.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLYZ01000021",88.406,5.23e-40,167,138,122.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLSP01000022",88.406,5.23e-40,167,138,122.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLZF01000029",88.406,5.23e-40,167,138,122.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLSH01000020",88.406,5.23e-40,167,138,122.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLYY01000023",88.406,5.23e-40,167,138,122.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLYC01000020",88.406,5.23e-40,167,138,122.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLXZ01000020",88.406,5.23e-40,167,138,122.00028,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLRI01000021",89.394,5.23e-40,167,132,118.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLRZ01000037",89.394,5.23e-40,167,132,118.00008,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLRO01000021",89.394,5.23e-40,167,132,118.00008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLXR01000021",89.394,5.23e-40,167,132,118.00008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLRG01000021",89.394,5.23e-40,167,132,118.00008,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLYG01000019",89.394,5.23e-40,167,132,118.00008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLRJ01000019",89.394,5.23e-40,167,132,118.00008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLSM01000018",89.394,5.23e-40,167,132,118.00008,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLSQ01000022",89.394,5.23e-40,167,132,118.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLXY01000024",89.394,5.23e-40,167,132,118.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLXS01000025",89.394,5.23e-40,167,132,118.00008,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLWB01000035",89.394,5.23e-40,167,132,118.00008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLUD01000021",89.394,5.23e-40,167,132,118.00008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLRC01000027",89.394,5.23e-40,167,132,118.00008,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLYZ01000021",89.394,5.23e-40,167,132,118.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLSP01000022",89.394,5.23e-40,167,132,118.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLZF01000029",89.394,5.23e-40,167,132,118.00008,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLSH01000020",89.394,5.23e-40,167,132,118.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLYY01000023",89.394,5.23e-40,167,132,118.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLYC01000020",89.394,5.23e-40,167,132,118.00008,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLXZ01000020",89.394,5.23e-40,167,132,118.00008,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_FLBI01000046",90.625,4.46e-40,167,128,116,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_FLBN01000099",90.625,4.46e-40,167,128,116,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_FLCN01000004",90.625,4.46e-40,167,128,116,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_JBGJJV010000032",90.625,4.46e-40,167,128,116,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_FLBI01000046",90.625,4.46e-40,167,128,116,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_FLBN01000099",90.625,4.46e-40,167,128,116,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_FLCN01000004",90.625,4.46e-40,167,128,116,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_JBGJJV010000032",90.625,4.46e-40,167,128,116,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLRZ01000037",87.075,5.27e-40,167,147,128.00025,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLWB01000035",87.075,5.27e-40,167,147,128.00025,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLZF01000029",87.075,5.27e-40,167,147,128.00025,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRI01000021",86.667,1.88e-39,165,150,130.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRZ01000037",86.667,1.88e-39,165,150,130.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRO01000021",86.667,1.88e-39,165,150,130.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLXR01000021",86.667,1.88e-39,165,150,130.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRG01000021",86.667,1.88e-39,165,150,130.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLYG01000019",86.667,1.88e-39,165,150,130.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRJ01000019",86.667,1.88e-39,165,150,130.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLSM01000018",86.667,1.88e-39,165,150,130.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLSQ01000022",86.667,1.88e-39,165,150,130.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLXY01000024",86.667,1.88e-39,165,150,130.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLXS01000025",86.667,1.88e-39,165,150,130.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLWB01000035",86.667,1.88e-39,165,150,130.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLUD01000021",86.667,1.88e-39,165,150,130.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLRC01000027",86.667,1.88e-39,165,150,130.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLYZ01000021",86.667,1.88e-39,165,150,130.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLSP01000022",86.667,1.88e-39,165,150,130.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLZF01000029",86.667,1.88e-39,165,150,130.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLSH01000020",86.667,1.88e-39,165,150,130.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLYY01000023",86.667,1.88e-39,165,150,130.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLYC01000020",86.667,1.88e-39,165,150,130.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLXZ01000020",86.667,1.88e-39,165,150,130.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_JBGJJV010000032",86.667,1.88e-39,165,150,130.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_FLBI01000046",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_FLBN01000099",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_FLCN01000004",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_FLBI01000046",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_FLBN01000099",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_FLCN01000004",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_FLBI01000046",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_FLBN01000099",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_FLCN01000004",86.335,1.9e-39,165,161,138.99935,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRI01000021",88.971,1.88e-39,165,136,121.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRE01000049",88.971,1.88e-39,165,136,121.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRZ01000037",88.971,1.88e-39,165,136,121.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRO01000021",88.971,1.88e-39,165,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLXR01000021",88.971,1.88e-39,165,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRG01000021",88.971,1.88e-39,165,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLYG01000019",88.971,1.88e-39,165,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRJ01000019",88.971,1.88e-39,165,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLSM01000018",88.971,1.88e-39,165,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLSQ01000022",88.971,1.88e-39,165,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLXY01000024",88.971,1.88e-39,165,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLXS01000025",88.971,1.88e-39,165,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLWB01000035",88.971,1.88e-39,165,136,121.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLUD01000021",88.971,1.88e-39,165,136,121.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLRC01000027",88.971,1.88e-39,165,136,121.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLYZ01000021",88.971,1.88e-39,165,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLSP01000022",88.971,1.88e-39,165,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLZF01000029",88.971,1.88e-39,165,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLSH01000020",88.971,1.88e-39,165,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLYY01000023",88.971,1.88e-39,165,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLYC01000020",88.971,1.88e-39,165,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLXZ01000020",88.971,1.88e-39,165,136,121.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRI01000021",88.489,1.9e-39,165,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRE01000049",88.489,1.9e-39,165,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRZ01000037",88.489,1.9e-39,165,139,122.99971,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRO01000021",88.489,1.9e-39,165,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLXR01000021",88.489,1.9e-39,165,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRG01000021",88.489,1.9e-39,165,139,122.99971,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLYG01000019",88.489,1.9e-39,165,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRJ01000019",88.489,1.9e-39,165,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLSM01000018",88.489,1.9e-39,165,139,122.99971,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLSQ01000022",88.489,1.9e-39,165,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLXY01000024",88.489,1.9e-39,165,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLXS01000025",88.489,1.9e-39,165,139,122.99971,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLWB01000035",88.489,1.9e-39,165,139,122.99971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLUD01000021",88.489,1.9e-39,165,139,122.99971,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLYZ01000021",88.489,1.9e-39,165,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLSP01000022",88.489,1.9e-39,165,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLZF01000029",88.489,1.9e-39,165,139,122.99971,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLSH01000020",88.489,1.9e-39,165,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLYY01000023",88.489,1.9e-39,165,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLYC01000020",88.489,1.9e-39,165,139,122.99971,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLXZ01000020",88.489,1.9e-39,165,139,122.99971,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRI01000021",88.971,1.88e-39,165,136,121.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRE01000049",88.971,1.88e-39,165,136,121.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRZ01000037",88.971,1.88e-39,165,136,121.00056,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRO01000021",88.971,1.88e-39,165,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLXR01000021",88.971,1.88e-39,165,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRG01000021",88.971,1.88e-39,165,136,121.00056,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLYG01000019",88.971,1.88e-39,165,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRJ01000019",88.971,1.88e-39,165,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLSM01000018",88.971,1.88e-39,165,136,121.00056,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLSQ01000022",88.971,1.88e-39,165,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLXY01000024",88.971,1.88e-39,165,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLXS01000025",88.971,1.88e-39,165,136,121.00056,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLWB01000035",88.971,1.88e-39,165,136,121.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLUD01000021",88.971,1.88e-39,165,136,121.00056,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLYZ01000021",88.971,1.88e-39,165,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLSP01000022",88.971,1.88e-39,165,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLZF01000029",88.971,1.88e-39,165,136,121.00056,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLSH01000020",88.971,1.88e-39,165,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLYY01000023",88.971,1.88e-39,165,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLYC01000020",88.971,1.88e-39,165,136,121.00056,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLXZ01000020",88.971,1.88e-39,165,136,121.00056,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_JBGJJV010000032",86.842,1.9e-39,165,152,131.99984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_FLBI01000046",86.667,1.88e-39,165,150,130.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_FLBN01000099",86.667,1.88e-39,165,150,130.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_FLCN01000004",86.667,1.88e-39,165,150,130.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLRE01000049",86.667,1.88e-39,165,150,130.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_FLBI01000046",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_FLBN01000099",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRI01000021",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRE01000049",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_FLCN01000004",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRZ01000037",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRO01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLXR01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRG01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLYG01000019",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRJ01000019",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLSM01000018",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLSQ01000022",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLXY01000024",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLXS01000025",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLWB01000035",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLUD01000021",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLRC01000027",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLYZ01000021",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLSP01000022",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLZF01000029",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLSH01000020",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLYY01000023",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLYC01000020",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLXZ01000020",89.764,6.82e-39,163,127,114.00028,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_JBGJJV010000032",86.897,6.82e-39,163,145,126.00065,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_JAUEGY010000142",86.897,6.82e-39,163,145,126.00065,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FLBI01000046",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FLBN01000099",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRI01000021",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRE01000049",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FLCN01000004",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRZ01000037",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRO01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXR01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRG01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLYG01000019",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRJ01000019",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSM01000018",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSQ01000022",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXY01000024",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXS01000025",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLWB01000035",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLUD01000021",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRC01000027",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLYZ01000021",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSP01000022",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLZF01000029",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSH01000020",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLYY01000023",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLYC01000020",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXZ01000020",89.764,6.82e-39,163,127,114.00028,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JBGJJV010000032",86.897,6.82e-39,163,145,126.00065,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JAUEGY010000142",86.897,6.82e-39,163,145,126.00065,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_FLBI01000046",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_FLBN01000099",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRI01000021",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRE01000049",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_FLCN01000004",86.897,6.82e-39,163,145,126.00065,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRZ01000037",89.764,6.82e-39,163,127,114.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRO01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLXR01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRG01000021",89.764,6.82e-39,163,127,114.00028,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLYG01000019",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRJ01000019",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLSM01000018",89.764,6.82e-39,163,127,114.00028,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLSQ01000022",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLXY01000024",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLXS01000025",89.764,6.82e-39,163,127,114.00028,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLWB01000035",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLUD01000021",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLRC01000027",89.764,6.82e-39,163,127,114.00028,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLYZ01000021",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLSP01000022",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLZF01000029",89.764,6.82e-39,163,127,114.00028,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLSH01000020",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLYY01000023",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLYC01000020",89.764,6.82e-39,163,127,114.00028,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLXZ01000020",89.764,6.82e-39,163,127,114.00028,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_JBGJJV010000032",86.897,6.82e-39,163,145,126.00065,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_JAUEGY010000142",86.897,6.82e-39,163,145,126.00065,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLRZ01000037",86.275,6.82e-39,163,153,132.00075,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLWB01000035",86.275,6.82e-39,163,153,132.00075,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLZF01000029",86.275,6.82e-39,163,153,132.00075,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_JBGJJV010000032",88.722,6.76e-39,163,133,118.00026,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_FLBI01000046",93.578,6.82e-39,163,109,102.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_FLBN01000099",93.578,6.82e-39,163,109,102.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_FLCN01000004",93.578,6.82e-39,163,109,102.00002,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLRC01000027",94.34,6.82e-39,163,106,100.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRI01000021",90.909,5.54e-39,163,121,109.99989,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRE01000049",90.909,5.54e-39,163,121,109.99989,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRZ01000037",90.909,5.54e-39,163,121,109.99989,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRO01000021",90.909,5.54e-39,163,121,109.99989,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLXR01000021",90.909,5.54e-39,163,121,109.99989,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRG01000021",90.909,5.54e-39,163,121,109.99989,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLYG01000019",90.909,5.54e-39,163,121,109.99989,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRJ01000019",90.909,5.54e-39,163,121,109.99989,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLSM01000018",90.909,5.54e-39,163,121,109.99989,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLSQ01000022",90.909,5.54e-39,163,121,109.99989,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLXY01000024",90.909,5.54e-39,163,121,109.99989,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLXS01000025",90.909,5.54e-39,163,121,109.99989,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLWB01000035",90.909,5.54e-39,163,121,109.99989,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLUD01000021",90.909,5.54e-39,163,121,109.99989,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLRC01000027",90.909,5.54e-39,163,121,109.99989,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLYZ01000021",90.909,5.54e-39,163,121,109.99989,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLSP01000022",90.909,5.54e-39,163,121,109.99989,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLZF01000029",90.909,5.54e-39,163,121,109.99989,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLSH01000020",90.909,5.54e-39,163,121,109.99989,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLYY01000023",90.909,5.54e-39,163,121,109.99989,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLYC01000020",90.909,5.54e-39,163,121,109.99989,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLXZ01000020",90.909,5.54e-39,163,121,109.99989,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_JBGJJV010000032",90.323,5.54e-39,163,124,112.00052,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_FLBI01000046",86.755,6.82e-39,163,151,131.00005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_FLBN01000099",86.755,6.82e-39,163,151,131.00005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_FLCN01000004",86.755,6.82e-39,163,151,131.00005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_JBGJJV010000032",87.162,6.76e-39,163,148,128.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRI01000021",87.671,6.76e-39,163,146,127.99966,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRE01000049",87.671,6.76e-39,163,146,127.99966,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRZ01000037",87.671,6.76e-39,163,146,127.99966,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRO01000021",87.671,6.76e-39,163,146,127.99966,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLXR01000021",87.671,6.76e-39,163,146,127.99966,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRG01000021",87.671,6.76e-39,163,146,127.99966,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLYG01000019",87.671,6.76e-39,163,146,127.99966,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRJ01000019",87.671,6.76e-39,163,146,127.99966,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLSM01000018",87.671,6.76e-39,163,146,127.99966,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLSQ01000022",87.671,6.76e-39,163,146,127.99966,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLXY01000024",87.671,6.76e-39,163,146,127.99966,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLXS01000025",87.671,6.76e-39,163,146,127.99966,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLWB01000035",87.671,6.76e-39,163,146,127.99966,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLUD01000021",87.671,6.76e-39,163,146,127.99966,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLRC01000027",87.671,6.76e-39,163,146,127.99966,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLYZ01000021",87.671,6.76e-39,163,146,127.99966,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLSP01000022",87.671,6.76e-39,163,146,127.99966,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLZF01000029",87.671,6.76e-39,163,146,127.99966,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLSH01000020",87.671,6.76e-39,163,146,127.99966,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLYY01000023",87.671,6.76e-39,163,146,127.99966,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLYC01000020",87.671,6.76e-39,163,146,127.99966,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLXZ01000020",87.671,6.76e-39,163,146,127.99966,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_FLBI01000046",88.636,2.43e-38,161,132,116.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_FLBN01000099",88.636,2.43e-38,161,132,116.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_FLCN01000004",88.636,2.43e-38,161,132,116.99952,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRI01000021",86.395,2.43e-38,161,147,127.00065,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRE01000049",86.395,2.43e-38,161,147,127.00065,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRZ01000037",86.395,2.43e-38,161,147,127.00065,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRO01000021",86.395,2.43e-38,161,147,127.00065,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLXR01000021",86.395,2.43e-38,161,147,127.00065,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRG01000021",86.395,2.43e-38,161,147,127.00065,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLYG01000019",86.395,2.43e-38,161,147,127.00065,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRJ01000019",86.395,2.43e-38,161,147,127.00065,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLSM01000018",86.395,2.43e-38,161,147,127.00065,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLSQ01000022",86.395,2.43e-38,161,147,127.00065,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLXY01000024",86.395,2.43e-38,161,147,127.00065,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLXS01000025",86.395,2.43e-38,161,147,127.00065,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLWB01000035",86.395,2.43e-38,161,147,127.00065,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLUD01000021",86.395,2.43e-38,161,147,127.00065,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLRC01000027",86.395,2.43e-38,161,147,127.00065,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLYZ01000021",86.395,2.43e-38,161,147,127.00065,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLSP01000022",86.395,2.43e-38,161,147,127.00065,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLZF01000029",86.395,2.43e-38,161,147,127.00065,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLSH01000020",86.395,2.43e-38,161,147,127.00065,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLYY01000023",86.395,2.43e-38,161,147,127.00065,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLYC01000020",86.395,2.43e-38,161,147,127.00065,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLXZ01000020",86.395,2.43e-38,161,147,127.00065,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRI01000021",89.313,2.07e-38,161,131,117.00003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRE01000049",89.313,2.07e-38,161,131,117.00003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRZ01000037",89.313,2.07e-38,161,131,117.00003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRO01000021",89.313,2.07e-38,161,131,117.00003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLXR01000021",89.313,2.07e-38,161,131,117.00003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRG01000021",89.313,2.07e-38,161,131,117.00003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLYG01000019",89.313,2.07e-38,161,131,117.00003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRJ01000019",89.313,2.07e-38,161,131,117.00003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLSM01000018",89.313,2.07e-38,161,131,117.00003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLSQ01000022",89.313,2.07e-38,161,131,117.00003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLXY01000024",89.313,2.07e-38,161,131,117.00003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLXS01000025",89.313,2.07e-38,161,131,117.00003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLWB01000035",89.313,2.07e-38,161,131,117.00003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLUD01000021",89.313,2.07e-38,161,131,117.00003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLRC01000027",89.313,2.07e-38,161,131,117.00003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLYZ01000021",89.313,2.07e-38,161,131,117.00003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLSP01000022",89.313,2.07e-38,161,131,117.00003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLZF01000029",89.313,2.07e-38,161,131,117.00003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLSH01000020",89.313,2.07e-38,161,131,117.00003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLYY01000023",89.313,2.07e-38,161,131,117.00003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLYC01000020",89.313,2.07e-38,161,131,117.00003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLXZ01000020",89.313,2.07e-38,161,131,117.00003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRI01000021",89.313,2.07e-38,161,131,117.00003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRE01000049",89.313,2.07e-38,161,131,117.00003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRZ01000037",89.313,2.07e-38,161,131,117.00003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRO01000021",89.313,2.07e-38,161,131,117.00003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLXR01000021",89.313,2.07e-38,161,131,117.00003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRG01000021",89.313,2.07e-38,161,131,117.00003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLYG01000019",89.313,2.07e-38,161,131,117.00003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRJ01000019",89.313,2.07e-38,161,131,117.00003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLSM01000018",89.313,2.07e-38,161,131,117.00003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLSQ01000022",89.313,2.07e-38,161,131,117.00003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLXY01000024",89.313,2.07e-38,161,131,117.00003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLXS01000025",89.313,2.07e-38,161,131,117.00003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLWB01000035",89.313,2.07e-38,161,131,117.00003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLUD01000021",89.313,2.07e-38,161,131,117.00003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLRC01000027",89.313,2.07e-38,161,131,117.00003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLYZ01000021",89.313,2.07e-38,161,131,117.00003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLSP01000022",89.313,2.07e-38,161,131,117.00003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLZF01000029",89.313,2.07e-38,161,131,117.00003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLSH01000020",89.313,2.07e-38,161,131,117.00003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLYY01000023",89.313,2.07e-38,161,131,117.00003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLYC01000020",89.313,2.07e-38,161,131,117.00003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLXZ01000020",89.313,2.07e-38,161,131,117.00003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_JBGJJV010000032",86.395,2.41e-38,161,147,127.00065,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_FLBI01000046",87.075,2.43e-38,161,147,128.00025,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_FLBN01000099",87.075,2.43e-38,161,147,128.00025,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_FLCN01000004",87.075,2.43e-38,161,147,128.00025,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLRZ01000037",86.184,2.43e-38,161,152,130.99968,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLWB01000035",86.184,2.43e-38,161,152,130.99968,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLZF01000029",86.184,2.43e-38,161,152,130.99968,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRE01000049",87.143,8.82e-38,159,140,122.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLRC01000027",88.235,8.75e-38,159,136,119.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_FLBI01000046",86.184,8.82e-38,159,152,130.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_FLBN01000099",86.184,8.82e-38,159,152,130.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_FLCN01000004",86.184,8.82e-38,159,152,130.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_JBGJJV010000032",86.275,8.82e-38,159,153,132.00075,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_FLBI01000046",86,8.82e-38,159,150,129,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_FLBN01000099",86,8.82e-38,159,150,129,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_FLCN01000004",86,8.82e-38,159,150,129,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_JBGJJV010000032",85.906,3.15e-37,158,149,127.99994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_FLBI01000046",93.396,3.15e-37,158,106,98.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_FLBN01000099",93.396,3.15e-37,158,106,98.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_FLCN01000004",93.396,3.15e-37,158,106,98.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_JBGJJV010000032",94.175,3.15e-37,158,103,97.00025,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRI01000021",85.714,1.12e-36,156,147,125.99958,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRE01000049",85.714,1.12e-36,156,147,125.99958,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRZ01000037",85.714,1.12e-36,156,147,125.99958,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRO01000021",85.714,1.12e-36,156,147,125.99958,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLXR01000021",85.714,1.12e-36,156,147,125.99958,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRG01000021",85.714,1.12e-36,156,147,125.99958,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLYG01000019",85.714,1.12e-36,156,147,125.99958,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRJ01000019",85.714,1.12e-36,156,147,125.99958,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLSM01000018",85.714,1.12e-36,156,147,125.99958,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLSQ01000022",85.714,1.12e-36,156,147,125.99958,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLXY01000024",85.714,1.12e-36,156,147,125.99958,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLXS01000025",85.714,1.12e-36,156,147,125.99958,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLWB01000035",85.714,1.12e-36,156,147,125.99958,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLUD01000021",85.714,1.12e-36,156,147,125.99958,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLRC01000027",85.714,1.12e-36,156,147,125.99958,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLYZ01000021",85.714,1.12e-36,156,147,125.99958,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLSP01000022",85.714,1.12e-36,156,147,125.99958,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLZF01000029",85.714,1.12e-36,156,147,125.99958,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLSH01000020",85.714,1.12e-36,156,147,125.99958,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLYY01000023",85.714,1.12e-36,156,147,125.99958,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLYC01000020",85.714,1.12e-36,156,147,125.99958,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLXZ01000020",85.714,1.12e-36,156,147,125.99958,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_FLBI01000046",90.598,4.07e-36,154,117,105.99966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_FLBN01000099",90.598,4.07e-36,154,117,105.99966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRI01000021",90.517,4.07e-36,154,116,104.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRE01000049",90.517,4.07e-36,154,116,104.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_FLCN01000004",90.598,4.07e-36,154,117,105.99966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRZ01000037",90.517,4.07e-36,154,116,104.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRO01000021",90.517,4.07e-36,154,116,104.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLXR01000021",90.517,4.07e-36,154,116,104.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRG01000021",90.517,4.07e-36,154,116,104.99972,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLYG01000019",90.517,4.07e-36,154,116,104.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRJ01000019",90.517,4.07e-36,154,116,104.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLSM01000018",90.517,4.07e-36,154,116,104.99972,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLSQ01000022",90.517,4.07e-36,154,116,104.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLXY01000024",90.517,4.07e-36,154,116,104.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLXS01000025",90.517,4.07e-36,154,116,104.99972,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLWB01000035",90.517,4.07e-36,154,116,104.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLUD01000021",90.517,4.07e-36,154,116,104.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLRC01000027",90.517,4.07e-36,154,116,104.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLYZ01000021",90.517,4.07e-36,154,116,104.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLSP01000022",90.517,4.07e-36,154,116,104.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLZF01000029",90.517,4.07e-36,154,116,104.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLSH01000020",90.517,4.07e-36,154,116,104.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLYY01000023",90.517,4.07e-36,154,116,104.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLYC01000020",90.517,4.07e-36,154,116,104.99972,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLXZ01000020",90.517,4.07e-36,154,116,104.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_JBGJJV010000032",90.517,4.07e-36,154,116,104.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_JBGJJV010000032",86.301,4.07e-36,154,146,125.99946,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRE01000049",86.429,4.1e-36,154,140,121.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRE01000049",86.429,4.1e-36,154,140,121.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_FLBI01000046",86.429,4.1e-36,154,140,121.0006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRI01000021",86.861,4.1e-36,154,137,118.99957,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRZ01000037",86.861,4.1e-36,154,137,118.99957,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRO01000021",86.861,4.1e-36,154,137,118.99957,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLXR01000021",86.861,4.1e-36,154,137,118.99957,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRG01000021",86.861,4.1e-36,154,137,118.99957,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLYG01000019",86.861,4.1e-36,154,137,118.99957,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRJ01000019",86.861,4.1e-36,154,137,118.99957,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLSM01000018",86.861,4.1e-36,154,137,118.99957,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLSQ01000022",86.861,4.1e-36,154,137,118.99957,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLXY01000024",86.861,4.1e-36,154,137,118.99957,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLXS01000025",86.861,4.1e-36,154,137,118.99957,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLWB01000035",86.861,4.1e-36,154,137,118.99957,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLUD01000021",86.861,4.1e-36,154,137,118.99957,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLRC01000027",86.861,4.1e-36,154,137,118.99957,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLYZ01000021",86.861,4.1e-36,154,137,118.99957,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLSP01000022",86.861,4.1e-36,154,137,118.99957,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLZF01000029",86.861,4.1e-36,154,137,118.99957,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLSH01000020",86.861,4.1e-36,154,137,118.99957,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLYY01000023",86.861,4.1e-36,154,137,118.99957,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLYC01000020",86.861,4.1e-36,154,137,118.99957,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLXZ01000020",86.861,4.1e-36,154,137,118.99957,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_JBGJJV010000032",86.429,4.1e-36,154,140,121.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_FLBI01000046",94.898,4.07e-36,154,98,93.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_FLBN01000099",94.898,4.07e-36,154,98,93.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_FLCN01000004",94.898,4.07e-36,154,98,93.00004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRI01000021",86.957,4.1e-36,154,138,120.00066,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRE01000049",86.957,4.1e-36,154,138,120.00066,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRZ01000037",86.957,4.1e-36,154,138,120.00066,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRO01000021",86.957,4.1e-36,154,138,120.00066,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLXR01000021",86.957,4.1e-36,154,138,120.00066,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRG01000021",86.957,4.1e-36,154,138,120.00066,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLYG01000019",86.957,4.1e-36,154,138,120.00066,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRJ01000019",86.957,4.1e-36,154,138,120.00066,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLSM01000018",86.957,4.1e-36,154,138,120.00066,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLSQ01000022",86.957,4.1e-36,154,138,120.00066,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLXY01000024",86.957,4.1e-36,154,138,120.00066,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLXS01000025",86.957,4.1e-36,154,138,120.00066,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLWB01000035",86.957,4.1e-36,154,138,120.00066,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLUD01000021",86.957,4.1e-36,154,138,120.00066,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLRC01000027",86.957,4.1e-36,154,138,120.00066,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLYZ01000021",86.957,4.1e-36,154,138,120.00066,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLSP01000022",86.957,4.1e-36,154,138,120.00066,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLZF01000029",86.957,4.1e-36,154,138,120.00066,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLSH01000020",86.957,4.1e-36,154,138,120.00066,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLYY01000023",86.957,4.1e-36,154,138,120.00066,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLYC01000020",86.957,4.1e-36,154,138,120.00066,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLXZ01000020",86.957,4.1e-36,154,138,120.00066,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_JBGJJV010000032",86.957,4.1e-36,154,138,120.00066,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLRZ01000037",85.621,4.1e-36,154,153,131.00013,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLWB01000035",85.621,4.1e-36,154,153,131.00013,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLZF01000029",85.621,4.1e-36,154,153,131.00013,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_FLBI01000046",86.111,3.9e-36,154,144,123.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_FLBN01000099",86.111,3.9e-36,154,144,123.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_FLCN01000004",86.111,3.9e-36,154,144,123.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_MLRZ01000037",86.111,3.9e-36,154,144,123.99984,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_MLWB01000035",86.111,3.9e-36,154,144,123.99984,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_MLZF01000029",86.111,3.9e-36,154,144,123.99984,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_JBGJJV010000032",86.111,3.9e-36,154,144,123.99984,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRI01000021",86.765,1.48e-35,152,136,118.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRE01000049",86.765,1.48e-35,152,136,118.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRZ01000037",86.765,1.48e-35,152,136,118.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRO01000021",86.765,1.48e-35,152,136,118.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLXR01000021",86.765,1.48e-35,152,136,118.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRG01000021",86.765,1.48e-35,152,136,118.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLYG01000019",86.765,1.48e-35,152,136,118.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRJ01000019",86.765,1.48e-35,152,136,118.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLSM01000018",86.765,1.48e-35,152,136,118.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLSQ01000022",86.765,1.48e-35,152,136,118.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLXY01000024",86.765,1.48e-35,152,136,118.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLXS01000025",86.765,1.48e-35,152,136,118.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLWB01000035",86.765,1.48e-35,152,136,118.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLUD01000021",86.765,1.48e-35,152,136,118.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLRC01000027",86.765,1.48e-35,152,136,118.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLYZ01000021",86.765,1.48e-35,152,136,118.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLSP01000022",86.765,1.48e-35,152,136,118.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLZF01000029",86.765,1.48e-35,152,136,118.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLSH01000020",86.765,1.48e-35,152,136,118.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLYY01000023",86.765,1.48e-35,152,136,118.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLYC01000020",86.765,1.48e-35,152,136,118.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLXZ01000020",86.765,1.48e-35,152,136,118.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_JBGJJV010000032",86.765,1.48e-35,152,136,118.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_FLBI01000046",87.786,1.25e-35,152,131,114.99966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_FLBN01000099",87.786,1.25e-35,152,131,114.99966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_FLCN01000004",87.786,1.25e-35,152,131,114.99966,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_FLBI01000046",86.861,1.32e-35,152,137,118.99957,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_FLBN01000099",86.861,1.32e-35,152,137,118.99957,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRE01000049",86.861,1.32e-35,152,137,118.99957,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_FLCN01000004",86.861,1.32e-35,152,137,118.99957,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_JAUEGY010000142",86.861,1.32e-35,152,137,118.99957,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLRZ01000037",85.526,1.46e-35,152,152,129.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLWB01000035",85.526,1.46e-35,152,152,129.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLZF01000029",85.526,1.46e-35,152,152,129.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRE01000049",87.692,4.49e-35,150,130,113.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLRZ01000037",85.065,5.31e-35,150,154,131.0001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLWB01000035",85.065,5.31e-35,150,154,131.0001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLZF01000029",85.065,5.31e-35,150,154,131.0001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FLBI01000046",89.256,5.31e-35,150,121,107.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FLBN01000099",89.256,5.31e-35,150,121,107.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRI01000021",89.256,5.31e-35,150,121,107.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRE01000049",89.256,5.31e-35,150,121,107.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_FLCN01000004",89.256,5.31e-35,150,121,107.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRZ01000037",89.256,5.31e-35,150,121,107.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRO01000021",89.256,5.31e-35,150,121,107.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLXR01000021",89.256,5.31e-35,150,121,107.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRG01000021",89.256,5.31e-35,150,121,107.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLYG01000019",89.256,5.31e-35,150,121,107.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRJ01000019",89.256,5.31e-35,150,121,107.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLSM01000018",89.256,5.31e-35,150,121,107.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLSQ01000022",89.256,5.31e-35,150,121,107.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLXY01000024",89.256,5.31e-35,150,121,107.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLXS01000025",89.256,5.31e-35,150,121,107.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLWB01000035",89.256,5.31e-35,150,121,107.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLUD01000021",89.256,5.31e-35,150,121,107.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLRC01000027",89.256,5.31e-35,150,121,107.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLYZ01000021",89.256,5.31e-35,150,121,107.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLSP01000022",89.256,5.31e-35,150,121,107.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLZF01000029",89.256,5.31e-35,150,121,107.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLSH01000020",89.256,5.31e-35,150,121,107.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLYY01000023",89.256,5.31e-35,150,121,107.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLYC01000020",89.256,5.31e-35,150,121,107.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLXZ01000020",89.256,5.31e-35,150,121,107.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_JBGJJV010000032",89.256,5.31e-35,150,121,107.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_JAUEGY010000142",89.256,5.31e-35,150,121,107.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_FLBI01000046",89.256,5.31e-35,150,121,107.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_FLBN01000099",89.256,5.31e-35,150,121,107.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRI01000021",89.256,5.31e-35,150,121,107.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRE01000049",89.256,5.31e-35,150,121,107.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_FLCN01000004",89.256,5.31e-35,150,121,107.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRZ01000037",89.256,5.31e-35,150,121,107.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRO01000021",89.256,5.31e-35,150,121,107.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLXR01000021",89.256,5.31e-35,150,121,107.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRG01000021",89.256,5.31e-35,150,121,107.99976,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLYG01000019",89.256,5.31e-35,150,121,107.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRJ01000019",89.256,5.31e-35,150,121,107.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLSM01000018",89.256,5.31e-35,150,121,107.99976,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLSQ01000022",89.256,5.31e-35,150,121,107.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLXY01000024",89.256,5.31e-35,150,121,107.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLXS01000025",89.256,5.31e-35,150,121,107.99976,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLWB01000035",89.256,5.31e-35,150,121,107.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLUD01000021",89.256,5.31e-35,150,121,107.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLRC01000027",89.256,5.31e-35,150,121,107.99976,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLYZ01000021",89.256,5.31e-35,150,121,107.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLSP01000022",89.256,5.31e-35,150,121,107.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLZF01000029",89.256,5.31e-35,150,121,107.99976,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLSH01000020",89.256,5.31e-35,150,121,107.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLYY01000023",89.256,5.31e-35,150,121,107.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLYC01000020",89.256,5.31e-35,150,121,107.99976,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLXZ01000020",89.256,5.31e-35,150,121,107.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_JBGJJV010000032",89.256,5.31e-35,150,121,107.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_JAUEGY010000142",89.256,5.31e-35,150,121,107.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_FLBI01000046",89.344,5.31e-35,150,122,108.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_FLBN01000099",89.344,5.31e-35,150,122,108.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_FLCN01000004",89.344,5.31e-35,150,122,108.99968,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_FLBI01000046",84.667,1.89e-34,148,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_FLBN01000099",84.667,1.89e-34,148,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_FLCN01000004",84.667,1.89e-34,148,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_FLBI01000046",89.431,1.44e-34,148,123,110.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_FLBN01000099",89.431,1.44e-34,148,123,110.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_FLCN01000004",89.431,1.44e-34,148,123,110.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_FLBI01000046",88.8,1.89e-34,148,125,111,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_FLBN01000099",88.8,1.89e-34,148,125,111,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_FLCN01000004",88.8,1.89e-34,148,125,111,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_MLRZ01000037",87.786,1.89e-34,148,131,114.99966,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_MLWB01000035",87.786,1.89e-34,148,131,114.99966,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_MLZF01000029",87.786,1.89e-34,148,131,114.99966,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_JBGJJV010000032",85.616,1.89e-34,148,146,124.99936,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_FLBI01000046",85.714,1.91e-34,148,140,119.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRI01000021",86.131,1.91e-34,148,137,117.99947,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRZ01000037",86.131,1.91e-34,148,137,117.99947,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRO01000021",86.131,1.91e-34,148,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLXR01000021",86.131,1.91e-34,148,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRG01000021",86.131,1.91e-34,148,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLYG01000019",86.131,1.91e-34,148,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRJ01000019",86.131,1.91e-34,148,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLSM01000018",86.131,1.91e-34,148,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLSQ01000022",86.131,1.91e-34,148,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLXY01000024",86.131,1.91e-34,148,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLXS01000025",86.131,1.91e-34,148,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLWB01000035",86.131,1.91e-34,148,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLUD01000021",86.131,1.91e-34,148,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLRC01000027",86.131,1.91e-34,148,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLYZ01000021",86.131,1.91e-34,148,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLSP01000022",86.131,1.91e-34,148,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLZF01000029",86.131,1.91e-34,148,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLSH01000020",86.131,1.91e-34,148,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLYY01000023",86.131,1.91e-34,148,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLYC01000020",86.131,1.91e-34,148,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLXZ01000020",86.131,1.91e-34,148,137,117.99947,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_JBGJJV010000032",85.714,1.91e-34,148,140,119.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_FLBI01000046",85.714,1.91e-34,148,140,119.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRI01000021",86.131,1.91e-34,148,137,117.99947,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRZ01000037",86.131,1.91e-34,148,137,117.99947,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRO01000021",86.131,1.91e-34,148,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLXR01000021",86.131,1.91e-34,148,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRG01000021",86.131,1.91e-34,148,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLYG01000019",86.131,1.91e-34,148,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRJ01000019",86.131,1.91e-34,148,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLSM01000018",86.131,1.91e-34,148,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLSQ01000022",86.131,1.91e-34,148,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLXY01000024",86.131,1.91e-34,148,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLXS01000025",86.131,1.91e-34,148,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLWB01000035",86.131,1.91e-34,148,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLUD01000021",86.131,1.91e-34,148,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLRC01000027",86.131,1.91e-34,148,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLYZ01000021",86.131,1.91e-34,148,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLSP01000022",86.131,1.91e-34,148,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLZF01000029",86.131,1.91e-34,148,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLSH01000020",86.131,1.91e-34,148,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLYY01000023",86.131,1.91e-34,148,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLYC01000020",86.131,1.91e-34,148,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLXZ01000020",86.131,1.91e-34,148,137,117.99947,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_JBGJJV010000032",85.714,1.91e-34,148,140,119.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRE01000049",85.714,1.91e-34,148,140,119.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRE01000049",85.714,1.91e-34,148,140,119.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_FLBI01000046",84.667,1.89e-34,148,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_FLBN01000099",84.667,1.89e-34,148,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_FLCN01000004",84.667,1.89e-34,148,150,127.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_FLBI01000046",86.232,1.91e-34,148,138,119.00016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_FLBN01000099",86.232,1.91e-34,148,138,119.00016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_FLCN01000004",86.232,1.91e-34,148,138,119.00016,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_FLBI01000046",86.029,6.86e-34,147,136,116.99944,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_FLBI01000046",87.023,5.8e-34,147,131,114.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_FLBN01000099",87.023,5.8e-34,147,131,114.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_FLCN01000004",87.023,5.8e-34,147,131,114.00013,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRI01000021",86.131,6.14e-34,147,137,117.99947,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRZ01000037",86.131,6.14e-34,147,137,117.99947,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRO01000021",86.131,6.14e-34,147,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLXR01000021",86.131,6.14e-34,147,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRG01000021",86.131,6.14e-34,147,137,117.99947,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLYG01000019",86.131,6.14e-34,147,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRJ01000019",86.131,6.14e-34,147,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLSM01000018",86.131,6.14e-34,147,137,117.99947,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLSQ01000022",86.131,6.14e-34,147,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLXY01000024",86.131,6.14e-34,147,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLXS01000025",86.131,6.14e-34,147,137,117.99947,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLWB01000035",86.131,6.14e-34,147,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLUD01000021",86.131,6.14e-34,147,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLRC01000027",86.131,6.14e-34,147,137,117.99947,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLYZ01000021",86.131,6.14e-34,147,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLSP01000022",86.131,6.14e-34,147,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLZF01000029",86.131,6.14e-34,147,137,117.99947,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLSH01000020",86.131,6.14e-34,147,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLYY01000023",86.131,6.14e-34,147,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLYC01000020",86.131,6.14e-34,147,137,117.99947,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLXZ01000020",86.131,6.14e-34,147,137,117.99947,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_JBGJJV010000032",86.131,6.14e-34,147,137,117.99947,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_FLBI01000046",85.417,2.37e-33,145,144,123.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_FLBN01000099",85.417,2.37e-33,145,144,123.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRI01000021",85.417,2.37e-33,145,144,123.00048,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRE01000049",85.417,2.37e-33,145,144,123.00048,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_FLCN01000004",85.417,2.37e-33,145,144,123.00048,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRZ01000037",85.417,2.37e-33,145,144,123.00048,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRO01000021",85.417,2.37e-33,145,144,123.00048,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLXR01000021",85.417,2.37e-33,145,144,123.00048,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRG01000021",85.417,2.37e-33,145,144,123.00048,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLYG01000019",85.417,2.37e-33,145,144,123.00048,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRJ01000019",85.417,2.37e-33,145,144,123.00048,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLSM01000018",85.417,2.37e-33,145,144,123.00048,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLSQ01000022",85.417,2.37e-33,145,144,123.00048,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLXY01000024",85.417,2.37e-33,145,144,123.00048,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLXS01000025",85.417,2.37e-33,145,144,123.00048,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLWB01000035",85.417,2.37e-33,145,144,123.00048,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLUD01000021",85.417,2.37e-33,145,144,123.00048,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLRC01000027",85.417,2.37e-33,145,144,123.00048,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLYZ01000021",85.417,2.37e-33,145,144,123.00048,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLSP01000022",85.417,2.37e-33,145,144,123.00048,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLZF01000029",85.417,2.37e-33,145,144,123.00048,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLSH01000020",85.417,2.37e-33,145,144,123.00048,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLYY01000023",85.417,2.37e-33,145,144,123.00048,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLYC01000020",85.417,2.37e-33,145,144,123.00048,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLXZ01000020",85.417,2.37e-33,145,144,123.00048,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_JBGJJV010000032",85.417,2.37e-33,145,144,123.00048,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_JAUEGY010000142",85.417,2.37e-33,145,144,123.00048,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRE01000049",86.923,2.09e-33,145,130,112.9999,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_FLBI01000046",87.5,2.09e-33,145,128,112,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_FLBN01000099",87.5,2.09e-33,145,128,112,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_FLCN01000004",87.5,2.09e-33,145,128,112,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_JBGJJV010000032",87.5,2.09e-33,145,128,112,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRI01000021",88.43,2.47e-33,145,121,107.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRE01000049",88.43,2.47e-33,145,121,107.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRZ01000037",88.43,2.47e-33,145,121,107.0003,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRO01000021",88.43,2.47e-33,145,121,107.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLXR01000021",88.43,2.47e-33,145,121,107.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRG01000021",88.43,2.47e-33,145,121,107.0003,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLYG01000019",88.43,2.47e-33,145,121,107.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRJ01000019",88.43,2.47e-33,145,121,107.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLSM01000018",88.43,2.47e-33,145,121,107.0003,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLSQ01000022",88.43,2.47e-33,145,121,107.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLXY01000024",88.43,2.47e-33,145,121,107.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLXS01000025",88.43,2.47e-33,145,121,107.0003,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLWB01000035",88.43,2.47e-33,145,121,107.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLUD01000021",88.43,2.47e-33,145,121,107.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLRC01000027",88.43,2.47e-33,145,121,107.0003,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLYZ01000021",88.43,2.47e-33,145,121,107.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLSP01000022",88.43,2.47e-33,145,121,107.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLZF01000029",88.43,2.47e-33,145,121,107.0003,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLSH01000020",88.43,2.47e-33,145,121,107.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLYY01000023",88.43,2.47e-33,145,121,107.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLYC01000020",88.43,2.47e-33,145,121,107.0003,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLXZ01000020",88.43,2.47e-33,145,121,107.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_JBGJJV010000032",88.43,2.47e-33,145,121,107.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_JAUEGY010000142",88.43,2.47e-33,145,121,107.0003,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4761","NZ_FLBI01000046",84,8.81e-33,143,150,126,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4761","NZ_FLBN01000099",84,8.81e-33,143,150,126,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4761","NZ_FLCN01000004",84,8.81e-33,143,150,126,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_FLBI01000046",88.618,6.71e-33,143,123,109.00014,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_FLBN01000099",88.618,6.71e-33,143,123,109.00014,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_FLCN01000004",88.618,6.71e-33,143,123,109.00014,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FLBI01000046",88,8.81e-33,143,125,110,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FLBN01000099",88,8.81e-33,143,125,110,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_FLCN01000004",88,8.81e-33,143,125,110,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_MLRZ01000037",87.023,8.81e-33,143,131,114.00013,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_MLWB01000035",87.023,8.81e-33,143,131,114.00013,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_MLZF01000029",87.023,8.81e-33,143,131,114.00013,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_JBGJJV010000032",84.932,8.81e-33,143,146,124.00072,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_FLBI01000046",85,8.88e-33,143,140,119,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRI01000021",85.401,8.88e-33,143,137,116.99937,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRZ01000037",85.401,8.88e-33,143,137,116.99937,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRO01000021",85.401,8.88e-33,143,137,116.99937,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLXR01000021",85.401,8.88e-33,143,137,116.99937,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRG01000021",85.401,8.88e-33,143,137,116.99937,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLYG01000019",85.401,8.88e-33,143,137,116.99937,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRJ01000019",85.401,8.88e-33,143,137,116.99937,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLSM01000018",85.401,8.88e-33,143,137,116.99937,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLSQ01000022",85.401,8.88e-33,143,137,116.99937,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLXY01000024",85.401,8.88e-33,143,137,116.99937,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLXS01000025",85.401,8.88e-33,143,137,116.99937,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLWB01000035",85.401,8.88e-33,143,137,116.99937,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLUD01000021",85.401,8.88e-33,143,137,116.99937,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLRC01000027",85.401,8.88e-33,143,137,116.99937,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLYZ01000021",85.401,8.88e-33,143,137,116.99937,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLSP01000022",85.401,8.88e-33,143,137,116.99937,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLZF01000029",85.401,8.88e-33,143,137,116.99937,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLSH01000020",85.401,8.88e-33,143,137,116.99937,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLYY01000023",85.401,8.88e-33,143,137,116.99937,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLYC01000020",85.401,8.88e-33,143,137,116.99937,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLXZ01000020",85.401,8.88e-33,143,137,116.99937,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_JBGJJV010000032",85,8.88e-33,143,140,119,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_FLBN01000099",85,8.88e-33,143,140,119,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_FLCN01000004",85,8.88e-33,143,140,119,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_FLBI01000046",85,8.88e-33,143,140,119,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRI01000021",85.401,8.88e-33,143,137,116.99937,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRZ01000037",85.401,8.88e-33,143,137,116.99937,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRO01000021",85.401,8.88e-33,143,137,116.99937,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLXR01000021",85.401,8.88e-33,143,137,116.99937,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRG01000021",85.401,8.88e-33,143,137,116.99937,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLYG01000019",85.401,8.88e-33,143,137,116.99937,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRJ01000019",85.401,8.88e-33,143,137,116.99937,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLSM01000018",85.401,8.88e-33,143,137,116.99937,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLSQ01000022",85.401,8.88e-33,143,137,116.99937,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLXY01000024",85.401,8.88e-33,143,137,116.99937,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLXS01000025",85.401,8.88e-33,143,137,116.99937,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLWB01000035",85.401,8.88e-33,143,137,116.99937,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLUD01000021",85.401,8.88e-33,143,137,116.99937,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLRC01000027",85.401,8.88e-33,143,137,116.99937,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLYZ01000021",85.401,8.88e-33,143,137,116.99937,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLSP01000022",85.401,8.88e-33,143,137,116.99937,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLZF01000029",85.401,8.88e-33,143,137,116.99937,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLSH01000020",85.401,8.88e-33,143,137,116.99937,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLYY01000023",85.401,8.88e-33,143,137,116.99937,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLYC01000020",85.401,8.88e-33,143,137,116.99937,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLXZ01000020",85.401,8.88e-33,143,137,116.99937,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_JBGJJV010000032",85,8.88e-33,143,140,119,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_FLBI01000046",84,8.81e-33,143,150,126,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_FLBN01000099",84,8.81e-33,143,150,126,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_FLCN01000004",84,8.81e-33,143,150,126,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_JAUEGY010000142",85.507,8.88e-33,143,138,117.99966,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_FLBI01000046",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_FLBN01000099",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRI01000021",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRE01000049",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_FLCN01000004",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRZ01000037",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRO01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLXR01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRG01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLYG01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRJ01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLSM01000018",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLSQ01000022",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLXY01000024",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLXS01000025",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLWB01000035",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLUD01000021",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLRC01000027",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLYZ01000021",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLSP01000022",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLZF01000029",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLSH01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLYY01000023",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLYC01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLXZ01000020",86.614,3.17e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_JBGJJV010000032",84.138,3.17e-32,141,145,122.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_JAUEGY010000142",84.138,3.17e-32,141,145,122.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_FLBI01000046",86.614,3.17e-32,141,127,109.99978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_FLBN01000099",86.614,3.17e-32,141,127,109.99978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRI01000021",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRE01000049",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_FLCN01000004",86.614,3.17e-32,141,127,109.99978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRZ01000037",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRO01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLXR01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRG01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLYG01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRJ01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLSM01000018",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLSQ01000022",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLXY01000024",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLXS01000025",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLWB01000035",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLUD01000021",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLRC01000027",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLYZ01000021",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLSP01000022",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLZF01000029",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLSH01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLYY01000023",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLYC01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLXZ01000020",86.614,3.17e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_JBGJJV010000032",86.614,3.17e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_JAUEGY010000142",86.614,3.17e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_FLBI01000046",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_FLBN01000099",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRI01000021",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRE01000049",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_FLCN01000004",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRZ01000037",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRO01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLXR01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRG01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLYG01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRJ01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLSM01000018",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLSQ01000022",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLXY01000024",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLXS01000025",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLWB01000035",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLUD01000021",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLRC01000027",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLYZ01000021",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLSP01000022",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLZF01000029",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLSH01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLYY01000023",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLYC01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLXZ01000020",86.614,3.17e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_JBGJJV010000032",84.138,3.17e-32,141,145,122.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_JAUEGY010000142",84.138,3.17e-32,141,145,122.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_FLBI01000046",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_FLBN01000099",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRI01000021",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRE01000049",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_FLCN01000004",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRZ01000037",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRO01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLXR01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRG01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLYG01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRJ01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLSM01000018",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLSQ01000022",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLXY01000024",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLXS01000025",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLWB01000035",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLUD01000021",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLRC01000027",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLYZ01000021",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLSP01000022",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLZF01000029",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLSH01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLYY01000023",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLYC01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLXZ01000020",86.614,3.17e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_JBGJJV010000032",84.138,3.17e-32,141,145,122.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_JAUEGY010000142",84.138,3.17e-32,141,145,122.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_FLBI01000046",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_FLBN01000099",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRI01000021",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRE01000049",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_FLCN01000004",84.138,3.17e-32,141,145,122.0001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRZ01000037",86.614,3.17e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRO01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLXR01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRG01000021",86.614,3.17e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLYG01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRJ01000019",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLSM01000018",86.614,3.17e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLSQ01000022",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLXY01000024",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLXS01000025",86.614,3.17e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLWB01000035",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLUD01000021",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLRC01000027",86.614,3.17e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLYZ01000021",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLSP01000022",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLZF01000029",86.614,3.17e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLSH01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLYY01000023",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLYC01000020",86.614,3.17e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLXZ01000020",86.614,3.17e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_JBGJJV010000032",84.138,3.17e-32,141,145,122.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_JAUEGY010000142",84.138,3.17e-32,141,145,122.0001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FLBI01000046",86.614,3.04e-32,141,127,109.99978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FLBN01000099",86.614,3.04e-32,141,127,109.99978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRI01000021",86.614,3.04e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRE01000049",86.614,3.04e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_FLCN01000004",86.614,3.04e-32,141,127,109.99978,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRZ01000037",86.614,3.04e-32,141,127,109.99978,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRO01000021",86.614,3.04e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXR01000021",86.614,3.04e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRG01000021",86.614,3.04e-32,141,127,109.99978,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLYG01000019",86.614,3.04e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRJ01000019",86.614,3.04e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSM01000018",86.614,3.04e-32,141,127,109.99978,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSQ01000022",86.614,3.04e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXY01000024",86.614,3.04e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXS01000025",86.614,3.04e-32,141,127,109.99978,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLWB01000035",86.614,3.04e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLUD01000021",86.614,3.04e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLRC01000027",86.614,3.04e-32,141,127,109.99978,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLYZ01000021",86.614,3.04e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSP01000022",86.614,3.04e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLZF01000029",86.614,3.04e-32,141,127,109.99978,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSH01000020",86.614,3.04e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLYY01000023",86.614,3.04e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLYC01000020",86.614,3.04e-32,141,127,109.99978,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLXZ01000020",86.614,3.04e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JBGJJV010000032",86.614,3.04e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JAUEGY010000142",86.614,3.04e-32,141,127,109.99978,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_FLBI01000046",85.211,3.14e-32,141,142,120.99962,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_FLBN01000099",85.211,3.14e-32,141,142,120.99962,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRI01000021",85.211,3.14e-32,141,142,120.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRE01000049",85.211,3.14e-32,141,142,120.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_FLCN01000004",85.211,3.14e-32,141,142,120.99962,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRZ01000037",85.211,3.14e-32,141,142,120.99962,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRO01000021",85.211,3.14e-32,141,142,120.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLXR01000021",85.211,3.14e-32,141,142,120.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRG01000021",85.211,3.14e-32,141,142,120.99962,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLYG01000019",85.211,3.14e-32,141,142,120.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRJ01000019",85.211,3.14e-32,141,142,120.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLSM01000018",85.211,3.14e-32,141,142,120.99962,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLSQ01000022",85.211,3.14e-32,141,142,120.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLXY01000024",85.211,3.14e-32,141,142,120.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLXS01000025",85.211,3.14e-32,141,142,120.99962,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLWB01000035",85.211,3.14e-32,141,142,120.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLUD01000021",85.211,3.14e-32,141,142,120.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLRC01000027",85.211,3.14e-32,141,142,120.99962,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLYZ01000021",85.211,3.14e-32,141,142,120.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLSP01000022",85.211,3.14e-32,141,142,120.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLZF01000029",85.211,3.14e-32,141,142,120.99962,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLSH01000020",85.211,3.14e-32,141,142,120.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLYY01000023",85.211,3.14e-32,141,142,120.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLYC01000020",85.211,3.14e-32,141,142,120.99962,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLXZ01000020",85.211,3.14e-32,141,142,120.99962,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_JBGJJV010000032",85.211,3.14e-32,141,142,120.99962,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_JAUEGY010000142",85.211,3.14e-32,141,142,120.99962,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRI01000021",86.154,9.71e-32,139,130,112.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRZ01000037",86.154,9.71e-32,139,130,112.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRO01000021",86.154,9.71e-32,139,130,112.0002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLXR01000021",86.154,9.71e-32,139,130,112.0002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRG01000021",86.154,9.71e-32,139,130,112.0002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLYG01000019",86.154,9.71e-32,139,130,112.0002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRJ01000019",86.154,9.71e-32,139,130,112.0002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLSM01000018",86.154,9.71e-32,139,130,112.0002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLSQ01000022",86.154,9.71e-32,139,130,112.0002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLXY01000024",86.154,9.71e-32,139,130,112.0002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLXS01000025",86.154,9.71e-32,139,130,112.0002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLWB01000035",86.154,9.71e-32,139,130,112.0002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLUD01000021",86.154,9.71e-32,139,130,112.0002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLRC01000027",86.154,9.71e-32,139,130,112.0002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLYZ01000021",86.154,9.71e-32,139,130,112.0002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLSP01000022",86.154,9.71e-32,139,130,112.0002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLZF01000029",86.154,9.71e-32,139,130,112.0002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLSH01000020",86.154,9.71e-32,139,130,112.0002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLYY01000023",86.154,9.71e-32,139,130,112.0002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLYC01000020",86.154,9.71e-32,139,130,112.0002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLXZ01000020",86.154,9.71e-32,139,130,112.0002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_JBGJJV010000032",88.136,9.71e-32,139,118,104.00048,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRI01000021",86.26,9.71e-32,139,131,113.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRE01000049",86.26,9.71e-32,139,131,113.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRZ01000037",86.26,9.71e-32,139,131,113.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRO01000021",86.26,9.71e-32,139,131,113.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLXR01000021",86.26,9.71e-32,139,131,113.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRG01000021",86.26,9.71e-32,139,131,113.0006,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLYG01000019",86.26,9.71e-32,139,131,113.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRJ01000019",86.26,9.71e-32,139,131,113.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLSM01000018",86.26,9.71e-32,139,131,113.0006,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLSQ01000022",86.26,9.71e-32,139,131,113.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLXY01000024",86.26,9.71e-32,139,131,113.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLXS01000025",86.26,9.71e-32,139,131,113.0006,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLWB01000035",86.26,9.71e-32,139,131,113.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLUD01000021",86.26,9.71e-32,139,131,113.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLRC01000027",86.26,9.71e-32,139,131,113.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLYZ01000021",86.26,9.71e-32,139,131,113.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLSP01000022",86.26,9.71e-32,139,131,113.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLZF01000029",86.26,9.71e-32,139,131,113.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLSH01000020",86.26,9.71e-32,139,131,113.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLYY01000023",86.26,9.71e-32,139,131,113.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLYC01000020",86.26,9.71e-32,139,131,113.0006,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLXZ01000020",86.26,9.71e-32,139,131,113.0006,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRI01000021",83.333,4.1e-31,137,150,124.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRE01000049",83.333,4.1e-31,137,150,124.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRZ01000037",83.333,4.1e-31,137,150,124.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRO01000021",83.333,4.1e-31,137,150,124.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLXR01000021",83.333,4.1e-31,137,150,124.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRG01000021",83.333,4.1e-31,137,150,124.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLYG01000019",83.333,4.1e-31,137,150,124.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRJ01000019",83.333,4.1e-31,137,150,124.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLSM01000018",83.333,4.1e-31,137,150,124.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLSQ01000022",83.333,4.1e-31,137,150,124.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLXY01000024",83.333,4.1e-31,137,150,124.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLXS01000025",83.333,4.1e-31,137,150,124.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLWB01000035",83.333,4.1e-31,137,150,124.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLUD01000021",83.333,4.1e-31,137,150,124.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLRC01000027",83.333,4.1e-31,137,150,124.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLYZ01000021",83.333,4.1e-31,137,150,124.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLSP01000022",83.333,4.1e-31,137,150,124.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLZF01000029",83.333,4.1e-31,137,150,124.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLSH01000020",83.333,4.1e-31,137,150,124.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLYY01000023",83.333,4.1e-31,137,150,124.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLYC01000020",83.333,4.1e-31,137,150,124.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLXZ01000020",83.333,4.1e-31,137,150,124.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_JBGJJV010000032",83.333,4.1e-31,137,150,124.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_JAUEGY010000142",83.333,4.1e-31,137,150,124.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FLBI01000046",87.2,4.1e-31,137,125,109,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FLBN01000099",87.2,4.1e-31,137,125,109,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_FLCN01000004",87.2,4.1e-31,137,125,109,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_MLRZ01000037",86.26,4.1e-31,137,131,113.0006,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_MLWB01000035",86.26,4.1e-31,137,131,113.0006,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_MLZF01000029",86.26,4.1e-31,137,131,113.0006,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_FLBN01000099",84.286,4.13e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_FLCN01000004",84.286,4.13e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_FLBN01000099",84.286,4.13e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_FLCN01000004",84.286,4.13e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRE01000049",84.286,4.13e-31,137,140,118.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRI01000021",83.333,4.1e-31,137,150,124.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRE01000049",83.333,4.1e-31,137,150,124.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRZ01000037",83.333,4.1e-31,137,150,124.9995,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRO01000021",83.333,4.1e-31,137,150,124.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLXR01000021",83.333,4.1e-31,137,150,124.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRG01000021",83.333,4.1e-31,137,150,124.9995,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLYG01000019",83.333,4.1e-31,137,150,124.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRJ01000019",83.333,4.1e-31,137,150,124.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLSM01000018",83.333,4.1e-31,137,150,124.9995,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLSQ01000022",83.333,4.1e-31,137,150,124.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLXY01000024",83.333,4.1e-31,137,150,124.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLXS01000025",83.333,4.1e-31,137,150,124.9995,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLWB01000035",83.333,4.1e-31,137,150,124.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLUD01000021",83.333,4.1e-31,137,150,124.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLRC01000027",83.333,4.1e-31,137,150,124.9995,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLYZ01000021",83.333,4.1e-31,137,150,124.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLSP01000022",83.333,4.1e-31,137,150,124.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLZF01000029",83.333,4.1e-31,137,150,124.9995,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLSH01000020",83.333,4.1e-31,137,150,124.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLYY01000023",83.333,4.1e-31,137,150,124.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLYC01000020",83.333,4.1e-31,137,150,124.9995,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLXZ01000020",83.333,4.1e-31,137,150,124.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_JBGJJV010000032",83.333,4.1e-31,137,150,124.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_JAUEGY010000142",83.333,4.1e-31,137,150,124.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_FLBI01000046",84.286,4.13e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_FLBN01000099",84.286,4.13e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRI01000021",86.4,4.13e-31,137,125,108,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRE01000049",86.4,4.13e-31,137,125,108,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_FLCN01000004",84.286,4.13e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRZ01000037",86.4,4.13e-31,137,125,108,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRO01000021",86.4,4.13e-31,137,125,108,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLXR01000021",86.4,4.13e-31,137,125,108,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRG01000021",86.4,4.13e-31,137,125,108,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLYG01000019",86.4,4.13e-31,137,125,108,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRJ01000019",86.4,4.13e-31,137,125,108,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLSM01000018",86.4,4.13e-31,137,125,108,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLSQ01000022",86.4,4.13e-31,137,125,108,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLXY01000024",86.4,4.13e-31,137,125,108,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLXS01000025",86.4,4.13e-31,137,125,108,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLWB01000035",86.4,4.13e-31,137,125,108,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLUD01000021",86.4,4.13e-31,137,125,108,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLRC01000027",86.4,4.13e-31,137,125,108,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLYZ01000021",86.4,4.13e-31,137,125,108,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLSP01000022",86.4,4.13e-31,137,125,108,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLZF01000029",86.4,4.13e-31,137,125,108,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLSH01000020",86.4,4.13e-31,137,125,108,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLYY01000023",86.4,4.13e-31,137,125,108,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLYC01000020",86.4,4.13e-31,137,125,108,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLXZ01000020",86.4,4.13e-31,137,125,108,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_JBGJJV010000032",84.286,4.13e-31,137,140,118.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_JAUEGY010000142",84.286,4.13e-31,137,140,118.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRI01000021",88.496,4.1e-31,137,113,100.00048,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRO01000021",88.496,4.1e-31,137,113,100.00048,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLXR01000021",88.496,4.1e-31,137,113,100.00048,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRG01000021",88.496,4.1e-31,137,113,100.00048,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLYG01000019",88.496,4.1e-31,137,113,100.00048,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRJ01000019",88.496,4.1e-31,137,113,100.00048,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLSM01000018",88.496,4.1e-31,137,113,100.00048,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLSQ01000022",88.496,4.1e-31,137,113,100.00048,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLXY01000024",88.496,4.1e-31,137,113,100.00048,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLXS01000025",88.496,4.1e-31,137,113,100.00048,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLUD01000021",88.496,4.1e-31,137,113,100.00048,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRC01000027",88.496,4.1e-31,137,113,100.00048,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLYZ01000021",88.496,4.1e-31,137,113,100.00048,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLSP01000022",88.496,4.1e-31,137,113,100.00048,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLSH01000020",88.496,4.1e-31,137,113,100.00048,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLYY01000023",88.496,4.1e-31,137,113,100.00048,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLYC01000020",88.496,4.1e-31,137,113,100.00048,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLXZ01000020",88.496,4.1e-31,137,113,100.00048,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRI01000021",90.476,3.49e-31,137,105,94.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRZ01000037",90.476,3.49e-31,137,105,94.9998,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRO01000021",90.476,3.49e-31,137,105,94.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLXR01000021",90.476,3.49e-31,137,105,94.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRG01000021",90.476,3.49e-31,137,105,94.9998,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLYG01000019",90.476,3.49e-31,137,105,94.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRJ01000019",90.476,3.49e-31,137,105,94.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLSM01000018",90.476,3.49e-31,137,105,94.9998,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLSQ01000022",90.476,3.49e-31,137,105,94.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLXY01000024",90.476,3.49e-31,137,105,94.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLXS01000025",90.476,3.49e-31,137,105,94.9998,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLWB01000035",90.476,3.49e-31,137,105,94.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLUD01000021",90.476,3.49e-31,137,105,94.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLRC01000027",90.476,3.49e-31,137,105,94.9998,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLYZ01000021",90.476,3.49e-31,137,105,94.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLSP01000022",90.476,3.49e-31,137,105,94.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLZF01000029",90.476,3.49e-31,137,105,94.9998,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLSH01000020",90.476,3.49e-31,137,105,94.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLYY01000023",90.476,3.49e-31,137,105,94.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLYC01000020",90.476,3.49e-31,137,105,94.9998,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLXZ01000020",90.476,3.49e-31,137,105,94.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_JBGJJV010000032",90.476,3.49e-31,137,105,94.9998,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_FLBI01000046",85.496,3.76e-31,137,131,111.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_FLBN01000099",85.496,3.76e-31,137,131,111.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRE01000049",85.496,3.76e-31,137,131,111.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_FLCN01000004",85.496,3.76e-31,137,131,111.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_JAUEGY010000142",85.496,3.76e-31,137,131,111.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_FLBI01000046",84.286,4.1e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_FLBN01000099",84.286,4.1e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRI01000021",86.4,4.1e-31,137,125,108,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRE01000049",86.4,4.1e-31,137,125,108,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_FLCN01000004",84.286,4.1e-31,137,140,118.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRZ01000037",86.4,4.1e-31,137,125,108,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRO01000021",86.4,4.1e-31,137,125,108,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLXR01000021",86.4,4.1e-31,137,125,108,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRG01000021",86.4,4.1e-31,137,125,108,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLYG01000019",86.4,4.1e-31,137,125,108,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRJ01000019",86.4,4.1e-31,137,125,108,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLSM01000018",86.4,4.1e-31,137,125,108,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLSQ01000022",86.4,4.1e-31,137,125,108,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLXY01000024",86.4,4.1e-31,137,125,108,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLXS01000025",86.4,4.1e-31,137,125,108,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLWB01000035",86.4,4.1e-31,137,125,108,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLUD01000021",86.4,4.1e-31,137,125,108,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLRC01000027",86.4,4.1e-31,137,125,108,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLYZ01000021",86.4,4.1e-31,137,125,108,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLSP01000022",86.4,4.1e-31,137,125,108,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLZF01000029",86.4,4.1e-31,137,125,108,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLSH01000020",86.4,4.1e-31,137,125,108,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLYY01000023",86.4,4.1e-31,137,125,108,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLYC01000020",86.4,4.1e-31,137,125,108,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLXZ01000020",86.4,4.1e-31,137,125,108,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_JBGJJV010000032",84.286,4.1e-31,137,140,118.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_JAUEGY010000142",84.286,4.1e-31,137,140,118.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_FLBN01000099",84.559,1.49e-30,135,136,115.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_FLCN01000004",84.559,1.49e-30,135,136,115.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_FLBI01000046",85.496,1.39e-30,135,131,111.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_FLBN01000099",85.496,1.39e-30,135,131,111.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRE01000049",85.496,1.39e-30,135,131,111.99976,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_FLCN01000004",85.496,1.39e-30,135,131,111.99976,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_JAUEGY010000142",85.496,1.39e-30,135,131,111.99976,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_FLBI01000046",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_FLBN01000099",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRI01000021",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRE01000049",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_FLCN01000004",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRZ01000037",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRO01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLXR01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRG01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLYG01000019",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRJ01000019",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLSM01000018",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLSQ01000022",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLXY01000024",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLXS01000025",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLWB01000035",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLUD01000021",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLRC01000027",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLYZ01000021",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLSP01000022",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLZF01000029",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLSH01000020",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLYY01000023",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLYC01000020",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLXZ01000020",92.632,9.18e-31,135,95,88.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_JBGJJV010000032",92.632,9.18e-31,135,95,88.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_FLBI01000046",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_FLBN01000099",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRI01000021",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRE01000049",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_FLCN01000004",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRZ01000037",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRO01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLXR01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRG01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLYG01000019",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRJ01000019",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLSM01000018",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLSQ01000022",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLXY01000024",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLXS01000025",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLWB01000035",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLUD01000021",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLRC01000027",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLYZ01000021",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLSP01000022",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLZF01000029",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLSH01000020",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLYY01000023",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLYC01000020",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLXZ01000020",92.632,9.18e-31,135,95,88.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_JBGJJV010000032",92.632,9.18e-31,135,95,88.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_FLBI01000046",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_FLBN01000099",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRI01000021",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRE01000049",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_FLCN01000004",92.632,9.18e-31,135,95,88.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRZ01000037",92.632,9.18e-31,135,95,88.0004,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRO01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLXR01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRG01000021",92.632,9.18e-31,135,95,88.0004,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLYG01000019",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRJ01000019",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLSM01000018",92.632,9.18e-31,135,95,88.0004,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLSQ01000022",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLXY01000024",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLXS01000025",92.632,9.18e-31,135,95,88.0004,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLWB01000035",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLUD01000021",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLRC01000027",92.632,9.18e-31,135,95,88.0004,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLYZ01000021",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLSP01000022",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLZF01000029",92.632,9.18e-31,135,95,88.0004,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLSH01000020",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLYY01000023",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLYC01000020",92.632,9.18e-31,135,95,88.0004,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLXZ01000020",92.632,9.18e-31,135,95,88.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_JBGJJV010000032",92.632,9.18e-31,135,95,88.0004,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41815","NZ_FLBI01000046",83.448,5.13e-30,134,145,120.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41815","NZ_FLBN01000099",83.448,5.13e-30,134,145,120.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41815","NZ_FLCN01000004",83.448,5.13e-30,134,145,120.9996,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLRI01000021",90.909,5.34e-30,134,99,89.99991,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLRO01000021",90.909,5.34e-30,134,99,89.99991,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLXR01000021",90.909,5.34e-30,134,99,89.99991,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLRG01000021",90.909,5.34e-30,134,99,89.99991,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLYG01000019",90.909,5.34e-30,134,99,89.99991,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLRJ01000019",90.909,5.34e-30,134,99,89.99991,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLSM01000018",90.909,5.34e-30,134,99,89.99991,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLSQ01000022",90.909,5.34e-30,134,99,89.99991,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLXY01000024",90.909,5.34e-30,134,99,89.99991,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLXS01000025",90.909,5.34e-30,134,99,89.99991,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLUD01000021",90.909,5.34e-30,134,99,89.99991,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLRC01000027",90.909,5.34e-30,134,99,89.99991,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLYZ01000021",90.909,5.34e-30,134,99,89.99991,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLSP01000022",90.909,5.34e-30,134,99,89.99991,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLSH01000020",90.909,5.34e-30,134,99,89.99991,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLYY01000023",90.909,5.34e-30,134,99,89.99991,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLYC01000020",90.909,5.34e-30,134,99,89.99991,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLXZ01000020",90.909,5.34e-30,134,99,89.99991,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_FLBN01000099",83.571,1.92e-29,132,140,116.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_FLCN01000004",83.571,1.92e-29,132,140,116.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_FLBI01000046",83.571,1.92e-29,132,140,116.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRI01000021",83.942,1.92e-29,132,137,115.00054,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRZ01000037",83.942,1.92e-29,132,137,115.00054,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRO01000021",83.942,1.92e-29,132,137,115.00054,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLXR01000021",83.942,1.92e-29,132,137,115.00054,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRG01000021",83.942,1.92e-29,132,137,115.00054,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLYG01000019",83.942,1.92e-29,132,137,115.00054,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRJ01000019",83.942,1.92e-29,132,137,115.00054,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLSM01000018",83.942,1.92e-29,132,137,115.00054,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLSQ01000022",83.942,1.92e-29,132,137,115.00054,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLXY01000024",83.942,1.92e-29,132,137,115.00054,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLXS01000025",83.942,1.92e-29,132,137,115.00054,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLWB01000035",83.942,1.92e-29,132,137,115.00054,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLUD01000021",83.942,1.92e-29,132,137,115.00054,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLRC01000027",83.942,1.92e-29,132,137,115.00054,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLYZ01000021",83.942,1.92e-29,132,137,115.00054,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLSP01000022",83.942,1.92e-29,132,137,115.00054,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLZF01000029",83.942,1.92e-29,132,137,115.00054,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLSH01000020",83.942,1.92e-29,132,137,115.00054,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLYY01000023",83.942,1.92e-29,132,137,115.00054,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLYC01000020",83.942,1.92e-29,132,137,115.00054,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLXZ01000020",83.942,1.92e-29,132,137,115.00054,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_JBGJJV010000032",83.571,1.92e-29,132,140,116.9994,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_FLBN01000099",83.571,1.92e-29,132,140,116.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_FLCN01000004",83.571,1.92e-29,132,140,116.9994,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRI01000021",82.667,1.91e-29,132,150,124.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRE01000049",82.667,1.91e-29,132,150,124.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRZ01000037",82.667,1.91e-29,132,150,124.0005,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRO01000021",82.667,1.91e-29,132,150,124.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLXR01000021",82.667,1.91e-29,132,150,124.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRG01000021",82.667,1.91e-29,132,150,124.0005,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLYG01000019",82.667,1.91e-29,132,150,124.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRJ01000019",82.667,1.91e-29,132,150,124.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLSM01000018",82.667,1.91e-29,132,150,124.0005,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLSQ01000022",82.667,1.91e-29,132,150,124.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLXY01000024",82.667,1.91e-29,132,150,124.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLXS01000025",82.667,1.91e-29,132,150,124.0005,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLWB01000035",82.667,1.91e-29,132,150,124.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLUD01000021",82.667,1.91e-29,132,150,124.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLRC01000027",82.667,1.91e-29,132,150,124.0005,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLYZ01000021",82.667,1.91e-29,132,150,124.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLSP01000022",82.667,1.91e-29,132,150,124.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLZF01000029",82.667,1.91e-29,132,150,124.0005,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLSH01000020",82.667,1.91e-29,132,150,124.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLYY01000023",82.667,1.91e-29,132,150,124.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLYC01000020",82.667,1.91e-29,132,150,124.0005,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLXZ01000020",82.667,1.91e-29,132,150,124.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_JBGJJV010000032",82.667,1.91e-29,132,150,124.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_JAUEGY010000142",82.667,1.91e-29,132,150,124.0005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_FLBI01000046",87.611,1.91e-29,132,113,99.00043,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_FLBN01000099",87.611,1.91e-29,132,113,99.00043,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_FLCN01000004",87.611,1.91e-29,132,113,99.00043,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_JBGJJV010000032",87.611,1.91e-29,132,113,99.00043,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRI01000021",88.182,1.92e-29,132,110,97.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRE01000049",88.182,1.92e-29,132,110,97.0002,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRO01000021",88.182,1.92e-29,132,110,97.0002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLXR01000021",88.182,1.92e-29,132,110,97.0002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRG01000021",88.182,1.92e-29,132,110,97.0002,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLYG01000019",88.182,1.92e-29,132,110,97.0002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRJ01000019",88.182,1.92e-29,132,110,97.0002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLSM01000018",88.182,1.92e-29,132,110,97.0002,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLSQ01000022",88.182,1.92e-29,132,110,97.0002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLXY01000024",88.182,1.92e-29,132,110,97.0002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLXS01000025",88.182,1.92e-29,132,110,97.0002,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLUD01000021",88.182,1.92e-29,132,110,97.0002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRC01000027",88.182,1.92e-29,132,110,97.0002,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLYZ01000021",88.182,1.92e-29,132,110,97.0002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLSP01000022",88.182,1.92e-29,132,110,97.0002,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLSH01000020",88.182,1.92e-29,132,110,97.0002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLYY01000023",88.182,1.92e-29,132,110,97.0002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLYC01000020",88.182,1.92e-29,132,110,97.0002,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLXZ01000020",88.182,1.92e-29,132,110,97.0002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27573","NZ_FLBI01000046",84.733,1.91e-29,132,131,111.00023,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRI01000021",84.733,1.75e-29,132,131,111.00023,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRZ01000037",84.733,1.75e-29,132,131,111.00023,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRO01000021",84.733,1.75e-29,132,131,111.00023,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLXR01000021",84.733,1.75e-29,132,131,111.00023,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRG01000021",84.733,1.75e-29,132,131,111.00023,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLYG01000019",84.733,1.75e-29,132,131,111.00023,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRJ01000019",84.733,1.75e-29,132,131,111.00023,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLSM01000018",84.733,1.75e-29,132,131,111.00023,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLSQ01000022",84.733,1.75e-29,132,131,111.00023,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLXY01000024",84.733,1.75e-29,132,131,111.00023,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLXS01000025",84.733,1.75e-29,132,131,111.00023,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLWB01000035",84.733,1.75e-29,132,131,111.00023,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLUD01000021",84.733,1.75e-29,132,131,111.00023,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLRC01000027",84.733,1.75e-29,132,131,111.00023,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLYZ01000021",84.733,1.75e-29,132,131,111.00023,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLSP01000022",84.733,1.75e-29,132,131,111.00023,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLZF01000029",84.733,1.75e-29,132,131,111.00023,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLSH01000020",84.733,1.75e-29,132,131,111.00023,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLYY01000023",84.733,1.75e-29,132,131,111.00023,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLYC01000020",84.733,1.75e-29,132,131,111.00023,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLXZ01000020",84.733,1.75e-29,132,131,111.00023,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_JBGJJV010000032",84.733,1.75e-29,132,131,111.00023,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRI01000021",83.333,1.91e-29,132,144,119.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRE01000049",83.333,1.91e-29,132,144,119.99952,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRO01000021",83.333,1.91e-29,132,144,119.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLXR01000021",83.333,1.91e-29,132,144,119.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRG01000021",83.333,1.91e-29,132,144,119.99952,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLYG01000019",83.333,1.91e-29,132,144,119.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRJ01000019",83.333,1.91e-29,132,144,119.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLSM01000018",83.333,1.91e-29,132,144,119.99952,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLSQ01000022",83.333,1.91e-29,132,144,119.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLXY01000024",83.333,1.91e-29,132,144,119.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLXS01000025",83.333,1.91e-29,132,144,119.99952,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLUD01000021",83.333,1.91e-29,132,144,119.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRC01000027",83.333,1.91e-29,132,144,119.99952,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLYZ01000021",83.333,1.91e-29,132,144,119.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLSP01000022",83.333,1.91e-29,132,144,119.99952,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLSH01000020",83.333,1.91e-29,132,144,119.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLYY01000023",83.333,1.91e-29,132,144,119.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLYC01000020",83.333,1.91e-29,132,144,119.99952,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLXZ01000020",83.333,1.91e-29,132,144,119.99952,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRI01000021",84.733,6.46e-29,130,131,111.00023,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRZ01000037",84.733,6.46e-29,130,131,111.00023,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRO01000021",84.733,6.46e-29,130,131,111.00023,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLXR01000021",84.733,6.46e-29,130,131,111.00023,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRG01000021",84.733,6.46e-29,130,131,111.00023,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLYG01000019",84.733,6.46e-29,130,131,111.00023,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRJ01000019",84.733,6.46e-29,130,131,111.00023,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLSM01000018",84.733,6.46e-29,130,131,111.00023,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLSQ01000022",84.733,6.46e-29,130,131,111.00023,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLXY01000024",84.733,6.46e-29,130,131,111.00023,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLXS01000025",84.733,6.46e-29,130,131,111.00023,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLWB01000035",84.733,6.46e-29,130,131,111.00023,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLUD01000021",84.733,6.46e-29,130,131,111.00023,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLRC01000027",84.733,6.46e-29,130,131,111.00023,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLYZ01000021",84.733,6.46e-29,130,131,111.00023,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLSP01000022",84.733,6.46e-29,130,131,111.00023,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLZF01000029",84.733,6.46e-29,130,131,111.00023,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLSH01000020",84.733,6.46e-29,130,131,111.00023,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLYY01000023",84.733,6.46e-29,130,131,111.00023,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLYC01000020",84.733,6.46e-29,130,131,111.00023,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLXZ01000020",84.733,6.46e-29,130,131,111.00023,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_JBGJJV010000032",84.733,6.46e-29,130,131,111.00023,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLRZ01000037",83.217,6.86e-29,130,143,119.00031,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLWB01000035",83.217,6.86e-29,130,143,119.00031,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLZF01000029",83.217,6.86e-29,130,143,119.00031,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_FLBI01000046",84.733,2.3e-28,128,131,111.00023,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_FLBN01000099",84.733,2.3e-28,128,131,111.00023,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRE01000049",84.733,2.3e-28,128,131,111.00023,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_FLCN01000004",84.733,2.3e-28,128,131,111.00023,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_JAUEGY010000142",84.733,2.3e-28,128,131,111.00023,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7225","NZ_FLBI01000046",82.237,2.49e-28,128,152,125.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_MLRZ01000037",94.048,1.17e-28,128,84,79.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_MLWB01000035",94.048,1.17e-28,128,84,79.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_MLZF01000029",94.048,1.17e-28,128,84,79.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRI01000021",83.099,2.49e-28,128,142,118.00058,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRE01000049",83.099,2.49e-28,128,142,118.00058,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRZ01000037",83.099,2.49e-28,128,142,118.00058,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRO01000021",83.099,2.49e-28,128,142,118.00058,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLXR01000021",83.099,2.49e-28,128,142,118.00058,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRG01000021",83.099,2.49e-28,128,142,118.00058,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLYG01000019",83.099,2.49e-28,128,142,118.00058,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRJ01000019",83.099,2.49e-28,128,142,118.00058,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLSM01000018",83.099,2.49e-28,128,142,118.00058,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLSQ01000022",83.099,2.49e-28,128,142,118.00058,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLXY01000024",83.099,2.49e-28,128,142,118.00058,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLXS01000025",83.099,2.49e-28,128,142,118.00058,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLWB01000035",83.099,2.49e-28,128,142,118.00058,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLUD01000021",83.099,2.49e-28,128,142,118.00058,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLRC01000027",83.099,2.49e-28,128,142,118.00058,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLYZ01000021",83.099,2.49e-28,128,142,118.00058,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLSP01000022",83.099,2.49e-28,128,142,118.00058,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLZF01000029",83.099,2.49e-28,128,142,118.00058,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLSH01000020",83.099,2.49e-28,128,142,118.00058,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLYY01000023",83.099,2.49e-28,128,142,118.00058,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLYC01000020",83.099,2.49e-28,128,142,118.00058,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLXZ01000020",83.099,2.49e-28,128,142,118.00058,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRI01000021",89.216,2.49e-28,128,102,91.00032,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRO01000021",89.216,2.49e-28,128,102,91.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLXR01000021",89.216,2.49e-28,128,102,91.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRG01000021",89.216,2.49e-28,128,102,91.00032,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLYG01000019",89.216,2.49e-28,128,102,91.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRJ01000019",89.216,2.49e-28,128,102,91.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLSM01000018",89.216,2.49e-28,128,102,91.00032,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLSQ01000022",89.216,2.49e-28,128,102,91.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLXY01000024",89.216,2.49e-28,128,102,91.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLXS01000025",89.216,2.49e-28,128,102,91.00032,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLUD01000021",89.216,2.49e-28,128,102,91.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRC01000027",89.216,2.49e-28,128,102,91.00032,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLYZ01000021",89.216,2.49e-28,128,102,91.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLSP01000022",89.216,2.49e-28,128,102,91.00032,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLSH01000020",89.216,2.49e-28,128,102,91.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLYY01000023",89.216,2.49e-28,128,102,91.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLYC01000020",89.216,2.49e-28,128,102,91.00032,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLXZ01000020",89.216,2.49e-28,128,102,91.00032,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_FLBN01000099",82.857,8.94e-28,126,140,115.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_FLCN01000004",82.857,8.94e-28,126,140,115.9998,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRZ01000037",86.726,8.87e-28,126,113,98.00038,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLWB01000035",86.726,8.87e-28,126,113,98.00038,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLZF01000029",86.726,8.87e-28,126,113,98.00038,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_FLBN01000099",87.85,8.94e-28,126,107,93.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_FLCN01000004",87.85,8.94e-28,126,107,93.9995,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_JBGJJV010000032",87.85,8.94e-28,126,107,93.9995,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_FLBI01000046",88.571,8.87e-28,126,105,92.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_FLBN01000099",88.571,8.87e-28,126,105,92.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRI01000021",88.571,8.87e-28,126,105,92.99955,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRE01000049",88.571,8.87e-28,126,105,92.99955,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_FLCN01000004",88.571,8.87e-28,126,105,92.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRZ01000037",88.571,8.87e-28,126,105,92.99955,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRO01000021",88.571,8.87e-28,126,105,92.99955,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLXR01000021",88.571,8.87e-28,126,105,92.99955,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRG01000021",88.571,8.87e-28,126,105,92.99955,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLYG01000019",88.571,8.87e-28,126,105,92.99955,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRJ01000019",88.571,8.87e-28,126,105,92.99955,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLSM01000018",88.571,8.87e-28,126,105,92.99955,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLSQ01000022",88.571,8.87e-28,126,105,92.99955,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLXY01000024",88.571,8.87e-28,126,105,92.99955,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLXS01000025",88.571,8.87e-28,126,105,92.99955,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLWB01000035",88.571,8.87e-28,126,105,92.99955,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLUD01000021",88.571,8.87e-28,126,105,92.99955,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLRC01000027",88.571,8.87e-28,126,105,92.99955,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLYZ01000021",88.571,8.87e-28,126,105,92.99955,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLSP01000022",88.571,8.87e-28,126,105,92.99955,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLZF01000029",88.571,8.87e-28,126,105,92.99955,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLSH01000020",88.571,8.87e-28,126,105,92.99955,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLYY01000023",88.571,8.87e-28,126,105,92.99955,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLYC01000020",88.571,8.87e-28,126,105,92.99955,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLXZ01000020",88.571,8.87e-28,126,105,92.99955,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_JBGJJV010000032",88.571,8.87e-28,126,105,92.99955,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_FLBI01000046",84.091,8.87e-28,126,132,111.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_FLBN01000099",84.091,8.87e-28,126,132,111.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_FLCN01000004",84.091,8.87e-28,126,132,111.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_JBGJJV010000032",84.091,8.87e-28,126,132,111.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_JAUEGY010000142",84.091,8.87e-28,126,132,111.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_JBGJJV010000032",82.759,8.94e-28,126,145,120.00055,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRI01000021",83.969,1.07e-26,122,131,109.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRZ01000037",83.969,1.07e-26,122,131,109.99939,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRO01000021",83.969,1.07e-26,122,131,109.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLXR01000021",83.969,1.07e-26,122,131,109.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRG01000021",83.969,1.07e-26,122,131,109.99939,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLYG01000019",83.969,1.07e-26,122,131,109.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRJ01000019",83.969,1.07e-26,122,131,109.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLSM01000018",83.969,1.07e-26,122,131,109.99939,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLSQ01000022",83.969,1.07e-26,122,131,109.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLXY01000024",83.969,1.07e-26,122,131,109.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLXS01000025",83.969,1.07e-26,122,131,109.99939,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLWB01000035",83.969,1.07e-26,122,131,109.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLUD01000021",83.969,1.07e-26,122,131,109.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLRC01000027",83.969,1.07e-26,122,131,109.99939,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLYZ01000021",83.969,1.07e-26,122,131,109.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLSP01000022",83.969,1.07e-26,122,131,109.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLZF01000029",83.969,1.07e-26,122,131,109.99939,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLSH01000020",83.969,1.07e-26,122,131,109.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLYY01000023",83.969,1.07e-26,122,131,109.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLYC01000020",83.969,1.07e-26,122,131,109.99939,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLXZ01000020",83.969,1.07e-26,122,131,109.99939,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_JBGJJV010000032",83.969,1.07e-26,122,131,109.99939,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14628","NZ_FLBI01000046",82.069,1.15e-26,122,145,119.00005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_JBGJJV010000032",82.069,1.16e-26,122,145,119.00005,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_FLBI01000046",88.235,1.16e-26,122,102,89.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_FLBN01000099",88.235,1.16e-26,122,102,89.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_FLCN01000004",88.235,1.16e-26,122,102,89.9997,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24863","NZ_FLBI01000046",81.879,4.13e-26,121,149,121.99971,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24863","NZ_FLBN01000099",81.879,4.13e-26,121,149,121.99971,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24863","NZ_FLCN01000004",81.879,4.13e-26,121,149,121.99971,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24865","NZ_FLBI01000046",81.879,4.13e-26,121,149,121.99971,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24865","NZ_FLBN01000099",81.879,4.13e-26,121,149,121.99971,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24865","NZ_FLCN01000004",81.879,4.13e-26,121,149,121.99971,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27573","NZ_FLBN01000099",83.206,4.13e-26,121,131,108.99986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27573","NZ_FLCN01000004",83.206,4.13e-26,121,131,108.99986,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14629","NZ_FLBI01000046",81.944,4.13e-26,121,144,117.99936,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_JAUEGY010000142",84.127,4.16e-26,121,126,106.00002,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_FLBI01000046",94.737,6.33e-26,119,76,72.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_FLBN01000099",94.737,6.33e-26,119,76,72.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRI01000021",94.737,6.33e-26,119,76,72.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRE01000049",94.737,6.33e-26,119,76,72.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_FLCN01000004",94.737,6.33e-26,119,76,72.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRZ01000037",94.737,6.33e-26,119,76,72.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRO01000021",94.737,6.33e-26,119,76,72.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLXR01000021",94.737,6.33e-26,119,76,72.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRG01000021",94.737,6.33e-26,119,76,72.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLYG01000019",94.737,6.33e-26,119,76,72.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRJ01000019",94.737,6.33e-26,119,76,72.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLSM01000018",94.737,6.33e-26,119,76,72.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLSQ01000022",94.737,6.33e-26,119,76,72.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLXY01000024",94.737,6.33e-26,119,76,72.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLXS01000025",94.737,6.33e-26,119,76,72.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLWB01000035",94.737,6.33e-26,119,76,72.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLUD01000021",94.737,6.33e-26,119,76,72.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLRC01000027",94.737,6.33e-26,119,76,72.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLYZ01000021",94.737,6.33e-26,119,76,72.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLSP01000022",94.737,6.33e-26,119,76,72.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLZF01000029",94.737,6.33e-26,119,76,72.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLSH01000020",94.737,6.33e-26,119,76,72.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLYY01000023",94.737,6.33e-26,119,76,72.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLYC01000020",94.737,6.33e-26,119,76,72.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLXZ01000020",94.737,6.33e-26,119,76,72.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_JBGJJV010000032",94.737,6.33e-26,119,76,72.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_FLBI01000046",92.683,2.45e-25,117,82,76.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_FLBN01000099",92.683,2.45e-25,117,82,76.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_FLCN01000004",92.683,2.45e-25,117,82,76.00006,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRZ01000037",87.255,5.38e-25,117,102,89.0001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLWB01000035",87.255,5.38e-25,117,102,89.0001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLZF01000029",87.255,5.38e-25,117,102,89.0001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24861","NZ_FLBI01000046",81.208,1.92e-24,115,149,120.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24861","NZ_FLBN01000099",81.208,1.92e-24,115,149,120.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24861","NZ_FLCN01000004",81.208,1.92e-24,115,149,120.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24862","NZ_FLBI01000046",81.208,1.92e-24,115,149,120.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24862","NZ_FLBN01000099",81.208,1.92e-24,115,149,120.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24862","NZ_FLCN01000004",81.208,1.92e-24,115,149,120.99992,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24864","NZ_FLBI01000046",81.081,1.92e-24,115,148,119.99988,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24864","NZ_FLBN01000099",81.081,1.92e-24,115,148,119.99988,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24864","NZ_FLCN01000004",81.081,1.92e-24,115,148,119.99988,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLRE01000049",84.956,1.92e-24,115,113,96.00028,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_FLBI01000046",85.981,1.94e-24,115,107,91.99967,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLRZ01000037",85.714,1.94e-24,115,112,95.99968,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLWB01000035",85.714,1.94e-24,115,112,95.99968,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLZF01000029",85.714,1.94e-24,115,112,95.99968,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_FLBI01000046",92.5,1.04e-24,115,80,74,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_FLBN01000099",92.5,1.04e-24,115,80,74,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_FLCN01000004",92.5,1.04e-24,115,80,74,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_JBGJJV010000032",92.5,1.04e-24,115,80,74,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7225","NZ_MLRZ01000037",80.519,6.96e-24,113,154,123.99926,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7225","NZ_MLWB01000035",80.519,6.96e-24,113,154,123.99926,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7225","NZ_MLZF01000029",80.519,6.96e-24,113,154,123.99926,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_FLBI01000046",84.615,5.04e-24,113,117,98.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_FLBN01000099",84.615,5.04e-24,113,117,98.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRE01000049",84.615,5.04e-24,113,117,98.99955,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_FLCN01000004",84.615,5.04e-24,113,117,98.99955,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_JAUEGY010000142",84.615,5.04e-24,113,117,98.99955,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_FLBI01000046",80.822,6.96e-24,113,146,118.00012,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_FLBI01000046",92.308,2.5e-23,111,78,72.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_FLBN01000099",92.308,2.5e-23,111,78,72.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRI01000021",92.308,2.5e-23,111,78,72.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRE01000049",92.308,2.5e-23,111,78,72.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_FLCN01000004",92.308,2.5e-23,111,78,72.00024,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRZ01000037",92.308,2.5e-23,111,78,72.00024,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRO01000021",92.308,2.5e-23,111,78,72.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLXR01000021",92.308,2.5e-23,111,78,72.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRG01000021",92.308,2.5e-23,111,78,72.00024,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLYG01000019",92.308,2.5e-23,111,78,72.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRJ01000019",92.308,2.5e-23,111,78,72.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLSM01000018",92.308,2.5e-23,111,78,72.00024,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLSQ01000022",92.308,2.5e-23,111,78,72.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLXY01000024",92.308,2.5e-23,111,78,72.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLXS01000025",92.308,2.5e-23,111,78,72.00024,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLWB01000035",92.308,2.5e-23,111,78,72.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLUD01000021",92.308,2.5e-23,111,78,72.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLRC01000027",92.308,2.5e-23,111,78,72.00024,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLYZ01000021",92.308,2.5e-23,111,78,72.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLSP01000022",92.308,2.5e-23,111,78,72.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLZF01000029",92.308,2.5e-23,111,78,72.00024,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLSH01000020",92.308,2.5e-23,111,78,72.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLYY01000023",92.308,2.5e-23,111,78,72.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLYC01000020",92.308,2.5e-23,111,78,72.00024,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLXZ01000020",92.308,2.5e-23,111,78,72.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_JBGJJV010000032",92.308,2.5e-23,111,78,72.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_JAUEGY010000142",92.308,2.5e-23,111,78,72.00024,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14628","NZ_FLBN01000099",80.69,2.48e-23,111,145,117.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14628","NZ_FLCN01000004",80.69,2.48e-23,111,145,117.0005,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRI01000021",91.25,4.83e-23,110,80,73,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRE01000049",91.25,4.83e-23,110,80,73,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRZ01000037",91.25,4.83e-23,110,80,73,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRO01000021",91.25,4.83e-23,110,80,73,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLXR01000021",91.25,4.83e-23,110,80,73,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRG01000021",91.25,4.83e-23,110,80,73,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLYG01000019",91.25,4.83e-23,110,80,73,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRJ01000019",91.25,4.83e-23,110,80,73,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLSM01000018",91.25,4.83e-23,110,80,73,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLSQ01000022",91.25,4.83e-23,110,80,73,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLXY01000024",91.25,4.83e-23,110,80,73,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLXS01000025",91.25,4.83e-23,110,80,73,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLWB01000035",91.25,4.83e-23,110,80,73,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLUD01000021",91.25,4.83e-23,110,80,73,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLRC01000027",91.25,4.83e-23,110,80,73,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLYZ01000021",91.25,4.83e-23,110,80,73,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLSP01000022",91.25,4.83e-23,110,80,73,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLZF01000029",91.25,4.83e-23,110,80,73,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLSH01000020",91.25,4.83e-23,110,80,73,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLYY01000023",91.25,4.83e-23,110,80,73,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLYC01000020",91.25,4.83e-23,110,80,73,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLXZ01000020",91.25,4.83e-23,110,80,73,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14629","NZ_FLBN01000099",80.556,8.93e-23,110,144,116.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14629","NZ_FLCN01000004",80.556,8.93e-23,110,144,116.00064,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_FLBN01000099",82.54,9.01e-23,110,126,104.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_FLCN01000004",82.54,9.01e-23,110,126,104.0004,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRI01000021",83.761,2.34e-22,108,117,98.00037,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRZ01000037",83.761,2.34e-22,108,117,98.00037,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRO01000021",83.761,2.34e-22,108,117,98.00037,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLXR01000021",83.761,2.34e-22,108,117,98.00037,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRG01000021",83.761,2.34e-22,108,117,98.00037,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLYG01000019",83.761,2.34e-22,108,117,98.00037,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRJ01000019",83.761,2.34e-22,108,117,98.00037,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLSM01000018",83.761,2.34e-22,108,117,98.00037,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLSQ01000022",83.761,2.34e-22,108,117,98.00037,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLXY01000024",83.761,2.34e-22,108,117,98.00037,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLXS01000025",83.761,2.34e-22,108,117,98.00037,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLWB01000035",83.761,2.34e-22,108,117,98.00037,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLUD01000021",83.761,2.34e-22,108,117,98.00037,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLRC01000027",83.761,2.34e-22,108,117,98.00037,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLYZ01000021",83.761,2.34e-22,108,117,98.00037,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLSP01000022",83.761,2.34e-22,108,117,98.00037,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLZF01000029",83.761,2.34e-22,108,117,98.00037,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLSH01000020",83.761,2.34e-22,108,117,98.00037,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLYY01000023",83.761,2.34e-22,108,117,98.00037,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLYC01000020",83.761,2.34e-22,108,117,98.00037,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLXZ01000020",83.761,2.34e-22,108,117,98.00037,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_JBGJJV010000032",83.761,2.34e-22,108,117,98.00037,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_JBGJJV010000032",90.244,1.47e-22,108,82,74.00008,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_FLBI01000046",94.203,6.35e-22,106,69,65.00007,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_FLBN01000099",94.203,6.35e-22,106,69,65.00007,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_FLCN01000004",94.203,6.35e-22,106,69,65.00007,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_MLRZ01000037",94.203,6.35e-22,106,69,65.00007,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_MLWB01000035",94.203,6.35e-22,106,69,65.00007,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_MLZF01000029",94.203,6.35e-22,106,69,65.00007,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_JBGJJV010000032",94.203,6.35e-22,106,69,65.00007,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLRE01000049",85.294,1.17e-21,106,102,86.99988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_FLBI01000046",79.866,4.19e-21,104,149,119.00034,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_FLBN01000099",79.866,4.19e-21,104,149,119.00034,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRI01000021",79.605,4.19e-21,104,152,120.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRE01000049",79.605,4.19e-21,104,152,120.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_FLCN01000004",79.866,4.19e-21,104,149,119.00034,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRZ01000037",79.605,4.19e-21,104,152,120.9996,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRO01000021",79.605,4.19e-21,104,152,120.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLXR01000021",79.605,4.19e-21,104,152,120.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRG01000021",79.605,4.19e-21,104,152,120.9996,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLYG01000019",79.605,4.19e-21,104,152,120.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRJ01000019",79.605,4.19e-21,104,152,120.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLSM01000018",79.605,4.19e-21,104,152,120.9996,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLSQ01000022",79.605,4.19e-21,104,152,120.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLXY01000024",79.605,4.19e-21,104,152,120.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLXS01000025",79.605,4.19e-21,104,152,120.9996,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLWB01000035",79.605,4.19e-21,104,152,120.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLUD01000021",79.605,4.19e-21,104,152,120.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLRC01000027",79.605,4.19e-21,104,152,120.9996,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLYZ01000021",79.605,4.19e-21,104,152,120.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLSP01000022",79.605,4.19e-21,104,152,120.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLZF01000029",79.605,4.19e-21,104,152,120.9996,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLSH01000020",79.605,4.19e-21,104,152,120.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLYY01000023",79.605,4.19e-21,104,152,120.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLYC01000020",79.605,4.19e-21,104,152,120.9996,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLXZ01000020",79.605,4.19e-21,104,152,120.9996,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_JBGJJV010000032",79.866,4.19e-21,104,149,119.00034,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_JAUEGY010000142",79.866,4.19e-21,104,149,119.00034,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_MLRZ01000037",84.259,1.49e-20,102,108,90.99972,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_MLWB01000035",84.259,1.49e-20,102,108,90.99972,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_MLZF01000029",84.259,1.49e-20,102,108,90.99972,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_JBGJJV010000032",84.259,1.49e-20,102,108,90.99972,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_FLBI01000046",84.112,5.38e-20,100,107,89.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_FLBN01000099",84.112,5.38e-20,100,107,89.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_FLCN01000004",84.112,5.38e-20,100,107,89.99984,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_FLBI01000046",79.195,1.95e-19,99,149,118.00055,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_FLBN01000099",79.195,1.95e-19,99,149,118.00055,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRI01000021",78.947,1.95e-19,99,152,119.99944,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRE01000049",78.947,1.95e-19,99,152,119.99944,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_FLCN01000004",79.195,1.95e-19,99,149,118.00055,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRZ01000037",78.947,1.95e-19,99,152,119.99944,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRO01000021",78.947,1.95e-19,99,152,119.99944,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLXR01000021",78.947,1.95e-19,99,152,119.99944,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRG01000021",78.947,1.95e-19,99,152,119.99944,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLYG01000019",78.947,1.95e-19,99,152,119.99944,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRJ01000019",78.947,1.95e-19,99,152,119.99944,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLSM01000018",78.947,1.95e-19,99,152,119.99944,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLSQ01000022",78.947,1.95e-19,99,152,119.99944,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLXY01000024",78.947,1.95e-19,99,152,119.99944,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLXS01000025",78.947,1.95e-19,99,152,119.99944,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLWB01000035",78.947,1.95e-19,99,152,119.99944,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLUD01000021",78.947,1.95e-19,99,152,119.99944,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLRC01000027",78.947,1.95e-19,99,152,119.99944,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLYZ01000021",78.947,1.95e-19,99,152,119.99944,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLSP01000022",78.947,1.95e-19,99,152,119.99944,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLZF01000029",78.947,1.95e-19,99,152,119.99944,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLSH01000020",78.947,1.95e-19,99,152,119.99944,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLYY01000023",78.947,1.95e-19,99,152,119.99944,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLYC01000020",78.947,1.95e-19,99,152,119.99944,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLXZ01000020",78.947,1.95e-19,99,152,119.99944,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_JBGJJV010000032",79.195,1.95e-19,99,149,118.00055,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_JAUEGY010000142",79.195,1.95e-19,99,149,118.00055,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_FLBI01000046",95,2.8e-18,93.5,60,57,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_FLBN01000099",95,2.8e-18,93.5,60,57,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRI01000021",95,2.8e-18,93.5,60,57,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRE01000049",95,2.8e-18,93.5,60,57,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_FLCN01000004",95,2.8e-18,93.5,60,57,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRZ01000037",95,2.8e-18,93.5,60,57,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRO01000021",95,2.8e-18,93.5,60,57,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLXR01000021",95,2.8e-18,93.5,60,57,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRG01000021",95,2.8e-18,93.5,60,57,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLYG01000019",95,2.8e-18,93.5,60,57,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRJ01000019",95,2.8e-18,93.5,60,57,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLSM01000018",95,2.8e-18,93.5,60,57,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLSQ01000022",95,2.8e-18,93.5,60,57,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLXY01000024",95,2.8e-18,93.5,60,57,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLXS01000025",95,2.8e-18,93.5,60,57,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLWB01000035",95,2.8e-18,93.5,60,57,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLUD01000021",95,2.8e-18,93.5,60,57,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLRC01000027",95,2.8e-18,93.5,60,57,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLYZ01000021",95,2.8e-18,93.5,60,57,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLSP01000022",95,2.8e-18,93.5,60,57,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLZF01000029",95,2.8e-18,93.5,60,57,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLSH01000020",95,2.8e-18,93.5,60,57,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLYY01000023",95,2.8e-18,93.5,60,57,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLYC01000020",95,2.8e-18,93.5,60,57,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLXZ01000020",95,2.8e-18,93.5,60,57,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_JBGJJV010000032",95,2.8e-18,93.5,60,57,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_JAUEGY010000142",95,2.8e-18,93.5,60,57,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_FLBI01000046",95,2.8e-18,93.5,60,57,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_FLBN01000099",95,2.8e-18,93.5,60,57,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRI01000021",95,2.8e-18,93.5,60,57,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRE01000049",95,2.8e-18,93.5,60,57,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_FLCN01000004",95,2.8e-18,93.5,60,57,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRZ01000037",95,2.8e-18,93.5,60,57,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRO01000021",95,2.8e-18,93.5,60,57,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLXR01000021",95,2.8e-18,93.5,60,57,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRG01000021",95,2.8e-18,93.5,60,57,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLYG01000019",95,2.8e-18,93.5,60,57,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRJ01000019",95,2.8e-18,93.5,60,57,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLSM01000018",95,2.8e-18,93.5,60,57,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLSQ01000022",95,2.8e-18,93.5,60,57,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLXY01000024",95,2.8e-18,93.5,60,57,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLXS01000025",95,2.8e-18,93.5,60,57,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLWB01000035",95,2.8e-18,93.5,60,57,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLUD01000021",95,2.8e-18,93.5,60,57,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLRC01000027",95,2.8e-18,93.5,60,57,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLYZ01000021",95,2.8e-18,93.5,60,57,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLSP01000022",95,2.8e-18,93.5,60,57,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLZF01000029",95,2.8e-18,93.5,60,57,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLSH01000020",95,2.8e-18,93.5,60,57,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLYY01000023",95,2.8e-18,93.5,60,57,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLYC01000020",95,2.8e-18,93.5,60,57,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLXZ01000020",95,2.8e-18,93.5,60,57,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_JBGJJV010000032",95,2.8e-18,93.5,60,57,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_JAUEGY010000142",95,2.8e-18,93.5,60,57,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRC01000027",86.585,1.49e-17,91.6,82,70.9997,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_FLBI01000046",86.747,1.49e-17,91.6,83,72.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_FLBN01000099",86.747,1.49e-17,91.6,83,72.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRI01000021",86.747,1.49e-17,91.6,83,72.00001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRE01000049",86.747,1.49e-17,91.6,83,72.00001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_FLCN01000004",86.747,1.49e-17,91.6,83,72.00001,"Prevotella intermedia","Esophageal cancer; Gastric cancer (gut-oral axis)","Gut-oral bacterial translocation; chronic inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRZ01000037",86.747,1.49e-17,91.6,83,72.00001,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRO01000021",86.747,1.49e-17,91.6,83,72.00001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLXR01000021",86.747,1.49e-17,91.6,83,72.00001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRG01000021",86.747,1.49e-17,91.6,83,72.00001,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLYG01000019",86.747,1.49e-17,91.6,83,72.00001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRJ01000019",86.747,1.49e-17,91.6,83,72.00001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLSM01000018",86.747,1.49e-17,91.6,83,72.00001,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLSQ01000022",86.747,1.49e-17,91.6,83,72.00001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLXY01000024",86.747,1.49e-17,91.6,83,72.00001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLXS01000025",86.747,1.49e-17,91.6,83,72.00001,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLWB01000035",86.747,1.49e-17,91.6,83,72.00001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLUD01000021",86.747,1.49e-17,91.6,83,72.00001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLRC01000027",86.747,1.49e-17,91.6,83,72.00001,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLYZ01000021",86.747,1.49e-17,91.6,83,72.00001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLSP01000022",86.747,1.49e-17,91.6,83,72.00001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLZF01000029",86.747,1.49e-17,91.6,83,72.00001,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLSH01000020",86.747,1.49e-17,91.6,83,72.00001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLYY01000023",86.747,1.49e-17,91.6,83,72.00001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLYC01000020",86.747,1.49e-17,91.6,83,72.00001,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLXZ01000020",86.747,1.49e-17,91.6,83,72.00001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_JBGJJV010000032",86.747,1.49e-17,91.6,83,72.00001,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRI01000021",85.366,6.91e-16,86.1,82,70.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRE01000049",85.366,6.91e-16,86.1,82,70.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRZ01000037",85.366,6.91e-16,86.1,82,70.00012,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRO01000021",85.366,6.91e-16,86.1,82,70.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLXR01000021",85.366,6.91e-16,86.1,82,70.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRG01000021",85.366,6.91e-16,86.1,82,70.00012,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLYG01000019",85.366,6.91e-16,86.1,82,70.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLRJ01000019",85.366,6.91e-16,86.1,82,70.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLSM01000018",85.366,6.91e-16,86.1,82,70.00012,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLSQ01000022",85.366,6.91e-16,86.1,82,70.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLXY01000024",85.366,6.91e-16,86.1,82,70.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLXS01000025",85.366,6.91e-16,86.1,82,70.00012,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLWB01000035",85.366,6.91e-16,86.1,82,70.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLUD01000021",85.366,6.91e-16,86.1,82,70.00012,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLYZ01000021",85.366,6.91e-16,86.1,82,70.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLSP01000022",85.366,6.91e-16,86.1,82,70.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLZF01000029",85.366,6.91e-16,86.1,82,70.00012,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLSH01000020",85.366,6.91e-16,86.1,82,70.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLYY01000023",85.366,6.91e-16,86.1,82,70.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLYC01000020",85.366,6.91e-16,86.1,82,70.00012,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLXZ01000020",85.366,6.91e-16,86.1,82,70.00012,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLRI01000021",90.476,5.46e-15,84.2,63,56.99988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLRO01000021",90.476,5.46e-15,84.2,63,56.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLXR01000021",90.476,5.46e-15,84.2,63,56.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLRG01000021",90.476,5.46e-15,84.2,63,56.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLYG01000019",90.476,5.46e-15,84.2,63,56.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLRJ01000019",90.476,5.46e-15,84.2,63,56.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLSM01000018",90.476,5.46e-15,84.2,63,56.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLSQ01000022",90.476,5.46e-15,84.2,63,56.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLXY01000024",90.476,5.46e-15,84.2,63,56.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLXS01000025",90.476,5.46e-15,84.2,63,56.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLUD01000021",90.476,5.46e-15,84.2,63,56.99988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLRC01000027",90.476,5.46e-15,84.2,63,56.99988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLYZ01000021",90.476,5.46e-15,84.2,63,56.99988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLSP01000022",90.476,5.46e-15,84.2,63,56.99988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLSH01000020",90.476,5.46e-15,84.2,63,56.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLYY01000023",90.476,5.46e-15,84.2,63,56.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLYC01000020",90.476,5.46e-15,84.2,63,56.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLXZ01000020",90.476,5.46e-15,84.2,63,56.99988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLRI01000021",90.476,5.41e-15,84.2,63,56.99988,"Parvimonas micra","Colorectal cancer; Oral-gut translocation","Oral-gut translocation; biofilm formation in tumors","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLRO01000021",90.476,5.41e-15,84.2,63,56.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLXR01000021",90.476,5.41e-15,84.2,63,56.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLRG01000021",90.476,5.41e-15,84.2,63,56.99988,"Actinomyces naeslundii","Head and neck cancer; Cervical cancer","Chronic cervical/oral inflammation; immune modulation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLYG01000019",90.476,5.41e-15,84.2,63,56.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLRJ01000019",90.476,5.41e-15,84.2,63,56.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLSM01000018",90.476,5.41e-15,84.2,63,56.99988,"Treponema denticola","Periodontal disease-associated systemic cancers","Spirochete invasion; chronic periodontal inflammation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLSQ01000022",90.476,5.41e-15,84.2,63,56.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLXY01000024",90.476,5.41e-15,84.2,63,56.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLXS01000025",90.476,5.41e-15,84.2,63,56.99988,"Tannerella forsythia","Oral cancer; Pancreatic cancer (systemic translocation)","Protease activity; systemic bacterial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLUD01000021",90.476,5.41e-15,84.2,63,56.99988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLRC01000027",90.476,5.41e-15,84.2,63,56.99988,"Enterobacter cloacae","Cancer patient mortality; Bloodstream infections","Nosocomial infections in immunocompromised cancer patients","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLYZ01000021",90.476,5.41e-15,84.2,63,56.99988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLSP01000022",90.476,5.41e-15,84.2,63,56.99988,"Veillonella parvula","Colorectal cancer; Oral-gut microbiome axis","Short-chain fatty acid disruption; microbial translocation","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLSH01000020",90.476,5.41e-15,84.2,63,56.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLYY01000023",90.476,5.41e-15,84.2,63,56.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLYC01000020",90.476,5.41e-15,84.2,63,56.99988,"Capnocytophaga gingivalis","Periodontal disease-cancer progression","Periodontal bone destruction; systemic inflammatory response","Emerging","3_Potential","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLXZ01000020",90.476,5.41e-15,84.2,63,56.99988,"Aggregatibacter actinomycetemcomitans","Aggressive periodontitis-oral cancer progression","Aggressive tissue invasion; leukotoxin production","Emerging","3_Potential","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLVX01000038",100,2.33e-73,278,150,150,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_JAMKRA010000075",100,2.33e-73,278,150,150,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_JAMKTM010000045",100,2.33e-73,278,150,150,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_JAMKRA010000075",100,2.33e-73,278,150,150,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_JAMKQZ010000090",100,2.33e-73,278,150,150,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_JAMKTM010000045",100,2.33e-73,278,150,150,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLSZ01000019",100,8.32e-73,276,149,149,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLSN01000023",100,8.32e-73,276,149,149,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_MLVX01000038",100,8.32e-73,276,149,149,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_JAMKRA010000075",100,8.32e-73,276,149,149,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_JAMKTM010000045",100,8.32e-73,276,149,149,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_JAMKRA010000075",100,8.32e-73,276,149,149,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_JAMKQZ010000090",100,8.32e-73,276,149,149,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_JAMKTM010000045",100,8.32e-73,276,149,149,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_MLVX01000038",100,8.32e-73,276,149,149,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_JAMKRA010000075",100,8.32e-73,276,149,149,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7155","NZ_JAMKTM010000045",100,8.32e-73,276,149,149,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_JAMKRA010000075",100,2.99e-72,274,148,148,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_JAMKTM010000045",100,2.99e-72,274,148,148,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLVX01000038",99.333,1.09e-71,272,150,148.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLSZ01000019",99.333,1.09e-71,272,150,148.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_MLSN01000023",99.333,1.09e-71,272,150,148.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_JAMKRA010000075",99.333,1.09e-71,272,150,148.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_JAMKQZ010000090",99.333,1.09e-71,272,150,148.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51611","NZ_JAMKTM010000045",99.333,1.09e-71,272,150,148.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_JAMKRA010000075",99.333,1.09e-71,272,150,148.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_JAMKQZ010000090",99.333,1.09e-71,272,150,148.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_JAMKTM010000045",99.333,1.09e-71,272,150,148.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLSZ01000019",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLSN01000023",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_MLVX01000038",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLSZ01000019",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLSN01000023",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_MLVX01000038",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLSZ01000019",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLSN01000023",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_MLVX01000038",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_JAMKRA010000075",99.329,3.87e-71,270,149,148.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_JAMKQZ010000090",99.329,3.87e-71,270,149,148.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71956","NZ_JAMKTM010000045",99.329,3.87e-71,270,149,148.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLSZ01000019",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLSN01000023",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_MLVX01000038",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_MLVX01000038",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_JAMKRA010000075",99.329,3.87e-71,270,149,148.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7153","NZ_JAMKTM010000045",99.329,3.87e-71,270,149,148.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_MLVX01000038",99.333,3.87e-71,270,150,148.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_JAMKRA010000075",99.333,3.87e-71,270,150,148.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7154","NZ_JAMKTM010000045",99.333,3.87e-71,270,150,148.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_MLVX01000038",99.329,3.87e-71,270,149,148.00021,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_JAMKRA010000075",99.329,3.87e-71,270,149,148.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7156","NZ_JAMKTM010000045",99.329,3.87e-71,270,149,148.00021,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLSZ01000019",100,1.4e-70,268,145,145,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLSN01000023",100,1.4e-70,268,145,145,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_MLVX01000038",100,1.4e-70,268,145,145,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLSZ01000019",98.667,5.05e-70,267,150,148.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_MLSN01000023",98.667,5.05e-70,267,150,148.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_JAMKRA010000075",98.667,5.05e-70,267,150,148.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_JAMKQZ010000090",98.667,5.05e-70,267,150,148.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51610","NZ_JAMKTM010000045",98.667,5.05e-70,267,150,148.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_JAMKRA010000075",99.32,5.05e-70,267,147,146.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_JAMKQZ010000090",100,5.05e-70,267,144,144,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_39128","NZ_JAMKTM010000045",99.32,5.05e-70,267,147,146.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_JAMKRA010000075",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_JAMKQZ010000090",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71953","NZ_JAMKTM010000045",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_JAMKRA010000075",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_JAMKQZ010000090",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71954","NZ_JAMKTM010000045",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_JAMKRA010000075",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_JAMKQZ010000090",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71955","NZ_JAMKTM010000045",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLSZ01000019",98.658,1.8e-69,265,149,147.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLSN01000023",98.658,1.8e-69,265,149,147.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_MLVX01000038",98.658,1.8e-69,265,149,147.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_JAMKRA010000075",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_JAMKQZ010000090",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71958","NZ_JAMKTM010000045",98.658,1.8e-69,265,149,147.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_JAMKRA010000075",98.649,6.53e-69,263,148,146.00052,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_JAMKQZ010000090",98.649,6.53e-69,263,148,146.00052,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_JAMKTM010000045",98.649,6.53e-69,263,148,146.00052,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLSZ01000019",98.649,6.48e-69,263,148,146.00052,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLSN01000023",98.649,6.48e-69,263,148,146.00052,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6729","NZ_MLVX01000038",98.649,6.48e-69,263,148,146.00052,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLVX01000038",98,2.35e-68,261,150,147,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLSZ01000019",98,2.35e-68,261,150,147,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLSN01000023",98,2.35e-68,261,150,147,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19572","NZ_MLVX01000038",98,2.35e-68,261,150,147,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLSZ01000019",98,2.35e-68,261,150,147,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLSN01000023",98,2.35e-68,261,150,147,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_MLVX01000038",98,2.35e-68,261,150,147,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_JAMKRA010000075",98,2.35e-68,261,150,147,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_JAMKQZ010000090",98,2.35e-68,261,150,147,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8764","NZ_JAMKTM010000045",98,2.35e-68,261,150,147,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_MLVX01000038",98.639,2.31e-68,261,147,144.99933,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_JAMKRA010000075",98.639,2.31e-68,261,147,144.99933,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7152","NZ_JAMKTM010000045",98.639,2.31e-68,261,147,144.99933,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLSZ01000019",97.987,8.38e-68,259,149,146.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLSN01000023",97.987,8.38e-68,259,149,146.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_MLVX01000038",97.987,8.38e-68,259,149,146.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_JAMKRA010000075",97.987,8.38e-68,259,149,146.00063,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_JAMKQZ010000090",97.987,8.38e-68,259,149,146.00063,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71957","NZ_JAMKTM010000045",97.987,8.38e-68,259,149,146.00063,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLSZ01000019",97.987,8.38e-68,259,149,146.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLSN01000023",97.987,8.38e-68,259,149,146.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19571","NZ_MLVX01000038",97.987,8.38e-68,259,149,146.00063,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_JAMKRA010000075",97.973,3.04e-67,257,148,145.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_JAMKQZ010000090",97.973,3.04e-67,257,148,145.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_JAMKTM010000045",97.973,3.04e-67,257,148,145.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_JAMKRA010000075",97.973,3.01e-67,257,148,145.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_JAMKTM010000045",97.973,3.01e-67,257,148,145.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLSZ01000019",97.333,1.09e-66,255,150,145.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_MLSN01000023",97.333,1.09e-66,255,150,145.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_JAMKRA010000075",97.333,1.09e-66,255,150,145.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_JAMKQZ010000090",97.333,1.09e-66,255,150,145.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_51612","NZ_JAMKTM010000045",97.333,1.09e-66,255,150,145.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLSZ01000019",97.333,1.09e-66,255,150,145.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLSN01000023",97.333,1.09e-66,255,150,145.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28291","NZ_MLVX01000038",97.333,1.09e-66,255,150,145.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLSZ01000019",97.333,1.09e-66,255,150,145.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLSN01000023",97.333,1.09e-66,255,150,145.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19573","NZ_MLVX01000038",97.333,1.09e-66,255,150,145.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_JAMKRA010000075",97.315,3.9e-66,254,149,144.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_JAMKQZ010000090",97.315,3.9e-66,254,149,144.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71952","NZ_JAMKTM010000045",97.315,3.9e-66,254,149,144.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLSZ01000019",97.315,3.9e-66,254,149,144.99935,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLSN01000023",97.315,3.9e-66,254,149,144.99935,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RB2.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20653","NZ_MLVX01000038",97.315,3.9e-66,254,149,144.99935,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLSZ01000019",96.667,5.09e-65,250,150,145.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLSN01000023",96.667,5.09e-65,250,150,145.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_MLVX01000038",96.667,5.09e-65,250,150,145.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_JAMKRA010000075",96.667,5.09e-65,250,150,145.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_JAMKQZ010000090",96.667,5.09e-65,250,150,145.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5548","NZ_JAMKTM010000045",96.667,5.09e-65,250,150,145.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLSZ01000019",96.622,6.53e-64,246,148,143.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLSN01000023",96.622,6.53e-64,246,148,143.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6730","NZ_MLVX01000038",96.622,6.53e-64,246,148,143.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLSZ01000019",96.599,2.35e-63,244,147,142.00053,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLSN01000023",96.599,2.35e-63,244,147,142.00053,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_MLVX01000038",96.599,2.35e-63,244,147,142.00053,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_JAMKRA010000075",96.599,2.35e-63,244,147,142.00053,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_JAMKQZ010000090",96.599,2.35e-63,244,147,142.00053,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48715","NZ_JAMKTM010000045",96.599,2.35e-63,244,147,142.00053,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLSZ01000019",96.599,2.35e-63,244,147,142.00053,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLSN01000023",96.599,2.35e-63,244,147,142.00053,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_MLVX01000038",96.599,2.35e-63,244,147,142.00053,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_JAMKRA010000075",96.599,2.35e-63,244,147,142.00053,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_JAMKQZ010000090",96.599,2.35e-63,244,147,142.00053,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_53456","NZ_JAMKTM010000045",96.599,2.35e-63,244,147,142.00053,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_MLVX01000038",96,2.37e-63,244,150,144,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_JAMKRA010000075",96,2.37e-63,244,150,144,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34076","NZ_JAMKTM010000045",96,2.37e-63,244,150,144,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_JAMKRA010000075",95.946,3.06e-62,241,148,142.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_JAMKQZ010000090",95.946,3.06e-62,241,148,142.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_JAMKTM010000045",95.946,3.06e-62,241,148,142.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_MLVX01000038",95.946,3.06e-62,241,148,142.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_JAMKRA010000075",95.946,3.06e-62,241,148,142.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34075","NZ_JAMKTM010000045",95.946,3.06e-62,241,148,142.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_MLVX01000038",95.333,1.1e-61,239,150,142.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_JAMKRA010000075",95.333,1.1e-61,239,150,142.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_34074","NZ_JAMKTM010000045",95.333,1.1e-61,239,150,142.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLSZ01000019",96.503,3.96e-61,237,143,137.99929,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLSN01000023",96.503,3.96e-61,237,143,137.99929,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_MLVX01000038",96.503,3.96e-61,237,143,137.99929,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_JAMKRA010000075",96.503,3.96e-61,237,143,137.99929,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_JAMKQZ010000090",96.503,3.96e-61,237,143,137.99929,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11909","NZ_JAMKTM010000045",96.503,3.96e-61,237,143,137.99929,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLSZ01000019",95.302,3.93e-61,237,149,141.99998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLSN01000023",95.302,3.93e-61,237,149,141.99998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_MLVX01000038",95.302,3.93e-61,237,149,141.99998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_JAMKRA010000075",95.302,3.93e-61,237,149,141.99998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_JAMKQZ010000090",95.302,3.93e-61,237,149,141.99998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_61754","NZ_JAMKTM010000045",95.302,3.93e-61,237,149,141.99998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLSZ01000019",96.479,1.41e-60,235,142,137.00018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLSN01000023",96.479,1.41e-60,235,142,137.00018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_MLVX01000038",96.479,1.41e-60,235,142,137.00018,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_JAMKRA010000075",96.479,1.41e-60,235,142,137.00018,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_JAMKQZ010000090",96.479,1.41e-60,235,142,137.00018,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19635","NZ_JAMKTM010000045",96.479,1.41e-60,235,142,137.00018,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLSZ01000019",95.27,1.41e-60,235,148,140.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLSN01000023",95.27,1.41e-60,235,148,140.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_MLVX01000038",95.27,1.41e-60,235,148,140.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLSZ01000019",95.27,1.42e-60,235,148,140.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLSN01000023",95.27,1.42e-60,235,148,140.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_MLVX01000038",95.27,1.42e-60,235,148,140.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_JAMKRA010000075",95.27,1.42e-60,235,148,140.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_JAMKQZ010000090",95.27,1.42e-60,235,148,140.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21228","NZ_JAMKTM010000045",95.27,1.42e-60,235,148,140.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLSZ01000019",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLSN01000023",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_MLVX01000038",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLSZ01000019",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLSN01000023",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_MLVX01000038",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_JAMKRA010000075",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_JAMKQZ010000090",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17459","NZ_JAMKTM010000045",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLSZ01000019",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLSN01000023",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_MLVX01000038",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_JAMKRA010000075",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_JAMKQZ010000090",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3974","NZ_JAMKTM010000045",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLSZ01000019",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLSN01000023",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_MLVX01000038",94.667,5.12e-60,233,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_JAMKRA010000075",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_JAMKQZ010000090",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20931","NZ_JAMKTM010000045",94.667,5.12e-60,233,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLSZ01000019",95.238,5.08e-60,233,147,139.99986,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLSN01000023",95.238,5.08e-60,233,147,139.99986,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_MLVX01000038",95.238,5.08e-60,233,147,139.99986,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_JAMKRA010000075",95.238,5.08e-60,233,147,139.99986,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_JAMKQZ010000090",95.238,5.08e-60,233,147,139.99986,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21227","NZ_JAMKTM010000045",95.238,5.08e-60,233,147,139.99986,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLSZ01000019",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLSN01000023",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_MLVX01000038",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_JAMKRA010000075",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_JAMKQZ010000090",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_26180","NZ_JAMKTM010000045",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_JAMKRA010000075",94.667,1.83e-59,231,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_JAMKQZ010000090",94.667,1.83e-59,231,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8075","NZ_JAMKTM010000045",94.667,1.83e-59,231,150,142.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLSZ01000019",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLSN01000023",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_MLVX01000038",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_JAMKRA010000075",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_JAMKQZ010000090",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18169","NZ_JAMKTM010000045",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLSZ01000019",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLSN01000023",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_MLVX01000038",94.631,1.83e-59,231,149,141.00019,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_JAMKRA010000075",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_JAMKQZ010000090",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22319","NZ_JAMKTM010000045",94.631,1.83e-59,231,149,141.00019,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_JAMKRA010000075",94.079,6.63e-59,230,152,143.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_JAMKQZ010000090",94.079,6.63e-59,230,152,143.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3114","NZ_JAMKTM010000045",94.079,6.63e-59,230,152,143.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_MLVX01000038",94.667,6.57e-59,230,150,142.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLSZ01000019",94.595,6.63e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLSN01000023",94.595,6.63e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49229","NZ_MLVX01000038",94.595,6.63e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLSZ01000019",94.595,6.63e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLSN01000023",94.595,6.63e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49231","NZ_MLVX01000038",94.595,6.63e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLSZ01000019",94.595,6.57e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLSN01000023",94.595,6.57e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_MLVX01000038",94.595,6.57e-59,230,148,140.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_MLVX01000038",94,2.38e-58,228,150,141,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_JAMKRA010000075",94,2.38e-58,228,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4898","NZ_JAMKTM010000045",94,2.38e-58,228,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLSZ01000019",94,2.38e-58,228,150,141,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLSN01000023",94,2.38e-58,228,150,141,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_MLVX01000038",94,2.38e-58,228,150,141,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_JAMKRA010000075",94,2.38e-58,228,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_JAMKQZ010000090",94,2.38e-58,228,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16455","NZ_JAMKTM010000045",94,2.38e-58,228,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_MLVX01000038",94,2.38e-58,228,150,141,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_JAMKRA010000075",94,2.38e-58,228,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21218","NZ_JAMKTM010000045",94,2.38e-58,228,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLSZ01000019",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLSN01000023",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_MLVX01000038",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_JAMKRA010000075",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_42316","NZ_JAMKTM010000045",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLSZ01000019",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLSN01000023",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_MLVX01000038",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_JAMKRA010000075",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_JAMKQZ010000090",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6542","NZ_JAMKTM010000045",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_JAMKRA010000075",94.558,8.5e-58,226,147,139.00026,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_JAMKQZ010000090",94.558,8.5e-58,226,147,139.00026,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_JAMKTM010000045",94.558,8.5e-58,226,147,139.00026,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_JAMKRA010000075",94,8.5e-58,226,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_JAMKQZ010000090",94,8.5e-58,226,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8076","NZ_JAMKTM010000045",94,8.5e-58,226,150,141,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLSZ01000019",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLSN01000023",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_MLVX01000038",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_JAMKRA010000075",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_JAMKQZ010000090",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18168","NZ_JAMKTM010000045",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLSZ01000019",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLSN01000023",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_MLVX01000038",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_JAMKRA010000075",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25267","NZ_JAMKTM010000045",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLSZ01000019",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLSN01000023",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_MLVX01000038",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_JAMKRA010000075",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25269","NZ_JAMKTM010000045",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLSZ01000019",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLSN01000023",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_MLVX01000038",93.96,8.5e-58,226,149,140.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_JAMKRA010000075",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8542","NZ_JAMKTM010000045",93.96,8.5e-58,226,149,140.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_MLVX01000038",94.558,3.06e-57,224,147,139.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLSZ01000019",94.483,3.06e-57,224,145,137.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLSN01000023",94.483,3.06e-57,224,145,137.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5274","NZ_MLVX01000038",94.483,3.06e-57,224,145,137.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_JAMKRA010000075",93.333,1.11e-56,222,150,139.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_JAMKQZ010000090",93.333,1.11e-56,222,150,139.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_JAMKTM010000045",93.333,1.11e-56,222,150,139.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLSZ01000019",93.289,3.96e-56,220,149,139.00061,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLSN01000023",93.289,3.96e-56,220,149,139.00061,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_MLVX01000038",93.289,3.96e-56,220,149,139.00061,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_JAMKRA010000075",93.289,3.96e-56,220,149,139.00061,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25268","NZ_JAMKTM010000045",93.289,3.96e-56,220,149,139.00061,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLSZ01000019",93.836,3.89e-56,220,146,137.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLSN01000023",93.836,3.89e-56,220,146,137.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_MLVX01000038",93.836,3.89e-56,220,146,137.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_JAMKRA010000075",93.836,3.89e-56,220,146,137.00056,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_8719","NZ_JAMKTM010000045",93.836,3.89e-56,220,146,137.00056,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLSZ01000019",92.667,5.16e-55,217,150,139.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLSN01000023",92.667,5.16e-55,217,150,139.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46109","NZ_MLVX01000038",92.667,5.16e-55,217,150,139.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_JAMKRA010000075",92.667,5.16e-55,217,150,139.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_JAMKQZ010000090",92.667,5.16e-55,217,150,139.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_JAMKTM010000045",92.667,5.16e-55,217,150,139.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLSZ01000019",93.75,5.12e-55,217,144,135,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLSN01000023",93.75,5.12e-55,217,144,135,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_MLVX01000038",93.75,5.12e-55,217,144,135,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_JAMKRA010000075",93.75,5.12e-55,217,144,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_JAMKQZ010000090",93.75,5.12e-55,217,144,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_44890","NZ_JAMKTM010000045",93.75,5.12e-55,217,144,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_MLVX01000038",92.617,1.84e-54,215,149,137.99933,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLSZ01000019",93.706,1.78e-54,215,143,133.99958,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLSN01000023",93.706,1.78e-54,215,143,133.99958,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_MLVX01000038",93.706,1.78e-54,215,143,133.99958,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_JAMKRA010000075",93.706,1.78e-54,215,143,133.99958,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_JAMKQZ010000090",93.706,1.78e-54,215,143,133.99958,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15783","NZ_JAMKTM010000045",93.706,1.78e-54,215,143,133.99958,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_JAMKRA010000075",96.85,6.62e-54,213,127,122.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40142","NZ_JAMKTM010000045",96.85,6.62e-54,213,127,122.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLSZ01000019",93.103,6.67e-54,213,145,134.99935,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLSN01000023",93.103,6.67e-54,213,145,134.99935,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_MLVX01000038",93.103,6.67e-54,213,145,134.99935,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_JAMKRA010000075",93.103,6.67e-54,213,145,134.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_JAMKQZ010000090",93.103,6.67e-54,213,145,134.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45193","NZ_JAMKTM010000045",93.103,6.67e-54,213,145,134.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLSZ01000019",92.568,6.67e-54,213,148,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLSN01000023",92.568,6.67e-54,213,148,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49230","NZ_MLVX01000038",92.568,6.67e-54,213,148,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_JAMKRA010000075",93.151,6.62e-54,213,146,136.00046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_JAMKTM010000045",93.151,6.62e-54,213,146,136.00046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_MLVX01000038",92.617,6.62e-54,213,149,137.99933,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_JAMKRA010000075",92.617,6.62e-54,213,149,137.99933,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11212","NZ_JAMKTM010000045",92.617,6.62e-54,213,149,137.99933,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLSZ01000019",92.568,6.62e-54,213,148,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLSN01000023",92.568,6.62e-54,213,148,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_MLVX01000038",92.568,6.62e-54,213,148,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_JAMKRA010000075",92.568,6.62e-54,213,148,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_JAMKQZ010000090",92.568,6.62e-54,213,148,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10950","NZ_JAMKTM010000045",92.568,6.62e-54,213,148,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLSZ01000019",92,2.4e-53,211,150,138,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLSN01000023",92,2.4e-53,211,150,138,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46110","NZ_MLVX01000038",92,2.4e-53,211,150,138,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_MLVX01000038",92,8.56e-53,209,150,138,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLSZ01000019",92.414,3.08e-52,207,145,134.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLSN01000023",92.414,3.08e-52,207,145,134.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_MLVX01000038",92.414,3.08e-52,207,145,134.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_JAMKRA010000075",92.414,3.08e-52,207,145,134.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24185","NZ_JAMKTM010000045",92.414,3.08e-52,207,145,134.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_JAMKRA010000075",92.466,3.08e-52,207,146,135.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_JAMKTM010000045",92.466,3.08e-52,207,146,135.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLSZ01000019",92.466,3.08e-52,207,146,135.00036,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLSN01000023",92.466,3.08e-52,207,146,135.00036,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6191","NZ_MLVX01000038",92.466,3.08e-52,207,146,135.00036,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_JAMKRA010000075",92.466,3.08e-52,207,146,135.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_JAMKTM010000045",92.466,3.08e-52,207,146,135.00036,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_MLVX01000038",91.946,3.08e-52,207,149,136.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_JAMKRA010000075",91.946,3.08e-52,207,149,136.99954,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11213","NZ_JAMKTM010000045",91.946,3.08e-52,207,149,136.99954,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_MLVX01000038",91.946,3.08e-52,207,149,136.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_JAMKRA010000075",91.946,3.08e-52,207,149,136.99954,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_11214","NZ_JAMKTM010000045",91.946,3.08e-52,207,149,136.99954,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLSZ01000019",91.195,3.1e-52,207,159,145.00005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLSN01000023",91.195,3.1e-52,207,159,145.00005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_MLVX01000038",91.195,3.1e-52,207,159,145.00005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_JAMKRA010000075",91.333,1.12e-51,206,150,136.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_JAMKQZ010000090",91.333,1.12e-51,206,150,136.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_JAMKTM010000045",91.333,1.12e-51,206,150,136.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_JAMKRA010000075",96.063,1.11e-51,206,127,122.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_40143","NZ_JAMKTM010000045",96.063,1.11e-51,206,127,122.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLSZ01000019",96.032,1.12e-51,206,126,121.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLSN01000023",96.032,1.12e-51,206,126,121.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_MLVX01000038",96.032,1.12e-51,206,126,121.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLSZ01000019",92.414,1.09e-51,206,145,134.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLSN01000023",92.414,1.09e-51,206,145,134.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_MLVX01000038",92.414,1.09e-51,206,145,134.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_JAMKRA010000075",92.414,1.09e-51,206,145,134.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_JAMKQZ010000090",92.414,1.09e-51,206,145,134.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17957","NZ_JAMKTM010000045",92.414,1.09e-51,206,145,134.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLSZ01000019",91.139,1.11e-51,206,158,143.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLSN01000023",91.139,1.11e-51,206,158,143.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_MLVX01000038",91.139,1.11e-51,206,158,143.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLSZ01000019",91.139,1.11e-51,206,158,143.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLSN01000023",91.139,1.11e-51,206,158,143.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_MLVX01000038",91.139,1.11e-51,206,158,143.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLSZ01000019",91.946,1.1e-51,206,149,136.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLSN01000023",91.946,1.1e-51,206,149,136.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_MLVX01000038",91.946,1.1e-51,206,149,136.99954,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_JAMKRA010000075",91.946,1.1e-51,206,149,136.99954,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7191","NZ_JAMKTM010000045",91.946,1.1e-51,206,149,136.99954,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLSZ01000019",91.275,3.98e-51,204,149,135.99975,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLSN01000023",91.275,3.98e-51,204,149,135.99975,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_MLVX01000038",91.275,3.98e-51,204,149,135.99975,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_JAMKRA010000075",91.275,3.98e-51,204,149,135.99975,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_JAMKQZ010000090",91.275,3.98e-51,204,149,135.99975,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18923","NZ_JAMKTM010000045",91.275,3.98e-51,204,149,135.99975,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLSZ01000019",96,3.98e-51,204,125,120,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLSN01000023",96,3.98e-51,204,125,120,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_MLVX01000038",96,3.98e-51,204,125,120,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLSZ01000019",91.724,1.44e-50,202,145,132.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLSN01000023",91.724,1.44e-50,202,145,132.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_MLVX01000038",91.724,1.44e-50,202,145,132.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_JAMKRA010000075",91.724,1.44e-50,202,145,132.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_JAMKQZ010000090",91.724,1.44e-50,202,145,132.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_66999","NZ_JAMKTM010000045",91.724,1.44e-50,202,145,132.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLSZ01000019",90.566,1.44e-50,202,159,143.99994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLSN01000023",90.566,1.44e-50,202,159,143.99994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_MLVX01000038",90.566,1.44e-50,202,159,143.99994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLSZ01000019",94.615,1.22e-50,202,130,122.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLSN01000023",94.615,1.22e-50,202,130,122.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_MLVX01000038",94.615,1.22e-50,202,130,122.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_JAMKRA010000075",94.615,1.22e-50,202,130,122.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_JAMKQZ010000090",94.615,1.22e-50,202,130,122.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29529","NZ_JAMKTM010000045",94.615,1.22e-50,202,130,122.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_JAMKRA010000075",92.308,1.43e-50,202,143,132.00044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_JAMKTM010000045",92.308,1.43e-50,202,143,132.00044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLSZ01000019",91.781,1.43e-50,202,146,134.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLSN01000023",91.781,1.43e-50,202,146,134.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6189","NZ_MLVX01000038",91.781,1.43e-50,202,146,134.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLSZ01000019",91.781,1.43e-50,202,146,134.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLSN01000023",91.781,1.43e-50,202,146,134.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6192","NZ_MLVX01000038",91.781,1.43e-50,202,146,134.00026,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLSZ01000019",90.566,1.44e-50,202,159,143.99994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLSN01000023",90.566,1.44e-50,202,159,143.99994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_MLVX01000038",90.566,1.44e-50,202,159,143.99994,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_MLVX01000038",94.656,1.43e-50,202,131,123.99936,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_JAMKRA010000075",94.656,1.43e-50,202,131,123.99936,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5236","NZ_JAMKTM010000045",94.656,1.43e-50,202,131,123.99936,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLSZ01000019",90.667,5.2e-50,200,150,136.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLSN01000023",90.667,5.2e-50,200,150,136.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_46108","NZ_MLVX01000038",90.667,5.2e-50,200,150,136.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLSZ01000019",90.506,5.15e-50,200,158,142.99948,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLSN01000023",90.506,5.15e-50,200,158,142.99948,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_MLVX01000038",90.506,5.15e-50,200,158,142.99948,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_MLVX01000038",90.728,5.2e-50,200,151,136.99928,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_JAMKRA010000075",90.728,5.2e-50,200,151,136.99928,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7338","NZ_JAMKTM010000045",90.728,5.2e-50,200,151,136.99928,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_JAMKRA010000075",90.667,1.85e-49,198,150,136.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_JAMKQZ010000090",90.667,1.85e-49,198,150,136.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_JAMKTM010000045",90.667,1.85e-49,198,150,136.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_JAMKRA010000075",90.667,1.85e-49,198,150,136.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_JAMKQZ010000090",90.667,1.85e-49,198,150,136.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_JAMKTM010000045",90.667,1.85e-49,198,150,136.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLSZ01000019",90.604,1.85e-49,198,149,134.99996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLSN01000023",90.604,1.85e-49,198,149,134.99996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_MLVX01000038",90.604,1.85e-49,198,149,134.99996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_JAMKRA010000075",90.604,1.85e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_JAMKQZ010000090",90.604,1.85e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18924","NZ_JAMKTM010000045",90.604,1.85e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_MLVX01000038",91.667,1.85e-49,198,144,132.00048,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_JAMKRA010000075",91.667,1.85e-49,198,144,132.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12935","NZ_JAMKTM010000045",91.667,1.85e-49,198,144,132.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_JAMKRA010000075",90.604,1.85e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_JAMKQZ010000090",90.604,1.85e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_JAMKTM010000045",90.604,1.85e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_MLVX01000038",91.667,1.85e-49,198,144,132.00048,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_JAMKRA010000075",91.667,1.85e-49,198,144,132.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9807","NZ_JAMKTM010000045",91.667,1.85e-49,198,144,132.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLSZ01000019",95.902,1.58e-49,198,122,117.00044,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLSN01000023",95.902,1.58e-49,198,122,117.00044,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_MLVX01000038",95.902,1.58e-49,198,122,117.00044,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_JAMKRA010000075",90.062,1.87e-49,198,161,144.99982,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_JAMKQZ010000090",90.062,1.87e-49,198,161,144.99982,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17492","NZ_JAMKTM010000045",90.062,1.87e-49,198,161,144.99982,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_JAMKRA010000075",90.604,1.87e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_JAMKQZ010000090",90.604,1.87e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_JAMKTM010000045",90.604,1.87e-49,198,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_JAMKRA010000075",90.604,6.67e-49,196,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_JAMKQZ010000090",90.604,6.67e-49,196,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_JAMKTM010000045",90.604,6.67e-49,196,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLSZ01000019",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLSN01000023",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_MLVX01000038",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLSZ01000019",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLSN01000023",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_MLVX01000038",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLSZ01000019",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLSN01000023",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_MLVX01000038",89.937,6.72e-49,196,159,142.99983,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLSZ01000019",93.846,5.68e-49,196,130,121.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLSN01000023",93.846,5.68e-49,196,130,121.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_MLVX01000038",93.846,5.68e-49,196,130,121.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_JAMKRA010000075",93.846,5.68e-49,196,130,121.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_JAMKQZ010000090",93.846,5.68e-49,196,130,121.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_29530","NZ_JAMKTM010000045",93.846,5.68e-49,196,130,121.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_JAMKRA010000075",91.667,6.67e-49,196,144,132.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_JAMKTM010000045",91.667,6.67e-49,196,144,132.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_JAMKRA010000075",90,6.67e-49,196,160,144,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_JAMKQZ010000090",90,6.67e-49,196,160,144,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20590","NZ_JAMKTM010000045",90,6.67e-49,196,160,144,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLSZ01000019",89.873,2.4e-48,195,158,141.99934,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLSN01000023",89.873,2.4e-48,195,158,141.99934,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_MLVX01000038",89.873,2.4e-48,195,158,141.99934,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLSZ01000019",90.132,2.42e-48,195,152,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLSN01000023",90.132,2.42e-48,195,152,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_MLVX01000038",90.132,2.42e-48,195,152,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_JAMKRA010000075",90.132,2.42e-48,195,152,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_JAMKQZ010000090",90.132,2.42e-48,195,152,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46927","NZ_JAMKTM010000045",90.132,2.42e-48,195,152,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLSZ01000019",90.132,2.42e-48,195,152,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLSN01000023",90.132,2.42e-48,195,152,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_MLVX01000038",90.132,2.42e-48,195,152,137.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_JAMKRA010000075",90.132,2.42e-48,195,152,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_JAMKQZ010000090",90.132,2.42e-48,195,152,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46928","NZ_JAMKTM010000045",90.132,2.42e-48,195,152,137.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_JAMKRA010000075",91.489,2.4e-48,195,141,128.99949,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_JAMKTM010000045",91.489,2.4e-48,195,141,128.99949,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_JAMKRA010000075",94.444,2.42e-48,195,126,118.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4116","NZ_JAMKTM010000045",94.444,2.42e-48,195,126,118.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLSZ01000019",90.476,2.42e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLSN01000023",90.476,2.42e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_MLVX01000038",90.476,2.42e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_JAMKRA010000075",90.476,2.42e-48,195,147,132.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_JAMKQZ010000090",91.489,2.42e-48,195,141,128.99949,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12762","NZ_JAMKTM010000045",90.476,2.42e-48,195,147,132.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLSZ01000019",90.476,2.38e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLSN01000023",90.476,2.38e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_MLVX01000038",90.476,2.38e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_JAMKRA010000075",90.476,2.38e-48,195,147,132.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_JAMKQZ010000090",91.489,2.38e-48,195,141,128.99949,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15944","NZ_JAMKTM010000045",90.476,2.38e-48,195,147,132.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLSZ01000019",90.476,2.4e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLSN01000023",90.476,2.4e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_MLVX01000038",90.476,2.4e-48,195,147,132.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_JAMKRA010000075",90.476,2.4e-48,195,147,132.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_JAMKQZ010000090",91.489,2.4e-48,195,141,128.99949,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15945","NZ_JAMKTM010000045",90.476,2.4e-48,195,147,132.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_JAMKRA010000075",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_JAMKQZ010000090",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_JAMKTM010000045",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_JAMKRA010000075",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_JAMKQZ010000090",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_JAMKTM010000045",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_JAMKRA010000075",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_JAMKQZ010000090",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_JAMKTM010000045",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_JAMKRA010000075",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_JAMKQZ010000090",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_JAMKTM010000045",90,8.62e-48,193,150,135,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_JAMKRA010000075",89.441,8.69e-48,193,161,144.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_JAMKQZ010000090",89.441,8.69e-48,193,161,144.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33916","NZ_JAMKTM010000045",89.441,8.69e-48,193,161,144.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLSZ01000019",89.933,8.62e-48,193,149,134.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLSN01000023",89.933,8.62e-48,193,149,134.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_30470","NZ_MLVX01000038",89.933,8.62e-48,193,149,134.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLVX01000038",91.034,8.62e-48,193,145,131.9993,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_MLVX01000038",92.537,8.48e-48,193,134,123.99958,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_JAMKRA010000075",92.537,8.48e-48,193,134,123.99958,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16584","NZ_JAMKTM010000045",92.537,8.48e-48,193,134,123.99958,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_JAMKRA010000075",89.441,8.69e-48,193,161,144.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_JAMKQZ010000090",89.441,8.69e-48,193,161,144.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17512","NZ_JAMKTM010000045",89.441,8.69e-48,193,161,144.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLSZ01000019",89.933,8.69e-48,193,149,134.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLSN01000023",89.933,8.69e-48,193,149,134.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19782","NZ_MLVX01000038",89.933,8.69e-48,193,149,134.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_JAMKRA010000075",94.4,8.62e-48,193,125,118,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4857","NZ_JAMKTM010000045",94.4,8.62e-48,193,125,118,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_JAMKRA010000075",89.375,3.1e-47,191,160,143,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_JAMKQZ010000090",89.375,3.1e-47,191,160,143,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2980","NZ_JAMKTM010000045",89.375,3.1e-47,191,160,143,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_JAMKRA010000075",90.604,3.13e-47,191,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_JAMKTM010000045",90.604,3.13e-47,191,149,134.99996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLSZ01000019",89.308,3.13e-47,191,159,141.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLSN01000023",89.308,3.13e-47,191,159,141.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_MLVX01000038",89.308,3.13e-47,191,159,141.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLSZ01000019",89.308,3.13e-47,191,159,141.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLSN01000023",89.308,3.13e-47,191,159,141.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_MLVX01000038",89.308,3.13e-47,191,159,141.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_JAMKRA010000075",89.375,3.1e-47,191,160,143,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_JAMKQZ010000090",89.375,3.1e-47,191,160,143,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20591","NZ_JAMKTM010000045",89.375,3.1e-47,191,160,143,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLSZ01000019",89.333,1.12e-46,189,150,133.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLSN01000023",89.333,1.12e-46,189,150,133.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_MLVX01000038",89.333,1.12e-46,189,150,133.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_JAMKRA010000075",89.333,1.12e-46,189,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_JAMKQZ010000090",89.333,1.12e-46,189,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_43188","NZ_JAMKTM010000045",89.333,1.12e-46,189,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLSZ01000019",90.411,1.08e-46,189,146,132.00006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLSN01000023",90.411,1.08e-46,189,146,132.00006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_MLVX01000038",90.411,1.08e-46,189,146,132.00006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_JAMKRA010000075",90.411,1.08e-46,189,146,132.00006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_JAMKQZ010000090",90.411,1.08e-46,189,146,132.00006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_20170","NZ_JAMKTM010000045",90.411,1.08e-46,189,146,132.00006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLSZ01000019",90.78,1.12e-46,189,141,127.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLSN01000023",90.78,1.12e-46,189,141,127.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4762","NZ_MLVX01000038",90.78,1.12e-46,189,141,127.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLSZ01000019",89.796,1.12e-46,189,147,132.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLSN01000023",89.796,1.12e-46,189,147,132.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_MLVX01000038",89.796,1.12e-46,189,147,132.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_JAMKRA010000075",89.796,1.12e-46,189,147,132.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_JAMKQZ010000090",90.78,1.12e-46,189,141,127.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15943","NZ_JAMKTM010000045",89.796,1.12e-46,189,147,132.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_JAMKRA010000075",89.404,4.01e-46,187,151,135.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_JAMKTM010000045",89.404,4.01e-46,187,151,135.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_JAMKRA010000075",89.333,4.01e-46,187,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_JAMKQZ010000090",89.333,4.01e-46,187,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_JAMKTM010000045",89.333,4.01e-46,187,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_JAMKRA010000075",89.333,4.01e-46,187,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_JAMKQZ010000090",89.333,4.01e-46,187,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_JAMKTM010000045",89.333,4.01e-46,187,150,133.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLSZ01000019",89.262,4.01e-46,187,149,133.00038,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLSN01000023",89.262,4.01e-46,187,149,133.00038,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_MLVX01000038",89.262,4.01e-46,187,149,133.00038,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_JAMKRA010000075",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_JAMKQZ010000090",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46894","NZ_JAMKTM010000045",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_JAMKRA010000075",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_JAMKQZ010000090",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_33915","NZ_JAMKTM010000045",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_JAMKRA010000075",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_JAMKQZ010000090",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_731","NZ_JAMKTM010000045",88.82,4.04e-46,187,161,143.0002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLVX01000038",90.411,4.01e-46,187,146,132.00006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_MLVX01000038",94.958,4.01e-46,187,119,113.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_JAMKRA010000075",94.958,4.01e-46,187,119,113.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27784","NZ_JAMKTM010000045",94.958,4.01e-46,187,119,113.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLVX01000038",89.333,4.01e-46,187,150,133.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_JAMKRA010000075",88.75,1.44e-45,185,160,142,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_JAMKQZ010000090",88.75,1.44e-45,185,160,142,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2979","NZ_JAMKTM010000045",88.75,1.44e-45,185,160,142,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLSZ01000019",89.189,1.45e-45,185,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLSN01000023",89.189,1.45e-45,185,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_MLVX01000038",89.189,1.45e-45,185,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_JAMKRA010000075",89.189,1.45e-45,185,148,131.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_JAMKQZ010000090",89.189,1.45e-45,185,148,131.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9309","NZ_JAMKTM010000045",89.189,1.45e-45,185,148,131.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLSZ01000019",89.189,1.44e-45,185,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLSN01000023",89.189,1.44e-45,185,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_MLVX01000038",89.189,1.44e-45,185,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_JAMKRA010000075",89.189,1.44e-45,185,148,131.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_JAMKQZ010000090",89.189,1.44e-45,185,148,131.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12385","NZ_JAMKTM010000045",89.189,1.44e-45,185,148,131.99972,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_JAMKRA010000075",90.345,1.44e-45,185,145,131.00025,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_JAMKTM010000045",90.345,1.44e-45,185,145,131.00025,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLSZ01000019",95.652,1.44e-45,185,115,109.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLSN01000023",95.652,1.44e-45,185,115,109.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_MLVX01000038",95.652,1.44e-45,185,115,109.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_JAMKRA010000075",95.652,1.44e-45,185,115,109.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_JAMKQZ010000090",95.652,1.44e-45,185,115,109.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6800","NZ_JAMKTM010000045",95.652,1.44e-45,185,115,109.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLSZ01000019",95.652,1.44e-45,185,115,109.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLSN01000023",95.652,1.44e-45,185,115,109.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_MLVX01000038",95.652,1.44e-45,185,115,109.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_JAMKRA010000075",95.652,1.44e-45,185,115,109.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_JAMKQZ010000090",95.652,1.44e-45,185,115,109.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15417","NZ_JAMKTM010000045",95.652,1.44e-45,185,115,109.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_JAMKRA010000075",91.176,5.23e-45,183,136,123.99936,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_JAMKTM010000045",91.176,5.23e-45,183,136,123.99936,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLSZ01000019",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLSN01000023",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16216","NZ_MLVX01000038",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLSZ01000019",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLSN01000023",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16217","NZ_MLVX01000038",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLSZ01000019",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLSN01000023",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16223","NZ_MLVX01000038",89.189,5.19e-45,183,148,131.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_JAMKRA010000075",93.548,4.42e-45,183,124,115.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_JAMKQZ010000090",93.548,4.42e-45,183,124,115.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_6918","NZ_JAMKTM010000045",93.548,4.42e-45,183,124,115.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLSZ01000019",92.913,5.19e-45,183,127,117.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLSN01000023",92.913,5.19e-45,183,127,117.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_MLVX01000038",92.913,5.19e-45,183,127,117.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_JAMKRA010000075",92.913,5.19e-45,183,127,117.99951,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9865","NZ_JAMKTM010000045",92.913,5.19e-45,183,127,117.99951,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLSZ01000019",92.913,5.19e-45,183,127,117.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLSN01000023",92.913,5.19e-45,183,127,117.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_MLVX01000038",92.913,5.19e-45,183,127,117.99951,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_JAMKRA010000075",92.913,5.19e-45,183,127,117.99951,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9866","NZ_JAMKTM010000045",92.913,5.19e-45,183,127,117.99951,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLSZ01000019",88.608,5.19e-45,183,158,140.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLSN01000023",88.608,5.19e-45,183,158,140.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_MLVX01000038",88.608,5.19e-45,183,158,140.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_JAMKRA010000075",91.176,1.87e-44,182,136,123.99936,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_JAMKTM010000045",91.176,1.87e-44,182,136,123.99936,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_JAMKRA010000075",88.591,1.87e-44,182,149,132.00059,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_17106","NZ_JAMKTM010000045",88.591,1.87e-44,182,149,132.00059,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_JAMKRA010000075",88.199,1.88e-44,182,161,142.00039,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_JAMKQZ010000090",88.199,1.88e-44,182,161,142.00039,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46892","NZ_JAMKTM010000045",88.199,1.88e-44,182,161,142.00039,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_JAMKRA010000075",88.199,1.88e-44,182,161,142.00039,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_JAMKQZ010000090",88.199,1.88e-44,182,161,142.00039,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_46893","NZ_JAMKTM010000045",88.199,1.88e-44,182,161,142.00039,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_MLVX01000038",94.118,1.87e-44,182,119,112.00042,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_JAMKRA010000075",94.118,1.87e-44,182,119,112.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27785","NZ_JAMKTM010000045",94.118,1.87e-44,182,119,112.00042,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLSZ01000019",88.591,1.87e-44,182,149,132.00059,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLSN01000023",88.591,1.87e-44,182,149,132.00059,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_MLVX01000038",88.591,1.87e-44,182,149,132.00059,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_JAMKRA010000075",88.591,1.87e-44,182,149,132.00059,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23967","NZ_JAMKTM010000045",88.591,1.87e-44,182,149,132.00059,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_JAMKRA010000075",88.816,1.87e-44,182,152,135.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_JAMKTM010000045",88.816,1.87e-44,182,152,135.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLSZ01000019",88.05,6.77e-44,180,159,139.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLSN01000023",88.05,6.77e-44,180,159,139.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_MLVX01000038",88.05,6.77e-44,180,159,139.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_JAMKRA010000075",89.928,6.71e-44,180,139,124.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_JAMKTM010000045",89.928,6.71e-44,180,139,124.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_67129","NZ_MLVX01000038",98.058,6.77e-44,180,103,100.99974,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_JAMKRA010000075",88.591,6.71e-44,180,149,132.00059,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_1306","NZ_JAMKTM010000045",88.591,6.71e-44,180,149,132.00059,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLSZ01000019",90.441,6.71e-44,180,136,122.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLSN01000023",90.441,6.71e-44,180,136,122.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_MLVX01000038",90.441,6.71e-44,180,136,122.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_JAMKRA010000075",90.441,6.71e-44,180,136,122.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_JAMKQZ010000090",91.538,6.71e-44,180,130,118.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40462","NZ_JAMKTM010000045",90.441,6.71e-44,180,136,122.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_JAMKRA010000075",91.667,5.72e-44,180,132,121.00044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_JAMKTM010000045",91.667,5.72e-44,180,132,121.00044,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_JAMKRA010000075",93.443,6.71e-44,180,122,114.00046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_JAMKQZ010000090",93.443,6.71e-44,180,122,114.00046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_JAMKTM010000045",93.443,6.71e-44,180,122,114.00046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLSZ01000019",92.126,6.71e-44,180,127,117.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLSN01000023",92.126,6.71e-44,180,127,117.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_MLVX01000038",92.126,6.71e-44,180,127,117.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_JAMKRA010000075",92.126,6.71e-44,180,127,117.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_JAMKQZ010000090",92.126,6.71e-44,180,127,117.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18093","NZ_JAMKTM010000045",92.126,6.71e-44,180,127,117.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLSZ01000019",92.126,6.77e-44,180,127,117.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLSN01000023",92.126,6.77e-44,180,127,117.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_MLVX01000038",92.126,6.77e-44,180,127,117.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_JAMKRA010000075",92.126,6.77e-44,180,127,117.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_JAMKQZ010000090",92.126,6.77e-44,180,127,117.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_18094","NZ_JAMKTM010000045",92.126,6.77e-44,180,127,117.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_JAMKRA010000075",90.441,2.43e-43,178,136,122.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_JAMKTM010000045",90.441,2.43e-43,178,136,122.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLSZ01000019",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLSN01000023",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16218","NZ_MLVX01000038",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLSZ01000019",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLSN01000023",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16219","NZ_MLVX01000038",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLSZ01000019",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLSN01000023",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16221","NZ_MLVX01000038",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLSZ01000019",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLSN01000023",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16224","NZ_MLVX01000038",88.514,2.41e-43,178,148,131.00072,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLSZ01000019",88.079,8.68e-43,176,151,132.99929,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLSN01000023",88.079,8.68e-43,176,151,132.99929,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21925","NZ_MLVX01000038",88.079,8.68e-43,176,151,132.99929,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_JAMKRA010000075",88,8.68e-43,176,150,132,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_JAMKQZ010000090",88,8.68e-43,176,150,132,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_JAMKTM010000045",88,8.68e-43,176,150,132,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_JAMKRA010000075",87.919,8.68e-43,176,149,130.99931,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_JAMKQZ010000090",87.919,8.68e-43,176,149,130.99931,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_JAMKTM010000045",87.919,8.68e-43,176,149,130.99931,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLSZ01000019",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLSN01000023",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_MLVX01000038",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLSZ01000019",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLSN01000023",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_MLVX01000038",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLSZ01000019",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLSN01000023",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_MLVX01000038",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLSZ01000019",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLSN01000023",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_MLVX01000038",87.421,3.15e-42,174,159,138.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_JAMKRA010000075",89.209,3.12e-42,174,139,124.00051,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_JAMKTM010000045",89.209,3.12e-42,174,139,124.00051,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_JAMKRA010000075",89.209,3.12e-42,174,139,124.00051,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_JAMKTM010000045",89.209,3.12e-42,174,139,124.00051,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLSZ01000019",89.209,3.12e-42,174,139,124.00051,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLSN01000023",89.209,3.12e-42,174,139,124.00051,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56283","NZ_MLVX01000038",89.209,3.12e-42,174,139,124.00051,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_JAMKRA010000075",88.356,3.12e-42,174,146,128.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3637","NZ_JAMKTM010000045",88.356,3.12e-42,174,146,128.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLSZ01000019",89.706,3.12e-42,174,136,122.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLSN01000023",89.706,3.12e-42,174,136,122.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47153","NZ_MLVX01000038",89.706,3.12e-42,174,136,122.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_JAMKRA010000075",87.838,3.12e-42,174,148,130.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_JAMKQZ010000090",87.838,3.12e-42,174,148,130.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_JAMKTM010000045",87.838,3.12e-42,174,148,130.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLSZ01000019",89.706,3.12e-42,174,136,122.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLSN01000023",89.706,3.12e-42,174,136,122.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_MLVX01000038",89.706,3.12e-42,174,136,122.00016,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_JAMKRA010000075",89.706,3.12e-42,174,136,122.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_JAMKQZ010000090",90.769,3.12e-42,174,130,117.9997,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_40461","NZ_JAMKTM010000045",89.706,3.12e-42,174,136,122.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLSZ01000019",95.413,3.12e-42,174,109,104.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLSN01000023",95.413,3.12e-42,174,109,104.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15310","NZ_MLVX01000038",95.413,3.12e-42,174,109,104.00017,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_JAMKRA010000075",88.966,3.12e-42,174,145,129.0007,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_JAMKTM010000045",88.966,3.12e-42,174,145,129.0007,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLSZ01000019",89.041,3.12e-42,174,146,129.99986,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLSN01000023",89.041,3.12e-42,174,146,129.99986,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22432","NZ_MLVX01000038",89.041,3.12e-42,174,146,129.99986,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_JAMKRA010000075",87.5,3.12e-42,174,160,140,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_JAMKQZ010000090",87.5,3.12e-42,174,160,140,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10597","NZ_JAMKTM010000045",87.5,3.12e-42,174,160,140,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLSZ01000019",89.781,1.13e-41,172,137,122.99997,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLSN01000023",89.781,1.13e-41,172,137,122.99997,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49680","NZ_MLVX01000038",89.781,1.13e-41,172,137,122.99997,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_JAMKRA010000075",89.13,1.12e-41,172,138,122.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_JAMKTM010000045",89.13,1.12e-41,172,138,122.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLSZ01000019",87.838,1.12e-41,172,148,130.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLSN01000023",87.838,1.12e-41,172,148,130.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16220","NZ_MLVX01000038",87.838,1.12e-41,172,148,130.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLSZ01000019",87.838,1.12e-41,172,148,130.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLSN01000023",87.838,1.12e-41,172,148,130.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16266","NZ_MLVX01000038",87.838,1.12e-41,172,148,130.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLSZ01000019",89.63,1.12e-41,172,135,121.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLSN01000023",89.63,1.12e-41,172,135,121.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47154","NZ_MLVX01000038",89.63,1.12e-41,172,135,121.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_JAMKRA010000075",87.755,1.11e-41,172,147,128.99985,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_JAMKTM010000045",87.755,1.11e-41,172,147,128.99985,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLSZ01000019",87.333,4.04e-41,171,150,130.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLSN01000023",87.333,4.04e-41,171,150,130.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23030","NZ_MLVX01000038",87.333,4.04e-41,171,150,130.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_JAMKRA010000075",87.333,4.04e-41,171,150,130.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_JAMKQZ010000090",87.333,4.04e-41,171,150,130.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_JAMKTM010000045",87.333,4.04e-41,171,150,130.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_JAMKRA010000075",86.957,4.07e-41,171,161,140.00077,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_JAMKQZ010000090",86.957,4.07e-41,171,161,140.00077,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31013","NZ_JAMKTM010000045",86.957,4.07e-41,171,161,140.00077,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_JAMKRA010000075",86.957,4.07e-41,171,161,140.00077,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_JAMKQZ010000090",86.957,4.07e-41,171,161,140.00077,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31015","NZ_JAMKTM010000045",86.957,4.07e-41,171,161,140.00077,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_JAMKRA010000075",87.248,4.04e-41,171,149,129.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_JAMKQZ010000090",87.248,4.04e-41,171,149,129.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_JAMKTM010000045",87.248,4.04e-41,171,149,129.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLSZ01000019",87.417,4.04e-41,171,151,131.99967,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_18948","NZ_MLSN01000023",87.417,4.04e-41,171,151,131.99967,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLSZ01000019",90.551,1.47e-40,169,127,114.99977,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLSN01000023",90.551,1.47e-40,169,127,114.99977,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_MLVX01000038",90.551,1.47e-40,169,127,114.99977,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_JAMKRA010000075",90.551,1.47e-40,169,127,114.99977,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_JAMKQZ010000090",87.586,1.47e-40,169,145,126.9997,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27203","NZ_JAMKTM010000045",90.551,1.47e-40,169,127,114.99977,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLSZ01000019",87.097,1.47e-40,169,155,135.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLSN01000023",87.097,1.47e-40,169,155,135.00035,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLSZ01000019",88.489,1.45e-40,169,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLSN01000023",88.489,1.45e-40,169,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56281","NZ_MLVX01000038",88.489,1.45e-40,169,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLSZ01000019",88.489,1.45e-40,169,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLSN01000023",88.489,1.45e-40,169,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56282","NZ_MLVX01000038",88.489,1.45e-40,169,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLSZ01000019",88.971,1.45e-40,169,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLSN01000023",88.971,1.45e-40,169,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_47152","NZ_MLVX01000038",88.971,1.45e-40,169,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLSZ01000019",90.152,1.24e-40,169,132,119.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLSN01000023",90.152,1.24e-40,169,132,119.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12258","NZ_MLVX01000038",90.152,1.24e-40,169,132,119.00064,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_JAMKRA010000075",91.736,1.19e-40,169,121,111.00056,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_JAMKTM010000045",91.736,1.19e-40,169,121,111.00056,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLSZ01000019",89.051,5.27e-40,167,137,121.99987,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLSN01000023",89.051,5.27e-40,167,137,121.99987,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_49679","NZ_MLVX01000038",89.051,5.27e-40,167,137,121.99987,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_JAMKRA010000075",86.755,5.27e-40,167,151,131.00005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_JAMKTM010000045",86.755,5.27e-40,167,151,131.00005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_MLVX01000038",94.545,5.27e-40,167,110,103.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_JAMKRA010000075",94.545,5.27e-40,167,110,103.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_48814","NZ_JAMKTM010000045",94.545,5.27e-40,167,110,103.9995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLSZ01000019",88.406,5.23e-40,167,138,122.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLSN01000023",88.406,5.23e-40,167,138,122.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_56284","NZ_MLVX01000038",88.406,5.23e-40,167,138,122.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLSZ01000019",89.394,5.23e-40,167,132,118.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLSN01000023",89.394,5.23e-40,167,132,118.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_MLVX01000038",89.394,5.23e-40,167,132,118.00008,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_JAMKRA010000075",90.076,4.46e-40,167,131,117.99956,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_JAMKTM010000045",90.076,4.46e-40,167,131,117.99956,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_JAMKRA010000075",90.076,4.46e-40,167,131,117.99956,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_JAMKTM010000045",90.076,4.46e-40,167,131,117.99956,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLVX01000038",87.075,5.27e-40,167,147,128.00025,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLSZ01000019",86.667,1.88e-39,165,150,130.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLSN01000023",86.667,1.88e-39,165,150,130.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_23031","NZ_MLVX01000038",86.667,1.88e-39,165,150,130.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_JAMKRA010000075",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_JAMKQZ010000090",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31014","NZ_JAMKTM010000045",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_JAMKRA010000075",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_JAMKQZ010000090",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31016","NZ_JAMKTM010000045",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_JAMKRA010000075",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_JAMKQZ010000090",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31017","NZ_JAMKTM010000045",86.335,1.9e-39,165,161,138.99935,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLSZ01000019",88.971,1.88e-39,165,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLSN01000023",88.971,1.88e-39,165,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_42346","NZ_MLVX01000038",88.971,1.88e-39,165,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLSZ01000019",88.489,1.9e-39,165,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLSN01000023",88.489,1.9e-39,165,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_MLVX01000038",88.489,1.9e-39,165,139,122.99971,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLSZ01000019",88.971,1.88e-39,165,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLSN01000023",88.971,1.88e-39,165,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_MLVX01000038",88.971,1.88e-39,165,136,121.00056,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_JAMKRA010000075",86.667,1.88e-39,165,150,130.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_JAMKTM010000045",86.667,1.88e-39,165,150,130.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLSZ01000019",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLSN01000023",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_MLVX01000038",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_JAMKRA010000075",89.764,6.82e-39,163,127,114.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_JAMKQZ010000090",86.897,6.82e-39,163,145,126.00065,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27202","NZ_JAMKTM010000045",89.764,6.82e-39,163,127,114.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSZ01000019",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSN01000023",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLVX01000038",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JAMKRA010000075",89.764,6.82e-39,163,127,114.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JAMKQZ010000090",86.897,6.82e-39,163,145,126.00065,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JAMKTM010000045",89.764,6.82e-39,163,127,114.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLSZ01000019",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLSN01000023",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_MLVX01000038",89.764,6.82e-39,163,127,114.00028,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_JAMKRA010000075",89.764,6.82e-39,163,127,114.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_JAMKQZ010000090",86.897,6.82e-39,163,145,126.00065,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27205","NZ_JAMKTM010000045",89.764,6.82e-39,163,127,114.00028,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLVX01000038",86.275,6.82e-39,163,153,132.00075,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_JAMKRA010000075",94.34,6.82e-39,163,106,100.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_JAMKQZ010000090",93.578,6.82e-39,163,109,102.00002,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_15030","NZ_JAMKTM010000045",94.34,6.82e-39,163,106,100.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLSZ01000019",90.909,5.54e-39,163,121,109.99989,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLSN01000023",90.909,5.54e-39,163,121,109.99989,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17597","NZ_MLVX01000038",90.909,5.54e-39,163,121,109.99989,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_JAMKRA010000075",86.755,6.82e-39,163,151,131.00005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_JAMKTM010000045",86.755,6.82e-39,163,151,131.00005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLSZ01000019",87.671,6.76e-39,163,146,127.99966,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLSN01000023",87.671,6.76e-39,163,146,127.99966,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_22431","NZ_MLVX01000038",87.671,6.76e-39,163,146,127.99966,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_JAMKRA010000075",88.636,2.43e-38,161,132,116.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19934","NZ_JAMKTM010000045",88.636,2.43e-38,161,132,116.99952,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLSZ01000019",86.395,2.43e-38,161,147,127.00065,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLSN01000023",86.395,2.43e-38,161,147,127.00065,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_MLVX01000038",86.395,2.43e-38,161,147,127.00065,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLSZ01000019",89.313,2.07e-38,161,131,117.00003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLSN01000023",89.313,2.07e-38,161,131,117.00003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28203","NZ_MLVX01000038",89.313,2.07e-38,161,131,117.00003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLSZ01000019",89.313,2.07e-38,161,131,117.00003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLSN01000023",89.313,2.07e-38,161,131,117.00003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28204","NZ_MLVX01000038",89.313,2.07e-38,161,131,117.00003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_JAMKRA010000075",86.667,2.43e-38,161,150,130.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_JAMKTM010000045",86.667,2.43e-38,161,150,130.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLVX01000038",86.184,2.43e-38,161,152,130.99968,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLSZ01000019",96.842,7.46e-38,159,95,91.9999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLSN01000023",96.842,7.46e-38,159,95,91.9999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_MLVX01000038",96.842,7.46e-38,159,95,91.9999,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_JAMKRA010000075",96.842,7.46e-38,159,95,91.9999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_JAMKQZ010000090",97.826,7.46e-38,159,92,89.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_32720","NZ_JAMKTM010000045",96.842,7.46e-38,159,95,91.9999,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_JAMKRA010000075",86.184,8.82e-38,159,152,130.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_JAMKTM010000045",86.184,8.82e-38,159,152,130.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_JAMKRA010000075",86.395,8.82e-38,159,147,127.00065,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_JAMKTM010000045",86.395,8.82e-38,159,147,127.00065,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_JAMKRA010000075",94.175,3.15e-37,158,103,97.00025,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_JAMKQZ010000090",93.396,3.15e-37,158,106,98.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13978","NZ_JAMKTM010000045",94.175,3.15e-37,158,103,97.00025,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLSZ01000019",85.714,1.12e-36,156,147,125.99958,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLSN01000023",85.714,1.12e-36,156,147,125.99958,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_12218","NZ_MLVX01000038",85.714,1.12e-36,156,147,125.99958,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLSZ01000019",90.517,4.07e-36,154,116,104.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLSN01000023",90.517,4.07e-36,154,116,104.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_MLVX01000038",90.517,4.07e-36,154,116,104.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_JAMKRA010000075",90.598,4.07e-36,154,117,105.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_31143","NZ_JAMKTM010000045",90.598,4.07e-36,154,117,105.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLSZ01000019",86.861,4.1e-36,154,137,118.99957,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLSN01000023",86.861,4.1e-36,154,137,118.99957,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_MLVX01000038",86.861,4.1e-36,154,137,118.99957,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_JAMKRA010000075",94.898,4.07e-36,154,98,93.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_JAMKQZ010000090",94.898,4.07e-36,154,98,93.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT01RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_8132","NZ_JAMKTM010000045",94.898,4.07e-36,154,98,93.00004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLSZ01000019",86.957,4.1e-36,154,138,120.00066,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLSN01000023",86.957,4.1e-36,154,138,120.00066,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_MLVX01000038",86.957,4.1e-36,154,138,120.00066,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLVX01000038",85.621,4.1e-36,154,153,131.00013,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_MLVX01000038",86.111,3.9e-36,154,144,123.99984,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_JAMKRA010000075",86.111,3.9e-36,154,144,123.99984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_21217","NZ_JAMKTM010000045",86.111,3.9e-36,154,144,123.99984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLSZ01000019",86.765,1.48e-35,152,136,118.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLSN01000023",86.765,1.48e-35,152,136,118.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_MLVX01000038",86.765,1.48e-35,152,136,118.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLSZ01000019",98.824,7.08e-36,152,85,84.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLSN01000023",98.824,7.08e-36,152,85,84.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_MLVX01000038",98.824,7.08e-36,152,85,84.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_JAMKRA010000075",98.824,7.08e-36,152,85,84.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_JAMKQZ010000090",98.824,7.08e-36,152,85,84.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_25105","NZ_JAMKTM010000045",98.824,7.08e-36,152,85,84.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_JAMKRA010000075",87.786,1.25e-35,152,131,114.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_JAMKQZ010000090",87.786,1.25e-35,152,131,114.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_JAMKTM010000045",87.786,1.25e-35,152,131,114.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_JAMKRA010000075",86.861,1.32e-35,152,137,118.99957,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_JAMKQZ010000090",86.861,1.32e-35,152,137,118.99957,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_JAMKTM010000045",86.861,1.32e-35,152,137,118.99957,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLVX01000038",85.526,1.46e-35,152,152,129.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLVX01000038",85.065,5.31e-35,150,154,131.0001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLSZ01000019",89.256,5.31e-35,150,121,107.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLSN01000023",89.256,5.31e-35,150,121,107.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_MLVX01000038",89.256,5.31e-35,150,121,107.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_JAMKRA010000075",89.256,5.31e-35,150,121,107.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_JAMKQZ010000090",89.256,5.31e-35,150,121,107.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26718","NZ_JAMKTM010000045",89.256,5.31e-35,150,121,107.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLSZ01000019",89.256,5.31e-35,150,121,107.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLSN01000023",89.256,5.31e-35,150,121,107.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_MLVX01000038",89.256,5.31e-35,150,121,107.99976,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_JAMKRA010000075",89.256,5.31e-35,150,121,107.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_JAMKQZ010000090",89.256,5.31e-35,150,121,107.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26719","NZ_JAMKTM010000045",89.256,5.31e-35,150,121,107.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_JAMKRA010000075",89.344,5.31e-35,150,122,108.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_JAMKQZ010000090",89.344,5.31e-35,150,122,108.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_JAMKTM010000045",89.344,5.31e-35,150,122,108.99968,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_JAMKRA010000075",84.667,1.89e-34,148,150,127.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_JAMKQZ010000090",84.667,1.89e-34,148,150,127.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_JAMKTM010000045",84.667,1.89e-34,148,150,127.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_MLVX01000038",97.674,1.44e-34,148,86,83.99964,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_JAMKRA010000075",97.674,1.44e-34,148,86,83.99964,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71299","NZ_JAMKTM010000045",97.674,1.44e-34,148,86,83.99964,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_MLVX01000038",87.786,1.89e-34,148,131,114.99966,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_JAMKRA010000075",87.786,1.89e-34,148,131,114.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11834","NZ_JAMKTM010000045",87.786,1.89e-34,148,131,114.99966,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLSZ01000019",86.131,1.91e-34,148,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLSN01000023",86.131,1.91e-34,148,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_MLVX01000038",86.131,1.91e-34,148,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLSZ01000019",86.131,1.91e-34,148,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLSN01000023",86.131,1.91e-34,148,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_MLVX01000038",86.131,1.91e-34,148,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_JAMKRA010000075",84.667,1.89e-34,148,150,127.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_JAMKQZ010000090",84.667,1.89e-34,148,150,127.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_JAMKTM010000045",84.667,1.89e-34,148,150,127.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_JAMKRA010000075",86.232,1.91e-34,148,138,119.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_JAMKQZ010000090",86.232,1.91e-34,148,138,119.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_20751","NZ_JAMKTM010000045",86.232,1.91e-34,148,138,119.00016,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLSZ01000019",97.647,3.29e-34,147,85,82.99995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLSN01000023",97.647,3.29e-34,147,85,82.99995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_MLVX01000038",97.647,3.29e-34,147,85,82.99995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_JAMKRA010000075",97.647,3.29e-34,147,85,82.99995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_JAMKQZ010000090",97.647,3.29e-34,147,85,82.99995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3525","NZ_JAMKTM010000045",97.647,3.29e-34,147,85,82.99995,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_JAMKRA010000075",87.023,5.8e-34,147,131,114.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_JAMKQZ010000090",87.023,5.8e-34,147,131,114.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_JAMKTM010000045",87.023,5.8e-34,147,131,114.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLSZ01000019",86.131,6.14e-34,147,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLSN01000023",86.131,6.14e-34,147,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5220","NZ_MLVX01000038",86.131,6.14e-34,147,137,117.99947,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLSZ01000019",85.417,2.37e-33,145,144,123.00048,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLSN01000023",85.417,2.37e-33,145,144,123.00048,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_MLVX01000038",85.417,2.37e-33,145,144,123.00048,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_JAMKRA010000075",85.417,2.37e-33,145,144,123.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_JAMKQZ010000090",85.417,2.37e-33,145,144,123.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_43069","NZ_JAMKTM010000045",85.417,2.37e-33,145,144,123.00048,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_JAMKRA010000075",87.023,2.09e-33,145,131,114.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_JAMKTM010000045",87.023,2.09e-33,145,131,114.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLSZ01000019",88.43,2.47e-33,145,121,107.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLSN01000023",88.43,2.47e-33,145,121,107.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_26720","NZ_MLVX01000038",88.43,2.47e-33,145,121,107.0003,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4761","NZ_JAMKRA010000075",84,8.81e-33,143,150,126,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4761","NZ_JAMKQZ010000090",84,8.81e-33,143,150,126,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4761","NZ_JAMKTM010000045",84,8.81e-33,143,150,126,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_MLVX01000038",96.512,6.71e-33,143,86,83.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_JAMKRA010000075",96.512,6.71e-33,143,86,83.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_71297","NZ_JAMKTM010000045",96.512,6.71e-33,143,86,83.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_MLVX01000038",87.023,8.81e-33,143,131,114.00013,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_JAMKRA010000075",87.023,8.81e-33,143,131,114.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11835","NZ_JAMKTM010000045",87.023,8.81e-33,143,131,114.00013,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLSZ01000019",85.401,8.88e-33,143,137,116.99937,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLSN01000023",85.401,8.88e-33,143,137,116.99937,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_MLVX01000038",85.401,8.88e-33,143,137,116.99937,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_JAMKRA010000075",85,8.88e-33,143,140,119,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_JAMKQZ010000090",85,8.88e-33,143,140,119,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64075","NZ_JAMKTM010000045",85,8.88e-33,143,140,119,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLSZ01000019",85.401,8.88e-33,143,137,116.99937,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLSN01000023",85.401,8.88e-33,143,137,116.99937,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_MLVX01000038",85.401,8.88e-33,143,137,116.99937,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_JAMKRA010000075",84,8.81e-33,143,150,126,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_JAMKQZ010000090",84,8.81e-33,143,150,126,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_JAMKTM010000045",84,8.81e-33,143,150,126,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLSZ01000019",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLSN01000023",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_MLVX01000038",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_JAMKRA010000075",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_JAMKQZ010000090",84.138,3.17e-32,141,145,122.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30760","NZ_JAMKTM010000045",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLSZ01000019",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLSN01000023",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_MLVX01000038",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_JAMKRA010000075",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_JAMKQZ010000090",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30761","NZ_JAMKTM010000045",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLSZ01000019",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLSN01000023",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_MLVX01000038",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_JAMKRA010000075",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_JAMKQZ010000090",84.138,3.17e-32,141,145,122.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30762","NZ_JAMKTM010000045",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLSZ01000019",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLSN01000023",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_MLVX01000038",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_JAMKRA010000075",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_JAMKQZ010000090",84.138,3.17e-32,141,145,122.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30763","NZ_JAMKTM010000045",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLSZ01000019",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLSN01000023",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_MLVX01000038",86.614,3.17e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_JAMKRA010000075",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_JAMKQZ010000090",84.138,3.17e-32,141,145,122.0001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_30764","NZ_JAMKTM010000045",86.614,3.17e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSZ01000019",86.614,3.04e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLSN01000023",86.614,3.04e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_MLVX01000038",86.614,3.04e-32,141,127,109.99978,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JAMKRA010000075",86.614,3.04e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JAMKQZ010000090",86.614,3.04e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_27204","NZ_JAMKTM010000045",86.614,3.04e-32,141,127,109.99978,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLSZ01000019",85.211,3.14e-32,141,142,120.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLSN01000023",85.211,3.14e-32,141,142,120.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_MLVX01000038",85.211,3.14e-32,141,142,120.99962,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_JAMKRA010000075",85.211,3.14e-32,141,142,120.99962,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_JAMKQZ010000090",85.211,3.14e-32,141,142,120.99962,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9285","NZ_JAMKTM010000045",85.211,3.14e-32,141,142,120.99962,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLSZ01000019",86.154,9.71e-32,139,130,112.0002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLSN01000023",86.154,9.71e-32,139,130,112.0002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15549","NZ_MLVX01000038",86.154,9.71e-32,139,130,112.0002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLSZ01000019",86.26,9.71e-32,139,131,113.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLSN01000023",86.26,9.71e-32,139,131,113.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28205","NZ_MLVX01000038",86.26,9.71e-32,139,131,113.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLSZ01000019",83.333,4.1e-31,137,150,124.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLSN01000023",83.333,4.1e-31,137,150,124.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4759","NZ_MLVX01000038",83.333,4.1e-31,137,150,124.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_MLVX01000038",86.26,4.1e-31,137,131,113.0006,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_JAMKRA010000075",86.26,4.1e-31,137,131,113.0006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES01RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_11836","NZ_JAMKTM010000045",86.26,4.1e-31,137,131,113.0006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_JAMKRA010000075",84.286,4.13e-31,137,140,118.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_JAMKQZ010000090",84.286,4.13e-31,137,140,118.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64072","NZ_JAMKTM010000045",84.286,4.13e-31,137,140,118.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_JAMKRA010000075",84.286,4.13e-31,137,140,118.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_JAMKQZ010000090",84.286,4.13e-31,137,140,118.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64073","NZ_JAMKTM010000045",84.286,4.13e-31,137,140,118.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLSZ01000019",83.333,4.1e-31,137,150,124.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLSN01000023",83.333,4.1e-31,137,150,124.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5430","NZ_MLVX01000038",83.333,4.1e-31,137,150,124.9995,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLSZ01000019",86.4,4.13e-31,137,125,108,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLSN01000023",86.4,4.13e-31,137,125,108,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_MLVX01000038",86.4,4.13e-31,137,125,108,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_JAMKRA010000075",86.4,4.13e-31,137,125,108,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_JAMKQZ010000090",84.286,4.13e-31,137,140,118.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_19759","NZ_JAMKTM010000045",86.4,4.13e-31,137,125,108,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLSZ01000019",88.496,4.1e-31,137,113,100.00048,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLSN01000023",88.496,4.1e-31,137,113,100.00048,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLSZ01000019",90.476,3.49e-31,137,105,94.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLSN01000023",90.476,3.49e-31,137,105,94.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15548","NZ_MLVX01000038",90.476,3.49e-31,137,105,94.9998,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_JAMKRA010000075",85.496,3.76e-31,137,131,111.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_JAMKQZ010000090",85.496,3.76e-31,137,131,111.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_JAMKTM010000045",85.496,3.76e-31,137,131,111.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLSZ01000019",86.4,4.1e-31,137,125,108,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLSN01000023",86.4,4.1e-31,137,125,108,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_MLVX01000038",86.4,4.1e-31,137,125,108,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_JAMKRA010000075",86.4,4.1e-31,137,125,108,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_JAMKQZ010000090",84.286,4.1e-31,137,140,118.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_19801","NZ_JAMKTM010000045",86.4,4.1e-31,137,125,108,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLSZ01000019",97.5,1.88e-31,137,80,78,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLSN01000023",97.5,1.88e-31,137,80,78,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_MLVX01000038",97.5,1.88e-31,137,80,78,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_JAMKRA010000075",97.5,1.88e-31,137,80,78,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_JAMKQZ010000090",97.5,1.88e-31,137,80,78,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_3894","NZ_JAMKTM010000045",97.5,1.88e-31,137,80,78,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_JAMKRA010000075",84.559,1.49e-30,135,136,115.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_JAMKQZ010000090",84.559,1.49e-30,135,136,115.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64076","NZ_JAMKTM010000045",84.559,1.49e-30,135,136,115.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_JAMKRA010000075",85.496,1.39e-30,135,131,111.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_JAMKQZ010000090",85.496,1.39e-30,135,131,111.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_JAMKTM010000045",85.496,1.39e-30,135,131,111.99976,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLSZ01000019",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLSN01000023",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_MLVX01000038",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_JAMKRA010000075",92.632,9.18e-31,135,95,88.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9098","NZ_JAMKTM010000045",92.632,9.18e-31,135,95,88.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLSZ01000019",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLSN01000023",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_MLVX01000038",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_JAMKRA010000075",92.632,9.18e-31,135,95,88.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_9099","NZ_JAMKTM010000045",92.632,9.18e-31,135,95,88.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLSZ01000019",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLSN01000023",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_MLVX01000038",92.632,9.18e-31,135,95,88.0004,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_JAMKRA010000075",92.632,9.18e-31,135,95,88.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_13905","NZ_JAMKTM010000045",92.632,9.18e-31,135,95,88.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41815","NZ_JAMKRA010000075",83.803,5.13e-30,134,142,119.00026,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41815","NZ_JAMKQZ010000090",83.448,5.13e-30,134,145,120.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES03RB_L6.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41815","NZ_JAMKTM010000045",83.803,5.13e-30,134,142,119.00026,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLSZ01000019",90.909,5.34e-30,134,99,89.99991,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_9151","NZ_MLSN01000023",90.909,5.34e-30,134,99,89.99991,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_JAMKRA010000075",83.571,1.92e-29,132,140,116.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_JAMKQZ010000090",83.571,1.92e-29,132,140,116.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64074","NZ_JAMKTM010000045",83.571,1.92e-29,132,140,116.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLSZ01000019",83.942,1.92e-29,132,137,115.00054,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLSN01000023",83.942,1.92e-29,132,137,115.00054,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_MLVX01000038",83.942,1.92e-29,132,137,115.00054,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_JAMKRA010000075",83.571,1.92e-29,132,140,116.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_JAMKQZ010000090",83.571,1.92e-29,132,140,116.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64078","NZ_JAMKTM010000045",83.571,1.92e-29,132,140,116.9994,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLSZ01000019",82.667,1.91e-29,132,150,124.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLSN01000023",82.667,1.91e-29,132,150,124.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5429","NZ_MLVX01000038",82.667,1.91e-29,132,150,124.0005,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_JAMKRA010000075",87.611,1.91e-29,132,113,99.00043,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_JAMKTM010000045",87.611,1.91e-29,132,113,99.00043,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLSZ01000019",88.182,1.92e-29,132,110,97.0002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLSN01000023",88.182,1.92e-29,132,110,97.0002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLSZ01000019",84.733,1.75e-29,132,131,111.00023,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLSN01000023",84.733,1.75e-29,132,131,111.00023,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_28255","NZ_MLVX01000038",84.733,1.75e-29,132,131,111.00023,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLSZ01000019",83.333,1.91e-29,132,144,119.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLSN01000023",83.333,1.91e-29,132,144,119.99952,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLSZ01000019",84.733,6.46e-29,130,131,111.00023,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLSN01000023",84.733,6.46e-29,130,131,111.00023,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21114","NZ_MLVX01000038",84.733,6.46e-29,130,131,111.00023,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_MLVX01000038",83.217,6.86e-29,130,143,119.00031,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_JAMKRA010000075",84.733,2.3e-28,128,131,111.00023,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_JAMKQZ010000090",84.733,2.3e-28,128,131,111.00023,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_JAMKTM010000045",84.733,2.3e-28,128,131,111.00023,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_MLVX01000038",94.048,1.17e-28,128,84,79.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_JAMKRA010000075",94.048,1.17e-28,128,84,79.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_28387","NZ_JAMKTM010000045",94.048,1.17e-28,128,84,79.00032,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLSZ01000019",96.154,1.05e-28,128,78,75.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLSN01000023",96.154,1.05e-28,128,78,75.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_MLVX01000038",96.154,1.05e-28,128,78,75.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_JAMKRA010000075",96.154,1.05e-28,128,78,75.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_JAMKQZ010000090",96.154,1.05e-28,128,78,75.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3621","NZ_JAMKTM010000045",96.154,1.05e-28,128,78,75.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLSZ01000019",83.099,2.49e-28,128,142,118.00058,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLSN01000023",83.099,2.49e-28,128,142,118.00058,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_MLVX01000038",83.099,2.49e-28,128,142,118.00058,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLSZ01000019",89.216,2.49e-28,128,102,91.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLSN01000023",89.216,2.49e-28,128,102,91.00032,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_JAMKRA010000075",82.857,8.94e-28,126,140,115.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_JAMKQZ010000090",82.857,8.94e-28,126,140,115.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_64077","NZ_JAMKTM010000045",82.857,8.94e-28,126,140,115.9998,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_15120","NZ_MLVX01000038",86.726,8.87e-28,126,113,98.00038,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_JAMKRA010000075",87.273,8.94e-28,126,110,96.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_JAMKTM010000045",87.273,8.94e-28,126,110,96.0003,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLSZ01000019",88.571,8.87e-28,126,105,92.99955,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLSN01000023",88.571,8.87e-28,126,105,92.99955,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_MLVX01000038",88.571,8.87e-28,126,105,92.99955,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_JAMKRA010000075",88.571,8.87e-28,126,105,92.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_JAMKQZ010000090",88.571,8.87e-28,126,105,92.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT07RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14608","NZ_JAMKTM010000045",88.571,8.87e-28,126,105,92.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_JAMKRA010000075",84.921,8.87e-28,126,126,107.00046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_JAMKQZ010000090",84.091,8.87e-28,126,132,111.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_6988","NZ_JAMKTM010000045",84.921,8.87e-28,126,126,107.00046,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLSZ01000019",83.969,1.07e-26,122,131,109.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLSN01000023",83.969,1.07e-26,122,131,109.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_21113","NZ_MLVX01000038",83.969,1.07e-26,122,131,109.99939,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_JAMKRA010000075",88.235,1.16e-26,122,102,89.9997,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_JAMKTM010000045",88.235,1.16e-26,122,102,89.9997,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24863","NZ_JAMKRA010000075",81.579,4.13e-26,121,152,124.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24863","NZ_JAMKQZ010000090",81.879,4.13e-26,121,149,121.99971,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24863","NZ_JAMKTM010000045",81.579,4.13e-26,121,152,124.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24865","NZ_JAMKRA010000075",81.579,4.13e-26,121,152,124.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24865","NZ_JAMKQZ010000090",81.879,4.13e-26,121,149,121.99971,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24865","NZ_JAMKTM010000045",81.579,4.13e-26,121,152,124.00008,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27573","NZ_JAMKRA010000075",81.633,4.13e-26,121,147,120.00051,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27573","NZ_JAMKQZ010000090",83.206,4.13e-26,121,131,108.99986,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT05RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_27573","NZ_JAMKTM010000045",81.633,4.13e-26,121,147,120.00051,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLSZ01000019",94.737,6.33e-26,119,76,72.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLSN01000023",94.737,6.33e-26,119,76,72.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_MLVX01000038",94.737,6.33e-26,119,76,72.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_JAMKRA010000075",94.737,6.33e-26,119,76,72.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_3322","NZ_JAMKTM010000045",94.737,6.33e-26,119,76,72.00012,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_JAMKRA010000075",92.683,2.45e-25,117,82,76.00006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_JAMKQZ010000090",92.683,2.45e-25,117,82,76.00006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_JAMKTM010000045",92.683,2.45e-25,117,82,76.00006,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2015","NZ_MLVX01000038",87.255,5.38e-25,117,102,89.0001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24861","NZ_JAMKRA010000075",80.921,1.92e-24,115,152,122.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24861","NZ_JAMKQZ010000090",81.208,1.92e-24,115,149,120.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24861","NZ_JAMKTM010000045",80.921,1.92e-24,115,152,122.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24862","NZ_JAMKRA010000075",80.921,1.92e-24,115,152,122.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24862","NZ_JAMKQZ010000090",81.208,1.92e-24,115,149,120.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24862","NZ_JAMKTM010000045",80.921,1.92e-24,115,152,122.99992,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24864","NZ_JAMKRA010000075",80.795,1.92e-24,115,151,122.00045,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24864","NZ_JAMKQZ010000090",81.081,1.92e-24,115,148,119.99988,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_24864","NZ_JAMKTM010000045",80.795,1.92e-24,115,151,122.00045,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1639","NZ_MLVX01000038",85.714,1.94e-24,115,112,95.99968,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_JAMKRA010000075",92.5,1.04e-24,115,80,74,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_JAMKQZ010000090",92.5,1.04e-24,115,80,74,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_JAMKTM010000045",92.5,1.04e-24,115,80,74,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7225","NZ_MLVX01000038",80.519,6.96e-24,113,154,123.99926,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_JAMKRA010000075",84.615,5.04e-24,113,117,98.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_JAMKQZ010000090",84.615,5.04e-24,113,117,98.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_JAMKTM010000045",84.615,5.04e-24,113,117,98.99955,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLSZ01000019",92.308,2.5e-23,111,78,72.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLSN01000023",92.308,2.5e-23,111,78,72.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_MLVX01000038",92.308,2.5e-23,111,78,72.00024,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_JAMKRA010000075",92.308,2.5e-23,111,78,72.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_JAMKQZ010000090",92.308,2.5e-23,111,78,72.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_10623","NZ_JAMKTM010000045",92.308,2.5e-23,111,78,72.00024,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14628","NZ_JAMKRA010000075",80.69,2.48e-23,111,145,117.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14628","NZ_JAMKQZ010000090",80.69,2.48e-23,111,145,117.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14628","NZ_JAMKTM010000045",80.69,2.48e-23,111,145,117.0005,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLSZ01000019",91.25,4.83e-23,110,80,73,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLSN01000023",91.25,4.83e-23,110,80,73,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_16521","NZ_MLVX01000038",91.25,4.83e-23,110,80,73,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14629","NZ_JAMKRA010000075",80.556,8.93e-23,110,144,116.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14629","NZ_JAMKQZ010000090",80.556,8.93e-23,110,144,116.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_14629","NZ_JAMKTM010000045",80.556,8.93e-23,110,144,116.00064,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_JAMKRA010000075",82.54,9.01e-23,110,126,104.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_JAMKQZ010000090",82.54,9.01e-23,110,126,104.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_7936","NZ_JAMKTM010000045",82.54,9.01e-23,110,126,104.0004,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLSZ01000019",83.761,2.34e-22,108,117,98.00037,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLSN01000023",83.761,2.34e-22,108,117,98.00037,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_4154","NZ_MLVX01000038",83.761,2.34e-22,108,117,98.00037,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLSZ01000019",96.875,1.24e-22,108,64,62,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLSN01000023",96.875,1.24e-22,108,64,62,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_MLVX01000038",96.875,1.24e-22,108,64,62,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_JAMKRA010000075",96.875,1.24e-22,108,64,62,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_JAMKQZ010000090",96.875,1.24e-22,108,64,62,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT09RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2616","NZ_JAMKTM010000045",96.875,1.24e-22,108,64,62,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_MLVX01000038",94.203,6.35e-22,106,69,65.00007,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_JAMKRA010000075",94.203,6.35e-22,106,69,65.00007,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_1966","NZ_JAMKTM010000045",94.203,6.35e-22,106,69,65.00007,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLSZ01000019",79.605,4.19e-21,104,152,120.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLSN01000023",79.605,4.19e-21,104,152,120.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_MLVX01000038",79.605,4.19e-21,104,152,120.9996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_JAMKRA010000075",79.605,4.19e-21,104,152,120.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_JAMKQZ010000090",79.866,4.19e-21,104,149,119.00034,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45678","NZ_JAMKTM010000045",79.605,4.19e-21,104,152,120.9996,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_MLVX01000038",84.259,1.49e-20,102,108,90.99972,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_JAMKRA010000075",84.112,5.38e-20,100,107,89.99984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT04RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_17203","NZ_JAMKTM010000045",84.112,5.38e-20,100,107,89.99984,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLSZ01000019",78.947,1.95e-19,99,152,119.99944,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLSN01000023",78.947,1.95e-19,99,152,119.99944,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_MLVX01000038",78.947,1.95e-19,99,152,119.99944,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_JAMKRA010000075",78.947,1.95e-19,99,152,119.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_JAMKQZ010000090",79.195,1.95e-19,99,149,118.00055,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES05RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_45677","NZ_JAMKTM010000045",78.947,1.95e-19,99,152,119.99944,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLSZ01000019",95,2.8e-18,93.5,60,57,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLSN01000023",95,2.8e-18,93.5,60,57,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_MLVX01000038",95,2.8e-18,93.5,60,57,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_JAMKRA010000075",95,2.8e-18,93.5,60,57,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_JAMKQZ010000090",95,2.8e-18,93.5,60,57,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_16425","NZ_JAMKTM010000045",95,2.8e-18,93.5,60,57,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLSZ01000019",95,2.8e-18,93.5,60,57,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLSN01000023",95,2.8e-18,93.5,60,57,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_MLVX01000038",95,2.8e-18,93.5,60,57,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_JAMKRA010000075",95,2.8e-18,93.5,60,57,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_JAMKQZ010000090",95,2.8e-18,93.5,60,57,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"ES02RT.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_41186","NZ_JAMKTM010000045",95,2.8e-18,93.5,60,57,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLSZ01000019",86.747,1.49e-17,91.6,83,72.00001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLSN01000023",86.747,1.49e-17,91.6,83,72.00001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_MLVX01000038",86.747,1.49e-17,91.6,83,72.00001,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_JAMKRA010000075",86.747,1.49e-17,91.6,83,72.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2247","NZ_JAMKTM010000045",86.747,1.49e-17,91.6,83,72.00001,"Streptococcus mitis","Oral cancer inhibition","Competitive inhibition of pathogenic bacteria (potential protective)","Experimental Strong","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLSZ01000019",85.366,6.91e-16,86.1,82,70.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLSN01000023",85.366,6.91e-16,86.1,82,70.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT08RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_2053","NZ_MLVX01000038",85.366,6.91e-16,86.1,82,70.00012,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLSZ01000019",90.476,5.46e-15,84.2,63,56.99988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"ES02RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_7298","NZ_MLSN01000023",90.476,5.46e-15,84.2,63,56.99988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLSZ01000019",90.476,5.41e-15,84.2,63,56.99988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT07RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_12231","NZ_MLSN01000023",90.476,5.41e-15,84.2,63,56.99988,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLSZ01000019",100,4.22e-11,71.3,38,38,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5685","NZ_MLSN01000023",100,4.22e-11,71.3,38,38,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLSZ01000019",100,4.22e-11,71.3,38,38,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT04RT.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_5686","NZ_MLSN01000023",100,4.22e-11,71.3,38,38,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLSZ01000019",95.349,1.53e-10,69.4,43,41.00007,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4070","NZ_MLSN01000023",95.349,1.53e-10,69.4,43,41.00007,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLSZ01000019",95.238,5.5e-10,67.6,42,39.99996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_1_classified_bact_90pct_coverage_filtered_hits","contig_4069","NZ_MLSN01000023",95.238,5.5e-10,67.6,42,39.99996,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLSZ01000019",95.122,1.96e-09,65.8,41,39.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
"HT06RB.unmapped_2_classified_bact_90pct_coverage_filtered_hits","contig_5940","NZ_MLSN01000023",95.122,1.96e-09,65.8,41,39.00002,"Stenotrophomonas maltophilia","Emerging lung cancer; Nosocomial cancer infections","Multidrug resistance; chronic pulmonary inflammation","Experimental","4_Experimental","Low"
